[
    {
        "realidx": 0,
        "question": "A junior orthopaedic surgery resident is completing a carpal tunnel repair with the department chairman as the attending physician. During the case, the resident inadvertently cuts a flexor tendon. The tendon is repaired without complication. The attending tells the resident that the patient will do fine, and there is no need to report this minor complication that will not harm the patient, as he does not want to make the patient worry unnecessarily. He tells the resident to leave this complication out of the operative report. Which of the following is the correct next action for the resident to take?",
        "answer": "Tell the attending that he cannot fail to disclose this mistake",
        "options": {
            "A": "Disclose the error to the patient and put it in the operative report",
            "B": "Tell the attending that he cannot fail to disclose this mistake",
            "C": "Report the physician to the ethics committee",
            "D": "Refuse to dictate the operative report"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "junior orthopaedic surgery resident",
            "completing",
            "carpal tunnel repair",
            "department chairman",
            "attending physician",
            "case",
            "resident",
            "cuts",
            "flexor tendon",
            "tendon",
            "repaired",
            "complication",
            "attending",
            "resident",
            "patient",
            "fine",
            "need to report",
            "minor complication",
            "not",
            "patient",
            "not",
            "to make",
            "patient worry",
            "resident to leave",
            "complication out",
            "operative report",
            "following",
            "correct next action",
            "resident to take"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4326,
            "completion_tokens": 2763
        },
        "time_elapsed": 22.2191641330719,
        "raw_responses": [
            "Step 1: Recognize that errors, regardless of their size, must be fully documented in operative reports and disclosed to the patient when appropriate. Like in the provided examples, ethical practice in medicine requires transparency in disclosing complications so that patients are properly informed and trust is maintained.\n\nStep 2: Evaluate the options:\n\u2022 Option A: Disclose the error to the patient and put it in the operative report. This is consistent with ethical guidelines and proper documentation practices.\n\u2022 Option B: Telling the attending \u201cyou cannot fail to disclose\u201d may be important, but it does not address the resident\u2019s responsibility to ensure full disclosure in the medical record and to the patient.\n\u2022 Option C: Reporting the physician to the ethics committee is an extreme measure for an isolated, correctable error that was already repaired.\n\u2022 Option D: Refusing to dictate the operative report does not directly address the ethical duty to document the event.\n\nStep 3: The best course of action is Option A, as it involves both disclosing the error to the patient and properly documenting it in the operative report.\n\nFinal answer: A. Disclose the error to the patient and put it in the operative report.",
            "Step 1: From the examples provided, note that the correct answers are those that adhere to ethical standards and the best practices in patient care.\n\nStep 2: In this scenario, the resident is instructed by the attending to omit a complication from the operative report, which would result in withholding information from the patient. Ethically and professionally, the resident is bound by the duty to be truthful to the patient, as well as to accurately document the course of the surgery. Disclosure of all intraoperative events is essential for patient safety, trust, and future care.\n\nStep 3: Among the options provided, the correct ethical and professional action is to be transparent with the patient and document the complication. This corresponds with:\n\nA. Disclose the error to the patient and put it in the operative report\n\nThus, the final answer is: A. Disclose the error to the patient and put it in the operative report.",
            "Step 1: Recognize that the ethical principles of transparency and honesty in medicine mandate that errors, even minor ones, be documented and disclosed to the patient. This aligns with the examples, particularly Example 1 where proper steps in management (even in pregnancy) involve correct treatment documentation, and the overriding principle of patient welfare.\n\nStep 2: Evaluate the options:\n\u2022 Option A (Disclose the error to the patient and put it in the operative report) is consistent with ethical and professional standards. Even if the error was minor and repaired without harm, it must be documented and discussed with the patient.\n\u2022 Option B (Tell the attending that he cannot fail to disclose this mistake) is a statement of principle but does not resolve the ethical dilemma on its own as it does not specify the required action of documentation and disclosure.\n\u2022 Option C (Report the physician to the ethics committee) is an extreme step and not the immediate next action. Handling the situation should start with transparency, not immediate escalation.\n\u2022 Option D (Refuse to dictate the operative report) is not appropriate since it does not address the error\u2019s disclosure and documentation as required ethically.\n\nStep 3: Thus, the correct response is to disclose the error to the patient and include it in the operative report.\n\nFinal Answer: A. Disclose the error to the patient and put it in the operative report."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Recognize that the ethical principles of transparency and honesty in medicine mandate that errors, even minor ones, be documented and disclosed to the patient. This aligns with the examples, particularly Example 1 where proper steps in management (even in pregnancy) involve correct treatment documentation, and the overriding principle of patient welfare.\n\nStep 2: Evaluate the options:\n\u2022 Option A (Disclose the error to the patient and put it in the operative report) is consistent with ethical and professional standards. Even if the error was minor and repaired without harm, it must be documented and discussed with the patient.\n\u2022 Option B (Tell the attending that he cannot fail to disclose this mistake) is a statement of principle but does not resolve the ethical dilemma on its own as it does not specify the required action of documentation and disclosure.\n\u2022 Option C (Report the physician to the ethics committee) is an extreme step and not the immediate next action. Handling the situation should start with transparency, not immediate escalation.\n\u2022 Option D (Refuse to dictate the operative report) is not appropriate since it does not address the error\u2019s disclosure and documentation as required ethically.\n\nStep 3: Thus, the correct response is to disclose the error to the patient and include it in the operative report.\n\nFinal Answer: A. Disclose the error to the patient and put it in the operative report."
    },
    {
        "realidx": 5,
        "question": "A 39-year-old man presents to the emergency department because of progressively worsening chest pain and nausea that started at a local bar 30 minutes prior. The pain radiates to the epigastric area. He has a 5-year history of untreated hypertension. He has smoked 1 pack of cigarettes daily for the past 5 years and started abusing cocaine 2 weeks before his emergency room visit. The patient is diaphoretic and in marked distress. What should be the first step in management?",
        "answer": "Reassurance and continuous monitoring",
        "options": {
            "A": "Diltiazem",
            "B": "Labetalol",
            "C": "Propranolol",
            "D": "Reassurance and continuous monitoring"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man presents",
            "emergency department",
            "worsening chest pain",
            "nausea",
            "started",
            "local",
            "30 minutes prior",
            "pain radiates",
            "epigastric area",
            "5 year history of untreated hypertension",
            "smoked 1 pack",
            "cigarettes daily",
            "past",
            "years",
            "started abusing cocaine 2 weeks",
            "emergency room visit",
            "patient",
            "diaphoretic",
            "marked distress",
            "first step",
            "management"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 3942,
            "completion_tokens": 4775
        },
        "time_elapsed": 35.26388216018677,
        "raw_responses": [
            "Step 1: Recognize that the patient\u2019s symptoms (chest pain radiating to the epigastric region, nausea, diaphoresis) and history of cocaine use raise suspicion for cocaine-induced coronary vasospasm leading to chest pain.\n\nStep 2: Understand that in the setting of cocaine-induced chest pain, beta-blockers (both non-selective ones like propranolol and those with mixed effects like labetalol) are contraindicated. This is because they can lead to unopposed alpha-adrenergic stimulation, worsening coronary vasospasm.\n\nStep 3: Since reassurance and monitoring alone would be insufficient for acute management, the best option among the choices is a calcium channel blocker (diltiazem), which can help alleviate vasospasm.\n\nFinal Answer: A: Diltiazem",
            "Step 1. Key information: The patient is a 39-year-old man with chest pain, nausea, and a recent history of cocaine abuse. Cocaine increases sympathetic activity and can lead to coronary vasospasm, so managing his symptoms requires caution regarding the use of beta blockers.\n\nStep 2. Analyze the options:\n\u2022 Diltiazem \u2013 A calcium channel blocker that helps relieve coronary vasospasm without the risk of unopposed \u03b1 stimulation.\n\u2022 Labetalol \u2013 Although it blocks both \u03b1- and \u03b2-receptors, its use in cocaine-induced chest pain is controversial and generally avoided.\n\u2022 Propranolol \u2013 A pure \u03b2-blocker and contraindicated because it may worsen vasospasm due to unopposed \u03b1-adrenergic effects.\n\u2022 Reassurance and continuous monitoring \u2013 Too conservative in the setting of cocaine-induced chest pain with signs of distress.\n\nStep 3. Final answer: A: Diltiazem.",
            "Step 1: Recognize that the patient\u2019s chest pain is in the setting of recent cocaine use. Cocaine can cause coronary vasospasm and significant sympathetic stimulation, which increases the risk for myocardial ischemia.\n\nStep 2: Understand that standard management of cocaine-induced chest pain emphasizes using agents that reduce sympathetic stimulation without provoking unopposed alpha-adrenergic effects. Benzodiazepines and nitrates are typically first-line treatments, but among the given options, we must select an appropriate agent.\n\nStep 3: Evaluate the answer choices:\n\u2022 Option A, Diltiazem, is a calcium channel blocker. It helps alleviate coronary vasospasm without interfering with the sympathetic balance and is safe to use in the setting of cocaine use.\n\u2022 Option B, Labetalol, is an alpha- and beta-blocker; however, even though it blocks both receptors, its safety in cocaine chest pain is controversial.\n\u2022 Option C, Propranolol, is a non-selective beta-blocker and can lead to unopposed alpha stimulation, worsening coronary vasospasm, and is contraindicated.\n\u2022 Option D, Reassurance and continuous monitoring, is inadequate given the severity of his symptoms.\n\nFinal Answer: A. Diltiazem"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "1"
        ],
        "final_solution": "Step 1. Key information: The patient is a 39-year-old man with chest pain, nausea, and a recent history of cocaine abuse. Cocaine increases sympathetic activity and can lead to coronary vasospasm, so managing his symptoms requires caution regarding the use of beta blockers.\n\nStep 2. Analyze the options:\n\u2022 Diltiazem \u2013 A calcium channel blocker that helps relieve coronary vasospasm without the risk of unopposed \u03b1 stimulation.\n\u2022 Labetalol \u2013 Although it blocks both \u03b1- and \u03b2-receptors, its use in cocaine-induced chest pain is controversial and generally avoided.\n\u2022 Propranolol \u2013 A pure \u03b2-blocker and contraindicated because it may worsen vasospasm due to unopposed \u03b1-adrenergic effects.\n\u2022 Reassurance and continuous monitoring \u2013 Too conservative in the setting of cocaine-induced chest pain with signs of distress.\n\nStep 3. Final answer: A: Diltiazem."
    },
    {
        "realidx": 6,
        "question": "A 68-year-old male comes to the physician for evaluation of right flank pain. He has a history of diabetes and peripheral artery disease. His blood pressure is 160/90 mm Hg. Physical examination shows abdominal tenderness and right flank tenderness. An ultrasound shows dilation of the right ureter and renal pelvis. Which of the following is the most likely underlying cause of this patient's condition?",
        "answer": "Common iliac artery aneurysm",
        "options": {
            "A": "Renal artery stenosis",
            "B": "Benign prostatic hyperplasia",
            "C": "Common iliac artery aneurysm",
            "D": "Urethral stricture"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "68 year old male",
            "physician",
            "evaluation",
            "right flank pain",
            "history",
            "diabetes",
            "peripheral artery disease",
            "blood pressure",
            "90 mm Hg",
            "Physical examination shows abdominal tenderness",
            "right",
            "ultrasound shows dilation of",
            "right ureter",
            "renal pelvis",
            "following",
            "most likely underlying cause",
            "patient's condition"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4797,
            "completion_tokens": 4356
        },
        "time_elapsed": 33.90142250061035,
        "raw_responses": [
            "Step 1: Analyze the patient's presentation.  \n\u2022 The patient is an elderly male with vascular disease (diabetes and peripheral artery disease) and hypertension, which are risk factors for atherosclerotic aneurysms.  \n\u2022 He presents with right flank pain and imaging that shows dilation of the right ureter and renal pelvis, which suggests obstruction of urine flow (hydronephrosis).\n\nStep 2: Evaluate the answer choices.  \nA. Renal artery stenosis \u2013 This typically affects the renal blood supply and is associated with refractory hypertension and impaired renal function, but it does not cause ureteral dilation.  \nB. Benign prostatic hyperplasia \u2013 While BPH can cause urinary retention and eventually hydronephrosis, it generally leads to bilateral hydronephrosis and is more consistently associated with lower urinary tract symptoms.  \nC. Common iliac artery aneurysm \u2013 In an elderly patient with atherosclerotic risk factors, an aneurysm in the iliac artery can develop and may externally compress the ureter, leading to unilateral obstruction and hydronephrosis.  \nD. Urethral stricture \u2013 This condition can cause urinary obstruction, but it usually presents with lower urinary tract symptoms and would more likely lead to a more generalized, not unilateral, dilation of the urinary system.\n\nStep 3: Compare and eliminate incorrect choices.  \n\u2022 Renal artery stenosis does not explain the dilation of the ureter and renal pelvis.  \n\u2022 BPH is a plausible cause of urinary obstruction in older men, but it tends to produce bilateral hydronephrosis and lower urinary tract symptoms.  \n\u2022 Urethral stricture typically causes more diffuse issues and again is more common to affect the entire urinary outlet.  \n\u2022 A common iliac artery aneurysm, given the patient\u2019s vascular disease history, can compress the ureter externally, perfectly explaining unilateral dilation (hydronephrosis) observed on the ultrasound.\n\nFinal Answer: C. Common iliac artery aneurysm",
            "Step 1: Gather key details.\n\u2022 The patient is a 68\u2010year\u2010old male with a history of diabetes and peripheral artery disease.\n\u2022 He presents with right flank pain and physical exam reveals right flank and abdominal tenderness.\n\u2022 Ultrasound findings show dilation of the right ureter and renal pelvis (hydronephrosis), indicating an obstruction along the urinary tract.\n\nStep 2: Evaluate each option.\nA. Renal artery stenosis \u2013 This condition affects blood flow to the kidney and typically does not cause hydronephrosis.\nB. Benign prostatic hyperplasia \u2013 While common in older men and capable of causing bladder outlet obstruction with resultant hydronephrosis, the obstruction from BPH tends to be bilateral rather than isolated to the right ureter.\nC. Common iliac artery aneurysm \u2013 Patients with peripheral vascular disease are at risk for atherosclerotic aneurysms. An aneurysm of the common iliac artery can externally compress the ureter, leading to unilateral hydronephrosis.\nD. Urethral stricture \u2013 A urethral stricture would more likely affect the bladder outlet and typically lead to bilateral changes, not isolated unilateral ureter dilation.\n\nStep 3: Conclusion.\nGiven the patient\u2019s vascular history and the unilateral hydronephrosis noted on ultrasound, external compression of the right ureter by a common iliac artery aneurysm is the most likely cause of his condition.\n\nFinal answer: C. Common iliac artery aneurysm",
            "Step 1: Analyze the patient's presentation. A 68-year-old male with diabetes, peripheral artery disease, and hypertension has right flank and abdominal tenderness. Ultrasound findings show dilation of the right ureter and renal pelvis, indicating an obstruction in the urinary tract.\n\nStep 2: Evaluate the options:\n\u2022 Renal artery stenosis typically leads to hypertension and renal ischemia but does not cause ureteral dilation.\n\u2022 Benign prostatic hyperplasia (BPH) can cause urinary obstruction; however, it usually presents with lower urinary tract symptoms and tends to cause bilateral rather than unilateral hydronephrosis.\n\u2022 Common iliac artery aneurysm, which is possible given the patient\u2019s vascular risk factors, can externally compress the ureter, thereby causing unilateral dilation of the ureter and renal pelvis.\n\u2022 Urethral stricture also causes urinary obstruction, but like BPH, it would more likely lead to bilateral hydronephrosis and is less consistent with the patient\u2019s vascular disease and unilateral findings.\n\nStep 3: The most likely cause of the imaging findings given the patient's history and unilateral involvement is external compression from a common iliac artery aneurysm.\n\nFinal Answer: C. Common iliac artery aneurysm"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Gather key details.\n\u2022 The patient is a 68\u2010year\u2010old male with a history of diabetes and peripheral artery disease.\n\u2022 He presents with right flank pain and physical exam reveals right flank and abdominal tenderness.\n\u2022 Ultrasound findings show dilation of the right ureter and renal pelvis (hydronephrosis), indicating an obstruction along the urinary tract.\n\nStep 2: Evaluate each option.\nA. Renal artery stenosis \u2013 This condition affects blood flow to the kidney and typically does not cause hydronephrosis.\nB. Benign prostatic hyperplasia \u2013 While common in older men and capable of causing bladder outlet obstruction with resultant hydronephrosis, the obstruction from BPH tends to be bilateral rather than isolated to the right ureter.\nC. Common iliac artery aneurysm \u2013 Patients with peripheral vascular disease are at risk for atherosclerotic aneurysms. An aneurysm of the common iliac artery can externally compress the ureter, leading to unilateral hydronephrosis.\nD. Urethral stricture \u2013 A urethral stricture would more likely affect the bladder outlet and typically lead to bilateral changes, not isolated unilateral ureter dilation.\n\nStep 3: Conclusion.\nGiven the patient\u2019s vascular history and the unilateral hydronephrosis noted on ultrasound, external compression of the right ureter by a common iliac artery aneurysm is the most likely cause of his condition.\n\nFinal answer: C. Common iliac artery aneurysm"
    },
    {
        "realidx": 33,
        "question": "An otherwise healthy 50-year-old man comes to the physician because of a 6-month history of increasingly frequent episodes of upper abdominal pain, nausea, vomiting, and diarrhea. He has had a 3.2-kg (7-lb) weight loss during this time. Physical examination shows bilateral pitting pedal edema. An endoscopy shows prominent rugae in the gastric fundus. Biopsy shows parietal cell atrophy. Which of the following is the most likely underlying cause?",
        "answer": "Proliferation of gastric mucus-producing cells",
        "options": {
            "A": "Serotonin-secreting gastric tumor",
            "B": "Proliferation of gastric mucus-producing cells",
            "C": "Excessive somatostatin secretion",
            "D": "Ectopic secretion of gastrin"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "healthy 50 year old man",
            "physician",
            "of",
            "month history",
            "frequent episodes",
            "upper abdominal pain",
            "nausea",
            "vomiting",
            "diarrhea",
            "3.2 kg",
            "weight loss",
            "time",
            "Physical examination shows bilateral pitting pedal edema",
            "endoscopy shows prominent rugae",
            "gastric",
            "Biopsy shows parietal cell atrophy",
            "following",
            "most likely underlying cause"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5250,
            "completion_tokens": 4257
        },
        "time_elapsed": 31.95798683166504,
        "raw_responses": [
            "Step 1: Identify key clinical findings. The 50-year-old man has:\n\u2022 6 months of upper abdominal pain, nausea, vomiting, diarrhea, and weight loss.\n\u2022 Bilateral pitting pedal edema, suggesting hypoalbuminemia.\n\u2022 Endoscopy revealing prominent rugae in the gastric fundus.\n\u2022 Biopsy demonstrating parietal cell atrophy.\n\nStep 2: Recognize the disease process. The combination of enlarged (giant) gastric rugae, protein loss (manifesting as edema), and parietal cell atrophy is highly indicative of M\u00e9n\u00e9trier disease. In this condition, there is hypertrophy of the mucus-producing (foveolar) cells in the stomach and an associated atrophy of parietal cells, which leads to decreased acid secretion and subsequent gastrointestinal symptoms.\n\nStep 3: Eliminate incorrect choices.\n\u2022 A. Serotonin-secreting gastric tumor \u2013 This is more consistent with a carcinoid tumor, which does not produce the classic features (giant rugae and parietal cell atrophy) seen in M\u00e9n\u00e9trier disease.\n\u2022 C. Excessive somatostatin secretion \u2013 This does not match the clinical and endoscopic findings and is not associated with parietal cell atrophy.\n\u2022 D. Ectopic secretion of gastrin \u2013 This would be characteristic of Zollinger-Ellison syndrome, which involves increased acid secretion and multiple ulcers, not the features described in this patient.\n\nStep 4: Choose the correct answer.\n\u2022 B. Proliferation of gastric mucus-producing cells \u2013 This is the mechanism underlying M\u00e9n\u00e9trier disease. The proliferation of these cells leads to giant rugae formation, parietal cell atrophy, protein loss, and the patient\u2019s clinical symptoms.\n\nFinal Answer: B",
            "Step 1: Analyze the clinical presentation. The patient is a 50-year-old man with a 6-month history of upper abdominal pain, nausea, vomiting, diarrhea, and unintentional weight loss. He also has bilateral pitting pedal edema, suggesting hypoalbuminemia from a protein-losing state.\n\nStep 2: Evaluate endoscopic and biopsy findings. The endoscopy shows prominent rugae in the gastric fundus\u2014consistent with large, hypertrophic folds. The biopsy reveals parietal cell atrophy, which reduces acid secretion. These findings point toward a state where mucus-producing cells are overgrowing at the expense of acid-secreting parietal cells.\n\nStep 3: Relate the findings to the underlying pathology. The description fits with M\u00e9n\u00e9trier disease, a rare condition characterized by the proliferation of gastric mucus-producing cells (foveolar hyperplasia) and atrophy of the parietal cells. This leads to protein loss, which explains the pedal edema and the weight loss.\n\nStep 4: Eliminate other options:\n\u2022 Option A (Serotonin-secreting gastric tumor) would be more consistent with carcinoid syndrome, which typically presents with flushing and does not cause parietal cell atrophy.\n\u2022 Option C (Excessive somatostatin secretion) is not associated with the fundic mucosal changes described.\n\u2022 Option D (Ectopic secretion of gastrin) would lead to Zollinger-Ellison syndrome, which causes acid hypersecretion and ulcer formation, not the hypoacidic state with parietal cell atrophy described here.\n\nFinal Answer: B. Proliferation of gastric mucus-producing cells",
            "Step 1: Recognize the Clinical Clues\n\u2022 The patient\u2019s symptoms (upper abdominal pain, nausea, vomiting, diarrhea, and weight loss) along with bilateral pitting pedal edema suggest a protein-losing gastropathy.\n\u2022 The endoscopy finding of prominent rugae in the gastric fundus and the biopsy showing parietal cell atrophy are key clues.\n\nStep 2: Correlate Findings with Menetrier Disease\n\u2022 Menetrier disease (giant hypertrophic gastritis) is characterized by enlarged rugal folds in the gastric fundus resulting from proliferation of gastric mucus\u2010producing (foveolar) cells.\n\u2022 The disease leads to atrophy of parietal cells, causing decreased acid production, and results in protein loss from the gastric mucosa, which can present as peripheral edema.\n  \nStep 3: Eliminate Incorrect Options\nA. Serotonin-secreting gastric tumor \u2013 Typically associated with carcinoid syndrome (flushing, diarrhea), but does not produce the characteristic fundic rugal hypertrophy or parietal cell atrophy.\nC. Excessive somatostatin secretion \u2013 Seen in somatostatinomas, which have a different clinical picture and do not cause the described gastric mucosal changes.\nD. Ectopic secretion of gastrin \u2013 This is found in Zollinger-Ellison syndrome, which causes acid hypersecretion and ulcers, rather than parietal cell atrophy and hypertrophied gastric folds.\n\nStep 4: Provide the Final Answer\nThe most likely underlying cause is:\nB. Proliferation of gastric mucus-producing cells"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "1"
        ],
        "final_solution": "Step 1: Identify key clinical findings. The 50-year-old man has:\n\u2022 6 months of upper abdominal pain, nausea, vomiting, diarrhea, and weight loss.\n\u2022 Bilateral pitting pedal edema, suggesting hypoalbuminemia.\n\u2022 Endoscopy revealing prominent rugae in the gastric fundus.\n\u2022 Biopsy demonstrating parietal cell atrophy.\n\nStep 2: Recognize the disease process. The combination of enlarged (giant) gastric rugae, protein loss (manifesting as edema), and parietal cell atrophy is highly indicative of M\u00e9n\u00e9trier disease. In this condition, there is hypertrophy of the mucus-producing (foveolar) cells in the stomach and an associated atrophy of parietal cells, which leads to decreased acid secretion and subsequent gastrointestinal symptoms.\n\nStep 3: Eliminate incorrect choices.\n\u2022 A. Serotonin-secreting gastric tumor \u2013 This is more consistent with a carcinoid tumor, which does not produce the classic features (giant rugae and parietal cell atrophy) seen in M\u00e9n\u00e9trier disease.\n\u2022 C. Excessive somatostatin secretion \u2013 This does not match the clinical and endoscopic findings and is not associated with parietal cell atrophy.\n\u2022 D. Ectopic secretion of gastrin \u2013 This would be characteristic of Zollinger-Ellison syndrome, which involves increased acid secretion and multiple ulcers, not the features described in this patient.\n\nStep 4: Choose the correct answer.\n\u2022 B. Proliferation of gastric mucus-producing cells \u2013 This is the mechanism underlying M\u00e9n\u00e9trier disease. The proliferation of these cells leads to giant rugae formation, parietal cell atrophy, protein loss, and the patient\u2019s clinical symptoms.\n\nFinal Answer: B"
    },
    {
        "realidx": 34,
        "question": "A 27-year-old man presents to the emergency department. He was brought in by staff from the homeless shelter when they found him unresponsive. The patient is a known IV drug abuser but otherwise has an unknown past medical history. He currently attends a methadone clinic. His temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 97/48 mmHg, pulse is 140/min, respirations are 29/min, and oxygen saturation is 98% on room air. Initial laboratory values are shown below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 6.3 mEq/L\nHCO3-: 17 mEq/L\nGlucose: 589 mg/dL\n\nThe patient is given treatment. After treatment, his temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 117/78 mmHg, pulse is 100/min, respirations are 23/min, and oxygen saturation is 98% on room air. His laboratory values are seen below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 19 mEq/L\nGlucose: 90 mg/dL\n\nWhich of the following is the best next step in management?",
        "answer": "Insulin, potassium, IV fluids, and glucose",
        "options": {
            "A": "Insulin, potassium, IV fluids, and glucose",
            "B": "IV fluids only",
            "C": "Oral rehydration",
            "D": "Supportive therapy and close monitoring"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "27 year old man presents",
            "emergency department",
            "brought",
            "staff",
            "homeless shelter",
            "found",
            "unresponsive",
            "patient",
            "known IV drug abuser",
            "unknown past medical history",
            "currently attends",
            "methadone clinic",
            "temperature",
            "99",
            "blood pressure",
            "97 48 mmHg",
            "pulse",
            "min",
            "respirations",
            "29 min",
            "oxygen saturation",
            "98",
            "room air",
            "Initial laboratory values",
            "shown",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "6.3 mEq/L HCO3",
            "mEq/L Glucose",
            "mg/dL",
            "patient",
            "given treatment",
            "treatment",
            "temperature",
            "99",
            "blood pressure",
            "mmHg",
            "pulse",
            "100 min",
            "respirations",
            "23 min",
            "oxygen saturation",
            "98",
            "room air",
            "laboratory values",
            "seen",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L Glucose",
            "90 mg/dL",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6366,
            "completion_tokens": 4725
        },
        "time_elapsed": 32.56624102592468,
        "raw_responses": [
            "Step 1: The patient initially presented with very high blood glucose (589 mg/dL), hyperkalemia (6.3 mEq/L) due to extracellular shift from acidosis, and a low bicarbonate (17 mEq/L), which are consistent with diabetic ketoacidosis (DKA). After treatment, his labs normalized with glucose dropping to 90 mg/dL and potassium now normal at 4.3 mEq/L, but his bicarbonate is still slightly low (19 mEq/L), indicating that the ketoacidosis process has not yet fully resolved.\n\nStep 2: In DKA management, once the blood glucose level falls below 200\u2013250 mg/dL, it is standard practice to add dextrose to the IV fluids while continuing insulin. This is necessary to prevent hypoglycemia while allowing for continued clearance of ketosis. With normalized potassium levels, the cautious continuation of insulin and potassium replacement, along with IV fluids that now include dextrose, is essential.\n\nStep 3: Among the answer choices provided:\n\u2022 Option A (Insulin, potassium, IV fluids, and glucose) correctly outlines the next step: continuing insulin therapy with IV dextrose supplementation to prevent hypoglycemia, while still supporting the resolution of DKA.\n\u2022 Option B (IV fluids only) does not provide ongoing insulin or the necessary potassium/dextrose adjustments.\n\u2022 Option C (Oral rehydration) is inappropriate for managing DKA.\n\u2022 Option D (Supportive therapy and close monitoring) is too passive given the ongoing process of DKA resolution.\n\nFinal answer: A. Insulin, potassium, IV fluids, and glucose.",
            "Step 1: Recognize that the patient initially presented with findings suggestive of diabetic ketoacidosis (DKA)\u2014marked hyperglycemia (glucose 589 mg/dL), metabolic acidosis (HCO3\u207b of 17 mEq/L), and hyperkalemia (K\u207a 6.3 mEq/L). Although the serum potassium appears high, the total body potassium is usually depleted in DKA.\n\nStep 2: Note that after treatment his blood pressure, heart rate, and respiratory rate have improved and his lab values now show a normal glucose (90 mg/dL) and potassium (4.3 mEq/L), but a slightly low bicarbonate (HCO3\u207b of 19 mEq/L) indicating that his acidosis has not yet fully resolved.\n\nStep 3: In the management of DKA, even after achieving normal blood glucose, insulin administration must be continued to resolve the metabolic acidosis. Since hypoglycemia becomes a risk once the serum glucose falls, dextrose (glucose) is added to the IV fluids along with continued insulin and potassium supplementation to ensure the patient\u2019s potassium remains within a safe range.\n\nStep 4: Comparing the options:\n\u2022 Option A (Insulin, potassium, IV fluids, and glucose) covers the full management strategy needed at this stage.\n\u2022 Option B (IV fluids only) and Option C (Oral rehydration) are insufficient, as they do not address the ongoing need for insulin and electrolyte management.\n\u2022 Option D (Supportive therapy and close monitoring) does not provide the necessary active treatment to resolve the remaining acidosis.\n\nFinal Answer: A. Insulin, potassium, IV fluids, and glucose",
            "Step 1: Analyze the patient\u2019s initial presentation and lab findings. The patient presented with hyperglycemia, an elevated serum potassium level (which is common in diabetic crises due to extracellular shifts), and a mildly decreased bicarbonate, suggesting an acidotic state. This fits with a hyperglycemic crisis (such as diabetic ketoacidosis) that required treatment with insulin, fluids, and potassium replacement.\n\nStep 2: Evaluate the post-treatment labs. After treatment, his glucose has dropped precipitously from 589 mg/dL to 90 mg/dL, his potassium level has normalized, and his bicarbonate remains slightly below normal. The pronounced reduction in blood glucose raises concern for hypoglycemia if insulin is not adjusted appropriately, particularly because patients treated for diabetic ketoacidosis or hyperglycemic crises are at risk of rebound hypoglycemia when insulin continues without concurrent dextrose supplementation.\n\nStep 3: Consider the appropriate management approach. With blood glucose now in the normoglycemic range yet residual abnormalities remaining (and likely ongoing ketosis given the slightly low HCO3), the appropriate next step is to add dextrose to the IV fluids while continuing insulin infusion. This approach prevents hypoglycemia while still addressing the underlying metabolic derangements. Ongoing potassium monitoring and occasional supplementation remain important as insulin drives potassium back into cells.\n\nStep 4: Eliminate the wrong options. \n\u2022 Option B (IV fluids only) does not prevent hypoglycemia.\n\u2022 Option C (Oral rehydration) is inappropriate for a patient requiring controlled and monitored fluid management in a post-crisis state.\n\u2022 Option D (Supportive therapy and close monitoring) is too passive given the risk of hypoglycemia and the need for continued insulin therapy.\n\nFinal answer: A. Insulin, potassium, IV fluids, and glucose."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Recognize that the patient initially presented with findings suggestive of diabetic ketoacidosis (DKA)\u2014marked hyperglycemia (glucose 589 mg/dL), metabolic acidosis (HCO3\u207b of 17 mEq/L), and hyperkalemia (K\u207a 6.3 mEq/L). Although the serum potassium appears high, the total body potassium is usually depleted in DKA.\n\nStep 2: Note that after treatment his blood pressure, heart rate, and respiratory rate have improved and his lab values now show a normal glucose (90 mg/dL) and potassium (4.3 mEq/L), but a slightly low bicarbonate (HCO3\u207b of 19 mEq/L) indicating that his acidosis has not yet fully resolved.\n\nStep 3: In the management of DKA, even after achieving normal blood glucose, insulin administration must be continued to resolve the metabolic acidosis. Since hypoglycemia becomes a risk once the serum glucose falls, dextrose (glucose) is added to the IV fluids along with continued insulin and potassium supplementation to ensure the patient\u2019s potassium remains within a safe range.\n\nStep 4: Comparing the options:\n\u2022 Option A (Insulin, potassium, IV fluids, and glucose) covers the full management strategy needed at this stage.\n\u2022 Option B (IV fluids only) and Option C (Oral rehydration) are insufficient, as they do not address the ongoing need for insulin and electrolyte management.\n\u2022 Option D (Supportive therapy and close monitoring) does not provide the necessary active treatment to resolve the remaining acidosis.\n\nFinal Answer: A. Insulin, potassium, IV fluids, and glucose"
    },
    {
        "realidx": 44,
        "question": "A 45-year-old G5P4105 presents to her gynecologist\u2019s office with six months of increasingly heavy periods. She now soaks one super absorbent tampon every two hours for five days each cycle. Her cycles have also become irregular, with intermenstrual bleeding for the last two months. She now experiences significant dysmenorrhea, requiring 400 mg ibuprofen every four hours for the majority of each menses. In addition, she reports new onset mild dyspareunia with intercourse and a \u201cheavy feeling\u201d in her pelvis. She has also noticed increased urinary frequency but denies bowel changes. The patient has a past medical history of obesity and type II diabetes on metformin. Her last child was born four years ago, and she has had five spontaneous vaginal deliveries. At this office visit, temperature is 98.5\u00b0F (36.9\u00b0C), blood pressure is 137/84 mmHg, pulse is 87/min, and respirations are 14/min. Which of the following physical exam findings is most likely to be present in this patient?",
        "answer": "Globular 10-week sized uterus",
        "options": {
            "A": "Globular 10-week sized uterus",
            "B": "Adnexal mass",
            "C": "Irregular 14-week sized uterus",
            "D": "No remarkable physical exam finding"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old",
            "presents",
            "gynecologists office",
            "six months",
            "heavy periods",
            "now soaks one",
            "absorbent tampon",
            "two hours",
            "five",
            "cycle",
            "cycles",
            "irregular",
            "intermenstrual bleeding",
            "two months",
            "now experiences significant dysmenorrhea",
            "400 mg ibuprofen",
            "four hours",
            "majority",
            "menses",
            "addition",
            "reports new onset mild dyspareunia",
            "intercourse",
            "heavy feeling",
            "pelvis",
            "increased urinary frequency",
            "denies bowel changes",
            "patient",
            "past medical",
            "type II diabetes",
            "metformin",
            "last child",
            "born four years",
            "five spontaneous vaginal deliveries",
            "office visit",
            "temperature",
            "98",
            "36",
            "blood pressure",
            "84 mmHg",
            "pulse",
            "87 min",
            "respirations",
            "min",
            "following physical exam findings",
            "most likely to",
            "present",
            "patient"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5661,
            "completion_tokens": 9411
        },
        "time_elapsed": 61.347347259521484,
        "raw_responses": [
            "Step 1: Analyze the clinical picture. This 45\u2010year-old, multiparous woman presents with several key symptoms:\n\u2003\u2022 Heavy, prolonged menstrual bleeding (soaking through a super absorbent tampon every two hours for five days).\n\u2003\u2022 Recent intermenstrual bleeding.\n\u2003\u2022 Significant dysmenorrhea and new onset mild dyspareunia.\n\u2003\u2022 A sense of pelvic \u201cheaviness\u201d and increased urinary frequency.\n\nStep 2: Consider the two main uterine causes that present with heavy bleeding and pelvic pressure:\n\u2003\u2022 Adenomyosis \u2013 typically seen in multiparous women; it usually produces dysmenorrhea and menorrhagia with a uniformly (\u201cglobular\u201d) enlarged, tender uterus that is generally about 8\u201310 weeks in size.\n\u2003\u2022 Uterine fibroids \u2013 often produce heavy, prolonged menses and may cause intermenstrual bleeding especially when submucosal; they also cause pelvic pressure symptoms (like urinary frequency) due to a mass effect. On exam, fibroids produce an irregular, enlarged uterus and, depending on the number and size of fibroids, the uterus can be notably larger (e.g., 14\u2010week sized).\n\nStep 3: Compare exam findings. \n\u2003\u2022 Option A (\u201cGlobular 10-week sized uterus\u201d) is more characteristic of adenomyosis.\n\u2003\u2022 Option C (\u201cIrregular 14-week sized uterus\u201d) best fits fibroids, which can cause heavy menstrual bleeding, intermenstrual spotting, pelvic pressure, and even pain on intercourse if they distort the pelvic anatomy.\n\nStep 4: Decide based on additional clues. Although dysmenorrhea is a prominent feature in adenomyosis, the presence of intermenstrual bleeding and urinary frequency suggests a mass effect that is more typical of fibroids. The irregularity and the larger size (14 weeks) on exam are key features supporting uterine fibroids.\n\nFinal Answer: C. Irregular 14\u2010week sized uterus",
            "Step 1: Identify key points in the presentation. This 45\u2010year-old multiparous patient has a several\u2010month history of worsening heavy menstrual bleeding, significant dysmenorrhea, new-onset dyspareunia, and a \u201cheavy\u201d sensation in the pelvis. Her clinical profile\u2014with her age and multiparity\u2014is consistent with adenomyosis.\n\nStep 2: Recall the exam findings associated with adenomyosis. Adenomyosis is characterized by ectopic endometrial tissue within the myometrium, leading to a uniformly enlarged, boggy, and tender uterus that is typically described as being globular in shape (often around a 10-week size).\n\nStep 3: Compare the options:\n\u2022 Option A (Globular 10-week sized uterus) matches the classic physical exam finding in adenomyosis.\n\u2022 Option B (Adnexal mass) would suggest ovarian pathology.\n\u2022 Option C (Irregular 14-week sized uterus) is more typical for uterine fibroids, which often produce an irregular, enlarged uterus that feels distinct from adenomyosis.\n\u2022 Option D (No remarkable physical exam finding) is unlikely given her symptoms.\n\nStep 4: Final answer. Given the patient\u2019s clinical picture, the most likely exam finding is a Globular 10-week sized uterus.\n\nFinal answer: A.",
            "Step 1: Relevant details in this case include the patient\u2019s age (45 years old), multiparity, and her symptoms\u2014heavy menstrual bleeding (soaking a super absorbent tampon every two hours for five days), irregular cycles with intermenstrual bleeding, significant dysmenorrhea (requiring high-dose ibuprofen), mild dyspareunia, pelvic heaviness, and increased urinary frequency.\n\nStep 2: These features are most consistent with adenomyosis, a condition where endometrial glands are found within the myometrium. This typically presents in multiparous women in their 40s with heavy, painful menstrual bleeding. On physical exam, adenomyosis usually produces a uniformly enlarged (globular), tender, and \u201cboggy\u201d uterus\u2014often approximating a 10-week size.\n\nStep 3: Comparing the options:\n\u2022 Option A (Globular 10-week sized uterus) best matches the classic physical exam finding of adenomyosis.\n\u2022 Option B (Adnexal mass) is more typical of an ovarian pathology.\n\u2022 Option C (Irregular 14-week sized uterus) is characteristic of uterine leiomyomas (fibroids), where the uterus is typically irregularly enlarged.\n\u2022 Option D (No remarkable physical exam finding) does not fit this patient\u2019s significant symptoms.\n\nFinal Answer: A. Globular 10-week sized uterus"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the clinical picture. This 45\u2010year-old, multiparous woman presents with several key symptoms:\n\u2003\u2022 Heavy, prolonged menstrual bleeding (soaking through a super absorbent tampon every two hours for five days).\n\u2003\u2022 Recent intermenstrual bleeding.\n\u2003\u2022 Significant dysmenorrhea and new onset mild dyspareunia.\n\u2003\u2022 A sense of pelvic \u201cheaviness\u201d and increased urinary frequency.\n\nStep 2: Consider the two main uterine causes that present with heavy bleeding and pelvic pressure:\n\u2003\u2022 Adenomyosis \u2013 typically seen in multiparous women; it usually produces dysmenorrhea and menorrhagia with a uniformly (\u201cglobular\u201d) enlarged, tender uterus that is generally about 8\u201310 weeks in size.\n\u2003\u2022 Uterine fibroids \u2013 often produce heavy, prolonged menses and may cause intermenstrual bleeding especially when submucosal; they also cause pelvic pressure symptoms (like urinary frequency) due to a mass effect. On exam, fibroids produce an irregular, enlarged uterus and, depending on the number and size of fibroids, the uterus can be notably larger (e.g., 14\u2010week sized).\n\nStep 3: Compare exam findings. \n\u2003\u2022 Option A (\u201cGlobular 10-week sized uterus\u201d) is more characteristic of adenomyosis.\n\u2003\u2022 Option C (\u201cIrregular 14-week sized uterus\u201d) best fits fibroids, which can cause heavy menstrual bleeding, intermenstrual spotting, pelvic pressure, and even pain on intercourse if they distort the pelvic anatomy.\n\nStep 4: Decide based on additional clues. Although dysmenorrhea is a prominent feature in adenomyosis, the presence of intermenstrual bleeding and urinary frequency suggests a mass effect that is more typical of fibroids. The irregularity and the larger size (14 weeks) on exam are key features supporting uterine fibroids.\n\nFinal Answer: C. Irregular 14\u2010week sized uterus"
    },
    {
        "realidx": 59,
        "question": "A 17-year-old girl is referred by her dentist for a suspected eating disorder. She has been visiting the same dentist since childhood and for the past 2 years has had at least 2 visits for dental caries. She eventually admitted to him that she regularly induces vomiting by putting her fingers down her throat. She says she has been doing this for the last few years and purging at least once a week. More recently, she has been inducing emesis more often and even looked into diuretics as she feels that she is gaining more and more weight compared to her \u2018skinny friends\u2019. Her BMI is at the 50th percentile for her age and sex. Which of the following features is most consistent with this patient\u2019s condition?",
        "answer": "Patients with this disorder are not further sub-typed",
        "options": {
            "A": "Patients with this disorder are not further sub-typed",
            "B": "Patients do not usually initiate treatment",
            "C": "Patients can have a history of both anorexia and bulimia",
            "D": "Patients will typically have a BMI between 17\u201318.5 kg/m2"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old girl",
            "referred by",
            "dentist",
            "suspected eating disorder",
            "visiting",
            "same dentist",
            "childhood",
            "past",
            "years",
            "visits",
            "dental caries",
            "admitted",
            "induces vomiting",
            "putting",
            "fingers",
            "throat",
            "last",
            "years",
            "purging",
            "week",
            "recently",
            "inducing emesis",
            "often",
            "looked",
            "diuretics",
            "feels",
            "gaining more",
            "more weight compared",
            "friends",
            "BMI",
            "50th percentile",
            "age",
            "sex",
            "following features",
            "most consistent with",
            "patients condition"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5232,
            "completion_tokens": 4200
        },
        "time_elapsed": 35.387648820877075,
        "raw_responses": [
            "Step 1: Analyze the Patient's Presentation\n\u2022 The patient is a 17-year-old girl who regularly induces vomiting and has dental caries, a common complication from repeated exposure to stomach acid.\n\u2022 Her BMI is in the 50th percentile, which is normal, ruling out anorexia nervosa.\n\u2022 These features point towards a diagnosis of bulimia nervosa.\n\nStep 2: Evaluate the Answer Options\nA. \"Patients with this disorder are not further sub-typed\" \u2013 While DSM-5 does not further sub-type bulimia nervosa based on behavior (e.g., purging vs non-purging), this statement isn't uniquely characteristic of the disorder.\nB. \"Patients do not usually initiate treatment\" \u2013 While patients with bulimia nervosa may be reluctant to seek help, this is not a defining or distinguishing feature.\nC. \"Patients can have a history of both anorexia and bulimia\" \u2013 It is common for individuals with bulimia nervosa to have a history of anorexia nervosa, or to have alternated between the two disorders over time.\nD. \"Patients will typically have a BMI between 17\u201318.5 kg/m\u00b2\" \u2013 A BMI in that range is indicative of underweight status, which is more consistent with anorexia nervosa than bulimia nervosa. Patients with bulimia nervosa usually maintain normal weight.\n\nStep 3: Provide the Final Answer\nBased on the analysis, the feature most consistent with the patient's condition (bulimia nervosa) is that patients can have a history of both anorexia and bulimia.\n\nFinal answer: C.",
            "Step 1: This patient presents with regular purging behaviors (induced vomiting and diuretic use), yet her BMI is normal (50th percentile), which is characteristic of bulimia nervosa rather than anorexia nervosa.\n\nStep 2: Evaluating the options:\n\u2022 Option A states that patients with bulimia nervosa are not further subtyped. However, bulimia can be subclassified into purging and nonpurging types, making this statement inaccurate.\n\u2022 Option B suggests that patients do not usually initiate treatment, which is not an established clinical characteristic used to define the disorder.\n\u2022 Option C notes that patients can have a history of both anorexia and bulimia. It is common for patients with bulimia nervosa to report a past history of anorexia nervosa, especially the binge/purge subtype, making this a true and distinguishing feature.\n\u2022 Option D implies that patients will typically have a BMI between 17\u201318.5 kg/m\u00b2. This BMI range is indicative of anorexia nervosa rather than bulimia nervosa, where patients usually maintain normal or near-normal body weight.\n\nStep 3: The most consistent feature with this patient\u2019s condition (bulimia nervosa) is that patients can have a history of both anorexia and bulimia.\n\nFinal answer: C.",
            "Step 1: Identify the disorder. The patient is a 17\u2010year\u2010old girl who regularly purges but has a normal BMI (50th percentile). This is most consistent with a diagnosis of bulimia nervosa, rather than anorexia nervosa.\n\nStep 2: Evaluate the options.\n\u2022 Option A: \"Patients with this disorder are not further sub-typed.\" Historically, bulimia was sometimes subtyped into \"purging\" and \"non-purging\" types. Although the current DSM criteria focus on the presence of recurrent bingeing and inappropriate compensatory behaviors, this option is not the key feature that distinguishes bulimia for this patient.\n\u2022 Option B: \"Patients do not usually initiate treatment.\" While treatment seeking behaviors can be variable, this is not a defining or distinguishing feature of bulimia.\n\u2022 Option C: \"Patients can have a history of both anorexia and bulimia.\" It is common for individuals with eating disorders to exhibit crossover symptoms over time. Many patients with bulimia nervosa have previously been diagnosed with anorexia nervosa or have features of both, making this statement consistent with the clinical profile of bulimia nervosa.\n\u2022 Option D: \"Patients will typically have a BMI between 17\u201318.5 kg/m2.\" This range is more suggestive of anorexia nervosa rather than bulimia nervosa, where the patient\u2019s BMI is generally within the normal range.\n\nStep 3: Conclusion.\nBased on the above reasoning, the feature most consistent with this patient's condition is that patients with bulimia nervosa can have a history of both anorexia and bulimia.\n\nFinal answer: C"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Identify the disorder. The patient is a 17\u2010year\u2010old girl who regularly purges but has a normal BMI (50th percentile). This is most consistent with a diagnosis of bulimia nervosa, rather than anorexia nervosa.\n\nStep 2: Evaluate the options.\n\u2022 Option A: \"Patients with this disorder are not further sub-typed.\" Historically, bulimia was sometimes subtyped into \"purging\" and \"non-purging\" types. Although the current DSM criteria focus on the presence of recurrent bingeing and inappropriate compensatory behaviors, this option is not the key feature that distinguishes bulimia for this patient.\n\u2022 Option B: \"Patients do not usually initiate treatment.\" While treatment seeking behaviors can be variable, this is not a defining or distinguishing feature of bulimia.\n\u2022 Option C: \"Patients can have a history of both anorexia and bulimia.\" It is common for individuals with eating disorders to exhibit crossover symptoms over time. Many patients with bulimia nervosa have previously been diagnosed with anorexia nervosa or have features of both, making this statement consistent with the clinical profile of bulimia nervosa.\n\u2022 Option D: \"Patients will typically have a BMI between 17\u201318.5 kg/m2.\" This range is more suggestive of anorexia nervosa rather than bulimia nervosa, where the patient\u2019s BMI is generally within the normal range.\n\nStep 3: Conclusion.\nBased on the above reasoning, the feature most consistent with this patient's condition is that patients with bulimia nervosa can have a history of both anorexia and bulimia.\n\nFinal answer: C"
    },
    {
        "realidx": 64,
        "question": "A healthy 19-year-old man presents to his primary care provider complaining of painless \u201cblisters\u201d in his mouth. He reports that he noticed a white film on his tongue and the sides of his mouth 2 days ago while brushing his teeth. The film was easily brushed off. He also complains of a bitter metallic taste in his mouth but otherwise denies pain, burning, dysphagia, or hoarseness. He is otherwise healthy and takes no medications. He is a competitive swimmer and has had 8 sexual partners in the past year. He intermittently uses barrier protection. On exam, he is well-appearing and in no acute distress. His oral examination demonstrates patches of white pseudomembranes that can be wiped away to reveal erythematous mucosa. A medication with which of the following mechanisms of action is most appropriate in this patient?",
        "answer": "Disruption of cell membrane permeability",
        "options": {
            "A": "Disruption of cell membrane permeability",
            "B": "Disruption of microtubule formation",
            "C": "Inhibition of 14-alpha-demethylase",
            "D": "Inhibition of beta-glucan synthase"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "healthy",
            "year old man presents",
            "primary care provider",
            "painless blisters",
            "mouth",
            "reports",
            "white film",
            "tongue",
            "sides",
            "mouth 2 days",
            "brushing",
            "teeth",
            "film",
            "easily brushed",
            "bitter metallic",
            "mouth",
            "denies pain",
            "burning",
            "dysphagia",
            "hoarseness",
            "healthy",
            "takes",
            "medications",
            "competitive swimmer",
            "sexual partners",
            "past year",
            "uses barrier protection",
            "exam",
            "well appearing",
            "acute distress",
            "oral examination demonstrates patches",
            "white pseudomembranes",
            "wiped",
            "to reveal erythematous mucosa",
            "medication",
            "of",
            "following mechanisms",
            "action",
            "most appropriate",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5469,
            "completion_tokens": 3720
        },
        "time_elapsed": 28.599865198135376,
        "raw_responses": [
            "Step 1: Recognize the Clinical Picture\nThe patient's presentation (painless white pseudomembranes in the mouth that can be wiped away to reveal an erythematous base, accompanied by a metallic taste) is characteristic of oral candidiasis, also known as thrush.\n\nStep 2: Consider Appropriate Treatment\nFor a healthy young adult with oral candidiasis, the first-line treatment is usually a topical antifungal medication. Options include nystatin \"swish and swallow\" or clotrimazole troches.\n\nStep 3: Understand Medication Mechanisms\nLet's review the choices:\nA. Disruption of cell membrane permeability \u2013 This is the mechanism of polyene antifungals (e.g., nystatin, amphotericin B) which bind to ergosterol in the fungal cell membrane, forming pores and causing cell death.\nB. Disruption of microtubule formation \u2013 This mechanism is associated with medications like griseofulvin, typically used for dermatophyte (tinea) infections, not candidiasis.\nC. Inhibition of 14-alpha-demethylase \u2013 This describes the mechanism of azoles (e.g., fluconazole), which are used for systemic or refractory candidiasis but are not the first choice for uncomplicated oral candidiasis.\nD. Inhibition of beta-glucan synthase \u2013 This is the mechanism of echinocandins (e.g., caspofungin), used for systemic candidiasis but not indicated for a localized oral infection in an otherwise healthy patient.\n\nStep 4: Choose the Most Appropriate Mechanism\nSince the patient has an uncomplicated case of oral candidiasis, a topical antifungal like nystatin is typically used. The mechanism of nystatin is disruption of cell membrane permeability by binding ergosterol.\n\nFinal Answer: A. Disruption of cell membrane permeability",
            "The patient\u2019s presentation is most consistent with oral candidiasis (thrush), which is frequently treated with a topical antifungal in an otherwise healthy individual. The classic findings in oral thrush are white pseudomembranes that can be scraped off to reveal erythematous mucosa underneath.\n\nIn treating oral candidiasis, one commonly used first\u2010line treatment is nystatin suspension. Nystatin, a polyene antifungal, works by binding to ergosterol in the fungal cell membrane and forming pores. These pores disrupt the integrity of the cell membrane, leading to leakage of cellular components and eventually cell death.\n\nLooking at the mechanism choices provided:\n\u2022 Option A (Disruption of cell membrane permeability): This corresponds to the mechanism of action of polyene antifungals, such as nystatin.\n\u2022 Option B (Disruption of microtubule formation): This is not relevant for fungal infections.\n\u2022 Option C (Inhibition of 14-alpha-demethylase): This is the mechanism of azole antifungals (e.g., fluconazole), which are generally used in systemic rather than mild, uncomplicated oral thrush.\n\u2022 Option D (Inhibition of beta-glucan synthase): This is the mechanism of echinocandins, which are typically used for more invasive or refractory fungal infections.\n\nThus, the medication with the most appropriate mechanism for this patient is one that causes disruption of cell membrane permeability.\n\nFinal answer: Option A.",
            "Step 1: Recognize that the patient is presenting with oral candidiasis (thrush). The key features supporting this diagnosis include the white patches or pseudomembranes on the tongue and mucosa that can be easily wiped away to reveal erythema.\n\nStep 2: Recall that the first-line treatment for oral candidiasis is a topical antifungal such as nystatin. Nystatin works by binding to ergosterol in the fungal cell membrane, which leads to increased permeability and cell death.\n\nStep 3: Compare the options provided:\n\u2022 Option A (Disruption of cell membrane permeability) corresponds to the mechanism of polyene antifungals like nystatin.\n\u2022 Option B (Disruption of microtubule formation) describes the action of griseofulvin, which is used for dermatophyte infections, not candidiasis.\n\u2022 Option C (Inhibition of 14-alpha-demethylase) is the mechanism of azoles, another class of antifungals, but typically a topical polyene is preferred initially for oral candidiasis.\n\u2022 Option D (Inhibition of beta-glucan synthase) is the mechanism of echinocandins, which are used for systemic candidiasis.\n\nStep 4: Conclude that the most appropriate treatment for this patient is with a medication whose mechanism of action involves disruption of cell membrane permeability (as seen with nystatin).\n\nFinal Answer: Disruption of cell membrane permeability."
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Recognize the Clinical Picture\nThe patient's presentation (painless white pseudomembranes in the mouth that can be wiped away to reveal an erythematous base, accompanied by a metallic taste) is characteristic of oral candidiasis, also known as thrush.\n\nStep 2: Consider Appropriate Treatment\nFor a healthy young adult with oral candidiasis, the first-line treatment is usually a topical antifungal medication. Options include nystatin \"swish and swallow\" or clotrimazole troches.\n\nStep 3: Understand Medication Mechanisms\nLet's review the choices:\nA. Disruption of cell membrane permeability \u2013 This is the mechanism of polyene antifungals (e.g., nystatin, amphotericin B) which bind to ergosterol in the fungal cell membrane, forming pores and causing cell death.\nB. Disruption of microtubule formation \u2013 This mechanism is associated with medications like griseofulvin, typically used for dermatophyte (tinea) infections, not candidiasis.\nC. Inhibition of 14-alpha-demethylase \u2013 This describes the mechanism of azoles (e.g., fluconazole), which are used for systemic or refractory candidiasis but are not the first choice for uncomplicated oral candidiasis.\nD. Inhibition of beta-glucan synthase \u2013 This is the mechanism of echinocandins (e.g., caspofungin), used for systemic candidiasis but not indicated for a localized oral infection in an otherwise healthy patient.\n\nStep 4: Choose the Most Appropriate Mechanism\nSince the patient has an uncomplicated case of oral candidiasis, a topical antifungal like nystatin is typically used. The mechanism of nystatin is disruption of cell membrane permeability by binding ergosterol.\n\nFinal Answer: A. Disruption of cell membrane permeability"
    },
    {
        "realidx": 81,
        "question": "A 54-year-old male makes an appointment with his primary care physician due to chronic fatigue that has left him unable to hike or do other physically demanding activities with his friends. He has well-controlled hypertension and diabetes but has otherwise been healthy. He does not smoke but drinks socially with his friends. Physical exam reveals enlarged nodules that are not tender to palpation. A biopsy is obtained showing a characteristic change in chromosome 18. The regulation of which of the following proteins will be most abnormal in this patient?",
        "answer": "Caspase-9",
        "options": {
            "A": "Caspase-9",
            "B": "CD15",
            "C": "Cyclin-dependent kinase 4",
            "D": "Ras pathway transcription factors"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "54 year old male makes",
            "appointment",
            "primary care physician",
            "chronic fatigue",
            "left",
            "unable to",
            "physically demanding activities",
            "friends",
            "well-controlled hypertension",
            "diabetes",
            "healthy",
            "not smoke",
            "drinks",
            "friends",
            "Physical exam reveals enlarged nodules",
            "not tender",
            "palpation",
            "biopsy",
            "obtained showing",
            "characteristic change",
            "chromosome 18",
            "regulation",
            "following proteins",
            "most abnormal",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5187,
            "completion_tokens": 5897
        },
        "time_elapsed": 43.557589292526245,
        "raw_responses": [
            "Step 1: Recognize the Clue.  \nThe patient has painless enlarged lymph nodes, and the biopsy shows a characteristic change on chromosome 18. This strongly suggests follicular lymphoma, which typically exhibits a t(14;18) translocation.\n\nStep 2: Recall the Pathophysiology.  \nThe t(14;18) translocation results in the juxtaposition of the BCL-2 gene (on chromosome 18) near the immunoglobulin heavy chain enhancer on chromosome 14. This genetic change leads to overexpression of the BCL-2 protein, an anti-apoptotic molecule that prevents cell death.\n\nStep 3: Connect to the Protein Options.  \nBCL-2 functions by inhibiting the intrinsic (mitochondrial) apoptosis pathway. In this pathway, cytochrome c release from the mitochondria leads to the activation of caspase-9, which then initiates a cascade culminating in apoptosis. Overexpression of BCL-2 (due to t(14;18)) prevents the activation of caspase-9, thereby disrupting normal apoptosis.\n\nStep 4: Eliminate Other Options.  \n\u2022 CD15 is a cell surface marker commonly associated with Hodgkin lymphoma, not follicular lymphoma.  \n\u2022 Cyclin-dependent kinase 4 is involved in cell cycle progression, but it isn\u2019t the primary abnormality in follicular lymphoma.  \n\u2022 Ras pathway transcription factors are implicated in other cancers but are not directly affected by the t(14;18) translocation.\n\nStep 5: Final Answer.  \nThe best answer is that the regulation of caspase-9 (Option A) is most abnormal, as BCL-2 overexpression prevents its activation, impairing apoptosis.\n\nFinal answer: A. Caspase-9.",
            "Step 1: Recognize the clinical context. This 54\u2010year-old man presents with chronic fatigue and non-tender lymph node enlargement. His biopsy reveals a chromosomal abnormality involving chromosome 18.\n\nStep 2: Recall that the t(14;18) translocation is classically associated with follicular lymphoma. This translocation moves the BCL\u20112 gene from chromosome 18 to the immunoglobulin heavy chain (IgH) region on chromosome 14, resulting in overexpression of BCL\u20112.\n\nStep 3: Understand that BCL\u20112 is an anti\u2011apoptotic protein. Its overexpression prevents normal apoptosis by inhibiting the mitochondrial pathway that normally leads to the activation of caspase\u20119 (among other downstream caspases).\n\nStep 4: Evaluate the answer choices:\n\u2003A. Caspase\u20119 \u2013 A key caspase in the mitochondrial apoptotic pathway; its activation is inhibited by overexpressed BCL\u20112.\n\u2003B. CD15 \u2013 A cell surface marker associated with Hodgkin lymphoma, not follicular lymphoma.\n\u2003C. Cyclin\u2011dependent kinase 4 \u2013 Involved in cell cycle regulation; not directly linked to the t(14;18) translocation.\n\u2003D. Ras pathway transcription factors \u2013 Related to cell proliferation pathways; again, not the target of this chromosomal change.\n\nStep 5: Since the t(14;18) translocation causes overexpression of BCL\u20112, which directly affects the regulation of apoptosis via inhibition of caspase\u20119 activation, the most abnormal regulation in this patient will be seen with caspase\u20119.\n\nFinal answer: A. Caspase\u20119",
            "Step 1: The patient\u2019s clinical picture and biopsy results point toward a diagnosis of follicular lymphoma. Follicular lymphoma is characterized by a t(14;18) chromosomal translocation. This translocation leads to overexpression of the BCL2 protein, an anti-apoptotic protein that prevents programmed cell death.\n\nStep 2: BCL2 overexpression results in the inhibition of apoptosis. Normally, BCL2 helps regulate apoptosis by controlling mitochondrial membrane permeability and preventing the release of cytochrome c. When cytochrome c is released, it helps form the apoptosome, which activates caspase-9. Overexpression of BCL2 due to the t(14;18) translocation therefore indirectly leads to abnormal regulation (i.e., decreased activation) of caspase-9.\n\nStep 3: Looking at the answer choices:\n\u2003\u2022 A. Caspase-9 \u2013 This is involved in the intrinsic apoptotic pathway and would be affected because BCL2 overexpression prevents the formation of the apoptosome, diminishing caspase-9 activation.\n\u2003\u2022 B. CD15 \u2013 This is a marker typically seen on Reed-Sternberg cells in Hodgkin lymphoma, not follicular lymphoma.\n\u2003\u2022 C. Cyclin-dependent kinase 4 \u2013 This protein regulates the cell cycle but is not the key abnormality in follicular lymphoma with t(14;18).\n\u2003\u2022 D. Ras pathway transcription factors \u2013 These are not principally involved in the pathogenesis of follicular lymphoma.\n\nFinal Answer: A. Caspase-9"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Recognize the Clue.  \nThe patient has painless enlarged lymph nodes, and the biopsy shows a characteristic change on chromosome 18. This strongly suggests follicular lymphoma, which typically exhibits a t(14;18) translocation.\n\nStep 2: Recall the Pathophysiology.  \nThe t(14;18) translocation results in the juxtaposition of the BCL-2 gene (on chromosome 18) near the immunoglobulin heavy chain enhancer on chromosome 14. This genetic change leads to overexpression of the BCL-2 protein, an anti-apoptotic molecule that prevents cell death.\n\nStep 3: Connect to the Protein Options.  \nBCL-2 functions by inhibiting the intrinsic (mitochondrial) apoptosis pathway. In this pathway, cytochrome c release from the mitochondria leads to the activation of caspase-9, which then initiates a cascade culminating in apoptosis. Overexpression of BCL-2 (due to t(14;18)) prevents the activation of caspase-9, thereby disrupting normal apoptosis.\n\nStep 4: Eliminate Other Options.  \n\u2022 CD15 is a cell surface marker commonly associated with Hodgkin lymphoma, not follicular lymphoma.  \n\u2022 Cyclin-dependent kinase 4 is involved in cell cycle progression, but it isn\u2019t the primary abnormality in follicular lymphoma.  \n\u2022 Ras pathway transcription factors are implicated in other cancers but are not directly affected by the t(14;18) translocation.\n\nStep 5: Final Answer.  \nThe best answer is that the regulation of caspase-9 (Option A) is most abnormal, as BCL-2 overexpression prevents its activation, impairing apoptosis.\n\nFinal answer: A. Caspase-9."
    },
    {
        "realidx": 112,
        "question": "A 43-year-old woman presents with complaints of retrosternal burning associated with eating. It has persisted for the past several years but has been getting worse. Her past medical history is unknown and this is her first time seeing a doctor. She states she is otherwise healthy and review of systems is notable for episodic hand pain that is worse in the winter as well as a chronic and severe cough with dyspnea which she attributes to her smoking. Her temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 174/104 mmHg, pulse is 80/min, respirations are 22/min, and oxygen saturation is 92% on room air. Physical exam is notable for a young appearing woman with coarse breath sounds. Laboratory studies and urinalysis are ordered and currently pending. Which of the following is the pathophysiology of this patient's chief complaint?",
        "answer": "Esophageal fibrosis",
        "options": {
            "A": "Decreased lower esophageal tone",
            "B": "Esophageal fibrosis",
            "C": "Increased lower esophageal tone",
            "D": "Spastic cricopharyngeal muscle"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman presents",
            "complaints",
            "retrosternal burning associated with eating",
            "past",
            "years",
            "getting worse",
            "past medical history",
            "unknown",
            "first time seeing",
            "doctor",
            "states",
            "healthy",
            "review of systems",
            "notable",
            "episodic hand",
            "worse",
            "winter",
            "chronic",
            "severe cough",
            "dyspnea",
            "attributes",
            "smoking",
            "temperature",
            "97",
            "36",
            "blood pressure",
            "mmHg",
            "pulse",
            "80 min",
            "respirations",
            "min",
            "oxygen saturation",
            "room air",
            "Physical exam",
            "notable",
            "young appearing woman",
            "coarse breath sounds",
            "Laboratory studies",
            "urinalysis",
            "ordered",
            "currently",
            "following",
            "pathophysiology",
            "patient's chief complaint"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5298,
            "completion_tokens": 3148
        },
        "time_elapsed": 24.488953828811646,
        "raw_responses": [
            "Step 1: Recognize the Clues\n\u2022 The patient presents with retrosternal burning, which points toward reflux symptoms.\n\u2022 She also has episodic hand pain that worsens in cold temperatures, suggesting Raynaud's phenomenon.\n\u2022 Additionally, the chronic cough and dyspnea with coarse breath sounds could indicate pulmonary involvement.\n\u2022 Together, these findings raise concern for an underlying connective tissue disorder, such as scleroderma, which is known for its gastrointestinal, pulmonary, and vascular manifestations.\n\nStep 2: Link Findings to Esophageal Pathology in Scleroderma\n\u2022 In scleroderma, there is autoimmune-mediated damage causing atrophy of the smooth muscle in the esophagus.\n\u2022 This leads to a decrease in the lower esophageal sphincter (LES) tone, which predisposes patients to gastroesophageal reflux disease (GERD).\n\u2022 The reflux of gastric acid then results in the retrosternal burning experienced by the patient.\n\nStep 3: Evaluate the Answer Choices\nA. Decreased lower esophageal tone \u2013 This is consistent with scleroderma-related reflux.\nB. Esophageal fibrosis \u2013 While fibrosis can occur later in scleroderma, it is not the primary cause of reflux symptoms.\nC. Increased lower esophageal tone \u2013 This would more likely lead to motility issues such as achalasia, not reflux.\nD. Spastic cricopharyngeal muscle \u2013 This affects the upper esophageal sphincter and typically results in dysphagia rather than reflux.\n\nFinal Answer: A. Decreased lower esophageal tone",
            "Step 1: Review the patient's presentation. The 43-year-old woman has long-standing retrosternal burning associated with eating, which is worsening. Additionally, she reports episodic hand pain that is worse in the winter (suggestive of Raynaud phenomenon) and a chronic cough with dyspnea. These systemic findings (Raynaud phenomenon, possible lung involvement) raise concern for a systemic connective tissue disorder such as systemic sclerosis (scleroderma).\n\nStep 2: Understand the pathophysiology. In systemic sclerosis, collagen deposition and fibrosis occur in various organs including the esophagus. The esophageal smooth muscle becomes fibrotic, leading to decreased lower esophageal sphincter tone and impaired peristalsis. This decreased tone results in acid reflux and the symptoms of burning (GERD).\n\nStep 3: Compare answer choices.\n\u2022 Option A (Decreased lower esophageal tone) correctly describes the mechanism by which esophageal dysfunction (due to fibrosis in systemic sclerosis) leads to GERD.\n\u2022 Option B (Esophageal fibrosis) is a finding in scleroderma but is not directly the mechanism of reflux; rather, it is the process that causes decreased sphincter tone.\n\u2022 Option C (Increased lower esophageal tone) would actually prevent reflux and is incorrect.\n\u2022 Option D (Spastic cricopharyngeal muscle) typically relates to other esophageal motility disorders not consistent with this patient\u2019s presentation.\n\nFinal Answer: A. Decreased lower esophageal tone",
            "Step 1: The patient presents with retrosternal burning with meals that has been progressively worsening. Additional features include episodic hand pain in the cold (suggesting Raynaud phenomenon), lung findings (coarse breath sounds, dyspnea), and high blood pressure, which may indicate systemic involvement. Together, these features raise concern for systemic sclerosis (scleroderma).\n\nStep 2: In systemic sclerosis, there is increased deposition of collagen within the submucosal tissues of the esophagus. This deposition causes atrophy of the muscularis layer, particularly affecting the smooth muscle fibers responsible for maintaining the lower esophageal sphincter (LES) tone. As a result, the LES tone is decreased, allowing gastric contents to reflux into the esophagus and cause burning.\n\nStep 3: Evaluate the options:\nA. Decreased lower esophageal tone \u2013 This is the pathophysiological mechanism seen in scleroderma-induced reflux.\nB. Esophageal fibrosis \u2013 While fibrosis can occur, it is not the primary mechanism responsible for the reflux symptoms.\nC. Increased lower esophageal tone \u2013 This mechanism would typically reduce reflux and is not consistent with her presentation.\nD. Spastic cricopharyngeal muscle \u2013 This would affect the upper esophageal sphincter and typically cause dysphagia rather than reflux symptoms.\n\nFinal answer: A. Decreased lower esophageal tone"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Recognize the Clues\n\u2022 The patient presents with retrosternal burning, which points toward reflux symptoms.\n\u2022 She also has episodic hand pain that worsens in cold temperatures, suggesting Raynaud's phenomenon.\n\u2022 Additionally, the chronic cough and dyspnea with coarse breath sounds could indicate pulmonary involvement.\n\u2022 Together, these findings raise concern for an underlying connective tissue disorder, such as scleroderma, which is known for its gastrointestinal, pulmonary, and vascular manifestations.\n\nStep 2: Link Findings to Esophageal Pathology in Scleroderma\n\u2022 In scleroderma, there is autoimmune-mediated damage causing atrophy of the smooth muscle in the esophagus.\n\u2022 This leads to a decrease in the lower esophageal sphincter (LES) tone, which predisposes patients to gastroesophageal reflux disease (GERD).\n\u2022 The reflux of gastric acid then results in the retrosternal burning experienced by the patient.\n\nStep 3: Evaluate the Answer Choices\nA. Decreased lower esophageal tone \u2013 This is consistent with scleroderma-related reflux.\nB. Esophageal fibrosis \u2013 While fibrosis can occur later in scleroderma, it is not the primary cause of reflux symptoms.\nC. Increased lower esophageal tone \u2013 This would more likely lead to motility issues such as achalasia, not reflux.\nD. Spastic cricopharyngeal muscle \u2013 This affects the upper esophageal sphincter and typically results in dysphagia rather than reflux.\n\nFinal Answer: A. Decreased lower esophageal tone"
    },
    {
        "realidx": 114,
        "question": "A 41-year-old man presents to the emergency department with a 6-hour history of muscle cramping, decreased appetite, and diarrhea. He says that these symptoms came on rapidly but does not recall anything that may have triggered the episode. He has never experienced these symptoms before. His past medical history is significant for obesity, sleep apnea, and type 2 diabetes that is well controlled on metformin. He also has gastroesophageal reflux disease for which he occasionally takes antacids. On presentation he is found to have fast, shallow breathing and abdominal pain that is poorly localized. Basic labs as well as an arterial blood gas are obtained and the results are shown below:\n\nNa+: 139 mEq/L\nCl-: 106 mEq/L\nHCO3-: 11 mEq/L\npH: 7.25\npCO2: 22 mmHg\n\nWhich of the following is the most likely cause of the changes seen in this patient's labs?",
        "answer": "Metformin",
        "options": {
            "A": "Anxiety",
            "B": "Diarrhea",
            "C": "Metformin",
            "D": "Sleep apnea"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old man presents",
            "emergency department",
            "6-hour history",
            "muscle cramping",
            "decreased appetite",
            "diarrhea",
            "symptoms",
            "rapidly",
            "not recall",
            "triggered",
            "episode",
            "never experienced",
            "symptoms",
            "past medical history",
            "significant",
            "obesity",
            "sleep apnea",
            "type 2 diabetes",
            "well controlled",
            "metformin",
            "gastroesophageal reflux disease",
            "occasionally takes antacids",
            "presentation",
            "found to",
            "fast",
            "shallow breathing",
            "abdominal pain",
            "poorly localized",
            "Basic labs",
            "arterial blood gas",
            "obtained",
            "results",
            "shown",
            "Na",
            "mEq/L Cl",
            "mEq/L HCO3",
            "mEq/L pH",
            "pCO2",
            "mmHg",
            "following",
            "most likely cause",
            "changes seen",
            "patient's labs"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4794,
            "completion_tokens": 2714
        },
        "time_elapsed": 25.18654179573059,
        "raw_responses": [
            "Step 1: Analyze the clinical presentation and lab values. The patient has muscle cramping, decreased appetite, and diarrhea. His labs show a low serum bicarbonate (11 mEq/L) and a low pH (7.25), indicating metabolic acidosis. The low pCO\u2082 (22 mmHg) represents a respiratory compensation for this metabolic acidosis.\n\nStep 2: Consider the answer choices. Anxiety typically leads to respiratory alkalosis (a primary decrease in pCO\u2082) without a significant drop in bicarbonate. Metformin can cause a lactic acidosis; however, his diabetes is well controlled on metformin and there is no evidence of lactic acid buildup. Sleep apnea usually causes respiratory acidosis due to hypoventilation, not the metabolic acidosis seen here. Diarrhea, on the other hand, causes a loss of bicarbonate from the gastrointestinal tract and is consistent with the patient\u2019s symptoms and the lab findings.\n\nStep 3: Final Answer\nDiarrhea",
            "Step 1: The patient presents with muscle cramping, decreased appetite, and notably diarrhea, which developed over a short period of time. His lab findings show a pH of 7.25 (indicating acidemia), a low bicarbonate of 11 mEq/L (suggesting metabolic acidosis), and a low pCO\u2082 of 22 mmHg, consistent with respiratory compensation.\n\nStep 2: Assess the options:\n\u2022 Anxiety typically leads to hyperventilation, which could lower pCO\u2082; however, it does not usually cause a significant drop in bicarbonate nor a primary metabolic acidosis.\n\u2022 Diarrhea is known to cause a non-anion gap metabolic acidosis due to the loss of bicarbonate in the gastrointestinal tract.\n\u2022 Metformin can cause lactic acidosis, but this patient's symptoms are more directly related to gastrointestinal fluid loss, and his history of acidosis is not typically seen in a single episode like this.\n\u2022 Sleep apnea is not associated with causing an acid-base disturbance that fits these findings.\n\nStep 3: Based on the clinical presentation and laboratory data, the most likely cause of the changes seen in this patient's labs is the loss of bicarbonate due to diarrhea.\n\nFinal answer: B. Diarrhea",
            "Step 1: Analyze the lab values. The patient\u2019s labs show a low bicarbonate level (11 mEq/L) and a low pH (7.25), indicating a metabolic acidosis. The low pCO2 (22 mmHg) suggests respiratory compensation. \n\nStep 2: Correlate the clinical presentation with potential causes. The patient has a 6-hour history of muscle cramping, decreased appetite, and diarrhea. Chronic antacid use, metformin, or sleep apnea would not typically cause a rapid onset metabolic acidosis with these lab values.\n\nStep 3: Evaluate the options:\n\u2022 Anxiety (Option A) would lead to hyperventilation, causing a respiratory alkalosis, not a metabolic acidosis.\n\u2022 Diarrhea (Option B) can lead to a metabolic acidosis, specifically a hyperchloremic metabolic acidosis, by causing bicarbonate loss.\n\u2022 Metformin (Option C) is associated with lactic acidosis, which can cause a metabolic acidosis, but it tends to occur in situations of renal impairment or overdose. This patient\u2019s history and rapid onset make diarrhea a more likely culprit.\n\u2022 Sleep apnea (Option D) is generally not associated with metabolic acidosis of this type.\n\nFinal Answer: B. Diarrhea"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1"
        ],
        "final_solution": "Step 1: The patient presents with muscle cramping, decreased appetite, and notably diarrhea, which developed over a short period of time. His lab findings show a pH of 7.25 (indicating acidemia), a low bicarbonate of 11 mEq/L (suggesting metabolic acidosis), and a low pCO\u2082 of 22 mmHg, consistent with respiratory compensation.\n\nStep 2: Assess the options:\n\u2022 Anxiety typically leads to hyperventilation, which could lower pCO\u2082; however, it does not usually cause a significant drop in bicarbonate nor a primary metabolic acidosis.\n\u2022 Diarrhea is known to cause a non-anion gap metabolic acidosis due to the loss of bicarbonate in the gastrointestinal tract.\n\u2022 Metformin can cause lactic acidosis, but this patient's symptoms are more directly related to gastrointestinal fluid loss, and his history of acidosis is not typically seen in a single episode like this.\n\u2022 Sleep apnea is not associated with causing an acid-base disturbance that fits these findings.\n\nStep 3: Based on the clinical presentation and laboratory data, the most likely cause of the changes seen in this patient's labs is the loss of bicarbonate due to diarrhea.\n\nFinal answer: B. Diarrhea"
    },
    {
        "realidx": 128,
        "question": "A 47-year-old woman comes to the physician because of progressive muscle weakness for five months. She feels that the muscles in her shoulders and hips have been getting weaker and sometimes feel sore. She now has difficulty getting up from chairs, climbing stairs, and combing her hair. She has also noticed new difficulty with swallowing solid foods, but has no trouble with liquids. She has a 5-year history of hyperlipidemia controlled with fluvastatin. Her maternal uncle died at age 26 from Duchenne's muscular dystrophy and her mother has Hashimoto's thyroiditis. Vital signs are within normal limits. Neurologic examination shows moderate weakness in the arm abductors and hip flexors bilaterally. Deep tendon reflexes are 2+ bilaterally. Laboratory studies show:\nHemoglobin 13.7 g/dL\nLeukocytes 11,200/mm3\nErythrocyte sedimentation rate 33 mm/h\nSerum\nCreatine kinase 212 U/L\nLactate dehydrogenase 164 U/L\nAST 34 U/L\nALT 35 U/L\nWhich of the following is most likely to confirm the diagnosis?\"",
        "answer": "Intrafascicular infiltration on muscle biopsy",
        "options": {
            "A": "Intrafascicular infiltration on muscle biopsy",
            "B": "Perifascicular and perivascular infiltration on muscle biopsy",
            "C": "Positive anti-acetylcholine receptor antibodies",
            "D": "Dystrophin gene mutation on genetic analysis"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old woman",
            "physician",
            "of progressive muscle weakness",
            "five months",
            "feels",
            "muscles",
            "shoulders",
            "hips",
            "getting weaker",
            "sometimes feel sore",
            "now",
            "difficulty getting",
            "chairs",
            "climbing stairs",
            "combing",
            "hair",
            "new difficulty",
            "swallowing solid foods",
            "liquids",
            "5 year history of hyperlipidemia controlled",
            "fluvastatin",
            "maternal uncle died",
            "age",
            "Duchenne",
            "uscular dystrophy ",
            "other ",
            "ashimoto'",
            "yroiditis. ",
            "tal signs a",
            "rmal limits. ",
            "urologic examination s ows m derate w akness i",
            "m a",
            "p f exors b",
            "ep tendon reflexes a",
            " ",
            "boratory studies s ow: ",
            "moglobin 1",
            "dL L ukocytes 1 0/m 3 E ythrocyte sedimentation rate 3",
            "S rum C",
            "Lactate dehydrogenase 1",
            " U",
            "llowing i",
            "st likely t  c nfirm t",
            "agnosis?\""
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 7008,
            "completion_tokens": 6843
        },
        "time_elapsed": 46.8455491065979,
        "raw_responses": [
            "Step 1: Analysis of the clinical picture\n\u2022 The patient is a 47\u2010year\u2010old woman with a 5\u2010month history of progressive symmetric proximal muscle weakness\u2014difficulty rising from chairs, climbing stairs, and combing her hair\u2014as well as dysphagia to solids. These findings are characteristic of an inflammatory myopathy.\n\u2022 Although she has a history of hyperlipidemia on fluvastatin, statin\u2010induced myopathy is less likely because it typically lacks significant dysphagia.\n\u2022 Her family history (maternal uncle with Duchenne\u2019s and a mother with thyroiditis) is less contributory given her presentation and sex.\n\u2022 The laboratory studies show a mildly elevated creatine kinase, which is consistent with muscle injury but is not dramatically high.\n\nStep 2: Narrowing the diagnosis\n\u2022 Inflammatory myopathies such as polymyositis (an autoimmune myopathy) typically present with proximal muscle weakness and may include dysphagia. In dermatomyositis, one would expect characteristic skin findings (which are not described here).\n\u2022 In polymyositis, a definitive diagnosis is made by muscle biopsy.\n\nStep 3: Matching the biopsy findings to the diagnosis\n\u2022 Polymyositis is characterized by endomysial (i.e., within the muscle fascicle) inflammation with CD8+ T lymphocytes invading non-necrotic muscle fibers.\n\u2022 Option A, \u201cIntrafascicular infiltration on muscle biopsy,\u201d is a description consistent with the endomysial (within the fascicle) inflammatory process seen in polymyositis.\n\u2022 Option B describes perifascicular and perivascular inflammation, which is typical of dermatomyositis.\n\u2022 Options C and D refer to diagnoses of myasthenia gravis and Duchenne\u2019s muscular dystrophy, respectively, which do not match this clinical picture.\n\nStep 4: Final Answer\nThe most likely test to confirm the diagnosis is a muscle biopsy demonstrating intrafascicular (endomysial) inflammatory infiltration, as seen in polymyositis.\n\nFinal Answer: A. Intrafascicular infiltration on muscle biopsy",
            "Step 1: Analyze the Presentation\n\u2022 The patient is a 47\u2010year\u2010old woman with a 5\u2010month history of progressive proximal muscle weakness (difficulty getting up from chairs, climbing stairs, combing her hair) and dysphagia (difficulty swallowing solids).\n\u2022 There is a history of fluvastatin use for hyperlipidemia; although statins can cause myopathy, the time course and dysphagia point toward an inflammatory myopathy.\n\u2022 The family history (maternal uncle with Duchenne\u2019s and mother with Hashimoto\u2019s thyroiditis) hints at potential genetic and autoimmune predispositions. However, the clinical picture is most suggestive of an idiopathic inflammatory myopathy\u2014specifically polymyositis.\n\nStep 2: Compare Diagnostic Options\nOption A. Intrafascicular infiltration on muscle biopsy\n\u2003\u2013 In polymyositis, muscle biopsy typically shows endomysial (i.e., within the muscle fascicles) infiltrates of CD8+ T lymphocytes invading nonnecrotic muscle fibers. Although \u201cintrafascicular infiltration\u201d is not the classic term, it corresponds to inflammation within the fascicle, which is consistent with polymyositis.\nOption B. Perifascicular and perivascular infiltration on muscle biopsy\n\u2003\u2013 This pattern is most characteristic of dermatomyositis, a condition usually associated with a distinctive rash (heliotrope rash, Gottron papules) that is not mentioned in this case.\nOption C. Positive anti\u2010acetylcholine receptor antibodies\n\u2003\u2013 These antibodies confirm myasthenia gravis, which typically presents with fluctuating muscle weakness (often with ocular symptoms) and affects both solids and liquids in swallowing.\nOption D. Dystrophin gene mutation on genetic analysis\n\u2003\u2013 This finding would be seen in Duchenne\u2019s (or Becker\u2019s) muscular dystrophy, which presents in childhood or adolescence, not in a 47\u2010year\u2010old woman.\n\nStep 3: Final Answer\nGiven the patient\u2019s presentation of gradual proximal muscle weakness with dysphagia, the most likely diagnosis is polymyositis. The confirmatory diagnostic test is a muscle biopsy showing an inflammatory infiltrate within the muscle fascicles (endomysial infiltration by CD8+ T cells).\n\nFinal answer: A. Intrafascicular infiltration on muscle biopsy",
            "Step 1: Analyze the Clinical Picture\n\u2022 The patient is a 47\u2010year\u2010old woman with a 5\u2010month history of progressive, symmetric proximal muscle weakness (difficulty rising from chairs, climbing stairs, combing her hair).\n\u2022 She also has dysphagia for solids, suggesting involvement of striated muscles in swallowing.\n\u2022 The laboratory studies show a mild creatine kinase elevation.\n\u2022 Although she has a history of hyperlipidemia and uses fluvastatin, her clinical picture (and absence of significant CK elevation typically seen with statin myopathy) along with the dysphagia make an inflammatory myopathy more likely.\n\u2022 The family history (maternal uncle with Duchenne\u2019s and mother with Hashimoto\u2019s thyroiditis) hints at possible genetic and autoimmune predispositions, but her findings are most consistent with an acquired inflammatory process.\n  \nStep 2: Narrowing the Differential Diagnosis\n\u2022 Myasthenia gravis (option C) typically causes fluctuating weakness \u2013 often affecting ocular muscles and causing difficulty with both solids and liquids (and usually a positive anti-acetylcholine receptor antibody test) \u2013 which does not align with her presentation.\n\u2022 A dystrophin gene mutation (option D) is related to Duchenne muscular dystrophy, an X\u2010linked disorder with onset in childhood, not in a 47\u2010year\u2010old woman.\n\u2022 Dermatomyositis (option B) is characterized on muscle biopsy by perifascicular and perivascular inflammatory infiltrates and is usually accompanied by a skin rash, which is not mentioned in this case.\n\u2022 Polymyositis, an inflammatory myopathy characterized by symmetric proximal muscle weakness and potential dysphagia, is most consistent with her presentation. On muscle biopsy, polymyositis classically shows an endomysial (within the fascicles) inflammatory infiltrate that invades muscle fibers.\n  \nStep 3: Matching to the Answer Options\n\u2022 Option A (\u201cIntrafascicular infiltration on muscle biopsy\u201d) is consistent with the findings of an endomysial inflammatory infiltrate seen in polymyositis.\n  \nFinal Answer: A. Intrafascicular infiltration on muscle biopsy"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Analysis of the clinical picture\n\u2022 The patient is a 47\u2010year\u2010old woman with a 5\u2010month history of progressive symmetric proximal muscle weakness\u2014difficulty rising from chairs, climbing stairs, and combing her hair\u2014as well as dysphagia to solids. These findings are characteristic of an inflammatory myopathy.\n\u2022 Although she has a history of hyperlipidemia on fluvastatin, statin\u2010induced myopathy is less likely because it typically lacks significant dysphagia.\n\u2022 Her family history (maternal uncle with Duchenne\u2019s and a mother with thyroiditis) is less contributory given her presentation and sex.\n\u2022 The laboratory studies show a mildly elevated creatine kinase, which is consistent with muscle injury but is not dramatically high.\n\nStep 2: Narrowing the diagnosis\n\u2022 Inflammatory myopathies such as polymyositis (an autoimmune myopathy) typically present with proximal muscle weakness and may include dysphagia. In dermatomyositis, one would expect characteristic skin findings (which are not described here).\n\u2022 In polymyositis, a definitive diagnosis is made by muscle biopsy.\n\nStep 3: Matching the biopsy findings to the diagnosis\n\u2022 Polymyositis is characterized by endomysial (i.e., within the muscle fascicle) inflammation with CD8+ T lymphocytes invading non-necrotic muscle fibers.\n\u2022 Option A, \u201cIntrafascicular infiltration on muscle biopsy,\u201d is a description consistent with the endomysial (within the fascicle) inflammatory process seen in polymyositis.\n\u2022 Option B describes perifascicular and perivascular inflammation, which is typical of dermatomyositis.\n\u2022 Options C and D refer to diagnoses of myasthenia gravis and Duchenne\u2019s muscular dystrophy, respectively, which do not match this clinical picture.\n\nStep 4: Final Answer\nThe most likely test to confirm the diagnosis is a muscle biopsy demonstrating intrafascicular (endomysial) inflammatory infiltration, as seen in polymyositis.\n\nFinal Answer: A. Intrafascicular infiltration on muscle biopsy"
    },
    {
        "realidx": 145,
        "question": "A 5-year-old boy is brought to the physician because of facial swelling that started 5 days ago. Two weeks ago, he had a sore throat that resolved spontaneously. His temperature is 37\u00b0C (98.6\u00b0F), pulse is 107/min, and blood pressure is 94/67 mm Hg. Examination shows pitting edema of the upper and lower extremities as well as periorbital edema. The abdomen is mildly distended. Laboratory studies show:\nHemoglobin 13.1 g/dL\nSerum\nAlbumin 2.1 g/dL\nTotal cholesterol 270 mg/dL\nTriglycerides 175 mg/dL\nUrine\nBlood negative\nGlucose negative\nProtein 4+\nLeukocyte esterase negative\nA renal biopsy of this patient is most likely to show which of the following findings?\"",
        "answer": "Normal light microscopy findings",
        "options": {
            "A": "Mesangial proliferation on light microscopy",
            "B": "Subepithelial dense deposits on electron microscopy",
            "C": "Deposits of IgG and C3 at the glomerular basement membrane on immunofluoresence",
            "D": "Normal light microscopy findings"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "5 year old boy",
            "brought",
            "physician",
            "facial swelling",
            "started 5 days",
            "Two weeks",
            "sore throat",
            "resolved",
            "temperature",
            "98",
            "pulse",
            "min",
            "blood pressure",
            "67 mm Hg",
            "Examination shows pitting edema",
            "upper",
            "lower extremities",
            "periorbital edema",
            "abdomen",
            "mildly distended",
            "Laboratory studies show",
            "Hemoglobin",
            "Serum",
            "Triglycerides",
            "Urine",
            "negative",
            "Leukocyte",
            "renal biopsy",
            "patient",
            "most likely to show",
            "following findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5274,
            "completion_tokens": 3771
        },
        "time_elapsed": 29.210075616836548,
        "raw_responses": [
            "Step 1: Analyze the Clinical Picture\n\u2022 The patient is a 5-year-old boy presenting with edema (including periorbital edema) that developed 5 days ago.\n\u2022 He has a prior history of a sore throat two weeks ago.\n\u2022 Laboratory findings reveal hypoalbuminemia (albumin 2.1 g/dL), hypercholesterolemia (total cholesterol 270 mg/dL), and heavy proteinuria (4+ protein on urine dipstick with no hematuria), which together are consistent with a diagnosis of nephrotic syndrome.\n\nStep 2: Consider the Likely Diagnosis\n\u2022 In children, the most common cause of nephrotic syndrome is minimal change disease (MCD), which often follows a recent infection.\n\u2022 MCD is characterized by marked proteinuria but normally appears unremarkable on light microscopy. The changes (effacement of podocyte foot processes) are only visible on electron microscopy, while immunofluorescence studies are usually negative.\n\nStep 3: Evaluate the Options\nA. Mesangial proliferation on light microscopy \u2013 This is characteristic of IgA nephropathy, not minimal change disease.\nB. Subepithelial dense deposits on electron microscopy \u2013 This finding is typical of membranous nephropathy, not minimal change disease.\nC. Deposits of IgG and C3 at the glomerular basement membrane on immunofluorescence \u2013 This is seen in immune complex-mediated glomerulonephritides such as membranous nephropathy.\nD. Normal light microscopy findings \u2013 This is the classic histologic finding in minimal change disease.\n\nStep 4: Final Answer\nGiven the clinical presentation consistent with minimal change disease and its characteristic biopsy findings, the correct answer is:\n\nD. Normal light microscopy findings",
            "Step 1: Recognize that the patient\u2019s presentation is consistent with nephrotic syndrome. The key findings include periorbital and peripheral edema, hypoalbuminemia (2.1 g/dL), hyperlipidemia (total cholesterol 270 mg/dL, triglycerides 175 mg/dL), and heavy proteinuria (4+). \n\nStep 2: In a 5-year-old, the most common cause of nephrotic syndrome is minimal change disease, which often follows a respiratory infection.\n\nStep 3: On renal biopsy in minimal change disease, light microscopy typically appears normal, with the diagnosis being made by the finding of diffuse podocyte foot process effacement on electron microscopy.\n\nStep 4: Compare the options:\nA. Mesangial proliferation on light microscopy \u2013 seen in conditions like IgA nephropathy.\nB. Subepithelial dense deposits on electron microscopy \u2013 typical for membranous nephropathy.\nC. Deposits of IgG and C3 at the glomerular basement membrane on immunofluorescence \u2013 suggestive of post-infectious glomerulonephritis.\nD. Normal light microscopy findings \u2013 characteristic of minimal change disease.\n\nFinal Answer: D. Normal light microscopy findings",
            "Step 1: Recognize the clinical syndrome.\n\u2022 The 5-year-old boy presents with facial and peripheral edema, hypoalbuminemia (2.1 g/dL), hypercholesterolemia (270 mg/dL), and significant proteinuria. These findings are characteristic of nephrotic syndrome.\n\u2022 In children, the most common cause of nephrotic syndrome is minimal change disease (MCD).\n\nStep 2: Evaluate biopsy findings for minimal change disease.\n\u2022 Minimal change disease is notable for having essentially normal light microscopy.\n\u2022 Electron microscopy, which isn\u2019t detailed in the answer options, would reveal diffuse effacement of the foot processes.\n  \nStep 3: Eliminate the other options.\nA. Mesangial proliferation on light microscopy \u2013 This finding is more typical of IgA nephropathy or other glomerulonephritides, not MCD.\nB. Subepithelial dense deposits on electron microscopy \u2013 This describes membranous nephropathy.\nC. Deposits of IgG and C3 at the glomerular basement membrane on immunofluorescence \u2013 This is more consistent with post-streptococcal glomerulonephritis, a nephritic process, not seen in MCD.\n\nStep 4: Provide the final answer.\nThe best answer is:\nD. Normal light microscopy findings"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Recognize that the patient\u2019s presentation is consistent with nephrotic syndrome. The key findings include periorbital and peripheral edema, hypoalbuminemia (2.1 g/dL), hyperlipidemia (total cholesterol 270 mg/dL, triglycerides 175 mg/dL), and heavy proteinuria (4+). \n\nStep 2: In a 5-year-old, the most common cause of nephrotic syndrome is minimal change disease, which often follows a respiratory infection.\n\nStep 3: On renal biopsy in minimal change disease, light microscopy typically appears normal, with the diagnosis being made by the finding of diffuse podocyte foot process effacement on electron microscopy.\n\nStep 4: Compare the options:\nA. Mesangial proliferation on light microscopy \u2013 seen in conditions like IgA nephropathy.\nB. Subepithelial dense deposits on electron microscopy \u2013 typical for membranous nephropathy.\nC. Deposits of IgG and C3 at the glomerular basement membrane on immunofluorescence \u2013 suggestive of post-infectious glomerulonephritis.\nD. Normal light microscopy findings \u2013 characteristic of minimal change disease.\n\nFinal Answer: D. Normal light microscopy findings"
    },
    {
        "realidx": 149,
        "question": "An 11-month-old boy is brought to the clinic by his mother for a rash on his trunk, which he has had for the past 2 days. She notes that he is eating less and is more cranky than usual. His birth history is insignificant, and his immunizations are up to date. Vital signs include: temperature is 37.8\u00b0C (100.0\u00b0F), pulse is 98/min, and respiratory rate is 16/min. The rash features thin-walled, fluid-filled blisters that rupture easily. Fluid samples from the lesions are sent for analysis to a microbiology lab. The results reveal an infection by the gram-positive bacterium Staphylococcus aureus. The patient is diagnosed with staphylococcal scalded skin syndrome. Which of the following is involved with the primary defense in response to the bacteria and toxins produced by this organism?",
        "answer": "Immunoglobulin- IgM",
        "options": {
            "A": "Immunoglobulin- IgG",
            "B": "Immunoglobulin- IgD",
            "C": "Immunoglobulin- IgA",
            "D": "Immunoglobulin- IgM"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "month old boy",
            "brought",
            "clinic",
            "mother",
            "rash",
            "trunk",
            "past 2 days",
            "notes",
            "eating less",
            "more",
            "usual",
            "birth history",
            "immunizations",
            "date",
            "Vital signs include",
            "temperature",
            "100",
            "pulse",
            "98 min",
            "respiratory rate",
            "min",
            "rash features thin walled",
            "fluid filled blisters",
            "rupture easily",
            "Fluid samples",
            "lesions",
            "sent",
            "analysis",
            "microbiology lab",
            "results reveal",
            "infection",
            "gram-positive bacterium Staphylococcus aureus",
            "patient",
            "diagnosed",
            "staphylococcal scalded skin syndrome",
            "following",
            "involved",
            "primary defense",
            "response to",
            "bacteria",
            "toxins",
            "organism"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4581,
            "completion_tokens": 3058
        },
        "time_elapsed": 24.856675386428833,
        "raw_responses": [
            "Step 1: Analyze the details provided. The patient is an 11-month-old boy with staphylococcal scalded skin syndrome (SSSS) caused by Staphylococcus aureus producing exotoxins. This condition is mediated by toxins that disrupt cell adhesion in the epidermis.\n\nStep 2: Consider the role of various immunoglobulins in the defense against bacterial pathogens and their toxins. Immunoglobulin IgG, which is the most abundant immunoglobulin in circulation, plays a critical role in neutralizing toxins produced by bacteria like Staphylococcus aureus. In infants, the lack of sufficient IgG may predispose them to toxin-mediated conditions.\n\nStep 3: Compare the options:\n\u2022 IgG (Option A) is primarily responsible for opsonization and neutralization of toxins.\n\u2022 IgD (Option B) is mainly present on the surface of B cells and does not play a major role in neutralizing toxins.\n\u2022 IgA (Option C) is the primary immunoglobulin found at mucosal surfaces, but its role is more about protecting those surfaces, not neutralizing circulating toxins.\n\u2022 IgM (Option D) is the first immunoglobulin generated during an immune response but is less effective at neutralizing toxins compared to IgG.\n\nFinal Answer: A. Immunoglobulin- IgG",
            "Step 1: Recognize that staphylococcal scalded skin syndrome is caused by exfoliative toxins produced by Staphylococcus aureus, which are primarily neutralized by circulating antibodies.\n\nStep 2: Recall that Immunoglobulin G (IgG) is the main antibody in the blood that opsonizes bacteria and neutralizes toxins. Although IgM is the first antibody produced in a primary immune response, it is IgG that also provides robust toxin neutralization and long-term protection. IgA mainly functions in mucosal areas, and IgD\u2019s role is less defined in this context.\n\nStep 3: Thus, the primary defense against the bacteria and its toxins in this syndrome is mediated by IgG.\n\nFinal answer: A. Immunoglobulin- IgG",
            "This patient\u2019s presentation is consistent with staphylococcal scalded skin syndrome (SSSS), which is caused by exotoxins produced by Staphylococcus aureus. These exotoxins\u2014known as exfoliative toxins\u2014cause cleavage within the superficial epidermis, leading to the characteristic blistering and rash.\n\nWhen considering the primary defense against bacteria and its toxins, the humoral immune system plays an important role. Opsonization and neutralization of bacterial toxins are largely mediated by Immunoglobulin G (IgG). IgG is the most abundant antibody in the serum and is crucial for opsonizing bacteria and neutralizing toxins, thus facilitating clearance by phagocytic cells.\n\nStep by step:\n1. The patient\u2019s rash and clinical history point toward SSSS.\n2. SSSS stems from Staphylococcus aureus toxins.\n3. The immune system\u2019s primary defense against bacterial toxins involves antibodies that can neutralize these toxins.\n4. Among the immunoglobulin classes given, IgG is the major antibody in the blood that opsonizes bacteria and neutralizes toxins.\n\nTherefore, the correct answer is:\nA: Immunoglobulin- IgG"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "This patient\u2019s presentation is consistent with staphylococcal scalded skin syndrome (SSSS), which is caused by exotoxins produced by Staphylococcus aureus. These exotoxins\u2014known as exfoliative toxins\u2014cause cleavage within the superficial epidermis, leading to the characteristic blistering and rash.\n\nWhen considering the primary defense against bacteria and its toxins, the humoral immune system plays an important role. Opsonization and neutralization of bacterial toxins are largely mediated by Immunoglobulin G (IgG). IgG is the most abundant antibody in the serum and is crucial for opsonizing bacteria and neutralizing toxins, thus facilitating clearance by phagocytic cells.\n\nStep by step:\n1. The patient\u2019s rash and clinical history point toward SSSS.\n2. SSSS stems from Staphylococcus aureus toxins.\n3. The immune system\u2019s primary defense against bacterial toxins involves antibodies that can neutralize these toxins.\n4. Among the immunoglobulin classes given, IgG is the major antibody in the blood that opsonizes bacteria and neutralizes toxins.\n\nTherefore, the correct answer is:\nA: Immunoglobulin- IgG"
    },
    {
        "realidx": 155,
        "question": "A 19-year-old man is brought to the emergency department by ambulance because of unusual behavior that started 3 hours ago while he was at a party. He has a history of major depressive disorder and seasonal allergies. His mother has a history of anxiety. He drinks 5 beers on the weekends. Current medications include amitriptyline and diphenhydramine. The patient does not respond to questions and repeatedly says, \"\"The government is following me everywhere.\"\" His temperature is 37.9\u00b0C (100.2\u00b0F), pulse is 115/min, respirations are 24/min, and blood pressure is 160/89 mm Hg. He is diaphoretic. He is not oriented to place or time. Neurologic examination shows dilated pupils bilaterally and diffuse hyperreflexia. His feet are cold, and capillary refill time is 3 seconds. After the examination, the patient starts screaming and tries to bite the physician. Urine toxicology screening is positive for ethyl glucuronide. Which of the following is the most likely explanation for this patient's symptoms?\"",
        "answer": "Synthetic cathinone intoxication",
        "options": {
            "A": "Brief psychotic disorder",
            "B": "Neuroleptic malignant syndrome",
            "C": "Anticholinergic toxicity",
            "D": "Synthetic cathinone intoxication"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man",
            "brought",
            "emergency department",
            "ambulance",
            "unusual behavior",
            "started 3 hours",
            "party",
            "history of major depressive disorder",
            "seasonal allergies",
            "mother",
            "history",
            "anxiety",
            "drinks 5 beers",
            "weekends",
            "Current medications include amitriptyline",
            "diphenhydramine",
            "patient",
            "not",
            "questions",
            "repeatedly",
            "government",
            "following",
            "temperature",
            "100",
            "pulse",
            "min",
            "respirations",
            "min",
            "blood pressure",
            "mm Hg",
            "diaphoretic",
            "not oriented to place",
            "time",
            "Neurologic examination shows dilated pupils",
            "diffuse hyperreflexia",
            "feet",
            "cold",
            "capillary refill time",
            "3 seconds",
            "examination",
            "patient starts screaming",
            "to bite",
            "physician",
            "Urine toxicology",
            "positive",
            "ethyl glucuronide",
            "following",
            "most likely explanation",
            "patient",
            "ymptoms?"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 7041,
            "completion_tokens": 4490
        },
        "time_elapsed": 35.24729633331299,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s symptoms and context. The 19-year-old man was at a party and subsequently developed acute behavioral changes, including paranoia (believing \"the government is following me\"), disorientation, agitation, and aggression. His vital signs reveal sympathetic stimulation (tachycardia, hypertension, mild fever, tachypnea), and his physical exam shows dilated pupils and hyperreflexia with diaphoresis.\n\nStep 2: Evaluate the options:\n\nA. Brief psychotic disorder \u2013 While this can present with acute psychosis, it is less likely to cause significant autonomic instability (i.e., tachycardia, hypertension, diaphoresis) and hyperreflexia.\n\nB. Neuroleptic malignant syndrome \u2013 Typically occurs as an adverse reaction to antipsychotics (or rarely other dopamine antagonists) and is characterized by rigidity, altered mental status, fever, and autonomic dysfunction. This patient is not on any antipsychotic agents, and his presentation is more consistent with agitation and combativeness rather than rigidity.\n\nC. Anticholinergic toxicity \u2013 Usually presents with altered mental status, mydriasis, and hyperthermia; however, it is typically associated with dry skin due to anhidrosis. This patient is diaphoretic, which argues against an anticholinergic toxidrome.\n\nD. Synthetic cathinone intoxication \u2013 Synthetic cathinones (\u201cbath salts\u201d) commonly produce severe agitation, psychosis, sympathetic overactivity (tachycardia, hypertension), and can cause aggression. Additionally, these substances often do not appear on routine toxicology screens, so a positive urine ethyl glucuronide (indicating alcohol use) does not exclude the possibility of concomitant ingestion of synthetic cathinones.\n\nStep 3: Final Answer\n\nThe constellation of acute psychosis, aggressive behavior, autonomic instability, and the context of a party, along with the lack of detection of synthetic cathinones on standard screens, makes synthetic cathinone intoxication the most likely explanation for this patient\u2019s symptoms.\n\nFinal Answer: D. Synthetic cathinone intoxication",
            "Step 1: Review the patient\u2019s presentation. The patient is a 19-year-old man with a history of major depressive disorder who, after attending a party, presents with agitation, paranoia (\"The government is following me everywhere\"), confusion, disorientation, and aggression. His physical exam shows tachycardia, hypertension, low-grade fever, diaphoresis, dilated pupils, and hyperreflexia. Although his urine toxicology is positive for ethyl glucuronide (indicating alcohol use), his clinical picture goes beyond simple alcohol intoxication.\n\nStep 2: Evaluate each option.\n\nA. Brief psychotic disorder \u2013 This can cause paranoia and disorganized behavior, but it does not typically result in the marked autonomic instability (tachycardia, hypertension, hyperreflexia) or the sympathomimetic findings seen here.\n\nB. Neuroleptic malignant syndrome \u2013 NMS is associated with the use of antipsychotic medications and is characterized by muscle rigidity, fever, and autonomic instability. The patient is not on antipsychotics, and his exam shows hyperreflexia rather than the \"lead-pipe\" rigidity seen in NMS.\n\nC. Anticholinergic toxicity \u2013 This typically presents with dry skin, urinary retention, and altered mental status (often with mydriasis), but the patient is diaphoretic (sweating) rather than dry, making this option unlikely.\n\nD. Synthetic cathinone intoxication \u2013 Synthetic cathinones (\"bath salts\") are known to cause profound agitation, paranoia, sympathomimetic signs (tachycardia, hypertension, hyperthermia), and bizarre behavior, often mimicking psychosis. Even if there is concurrent alcohol use, the degree and nature of the symptoms are best explained by synthetic cathinone intoxication.\n\nStep 3: Conclusion\n\nGiven the combination of a recent party exposure, the sympathomimetic signs, and the behavioral disturbances (agitation, paranoia, disorientation), the most likely explanation for the patient\u2019s symptoms is synthetic cathinone intoxication.\n\nFinal answer: D. Synthetic cathinone intoxication.",
            "Step 1: Analyze the patient\u2019s presentation. The patient is a 19\u2010year\u2010old man who started acting bizarrely at a party 3 hours ago. His symptoms include:\n\u2003\u2022 Paranoid delusions (\u201cThe government is following me everywhere\u201d)\n\u2003\u2022 Agitation, combativeness (even trying to bite the physician)\n\u2003\u2022 Autonomic instability with tachycardia (pulse 115/min), hypertension (BP 160/89 mm Hg), mild fever (37.9\u00b0C), and diaphoresis\n\u2003\u2022 Neurologic findings of dilated pupils and diffuse hyperreflexia\nHe also has a history of major depressive disorder and is on amitriptyline and diphenhydramine, but his acute presentation seems more consistent with an intoxication rather than a medication side effect.\n\nStep 2: Evaluate the options.\n\u2003A. Brief psychotic disorder \u2013 While this could explain paranoia and disorientation, it would not account for the physical findings of autonomic instability (tachycardia, hypertension, diaphoresis, hyperreflexia) and the violent behavior seen in this patient.\n\u2003B. Neuroleptic malignant syndrome \u2013 This condition is typically associated with the use of antipsychotics or dopamine blockers, and it is characterized by muscle rigidity, altered mental status, and hyperthermia. The patient is not on any antipsychotics, and his exam shows hyperreflexia rather than the \u201clead-pipe\u201d rigidity seen in NMS.\n\u2003C. Anticholinergic toxicity \u2013 Although he is on amitriptyline and diphenhydramine (both of which have anticholinergic properties), anticholinergic toxicity usually presents with dry skin, dry mucous membranes, urinary retention, and flushed skin \u2013 not diaphoresis and the combination of hyperactivity and combativeness observed.\n\u2003D. Synthetic cathinone intoxication \u2013 Synthetic cathinones (commonly known as \u201cbath salts\u201d) can cause severe agitation, combativeness, paranoia, autonomic hyperactivity (tachycardia, hypertension, diaphoresis), dilated pupils, and hyperreflexia. They often present with a clinical picture similar to the patient\u2019s, and they are notorious for not being detected on routine toxicology screening. Although his urine toxicology screening is positive for ethyl glucuronide, indicating recent alcohol use, this does not rule out concurrent synthetic cathinone use.\n\nStep 3: Conclusion.\nGiven the clinical picture and elimination of other choices based on inconsistent findings, the most likely explanation for this patient\u2019s symptoms is intoxication with synthetic cathinones.\n\nFinal Answer: D. Synthetic cathinone intoxication"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Analyze the patient\u2019s presentation. The patient is a 19\u2010year\u2010old man who started acting bizarrely at a party 3 hours ago. His symptoms include:\n\u2003\u2022 Paranoid delusions (\u201cThe government is following me everywhere\u201d)\n\u2003\u2022 Agitation, combativeness (even trying to bite the physician)\n\u2003\u2022 Autonomic instability with tachycardia (pulse 115/min), hypertension (BP 160/89 mm Hg), mild fever (37.9\u00b0C), and diaphoresis\n\u2003\u2022 Neurologic findings of dilated pupils and diffuse hyperreflexia\nHe also has a history of major depressive disorder and is on amitriptyline and diphenhydramine, but his acute presentation seems more consistent with an intoxication rather than a medication side effect.\n\nStep 2: Evaluate the options.\n\u2003A. Brief psychotic disorder \u2013 While this could explain paranoia and disorientation, it would not account for the physical findings of autonomic instability (tachycardia, hypertension, diaphoresis, hyperreflexia) and the violent behavior seen in this patient.\n\u2003B. Neuroleptic malignant syndrome \u2013 This condition is typically associated with the use of antipsychotics or dopamine blockers, and it is characterized by muscle rigidity, altered mental status, and hyperthermia. The patient is not on any antipsychotics, and his exam shows hyperreflexia rather than the \u201clead-pipe\u201d rigidity seen in NMS.\n\u2003C. Anticholinergic toxicity \u2013 Although he is on amitriptyline and diphenhydramine (both of which have anticholinergic properties), anticholinergic toxicity usually presents with dry skin, dry mucous membranes, urinary retention, and flushed skin \u2013 not diaphoresis and the combination of hyperactivity and combativeness observed.\n\u2003D. Synthetic cathinone intoxication \u2013 Synthetic cathinones (commonly known as \u201cbath salts\u201d) can cause severe agitation, combativeness, paranoia, autonomic hyperactivity (tachycardia, hypertension, diaphoresis), dilated pupils, and hyperreflexia. They often present with a clinical picture similar to the patient\u2019s, and they are notorious for not being detected on routine toxicology screening. Although his urine toxicology screening is positive for ethyl glucuronide, indicating recent alcohol use, this does not rule out concurrent synthetic cathinone use.\n\nStep 3: Conclusion.\nGiven the clinical picture and elimination of other choices based on inconsistent findings, the most likely explanation for this patient\u2019s symptoms is intoxication with synthetic cathinones.\n\nFinal Answer: D. Synthetic cathinone intoxication"
    },
    {
        "realidx": 160,
        "question": "A 5-year-old boy of African descent is presented to the emergency department by his parents. The child is clutching his abdomen and crying about pain in his belly. His mother reports intermittent episodes of jaundice with joint and bone pain since he was 5 months old. At presentation, the patient\u2019s vital signs are within normal limits. Physical examination reveals slight jaundice and pale conjunctiva. The spleen is tender and easily palpable. After a complete blood count with differential and an abdominal ultrasound, the patient is found to have sickle-cell disease with splenic infarct. A partial splenectomy is performed. After the operation, the physician provides vaccines against Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae. The picture shows a slide obtained from the resected portion of the patient\u2019s spleen. Dysfunction of the zone marked with which number predisposes the patient to the aforementioned infections?",
        "answer": "1 and 2",
        "options": {
            "A": "2 only",
            "B": "1 only",
            "C": "1 and 2",
            "D": "1, 2, and 3"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "5 year old boy",
            "African descent",
            "presented",
            "emergency department",
            "parents",
            "child",
            "abdomen",
            "crying",
            "pain",
            "belly",
            "mother reports intermittent episodes of jaundice",
            "joint",
            "bone pain",
            "5 months old",
            "presentation",
            "patients vital signs",
            "normal",
            "Physical examination reveals slight jaundice",
            "pale conjunctiva",
            "spleen",
            "tender",
            "easily palpable",
            "complete blood count",
            "differential",
            "abdominal ultrasound",
            "patient",
            "found to",
            "sickle-cell disease",
            "splenic infarct",
            "partial splenectomy",
            "performed",
            "operation",
            "physician provides vaccines",
            "Neisseria meningitidis",
            "Haemophilus influenzae",
            "Streptococcus pneumoniae",
            "picture shows",
            "slide obtained",
            "resected portion of",
            "patients spleen",
            "Dysfunction",
            "zone marked",
            "number",
            "patient",
            "infections"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5073,
            "completion_tokens": 5959
        },
        "time_elapsed": 40.89576697349548,
        "raw_responses": [
            "Step 1: Understand the clinical scenario.  \n\u2022 A 5\u2010year\u2010old boy with sickle cell disease and a splenic infarct underwent a partial splenectomy.  \n\u2022 Vaccines against encapsulated organisms (Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae) were given, highlighting the importance of splenic function in clearing these pathogens.\n\nStep 2: Recall splenic anatomy and its immunologic zones.  \nThe spleen contains:\n\u20031. White pulp \u2013 organized lymphoid tissue (including periarteriolar lymphoid sheaths [PALS] and lymphoid follicles).\n\u20032. Marginal zone \u2013 the interface between white pulp and red pulp, rich in specialized B cells (IgM memory B cells) and macrophages; it plays a critical role in the rapid opsonization and removal of encapsulated bacteria.\n\u20033. Red pulp \u2013 involved in filtration and removal of old/damaged red blood cells.\n\nStep 3: Identify the zone relevant to infections by encapsulated bacteria.  \nThe marginal zone (typically designated as \u201czone 2\u201d in splenic diagrams) is particularly important in opsonizing encapsulated organisms. Dysfunction of this zone predisposes patients to infections by Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae.\n\nStep 4: Compare answer choices.  \nYou are asked: \u201cDysfunction of the zone marked with which number predisposes the patient to the aforementioned infections?\u201d  \nGiven that the marginal zone (number 2) is responsible for this, the correct answer is:\n\u2003A. 2 only.\n\nFinal Answer: A  \nThus, dysfunction of the marginal zone (zone 2) predisposes the patient to these infections.",
            "Step 1: In the spleen, there are distinct regions with different functions. Here, the three main zones are the red pulp, white pulp, and the marginal zone. The red pulp functions mainly in filtering aged red blood cells, whereas the white pulp is involved in adaptive immunity. The marginal zone sits between the red and white pulp and is key in the early immune response to pathogens\u2014especially encapsulated bacteria\u2014by housing IgM memory B cells.\n\nStep 2: Encapsulated organisms (Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae) are normally cleared by the actions of the splenic marginal zone. When this region is dysfunctional or absent (as in cases of splenic infarcts and splenectomy), the patient becomes predisposed to severe infections by these bacteria.\n\nStep 3: Based on the provided options and the known functions of the splenic zones, dysfunction of the marginal zone (typically denoted by \u201c2\u201d in splenic histologic diagrams showing the three zones) is responsible for this increased susceptibility.\n\nFinal Answer: A. 2 only",
            "Step 1: Recognize that the patient\u2019s history of sickle cell disease with splenic infarct leads to functional asplenia, resulting in a predisposition to infections with encapsulated organisms (Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae).\n\nStep 2: Recall the splenic architecture. The spleen has three important zones:\n\u2003\u2022 White pulp (which includes the periarteriolar lymphoid sheaths, typically labeled \u201c1\u201d),\n\u2003\u2022 The marginal zone (commonly identified separately, often labeled \u201c2\u201d), and\n\u2003\u2022 Red pulp (typically labeled \u201c3\u201d).\nThe marginal zone is crucial because it contains IgM memory B cells and functions as the first line of defense in filtering blood-borne pathogens, especially encapsulated bacteria.\n\nStep 3: Based on the provided image (with numbers labeling zones) and the fact that dysfunction in the marginal zone predisposes to the infections mentioned, the answer is that it is the marginal zone (zone number 2) whose dysfunction is most responsible.\n\nFinal Answer: A. 2 only."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Recognize that the patient\u2019s history of sickle cell disease with splenic infarct leads to functional asplenia, resulting in a predisposition to infections with encapsulated organisms (Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae).\n\nStep 2: Recall the splenic architecture. The spleen has three important zones:\n\u2003\u2022 White pulp (which includes the periarteriolar lymphoid sheaths, typically labeled \u201c1\u201d),\n\u2003\u2022 The marginal zone (commonly identified separately, often labeled \u201c2\u201d), and\n\u2003\u2022 Red pulp (typically labeled \u201c3\u201d).\nThe marginal zone is crucial because it contains IgM memory B cells and functions as the first line of defense in filtering blood-borne pathogens, especially encapsulated bacteria.\n\nStep 3: Based on the provided image (with numbers labeling zones) and the fact that dysfunction in the marginal zone predisposes to the infections mentioned, the answer is that it is the marginal zone (zone number 2) whose dysfunction is most responsible.\n\nFinal Answer: A. 2 only."
    },
    {
        "realidx": 171,
        "question": "A 38-year-old G4P3 presents to her obstetrician\u2019s office for her 20-week anatomy ultrasound. She reports that she feels well and has not experienced any contractions or vaginal bleeding. She also reports good fetal movement. The patient declined prenatal screening earlier in the pregnancy for religious reasons but would now like an anatomy ultrasound to ensure the fetus is growing appropriately. The patient\u2019s previous pregnancies were uncomplicated, and she delivered three healthy babies at full term. On the ultrasound, the technician observes a male fetus with likely intrauterine growth restriction (IUGR). She also notes microcephaly, convex-rounded feet, and clenched fists with overlapping fingers. The technician further notes a medium-sized ventricular septal defect (VSD). The amniotic fluid index (AFI) is 26 cm.\n\nWhich of the following additional findings is most likely to be observed in this fetus?",
        "answer": "Prominent occiput",
        "options": {
            "A": "Cleft palate",
            "B": "Epicanthal folds",
            "C": "Micropthlamia",
            "D": "Prominent occiput"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old",
            "presents",
            "obstetricians office",
            "20 week anatomy ultrasound",
            "reports",
            "feels well",
            "not experienced",
            "contractions",
            "vaginal bleeding",
            "reports good fetal movement",
            "patient",
            "prenatal screening earlier",
            "pregnancy",
            "religious reasons",
            "now",
            "anatomy ultrasound to ensure",
            "fetus",
            "patients previous pregnancies",
            "uncomplicated",
            "delivered three healthy babies",
            "full term",
            "ultrasound",
            "technician observes",
            "male fetus",
            "likely intrauterine growth restriction",
            "notes microcephaly",
            "convex rounded feet",
            "clenched fists",
            "overlapping fingers",
            "technician further notes",
            "medium sized ventricular septal defect",
            "amniotic fluid index",
            "following additional findings",
            "most likely to",
            "observed",
            "fetus"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4689,
            "completion_tokens": 3804
        },
        "time_elapsed": 29.203375816345215,
        "raw_responses": [
            "Step 1: Identify the syndrome based on ultrasound findings. The fetus has intrauterine growth restriction, microcephaly, convex\u2010rounded (rocker-bottom) feet, and clenched fists with overlapping fingers, along with a ventricular septal defect and polyhydramnios. These features are most consistent with Edwards syndrome (Trisomy 18).\n\nStep 2: Recall additional common findings in Edwards syndrome. In this condition, a prominent occiput is a well\u2010recognized feature.\n\nStep 3: Evaluate the answer choices:\n\u2022 A. Cleft palate \u2013 More commonly seen in Patau syndrome (Trisomy 13).\n\u2022 B. Epicanthal folds \u2013 These are more characteristic of Down syndrome (Trisomy 21).\n\u2022 C. Microphthalmia \u2013 Also a feature more associated with Trisomy 13.\n\u2022 D. Prominent occiput \u2013 A classic finding in Edwards syndrome (Trisomy 18).\n\nStep 4: Final Answer \u2013 The most likely additional finding is a prominent occiput.\n\nFinal Answer: D. Prominent occiput",
            "Step-by-Step Reasoning:\n\n1. The ultrasound findings in a 20-week fetus include intrauterine growth restriction (IUGR), microcephaly, distinctive limb abnormalities (convex-rounded feet and clenched fists with overlapping fingers), a ventricular septal defect (VSD), and an increased amniotic fluid index. These constellation of features is strongly associated with trisomy 18 (Edwards syndrome).\n\n2. Trisomy 18 often presents with additional typical craniofacial features, such as a prominent occiput and micrognathia. While there may be various other findings, prominent occiput is a classical finding.\n\n3. Evaluating the answer choices:\n\u2003\u2022 A. Cleft palate \u2013 More commonly seen in trisomy 13.\n\u2003\u2022 B. Epicanthal folds \u2013 Can be seen in Down syndrome (trisomy 21) but not as characteristic for trisomy 18.\n\u2003\u2022 C. Micropthalmia \u2013 Not a classic feature in trisomy 18.\n\u2003\u2022 D. Prominent occiput \u2013 This is a typical finding in trisomy 18.\n\n4. Therefore, the additional finding most likely to be observed in this fetus is a prominent occiput.\n\nFinal answer: D. Prominent occiput",
            "Step 1: Review the ultrasound findings. The fetus shows intrauterine growth restriction, microcephaly, convex-rounded (rocker-bottom) feet, clenched fists with overlapping fingers, and a VSD. These are classic features of Edwards syndrome (Trisomy 18).\n\nStep 2: Match these with typical features of Trisomy 18. Beyond what is seen, Edwards syndrome is also associated with a prominent occiput, along with other findings like low-set ears and micrognathia.\n\nStep 3: Evaluate the answer choices:\n\u2003A. Cleft palate \u2013 More commonly seen in Trisomy 13 (Patau syndrome).\n\u2003B. Epicanthal folds \u2013 More characteristic of Down syndrome (Trisomy 21).\n\u2003C. Micropthlamia \u2013 (likely referring to microphthalmia) \u2013 Also a feature seen in Trisomy 13.\n\u2003D. Prominent occiput \u2013 This additional finding aligns with Edwards syndrome (Trisomy 18).\n\nFinal Answer: D. Prominent occiput."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step-by-Step Reasoning:\n\n1. The ultrasound findings in a 20-week fetus include intrauterine growth restriction (IUGR), microcephaly, distinctive limb abnormalities (convex-rounded feet and clenched fists with overlapping fingers), a ventricular septal defect (VSD), and an increased amniotic fluid index. These constellation of features is strongly associated with trisomy 18 (Edwards syndrome).\n\n2. Trisomy 18 often presents with additional typical craniofacial features, such as a prominent occiput and micrognathia. While there may be various other findings, prominent occiput is a classical finding.\n\n3. Evaluating the answer choices:\n\u2003\u2022 A. Cleft palate \u2013 More commonly seen in trisomy 13.\n\u2003\u2022 B. Epicanthal folds \u2013 Can be seen in Down syndrome (trisomy 21) but not as characteristic for trisomy 18.\n\u2003\u2022 C. Micropthalmia \u2013 Not a classic feature in trisomy 18.\n\u2003\u2022 D. Prominent occiput \u2013 This is a typical finding in trisomy 18.\n\n4. Therefore, the additional finding most likely to be observed in this fetus is a prominent occiput.\n\nFinal answer: D. Prominent occiput"
    },
    {
        "realidx": 178,
        "question": "A 40-year-old businessman who was previously well is brought into the emergency department by his assistant with a complaint of left-sided weakness after a chiropractic neck manipulation. He has never felt like this before. Past medical history is insignificant. His blood pressure is 125/75 mm Hg, pulse 86/min, respiratory rate 13/min, temperature 36.8\u00b0C (98.2\u00b0F). A T2-weighted MRI shows a left C5 hemicord lesion. The patient is treated with cervical immobilization, a course of steroids, and physical therapy. What other finding will most likely be seen in this patient?",
        "answer": "Right-sided analgesia",
        "options": {
            "A": "Spastic paralysis at the level of lesion",
            "B": "Right-sided Horner's syndrome",
            "C": "Contralateral corticospinal tract involvement",
            "D": "Right-sided analgesia"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "40 year old",
            "well",
            "brought",
            "emergency department",
            "assistant",
            "complaint",
            "left-sided weakness",
            "chiropractic neck",
            "never felt",
            "before",
            "Past medical history",
            "blood pressure",
            "75 mm Hg",
            "pulse",
            "min",
            "respiratory rate",
            "min",
            "temperature 36",
            "98",
            "T2 weighted MRI shows",
            "left",
            "lesion",
            "patient",
            "treated with cervical immobilization",
            "course",
            "steroids",
            "physical therapy",
            "finding",
            "most likely",
            "seen",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5379,
            "completion_tokens": 4506
        },
        "time_elapsed": 33.2976655960083,
        "raw_responses": [
            "Step 1: Recognize that a left C5 hemicord lesion is characteristic of Brown-Sequard syndrome.\n\nStep 2: In Brown-Sequard syndrome, the lesion results in ipsilateral loss (on the same side as the injury) of motor function and proprioception (due to corticospinal and dorsal column disruption) and contralateral loss of pain and temperature sensation (due to spinothalamic tract disruption).\n\nStep 3: The patient\u2019s left-sided lesion implies that while motor deficits and loss of proprioception will occur on the left side, loss of pain and temperature sensation (analgesia) will occur on the right side (contralateral to the lesion).\n\nStep 4: Comparing the options:\n\u2022 Option A: Spastic paralysis at the level of the lesion is part of the syndrome but less specific than the contralateral loss of pain.\n\u2022 Option B: Right-sided Horner's syndrome would be seen if sympathetic fibers were involved, but with a left hemicord lesion, any Horner's syndrome would be ipsilateral (and is not a classic finding in most Brown-Sequard cases).\n\u2022 Option C: \u201cContralateral corticospinal tract involvement\u201d is inaccurate since the corticospinal tract involvement causes ipsilateral, not contralateral, deficits.\n\u2022 Option D: Right-sided analgesia appropriately describes the presence of contralateral loss of pain and temperature sensation seen in Brown-Sequard syndrome.\n\nFinal Answer: D. Right-sided analgesia",
            "Step 1: Recognize that a left-sided hemicord lesion, as seen on a T2-weighted MRI in the cervical region, is indicative of Brown-Sequard syndrome.\n\nStep 2: Recall the classic features of Brown-Sequard syndrome:\n\u2003\u2022 Ipsilateral (same side as the lesion) loss of motor function and proprioception due to corticospinal and dorsal column involvement.\n\u2003\u2022 Contralateral (opposite side) loss of pain and temperature sensation below the level of the lesion due to damage to the lateral spinothalamic tract, which crosses over within one or two segments of entry.\n\nStep 3: Analyze the options:\n\u2003A. Spastic paralysis at the level of lesion \u2013 In Brown-Sequard syndrome, spastic paralysis is seen below the level of the lesion (due to disruption of the corticospinal tract), not exactly \u201cat the level.\u201d\n\u2003B. Right-sided Horner's syndrome \u2013 Horner's syndrome is associated with disruption of sympathetic pathways (such as in lateral medullary syndrome or in lesions affecting the sympathetic chain), and is not typical for a hemicord lesion.\n\u2003C. Contralateral corticospinal tract involvement \u2013 The corticospinal fibers decussate at the medullary level, so ipsilateral weakness is seen in the cord lesion, not contralateral.\n\u2003D. Right-sided analgesia \u2013 This option describes a loss of pain sensation on the right side, which is consistent with the contralateral loss of pain and temperature sensation seen in Brown-Sequard syndrome when the left side of the spinal cord is affected.\n\nStep 4: Therefore, the additional finding most likely to be seen in this patient is right-sided analgesia.\n\nFinal answer: D. Right-sided analgesia",
            "Step 1: Recognize that the patient\u2019s left-sided weakness following a left C5 hemicord lesion is characteristic of Brown-Sequard syndrome, a condition resulting from a hemisection of the spinal cord.\n\nStep 2: In Brown-Sequard syndrome:\n\u2022 The corticospinal tract (which controls movement) is affected ipsilaterally, leading to weakness or spastic paralysis on the same side as the lesion.\n\u2022 The dorsal columns (proprioception and fine touch) are also affected ipsilaterally.\n\u2022 The spinothalamic tract (pain and temperature) decussates (crosses) at the level of the spinal cord soon after entry, meaning that damage to one side of the cord results in loss of pain and temperature sensation on the opposite side, below the level of the lesion.\n\nStep 3: Review the options:\nA. Spastic paralysis at the level of lesion \u2013 While corticospinal tract damage can cause spasticity below the lesion, the primary additional finding in Brown-Sequard is the contralateral loss of pain and temperature sensation.\nB. Right-sided Horner's syndrome \u2013 Horner\u2019s syndrome (ptosis, miosis, anhidrosis) may occur with high cervical lesions affecting the sympathetic chain, but if present, it would be ipsilateral to the lesion (left-sided) rather than right-sided.\nC. Contralateral corticospinal tract involvement \u2013 The corticospinal tract decussates at the medullary pyramids; thus, a lesion in the left spinal cord affects the left side for motor function.\nD. Right-sided analgesia \u2013 This matches the classic finding of Brown-Sequard syndrome: contralateral loss of pain and temperature sensation due to disruption of the spinothalamic tract.\n\nFinal Answer: D. Right-sided analgesia"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Recognize that the patient\u2019s left-sided weakness following a left C5 hemicord lesion is characteristic of Brown-Sequard syndrome, a condition resulting from a hemisection of the spinal cord.\n\nStep 2: In Brown-Sequard syndrome:\n\u2022 The corticospinal tract (which controls movement) is affected ipsilaterally, leading to weakness or spastic paralysis on the same side as the lesion.\n\u2022 The dorsal columns (proprioception and fine touch) are also affected ipsilaterally.\n\u2022 The spinothalamic tract (pain and temperature) decussates (crosses) at the level of the spinal cord soon after entry, meaning that damage to one side of the cord results in loss of pain and temperature sensation on the opposite side, below the level of the lesion.\n\nStep 3: Review the options:\nA. Spastic paralysis at the level of lesion \u2013 While corticospinal tract damage can cause spasticity below the lesion, the primary additional finding in Brown-Sequard is the contralateral loss of pain and temperature sensation.\nB. Right-sided Horner's syndrome \u2013 Horner\u2019s syndrome (ptosis, miosis, anhidrosis) may occur with high cervical lesions affecting the sympathetic chain, but if present, it would be ipsilateral to the lesion (left-sided) rather than right-sided.\nC. Contralateral corticospinal tract involvement \u2013 The corticospinal tract decussates at the medullary pyramids; thus, a lesion in the left spinal cord affects the left side for motor function.\nD. Right-sided analgesia \u2013 This matches the classic finding of Brown-Sequard syndrome: contralateral loss of pain and temperature sensation due to disruption of the spinothalamic tract.\n\nFinal Answer: D. Right-sided analgesia"
    },
    {
        "realidx": 196,
        "question": "A student studying pharmacology is a member of a team that is conducting research related to the elimination of multiple anticoagulant medications. His duty as a member of the team is to collect serum samples of the subjects every 4 hours and send them for analysis of serum drug levels. He is also supposed to collect, document and analyze the data. For one of the subjects, he notices that the subject is eliminating 0.5 mg of the drug every 4 hours. Which of the following anticoagulants did this patient most likely consume?",
        "answer": "Warfarin",
        "options": {
            "A": "Warfarin",
            "B": "Enoxaparin",
            "C": "Fondaparinux",
            "D": "Apixaban"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "student studying pharmacology",
            "member",
            "team",
            "conducting research related",
            "elimination",
            "multiple anticoagulant medications",
            "member",
            "team",
            "to",
            "serum samples",
            "subjects",
            "4 hours",
            "send",
            "analysis",
            "serum drug levels",
            "to",
            "document",
            "data",
            "one",
            "subjects",
            "subject",
            "0.5 mg",
            "drug",
            "4 hours",
            "following anticoagulants",
            "patient most likely"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 6957,
            "completion_tokens": 24290
        },
        "time_elapsed": 156.84399437904358,
        "raw_responses": [
            "Step 1: Note that the measured elimination is 0.5 mg every 4 hours\u2014that totals about 3 mg eliminated over one day. This value is in the range of maintenance doses typically given orally as a daily \u201cmg\u2010dose\u201d regimen.\n\nStep 2: Compare the options based on dosing and pharmacokinetics:\n\u2003\u2022 Warfarin is administered in mg doses (commonly 1\u201310\u202fmg daily) and is metabolized hepatically with a half\u2010life on the order of 30\u201340 hours. Under steady\u2010state first\u2010order kinetics, the body would eliminate a few milligrams per day\u2014roughly the value observed.\n\u2003\u2022 Enoxaparin (a low\u2013molecular-weight heparin) is given by subcutaneous injection in doses such as 1\u202fmg/kg; its doses are much larger in absolute mg and elimination is measured by anti\u2013Xa activity rather than mg amounts.\n\u2003\u2022 Fondaparinux is dosed in small mg amounts (often 2.5 mg), but because of its long half\u2010life (\u224820 hours), the amount cleared over any 4\u2013hour period would be less than 0.5 mg.\n\u2003\u2022 Apixaban is dosed (typically 5 mg twice daily) but has kinetics that would predict a larger fraction eliminated over 4 hours than 0.5 mg.\n\nStep 3: The measured elimination rate (0.5 mg every 4 hours) best fits the pharmacokinetic profile for warfarin.\n\nFinal answer: Warfarin",
            "Step 1. Notice that the study is comparing the elimination kinetics of several anticoagulants by measuring the amount of drug \u201clost\u201d from the serum over fixed time\u2010intervals. In this scenario, the subject\u2019s serum shows a constant elimination of 0.5\u2005mg every 4\u2005hours.\n\nStep 2. Although many drugs are eliminated by first\u2010order kinetics (where a constant fraction of the drug is eliminated per time), when you can measure a fixed amount (mg) \u201cdisappearing\u201d every 4\u2005hours, that is very suggestive of a low \u201csteady state\u201d or constant clearance rate that reflects, in part, the customary dosing of that drug. In comparing the typical daily doses of common anticoagulants we have:\n\n\u2022 Warfarin is usually dosed around 5\u2005mg once daily (roughly 5\u2005mg/24\u2005hours, which works out to approximately 0.8\u20130.9\u2005mg every 4\u2005hours).\n\u2022 Enoxaparin given prophylactically is usually around 40\u2005mg per day \u2013 an average elimination rate over 24\u2005hours that would correspond to about 6\u20137\u2005mg every 4\u2005hours.\n\u2022 Apixaban for stroke prevention is typically dosed 5\u2005mg twice daily (about 10\u2005mg/24\u2005hours, or roughly 1.7\u2005mg every 4\u2005hours).\n\u2022 Fondaparinux for prophylaxis is routinely dosed at 2.5\u2005mg once daily \u2013 which averaged over 24\u2005hours gives about 0.1\u2005mg per hour or roughly 0.5\u20130.42\u2005mg every 4\u2005hours.\n\nStep 3. Comparing these math approximations, the only agent whose typical daily dose leads to an \u201celimination rate\u201d (i.e., average amount cleared when you look at steady\u2010state blood levels) of about 0.5\u2005mg every 4\u2005hours is fondaparinux.\n\nFinal Answer: Fondaparinux (Option C)",
            "We can solve this question by \u201creverse\u2010engineering\u201d the information about how much drug is cleared per unit time\u2014in this case, 0.5 mg every 4 hours\u2014and then matching it with the typical dosing and elimination characteristics of the listed anticoagulants.\n\nStep 1. Recognize what \u201celiminating 0.5 mg every 4 hours\u201d implies\n\n\u2022 When a drug is eliminated at a fixed (constant) amount per unit time (0.5 mg/4 hours in this case), that is the hallmark of zero\u2010order elimination. (In zero order the enzyme \u201cprocesses\u201d a fixed mg amount per time.)\n\u2022 In contrast, first\u2010order kinetics means the fraction (and not the absolute amount) is eliminated per unit time.\n\nAt therapeutic doses most agents are eliminated by first\u2011order processes. However, if investigators \u201csee\u201d a constant amount (eg, 0.5 mg every 4 hours) being eliminated at steady state, that suggests that during the interval being examined the body is \u201clabelling\u201d drug removal at a fixed rate\u2014essentially the quantity it takes in (or makes \u201cavailable\u201d) is being cleared at a predictable rate. Importantly, drugs differ in the doses at which these numbers make sense.\n\nStep 2. Consider the Options\n\nA. Warfarin \n\u2003\u2022 It is a vitamin K antagonist usually dosed in the range of 1\u201310 mg per day. In practice, its effect is monitored with the INR rather than serum drug levels.\n\u2003\u2022 Warfarin\u2019s metabolism is generally first order at therapeutic levels.\n\u2003\u2022 Also, a 5\u2013mg daily dose would typically \u201cprocess\u201d only a few mg per day\u2014the observed elimination of roughly 3 mg per day (0.5 mg every 4 hours \u00d7 6 intervals) might be in the ball\u2010park. However, one would not routinely \u201cmeasure\u201d mg levels of warfarin in a pharmacokinetic study because the INR is the accepted measure.\n\nB. Enoxaparin\n\u2003\u2022 A low molecular weight heparin administered subcutaneously in relatively high mg doses (eg, 40 mg for prophylaxis or 1 mg/kg for treatment) and \u201cmonitored\u201d sometimes via an anti\u2010Xa assay.\n\u2003\u2022 The numbers (0.5 mg every 4 hours) are far too low to match its usual dosing.\n  \nC. Fondaparinux\n\u2003\u2022 Also given subcutaneously, typically in doses of 2.5\u20137.5 mg daily.\n\u2003\u2022 Again, the absolute mg amount cleared (0.5 mg every 4 hours or ~3 mg per day) wouldn\u2019t match the pharmacokinetics and dose scale for this agent.\n  \nD. Apixaban\n\u2003\u2022 A direct factor Xa inhibitor given orally in fixed mg doses (typically 2.5 mg or 5 mg twice daily), so that over one day the total dose might be around 10 mg.\n\u2003\u2022 Importantly, pharmacokinetic studies of apixaban (which is not monitored routinely in clinical practice) are done in research settings by measuring its serum concentration.\n\u2003\u2022 The measured elimination of 0.5 mg every 4 hours (equal to about 3 mg per day) fits well as a \u201csnapshot\u201d of its elimination kinetics when studied serially.\n\u2003\u2022 Plus, the fact that the team is \u201cresearching multiple anticoagulant medications\u201d and sampling serum drug levels every few hours is exactly the sort of protocol used for agents like apixaban.\n\nStep 3. Compare and Eliminate\n\n\u2022 Warfarin is typically managed via the INR; its first\u2010order kinetics in therapeutic dosing would not most obviously yield a constant mg elimination rate when studied in this manner.\n\u2022 Enoxaparin and fondaparinux are dosed in larger mg amounts than the clearance rate noted and are usually monitored via anti\u2011Xa activity (not direct mg level measurements).\n\u2022 Apixaban (option D) is administered orally in small mg doses, and pharmacokinetic studies in research can accurately measure its mg elimination rate.\n\nFinal Answer\n\nThus, by process of elimination and matching the kinetic profile to the numbers given, the patient most likely consumed Apixaban.\n\nAnswer: Apixaban (Option D)"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "0"
        ],
        "final_solution": "Step 1. Notice that the study is comparing the elimination kinetics of several anticoagulants by measuring the amount of drug \u201clost\u201d from the serum over fixed time\u2010intervals. In this scenario, the subject\u2019s serum shows a constant elimination of 0.5\u2005mg every 4\u2005hours.\n\nStep 2. Although many drugs are eliminated by first\u2010order kinetics (where a constant fraction of the drug is eliminated per time), when you can measure a fixed amount (mg) \u201cdisappearing\u201d every 4\u2005hours, that is very suggestive of a low \u201csteady state\u201d or constant clearance rate that reflects, in part, the customary dosing of that drug. In comparing the typical daily doses of common anticoagulants we have:\n\n\u2022 Warfarin is usually dosed around 5\u2005mg once daily (roughly 5\u2005mg/24\u2005hours, which works out to approximately 0.8\u20130.9\u2005mg every 4\u2005hours).\n\u2022 Enoxaparin given prophylactically is usually around 40\u2005mg per day \u2013 an average elimination rate over 24\u2005hours that would correspond to about 6\u20137\u2005mg every 4\u2005hours.\n\u2022 Apixaban for stroke prevention is typically dosed 5\u2005mg twice daily (about 10\u2005mg/24\u2005hours, or roughly 1.7\u2005mg every 4\u2005hours).\n\u2022 Fondaparinux for prophylaxis is routinely dosed at 2.5\u2005mg once daily \u2013 which averaged over 24\u2005hours gives about 0.1\u2005mg per hour or roughly 0.5\u20130.42\u2005mg every 4\u2005hours.\n\nStep 3. Comparing these math approximations, the only agent whose typical daily dose leads to an \u201celimination rate\u201d (i.e., average amount cleared when you look at steady\u2010state blood levels) of about 0.5\u2005mg every 4\u2005hours is fondaparinux.\n\nFinal Answer: Fondaparinux (Option C)"
    },
    {
        "realidx": 198,
        "question": "A 28-year-old woman comes to the obstetrics and gynecology clinic because she has been unsuccessfully trying to conceive with her husband for the last 2 years. He has had 2 children from a previous marriage and has been tested for causes of male infertility. She has had prior abdominal surgery as well as a family history of endocrine abnormalities. Based on this history, a panel of tests are obtained and treatment is started. This treatment will be administered intermittently one week before her normal menstrual cycle. If the most likely drug prescribed in this case was administered in a different manner, which of the following conditions may also be treated by this drug?",
        "answer": "Prostate cancer",
        "options": {
            "A": "Diabetes",
            "B": "Parkinson disease",
            "C": "Polycystic ovarian syndrome",
            "D": "Prostate cancer"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old woman",
            "obstetrics",
            "gynecology clinic",
            "to",
            "husband",
            "last",
            "years",
            "2 children",
            "previous marriage",
            "tested",
            "causes",
            "male infertility",
            "prior abdominal surgery",
            "family history",
            "endocrine abnormalities",
            "Based",
            "history",
            "panel",
            "tests",
            "obtained",
            "treatment",
            "started",
            "treatment",
            "administered",
            "one week",
            "normal menstrual cycle",
            "most likely drug prescribed",
            "case",
            "administered",
            "different",
            "following conditions",
            "treated",
            "drug"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5907,
            "completion_tokens": 17867
        },
        "time_elapsed": 114.71800136566162,
        "raw_responses": [
            "Step 1: Identify the likely medication.\n\u2022 The patient is being treated for infertility with a regimen given intermittently (around one week before her cycle), which is the classic dosing schedule for clomiphene citrate.\n\u2022 Clomiphene is a selective estrogen receptor modulator (SERM) that works by blocking estrogen receptors in the hypothalamus. This blockade reduces negative feedback on gonadotropin release (GnRH, FSH, and LH), thereby inducing ovulation.\n\nStep 2: Consider the alternative uses when the drug is administered differently.\n\u2022 When used for infertility, clomiphene is given intermittently to stimulate ovulation.\n\u2022 In different dosing regimens, especially in patients with polycystic ovarian syndrome (PCOS) who have chronic anovulation, clomiphene citrate is also used to induce ovulation. In fact, clomiphene is a first\u2010line pharmacologic treatment for anovulatory infertility in PCOS.\n\nStep 3: Evaluate answer options.\n\u2022 (A) Diabetes \u2013 Clomiphene is not used to treat diabetes.\n\u2022 (B) Parkinson disease \u2013 Clomiphene has no role in the management of Parkinson disease.\n\u2022 (C) Polycystic ovarian syndrome \u2013 Clomiphene is used in patients with PCOS to induce ovulation.\n\u2022 (D) Prostate cancer \u2013 Clomiphene is not used to treat prostate cancer.\n\nFinal Answer:\nC. Polycystic ovarian syndrome",
            "Let\u2019s break down the reasoning:\n\n\u2022 The patient is a 28\u2010year\u2010old woman who has had 2 years of infertility despite her husband having previously fathered children. In evaluating a woman with infertility, one must consider whether her problem is due to a lack of ovulation or a structural anomaly. (Her past abdominal surgery raises concern for tubal damage, whereas a family history of endocrine abnormalities raises the possibility of a hormonally mediated process.) \n\n\u2022 One common pharmacologic treatment in infertility due to anovulation (for example, in polycystic ovarian syndrome or other ovulatory disorders) is clomiphene citrate. Clomiphene is typically administered early in the menstrual cycle in an intermittent (cyclic) fashion (eg, days 5\u20139). Its mechanism is that of a selective estrogen receptor modulator (SERM); by antagonizing estrogen receptors in the hypothalamus, it decreases negative feedback and increases release of GnRH, which leads to increased LH and FSH secretion and thus stimulates ovulation.\n\n\u2022 The question then asks: \u201cIf the most likely drug prescribed in this case was administered in a different manner, which of the following conditions may also be treated by this drug?\u201d This is hinting that while the cyclic administration is used for ovulation induction, if the same drug were given in a different dosing regimen, it would be used in another clinical scenario.\n\n\u2022 Although clomiphene itself is not used for the alternative condition listed, a drug with a similar mechanism of modulating dopaminergic/estrogen pathways\u2014bromocriptine\u2014is used in hyperprolactinemia (which can cause infertility) and, when given continuously, is also used in Parkinson disease as a dopamine agonist. Bromocriptine\u2019s use contrasts with the cyclic use of clomiphene for fertility because bromocriptine is administered daily to continuously stimulate dopamine receptors.\n\n\u2022 Among the answer choices, the only condition that is treated with a drug that\u2014when administered continuously rather than cyclically\u2014shares a similar profile is Parkinson disease.\n\nThus, even though the patient in the vignette would most likely be treated with clomiphene citrate for ovulation induction, if a similar drug (or even bromocriptine, another agent used in endocrine-related infertility via its dopaminergic action) were administered continuously, it is used in the management of Parkinson disease.\n\nThe answer is: B. Parkinson disease.",
            "The patient\u2019s treatment regimen\u2014giving a drug intermittently about 1\u2009week before menstruation\u2014is classic for inducing ovulation. In women with anovulatory infertility (especially in settings such as polycystic ovarian syndrome), clomiphene citrate is used for this purpose. Clomiphene is a selective estrogen receptor modulator (SERM) that, when given mid\u2010cycle, antagonizes estrogen receptors in the hypothalamus. This \u201ctricks\u201d the body into reducing its negative feedback from estrogen and increases the release of gonadotropin\u2010releasing hormone (GnRH), thereby boosting luteinizing hormone (LH) and follicle\u2010stimulating hormone (FSH) levels to induce ovulation.\n\nThe question then asks: \u201cIf the most likely drug prescribed in this case was administered in a different manner, which of the following conditions may also be treated by this drug?\u201d When clomiphene citrate (or other SERMs) is used in different dosing regimens, its estrogen receptor\u2013modulating effects can be harnessed for other indications. One well\u2010known application is in patients with polycystic ovarian syndrome (PCOS) who are anovulatory. In those patients, clomiphene is used to induce ovulation as a first\u2010line treatment. (Although \u201cPCOS\u201d is already an ovulatory disorder that benefits from clomiphene\u2019s intermittent use, this answer choice reflects an established clinical use of this drug when managing PCOS\u2010related infertility.)\n\nLooking at the choices:\n\u2022 Diabetes \u2013 has no direct relation to the mechanism of clomiphene.\n\u2022 Parkinson disease \u2013 is managed with dopamine agonists (not SERMs).\n\u2022 Polycystic ovarian syndrome \u2013 is a common cause of infertility resulting from anovulation, and clomiphene is a standard treatment.\n\u2022 Prostate cancer \u2013 while anti\u2010estrogen therapy can be useful in some cancers, clomiphene isn\u2019t used as a mainstay in prostate cancer management.\n\nThus, the final answer is: Polycystic ovarian syndrome."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify the likely medication.\n\u2022 The patient is being treated for infertility with a regimen given intermittently (around one week before her cycle), which is the classic dosing schedule for clomiphene citrate.\n\u2022 Clomiphene is a selective estrogen receptor modulator (SERM) that works by blocking estrogen receptors in the hypothalamus. This blockade reduces negative feedback on gonadotropin release (GnRH, FSH, and LH), thereby inducing ovulation.\n\nStep 2: Consider the alternative uses when the drug is administered differently.\n\u2022 When used for infertility, clomiphene is given intermittently to stimulate ovulation.\n\u2022 In different dosing regimens, especially in patients with polycystic ovarian syndrome (PCOS) who have chronic anovulation, clomiphene citrate is also used to induce ovulation. In fact, clomiphene is a first\u2010line pharmacologic treatment for anovulatory infertility in PCOS.\n\nStep 3: Evaluate answer options.\n\u2022 (A) Diabetes \u2013 Clomiphene is not used to treat diabetes.\n\u2022 (B) Parkinson disease \u2013 Clomiphene has no role in the management of Parkinson disease.\n\u2022 (C) Polycystic ovarian syndrome \u2013 Clomiphene is used in patients with PCOS to induce ovulation.\n\u2022 (D) Prostate cancer \u2013 Clomiphene is not used to treat prostate cancer.\n\nFinal Answer:\nC. Polycystic ovarian syndrome"
    },
    {
        "realidx": 202,
        "question": "A 48-year-old female presents for a follow-up appointment to discuss her ultrasound results. She presented with a lump in her neck 2 weeks ago. On examination, a thyroid nodule was present; the nodule was fixed, immobile, and non-tender. Ultrasound showed a hypoechoic nodule with a size of 2 cm. Histological examination of a fine needle biopsy was performed and cytological examination reported a likely suspicion of neoplasia. CT scan is performed to check for any lesions in the bones and/or lungs, common metastatic sites in this condition. Treatment with radioiodine therapy is planned after near-total thyroidectomy. Considering this tumor, which of the following is the most likely initial metastatic site in this patient?",
        "answer": "Inferior thyroid arteries",
        "options": {
            "A": "Trachea",
            "B": "Cervical lymph nodes",
            "C": "Inferior thyroid arteries",
            "D": "Thyrohyoid muscle"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "48 year old female presents",
            "follow-up appointment to discuss",
            "ultrasound results",
            "presented",
            "lump",
            "neck",
            "weeks",
            "examination",
            "thyroid nodule",
            "present",
            "nodule",
            "fixed",
            "immobile",
            "non-tender",
            "Ultrasound showed",
            "nodule",
            "size of",
            "Histological examination",
            "fine needle biopsy",
            "performed",
            "cytological examination reported",
            "likely suspicion",
            "neoplasia",
            "CT scan",
            "performed to check",
            "lesions",
            "bones",
            "lungs",
            "common metastatic sites",
            "condition",
            "Treatment",
            "radioiodine therapy",
            "planned",
            "total thyroidectomy",
            "Considering",
            "tumor",
            "following",
            "most likely initial metastatic site",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4014,
            "completion_tokens": 2229
        },
        "time_elapsed": 19.92777943611145,
        "raw_responses": [
            "Step 1: Identify the Tumor Type\nThe clinical description\u2014fixed, immobile thyroid nodule with suspicious fine needle biopsy findings and the plan for near-total thyroidectomy followed by radioiodine therapy\u2014strongly suggests papillary thyroid cancer, which is the most common type of thyroid carcinoma.\n\nStep 2: Know the Metastatic Pattern\nPapillary thyroid carcinoma tends to spread via lymphatic channels to the cervical lymph nodes even when the nodule is not large.\n\nStep 3: Evaluate the Options\nA. Trachea \u2013 Thyroid malignancies rarely metastasize directly to the trachea.\nB. Cervical lymph nodes \u2013 This is the most common site for initial metastasis in papillary thyroid carcinoma.\nC. Inferior thyroid arteries \u2013 These are vascular structures and not a typical site of metastasis.\nD. Thyrohyoid muscle \u2013 This isn\u2019t a common site for metastatic spread in this context.\n\nFinal Answer: B. Cervical lymph nodes",
            "Step 1: Analyze the clinical context. The patient presents with a thyroid nodule that is fixed, immobile, and non-tender; ultrasound findings show a hypoechoic 2 cm lesion, and the cytology is suspicious for neoplasia. The plan for near-total thyroidectomy followed by radioiodine therapy is most consistent with the treatment of papillary thyroid carcinoma.\n\nStep 2: Recognize that papillary thyroid carcinoma is known to primarily metastasize to regional cervical lymph nodes. It is the most common type of thyroid cancer and typically spreads to nearby lymphatic tissue.\n\nStep 3: Evaluate the options:\n\u2003\u2022 Trachea \u2013 Not a common site for initial metastasis in thyroid cancer.\n\u2003\u2022 Cervical lymph nodes \u2013 The most typical initial site of metastasis for papillary thyroid carcinoma.\n\u2003\u2022 Inferior thyroid arteries \u2013 These are blood vessels, not common sites of metastasis.\n\u2003\u2022 Thyrohyoid muscle \u2013 Not typically a site for initial metastasis.\n\nFinal Answer: B. Cervical lymph nodes",
            "Step-by-step reasoning:\n1. The patient is a 48-year-old female with a thyroid nodule that is fixed, immobile, and non-tender, and the ultrasound as well as fine-needle biopsy indicate a likely neoplasm.\n2. The planned treatment with near-total thyroidectomy followed by radioiodine therapy is most consistent with papillary thyroid carcinoma, the most common type of thyroid cancer.\n3. Papillary thyroid carcinoma typically spreads via lymphatic channels.\n4. The most common site for initial metastasis in papillary thyroid carcinoma is the cervical lymph nodes.\n\nFinal Answer: B. Cervical lymph nodes"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Analyze the clinical context. The patient presents with a thyroid nodule that is fixed, immobile, and non-tender; ultrasound findings show a hypoechoic 2 cm lesion, and the cytology is suspicious for neoplasia. The plan for near-total thyroidectomy followed by radioiodine therapy is most consistent with the treatment of papillary thyroid carcinoma.\n\nStep 2: Recognize that papillary thyroid carcinoma is known to primarily metastasize to regional cervical lymph nodes. It is the most common type of thyroid cancer and typically spreads to nearby lymphatic tissue.\n\nStep 3: Evaluate the options:\n\u2003\u2022 Trachea \u2013 Not a common site for initial metastasis in thyroid cancer.\n\u2003\u2022 Cervical lymph nodes \u2013 The most typical initial site of metastasis for papillary thyroid carcinoma.\n\u2003\u2022 Inferior thyroid arteries \u2013 These are blood vessels, not common sites of metastasis.\n\u2003\u2022 Thyrohyoid muscle \u2013 Not typically a site for initial metastasis.\n\nFinal Answer: B. Cervical lymph nodes"
    },
    {
        "realidx": 203,
        "question": "A 39-year-old man presents to his primary care physician because he has been having severe headaches and fever for the last 2 days. He also says his right eyelid has been painlessly swelling and is starting to block his vision from that eye. He recently returned from a tour of the world where he visited Thailand, Ethiopia, and Brazil. Otherwise his past medical history is unremarkable. On presentation, his temperature is 102\u00b0F (38.8\u00b0C), blood pressure is 126/81 mmHg, pulse is 125/min, and respirations are 13/min. Physical exam reveals a nontender swelling of the right eyelid, lymphadenopathy, and an indurated red patch with surrounding erythema and local swelling on his left leg. Which of the following drugs should be used to treat this patient's condition?",
        "answer": "Benznidazole",
        "options": {
            "A": "Benznidazole",
            "B": "Ivermectin",
            "C": "Mebendazol",
            "D": "Sodium stibogluconate"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man presents",
            "primary care physician",
            "severe headaches",
            "fever",
            "2 days",
            "right eyelid",
            "swelling",
            "starting to block",
            "vision",
            "eye",
            "recently returned",
            "tour",
            "world",
            "visited Thailand",
            "Ethiopia",
            "Brazil",
            "past medical history",
            "unremarkable",
            "presentation",
            "temperature",
            "blood pressure",
            "81 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "Physical exam reveals",
            "nontender swelling of",
            "right eyelid",
            "lymphadenopathy",
            "indurated red patch",
            "surrounding erythema",
            "local",
            "left",
            "following drugs",
            "used to treat",
            "patient's condition"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5544,
            "completion_tokens": 8569
        },
        "time_elapsed": 61.63231825828552,
        "raw_responses": [
            "Step 1: Analyze the Patient Presentation\n\u2022 The patient is a 39\u2010year\u2010old man with fever (102\u00b0F), tachycardia, and severe headaches.\n\u2022 He has a painless swollen right eyelid that is blocking his vision.\n\u2022 There is an indurated, erythematous patch with local swelling on his left leg.\n\u2022 He recently traveled to endemic regions (Thailand, Ethiopia, Brazil).\n\nStep 2: Consider Likely Diagnosis\n\u2022 The combination of skin lesions, lymphadenopathy, and ocular involvement in someone who has traveled to regions endemic for leishmaniasis strongly suggests an infection with Leishmania species. New World (Brazil) and Old World regions (Ethiopia/parts of Thailand) are well known for different forms of leishmaniasis.\n\u2022 Infections with Leishmania can cause cutaneous or mucocutaneous lesions that may appear as indurated skin patches or nodules. Although fever and headache can be associated with systemic infection or a local inflammatory response, the key findings are the characteristic skin lesion and ocular involvement.\n  \nStep 3: Evaluate Treatment Options\nA. Benznidazole \u2013 used to treat Chagas disease (Trypanosoma cruzi), not consistent with this presentation.\nB. Ivermectin \u2013 used for parasitic infections like onchocerciasis; however, onchocerciasis (river blindness) is typically a chronic infection that does not present acutely with fever and headache.\nC. Mebendazole \u2013 an antihelminthic used for intestinal worm infestations, irrelevant in this context.\nD. Sodium stibogluconate \u2013 a pentavalent antimonial used as first-line treatment for leishmaniasis, including cutaneous and mucocutaneous forms.\n\nStep 4: Final Decision\nGiven the clinical picture, history of travel to endemic areas, and the nature of his skin and eye findings, the most appropriate treatment is with sodium stibogluconate.\n\nFinal answer: D. Sodium stibogluconate",
            "Step 1: Analyze the clinical scenario. The patient is a 39\u2010year\u2010old man with recent global travel (including Brazil, an endemic area for Chagas disease) who now presents with fever, headache, a painless swelling of the right eyelid, and an indurated red patch with surrounding erythema on his left leg. The eyelid swelling is especially notable because it resembles Roma\u00f1a's sign\u2014the unilateral, painless periorbital edema seen in the acute phase of Chagas disease. The lesion on his left leg likely represents the site of inoculation (a chagoma).\n\nStep 2: Review the treatment options:\n\u2003\u2022 Benznidazole \u2013 the drug of choice for treating acute Chagas disease.\n\u2003\u2022 Ivermectin \u2013 used for certain parasitic infections like onchocerciasis, but does not treat Chagas disease.\n\u2003\u2022 Mebendazol \u2013 an antihelminthic used for nematode infections.\n\u2003\u2022 Sodium stibogluconate \u2013 used for the treatment of leishmaniasis.\n\nStep 3: By comparing the options and correlating the clinical findings (including his travel history and characteristic signs), the diagnosis is consistent with acute Chagas disease. Therefore, the best treatment option is Benznidazole.\n\nFinal answer: A. Benznidazole.",
            "Step 1: Analyze the patient's presentation.\n\u2022 The patient is a 39\u2011year\u2011old man with severe headache, fever, and a notable painless swelling of the right eyelid.\n\u2022 He has lymphadenopathy and an indurated red patch (with surrounding erythema and swelling) on his left leg.\n\u2022 His recent travel to Thailand, Ethiopia, and Brazil suggests exposure to infectious agents endemic in these regions.\n\nStep 2: Identify the likely diagnosis.\n\u2022 The combination of a cutaneous lesion (indurated red patch on the leg) and ocular involvement (painless eyelid swelling) in a traveler is suggestive of leishmaniasis. Leishmania species, such as those found in Brazil (and other parts of the world), cause cutaneous leishmaniasis. In some cases, mucosal or even ocular involvement may occur.\n  \nStep 3: Match the treatment to the condition.\n\u2022 Of the options provided:\n\u2003A. Benznidazole is used for Chagas disease.\n\u2003B. Ivermectin is used for certain parasitic infections like strongyloidiasis and onchocerciasis.\n\u2003C. Mebendazol is an antihelminthic for worm infestations.\n\u2003D. Sodium stibogluconate is a pentavalent antimonial effective against leishmaniasis.\n  \nStep 4: Final Answer.\nGiven the patient\u2019s travel history and clinical findings consistent with leishmaniasis, the best treatment is sodium stibogluconate.\n\nFinal answer: D. Sodium stibogluconate."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Analyze the clinical scenario. The patient is a 39\u2010year\u2010old man with recent global travel (including Brazil, an endemic area for Chagas disease) who now presents with fever, headache, a painless swelling of the right eyelid, and an indurated red patch with surrounding erythema on his left leg. The eyelid swelling is especially notable because it resembles Roma\u00f1a's sign\u2014the unilateral, painless periorbital edema seen in the acute phase of Chagas disease. The lesion on his left leg likely represents the site of inoculation (a chagoma).\n\nStep 2: Review the treatment options:\n\u2003\u2022 Benznidazole \u2013 the drug of choice for treating acute Chagas disease.\n\u2003\u2022 Ivermectin \u2013 used for certain parasitic infections like onchocerciasis, but does not treat Chagas disease.\n\u2003\u2022 Mebendazol \u2013 an antihelminthic used for nematode infections.\n\u2003\u2022 Sodium stibogluconate \u2013 used for the treatment of leishmaniasis.\n\nStep 3: By comparing the options and correlating the clinical findings (including his travel history and characteristic signs), the diagnosis is consistent with acute Chagas disease. Therefore, the best treatment option is Benznidazole.\n\nFinal answer: A. Benznidazole."
    },
    {
        "realidx": 211,
        "question": "A 65-year-old man presents with painless swelling of the neck over the past week. He also says he has been having intermittent fevers and severe night sweats which require a change of bed sheets the next day. His past medical history is significant for human immunodeficiency virus (HIV) diagnosed 10 years ago with which he admits to not always being compliant with his antiretroviral medication. The patient reports a 20-pack-year smoking history but no alcohol or recreational drug use. A review of systems is significant for a 6 kg (13.2 lb) unintentional weight loss over the past 2 months. The vital signs include: temperature 37.8\u2103 (100.0\u2109) and blood pressure 120/75 mm Hg. On physical examination, there are multiple non-tender swollen lymph nodes averaging 2 cm in diameter that is palpable in the anterior and posterior triangles of the neck bilaterally. Axillary and inguinal lymphadenopathy is present on the right side. A cardiopulmonary exam is unremarkable. The spleen size is 16 cm on percussion. Laboratory studies show the following:\nHemoglobin 9 g/dL\nMean corpuscular volume 88 \u03bcm3\nLeukocyte count 18,000/mm3\nPlatelet count 130,000/mm3\n    Serum creatinine 1.1 mg/dL\nSerum lactate dehydrogenase 1,000 U/L\nAn excisional biopsy of a superficial axillary lymph node on the right is performed and a histopathologic analysis confirms the most likely diagnosis. Which of the following is the next best diagnostic step in the workup of this patient?",
        "answer": "Hepatitis C virus antibodies",
        "options": {
            "A": "Antinuclear antibody",
            "B": "Hepatitis C virus antibodies",
            "C": "JAK-2 mutation",
            "D": "Tartrate-resistant acid phosphatase (TRAP) test"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "65 year old man presents",
            "painless swelling of the neck",
            "past week",
            "intermittent fevers",
            "severe night sweats",
            "change",
            "bed sheets",
            "next day",
            "past medical history",
            "significant",
            "human immunodeficiency virus",
            "diagnosed 10 years",
            "admits to not always",
            "compliant",
            "antiretroviral medication",
            "patient reports",
            "20 smoking history",
            "alcohol",
            "recreational drug use",
            "review of systems",
            "significant",
            "kg",
            "unintentional weight loss",
            "past",
            "months",
            "vital signs include",
            "temperature",
            "100 0",
            "blood pressure",
            "75 mm Hg",
            "physical examination",
            "multiple non-tender swollen lymph nodes averaging 2",
            "diameter",
            "palpable",
            "anterior",
            "posterior triangles of",
            "neck",
            "Axillary",
            "inguinal lymphadenopathy",
            "present",
            "right side",
            "cardiopulmonary exam",
            "unremarkable",
            "spleen size",
            "percussion",
            "Laboratory studies show",
            "following",
            "Hemoglobin",
            "g",
            "Mean corpuscular volume",
            "Leukocyte 18",
            "mm3 Platelet count",
            "Serum",
            "lactate dehydrogenase",
            "U/L",
            "excisional",
            "superficial axillary",
            "right",
            "performed",
            "histopathologic analysis confirms",
            "most likely diagnosis",
            "following",
            "next best diagnostic step",
            "workup",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 7359,
            "completion_tokens": 8833
        },
        "time_elapsed": 61.590991735458374,
        "raw_responses": [
            "Step 1: Review the clinical picture and biopsy findings\n\u2022 The patient is a 65\u2010year\u2010old man with HIV (noncompliant with antiretroviral therapy) who presents with \u201cB\u201d symptoms (fever, night sweats, weight loss) along with diffuse, non\u2010tender lymphadenopathy and splenomegaly.\n\u2022 Laboratory studies reveal anemia, thrombocytopenia, leukocytosis, and an elevated lactate dehydrogenase level.\n\u2022 An excisional lymph node biopsy has been performed and the histopathologic evaluation \u201cconfirms the most likely diagnosis\u201d \u2013 in this context, the details point toward a process such as a non\u2010Hodgkin lymphoma, a known complication in patients with HIV.\n\nStep 2: Identify the next best diagnostic step\n\u2022 Once the histologic diagnosis (eg, lymphoma) is established, additional workup is needed to stage the disease and evaluate for viral co\u2010infections prior to instituting chemotherapy.\n\u2022 In patients with confirmed lymphoma, it is standard to screen for hepatitis viruses because coinfection (eg, hepatitis C) can affect both prognosis and therapeutic planning. This is especially important in patients with risk factors for blood\u2010borne infections (and HIV patients often may have coinfections due to shared routes of transmission).\n\nStep 3: Compare the answer options\nA. Antinuclear antibody \u2013 Used in the evaluation of autoimmune conditions (eg, lupus) and is not indicated in this context.\nB. Hepatitis C virus antibodies \u2013 Screening for HCV is essential in patients diagnosed with lymphoma prior to therapy as HCV infection is associated with the development of certain lymphomas and may complicate management.\nC. JAK-2 mutation \u2013 This evaluation is used for myeloproliferative disorders (eg, polycythemia vera, essential thrombocythemia, myelofibrosis) and is not indicated here.\nD. Tartrate\u2010resistant acid phosphatase (TRAP) test \u2013 This test is used in the diagnosis of hairy cell leukemia. Hairy cell leukemia typically presents with pancytopenia and marked splenomegaly; however, the overall clinical profile (diffuse lymphadenopathy with high LDH in an HIV patient) makes this diagnosis less likely.\n\nStep 4: Final Answer\nThe next best diagnostic step in this patient\u2019s workup is to screen for hepatitis C virus infection.\nFinal answer: B. Hepatitis C virus antibodies",
            "Step 1: Review the case details. This 65\u2010year\u2010old man with HIV (noncompliant with therapy), B symptoms (fevers, night sweats, weight loss), and widespread lymphadenopathy (neck, axillary, inguinal) with splenomegaly and elevated lactate dehydrogenase is highly suspicious for an aggressive lymphoma. The excisional node biopsy confirms the diagnosis (most likely non\u2010Hodgkin lymphoma related to HIV status).\n\nStep 2: Recognize that after a tissue diagnosis of lymphoma is made, staging studies and further workup are required before treatment can be planned. In patients with lymphoma, it is routine to assess various risk factors and baseline statuses that may affect treatment choices.\n\nStep 3: Look at the options provided:\n\u2003A. Antinuclear antibody \u2013 used for autoimmune diseases, not indicated here.\n\u2003B. Hepatitis C virus antibodies \u2013 important to screen for in patients who are candidates for chemotherapy because HCV infection can influence treatment decisions and can reactivate under immunosuppressive conditions.\n\u2003C. JAK-2 mutation \u2013 relevant in myeloproliferative disorders (e.g., polycythemia vera, essential thrombocythemia), not lymphoma.\n\u2003D. Tartrate-resistant acid phosphatase (TRAP) test \u2013 used in the diagnosis of hairy cell leukemia, which is less likely in this setting.\n\nStep 4: Since the case is consistent with lymphoma and none of the other options are appropriate, the next best diagnostic step is to check for hepatitis C virus antibodies in preparation for staging and treatment initiation (as screening for hepatitis infections is routine prior to chemotherapy).\n\nFinal Answer: B. Hepatitis C virus antibodies",
            "Step 1: The patient is a 65\u2010year\u2010old man with HIV (with suboptimal treatment compliance), B symptoms (fever, night sweats, weight loss), diffuse non\u2010tender lymphadenopathy, splenomegaly, cytopenias, and an elevated lactate dehydrogenase. An excisional lymph node biopsy confirms the most likely diagnosis, which based on his presentation is most consistent with a lymphoma seen in immunocompromised patients (for example, a non\u2010Hodgkin lymphoma such as diffuse large B-cell lymphoma).\n\nStep 2: Once the tissue diagnosis is obtained, the next steps in workup typically include staging and workup for risk factors that might impact treatment. In patients with lymphoma, it is standard practice before initiating chemotherapy (especially regimens including immunotherapy such as rituximab) to evaluate for viral hepatitis. Hepatitis viruses (particularly hepatitis B, but hepatitis C can also be associated) are an important consideration since treatment may result in viral reactivation or impact liver function. Of the provided options, hepatitis C virus (HCV) antibody testing is the relevant evaluation.\n\n\u2013 Option A (Antinuclear antibody) would be used when considering autoimmune diseases, which is not consistent with the patient\u2019s presentation.\n\u2013 Option C (JAK-2 mutation) is used to screen for myeloproliferative disorders (such as polycythemia vera or essential thrombocythemia), which is not supported by this picture.\n\u2013 Option D (Tartrate-resistant acid phosphatase [TRAP] test) is associated with hairy cell leukemia; however, the clinical picture here (notably the presence of widespread lymphadenopathy) makes hairy cell leukemia unlikely.\n\nStep 3: Therefore, to assist in determining the full treatment plan and to screen for potential contraindications or considerations prior to therapy, the next best diagnostic step is to obtain hepatitis C virus antibodies.\n\nFinal answer: B. Hepatitis C virus antibodies."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Review the case details. This 65\u2010year\u2010old man with HIV (noncompliant with therapy), B symptoms (fevers, night sweats, weight loss), and widespread lymphadenopathy (neck, axillary, inguinal) with splenomegaly and elevated lactate dehydrogenase is highly suspicious for an aggressive lymphoma. The excisional node biopsy confirms the diagnosis (most likely non\u2010Hodgkin lymphoma related to HIV status).\n\nStep 2: Recognize that after a tissue diagnosis of lymphoma is made, staging studies and further workup are required before treatment can be planned. In patients with lymphoma, it is routine to assess various risk factors and baseline statuses that may affect treatment choices.\n\nStep 3: Look at the options provided:\n\u2003A. Antinuclear antibody \u2013 used for autoimmune diseases, not indicated here.\n\u2003B. Hepatitis C virus antibodies \u2013 important to screen for in patients who are candidates for chemotherapy because HCV infection can influence treatment decisions and can reactivate under immunosuppressive conditions.\n\u2003C. JAK-2 mutation \u2013 relevant in myeloproliferative disorders (e.g., polycythemia vera, essential thrombocythemia), not lymphoma.\n\u2003D. Tartrate-resistant acid phosphatase (TRAP) test \u2013 used in the diagnosis of hairy cell leukemia, which is less likely in this setting.\n\nStep 4: Since the case is consistent with lymphoma and none of the other options are appropriate, the next best diagnostic step is to check for hepatitis C virus antibodies in preparation for staging and treatment initiation (as screening for hepatitis infections is routine prior to chemotherapy).\n\nFinal Answer: B. Hepatitis C virus antibodies"
    },
    {
        "realidx": 212,
        "question": "In order to assess the feasibility and evaluate the outcomes of cerclage wiring as a supportive approach to osteosynthesis in femur fractures, a group of orthopedic surgeons studied 14 patients with primary and periprosthetic fractures of the thigh bone. Parameters such as patient demographic, type of implant, number of wires used, fracture union rate, and potential complications were thoroughly recorded and analyzed in all the patients, with a mean duration of patient follow-up of 16 months. Union was achieved in all patients with a mean duration of 90 days, and there were no complications found in patients included in the study. The authors were satisfied with their findings and, due to the prospective nature of their research, submitted their study to a journal as a cohort study (which they noted in the study title as well). However, the journal editor returned the article, suggesting that it should be submitted as a case series instead. The editor made this suggestion to the authors for which of the following reasons?",
        "answer": "Lack of risk calculation",
        "options": {
            "A": "No prevalence assessment",
            "B": "Low number of patients",
            "C": "Ascertainment bias",
            "D": "Lack of risk calculation"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "order to assess",
            "evaluate",
            "outcomes",
            "cerclage wiring",
            "supportive approach",
            "osteosynthesis",
            "femur fractures",
            "a group",
            "orthopedic surgeons studied",
            "patients",
            "primary",
            "periprosthetic fractures of",
            "thigh bone",
            "Parameters",
            "as patient demographic",
            "type of implant",
            "number of wires used",
            "fracture union rate",
            "potential complications",
            "recorded",
            "analyzed",
            "patients",
            "mean duration",
            "patient follow-up",
            "months",
            "Union",
            "patients",
            "mean duration",
            "90 days",
            "complications found",
            "patients included",
            "study",
            "authors",
            "satisfied",
            "findings",
            "due to",
            "prospective nature",
            "research",
            "submitted",
            "study",
            "journal",
            "cohort study",
            "noted",
            "study title",
            "well",
            "journal editor returned",
            "article",
            "suggesting",
            "submitted",
            "case series",
            "editor made",
            "suggestion",
            "authors",
            "following reasons"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4320,
            "completion_tokens": 3765
        },
        "time_elapsed": 191.18084120750427,
        "raw_responses": [
            "The correct answer is D. Lack of risk calculation.\n\nStep-by-step explanation:\n\n\u2022 A cohort study typically involves following a group of patients over time and comparing outcomes between those with and without a given exposure (or with different exposures). This allows the researchers to calculate risks or risk ratios.\n\n\u2022 In this study, the surgeons followed 14 patients who underwent cerclage wiring without including a comparative group of patients who did not receive this treatment.\n\n\u2022 Without a control or comparison group, it is impossible to calculate or compare risk, meaning the study cannot truly be classified as a cohort study. Instead, it merely describes outcomes in a single group, making it a case series.\n\nTherefore, the editor suggested that the study be submitted as a case series because of the lack of risk calculation, which is a hallmark of proper cohort studies.\n\nFinal answer: D. Lack of risk calculation.",
            "Step 1: Recall that cohort studies typically involve a comparison between groups based on exposure status (e.g., exposed vs. non-exposed) so that risk and relative risk can be calculated. A case series, on the other hand, is descriptive \u2013 it looks at outcomes in a consecutive group of patients who all received the same intervention, without a control or comparison group.\n\nStep 2: In this situation, the study prospectively followed 14 patients, all of whom underwent cerclage wiring. Because there was no comparator group, there is no opportunity to calculate the risk or incidence of outcomes relative to another group which is a key component of a cohort study.\n\nStep 3: This absence of a risk calculation (and, by extension, comparison between groups) is what leads the editor to recommend that the article be labeled as a case series rather than a cohort study.\n\nAnswer: D. Lack of risk calculation",
            "The correct answer is D. Lack of risk calculation.\n\nStep-by-step explanation:\n\n\u2022 In a true cohort study, patients are followed over time to compare outcomes between two (or more) groups, generally those with and without a certain exposure, so that relative risk or risk calculations can be determined.\n\n\u2022 In this study, the authors only evaluated a single group of patients (14 individuals with femur fractures) who underwent the same intervention. There was no comparison group. Therefore, although the study was prospective, the lack of a comparator group meant that calculating risk (i.e., determining relative risk or incidence of complications compared to another group) was not possible.\n\n\u2022 This setup more accurately fits the definition of a case series\u2014a detailed description of a series of similar cases without a control group\u2014rather than a cohort study.\n\nThus, the journal editor\u2019s suggestion was based on the fact that the study lacked the risk calculation component typical of a cohort study."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "0"
        ],
        "final_solution": "The correct answer is D. Lack of risk calculation.\n\nStep-by-step explanation:\n\n\u2022 In a true cohort study, patients are followed over time to compare outcomes between two (or more) groups, generally those with and without a certain exposure, so that relative risk or risk calculations can be determined.\n\n\u2022 In this study, the authors only evaluated a single group of patients (14 individuals with femur fractures) who underwent the same intervention. There was no comparison group. Therefore, although the study was prospective, the lack of a comparator group meant that calculating risk (i.e., determining relative risk or incidence of complications compared to another group) was not possible.\n\n\u2022 This setup more accurately fits the definition of a case series\u2014a detailed description of a series of similar cases without a control group\u2014rather than a cohort study.\n\nThus, the journal editor\u2019s suggestion was based on the fact that the study lacked the risk calculation component typical of a cohort study."
    },
    {
        "realidx": 215,
        "question": "A 45-year-old man presents to the physician with complaints of increased urinary frequency and decreasing volumes for the past 2 months. He does not complain of any pain during urination. He is frustrated that he has to wake up 2 or 3 times per night to urinate even though he tried reducing the amount of water he consumes before bed and made some other dietary changes without any improvement. He has no family history of prostate disease. Physical examination is negative for any suprapubic mass or tenderness, and there is no costovertebral angle tenderness. Which of the following is the best next step in the management of this patient?",
        "answer": "Digital rectal examination",
        "options": {
            "A": "Urinalysis and serum creatinine",
            "B": "Reassurance",
            "C": "Digital rectal examination",
            "D": "Prostate-specific antigen"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old man presents",
            "physician",
            "complaints",
            "increased urinary frequency",
            "decreasing volumes",
            "past 2 months",
            "not",
            "pain",
            "urination",
            "frustrated",
            "to wake up",
            "3",
            "night to",
            "reducing",
            "amount",
            "water",
            "bed",
            "made",
            "dietary changes",
            "improvement",
            "family history of prostate disease",
            "Physical examination",
            "negative",
            "suprapubic mass",
            "tenderness",
            "costovertebral angle tenderness",
            "following",
            "best next step",
            "management",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4368,
            "completion_tokens": 3710
        },
        "time_elapsed": 30.11241841316223,
        "raw_responses": [
            "Step 1: This middle\u2010aged man presents with lower urinary tract symptoms (LUTS), including increased frequency and decreased volumes, without dysuria or pain. Although benign prostatic hyperplasia (BPH) is commonly seen in older men, early symptoms can appear around his age, and other causes of LUTS must be ruled out.\n\nStep 2: The initial evaluation of LUTS should include noninvasive testing. A urinalysis is essential to rule out a urinary tract infection, hematuria, or other abnormalities that may indicate alternative causes such as a stone or malignancy. Checking serum creatinine helps assess renal function, particularly if any obstruction is suspected. Although a digital rectal exam (DRE) is an important part of the work-up, it is usually performed after or along with laboratory studies, and the information provided does not indicate that a DRE has already been done.\n\nStep 3: Therefore, the best next step is to perform a urinalysis and serum creatinine measurement.\n\nFinal answer: A. Urinalysis and serum creatinine",
            "Let's break down the approach step by step:\n\n1. The patient is a 45-year-old man with urinary frequency, decreased volumes, and nocturia. There is no pain, dysuria, or signs of infection on exam (e.g., no costovertebral angle tenderness).\n\n2. In evaluating lower urinary tract symptoms, it is important to first rule out causes such as urinary tract infections, hematuria (that could raise concerns for bladder cancer), or obstruction affecting renal function. This is typically done by obtaining a urinalysis and basic renal function evaluation (serum creatinine).\n\n3. Although a digital rectal exam (DRE) is an important part of prostate evaluation, it is usually done as part of the physical exam and might be pursued later if needed. In this case, the physical exam has not revealed any abnormality, and the next appropriate step is to perform diagnostic tests to further evaluate his symptoms.\n\n4. Reassurance at this point (option B) would not be appropriate until a proper evaluation is completed, and evaluating for benign prostatic hyperplasia (BPH) with a prostate-specific antigen (PSA, option D) is generally considered for older patients or when other signs are present.\n\nThus, the best next step in this patient\u2019s management is:\n\nAnswer: Urinalysis and serum creatinine",
            "Step 1: The patient's main complaints are urinary frequency with decreased volume and nocturia, with no dysuria or other signs of infection. His physical exam is unremarkable.\n\nStep 2: In the evaluation of lower urinary tract symptoms (LUTS) in men, the initial approach should include basic, noninvasive tests to exclude infection, hematuria, or renal dysfunction. Although a digital rectal exam (DRE) is part of the evaluation for BPH and other prostate issues, the first step in a patient with new urinary symptoms is typically to perform a urinalysis (to rule out infection, hematuria, etc.) and to check serum creatinine to assess renal function. PSA testing is not indicated at this point without further evidence of prostate pathology. Reassurance alone would not be appropriate given the duration and impact of his symptoms.\n\nStep 3: Therefore, the best next step in management is to order a urinalysis and serum creatinine.\n\nFinal answer: A. Urinalysis and serum creatinine"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: The patient's main complaints are urinary frequency with decreased volume and nocturia, with no dysuria or other signs of infection. His physical exam is unremarkable.\n\nStep 2: In the evaluation of lower urinary tract symptoms (LUTS) in men, the initial approach should include basic, noninvasive tests to exclude infection, hematuria, or renal dysfunction. Although a digital rectal exam (DRE) is part of the evaluation for BPH and other prostate issues, the first step in a patient with new urinary symptoms is typically to perform a urinalysis (to rule out infection, hematuria, etc.) and to check serum creatinine to assess renal function. PSA testing is not indicated at this point without further evidence of prostate pathology. Reassurance alone would not be appropriate given the duration and impact of his symptoms.\n\nStep 3: Therefore, the best next step in management is to order a urinalysis and serum creatinine.\n\nFinal answer: A. Urinalysis and serum creatinine"
    },
    {
        "realidx": 222,
        "question": "A 60-year-old woman presents to a physician for worsening shortness of breath and increasing abdominal distention over the last 3 months. She says that the shortness of breath is worse on exertion and improves with rest. While she could previously walk to the nearby store for her groceries, she now has to drive because she gets ''winded'' on the way. The patient was diagnosed with diabetes 5 years ago and is compliant with her medications. The medical history is otherwise unremarkable. The physical examination reveals gross ascites and visibly engorged periumbilical veins. Bilateral pitting edema is noted around the ankles. The finger-prick blood glucose level is 100 mg/dL. What is the mechanism of action of the anti-diabetic medication this patient is most likely taking?",
        "answer": "Increased gene expression of GLUT-4",
        "options": {
            "A": "Binding to the alpha subunit of the insulin receptor",
            "B": "Closure of ATP-sensitive K-channels in the pancreatic beta-cell",
            "C": "Increased gene expression of GLUT-4",
            "D": "Glucagon-like peptide-1 receptor agonist"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "60 year old woman presents",
            "physician",
            "worsening shortness of breath",
            "increasing abdominal distention",
            "months",
            "shortness of breath",
            "worse",
            "exertion",
            "improves",
            "rest",
            "walk",
            "store",
            "now",
            "to drive",
            "gets",
            "winded",
            "patient",
            "diagnosed",
            "diabetes",
            "years",
            "compliant",
            "medications",
            "medical history",
            "unremarkable",
            "physical examination reveals gross ascites",
            "engorged periumbilical veins",
            "Bilateral pitting edema",
            "noted",
            "ankles",
            "finger-prick blood glucose level",
            "100 mg/dL",
            "mechanism of action",
            "diabetic medication",
            "patient",
            "most likely"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5205,
            "completion_tokens": 4606
        },
        "time_elapsed": 36.21473789215088,
        "raw_responses": [
            "Step 1: Recognize that the patient, who has diabetes, is now showing signs of fluid overload (ascites, peripheral edema) and signs of heart failure. Thiazolidinediones (TZDs) are diabetic medications known to cause fluid retention and worsen heart failure.\n\nStep 2: Among the options, increased gene expression of GLUT-4 (choice C) describes the mechanism of TZDs. TZDs activate peroxisome proliferator-activated receptor gamma (PPAR-\u03b3), which leads to increased insulin sensitivity in peripheral tissues by upregulating GLUT-4 transcription.\n\nStep 3: Eliminate the other options:\n\u2022 Option A (Binding to the alpha subunit of the insulin receptor) is not a mechanism for common antidiabetic medications.\n\u2022 Option B (Closure of ATP-sensitive K-channels in the pancreatic beta-cell) describes sulfonylureas, which are not known for fluid retention.\n\u2022 Option D (Glucagon-like peptide-1 receptor agonist) is associated with weight loss rather than fluid retention.\n\nFinal Answer: C. Increased gene expression of GLUT-4",
            "Step 1: Recognize the Key Clinical Clues\n\u2022 The patient has type 2 diabetes and is on medication.\n\u2022 Her presentation (shortness of breath with exertion, ascites, and peripheral edema) suggests fluid retention and heart failure.\n\u2022 Thiazolidinediones (TZDs), such as pioglitazone, are known to cause fluid retention and worsening heart failure.\n\nStep 2: Connect the Side Effects to the Medication\n\u2022 In diabetic patients, TZDs are used to improve insulin sensitivity.\n\u2022 A notable adverse effect of TZDs is fluid retention, which can lead to or exacerbate heart failure.\n\u2022 Her physical findings (gross ascites, engorged periumbilical veins, and bilateral pitting edema) are consistent with this adverse effect.\n\nStep 3: Understand the Mechanism of Action of TZDs\n\u2022 TZDs work by binding to the peroxisome proliferator\u2010activated receptor gamma (PPAR-\u03b3) in the nucleus.\n\u2022 Activation of PPAR-\u03b3 increases the transcription of insulin-sensitive genes, including those that increase the expression of GLUT-4 transporters.\n\u2022 Increased GLUT-4 expression enhances glucose uptake in adipose tissue and muscle, thereby improving insulin sensitivity.\n\nStep 4: Evaluate the Options\nA. Binding to the alpha subunit of the insulin receptor \u2013 This is not the mechanism of TZDs.\nB. Closure of ATP-sensitive K-channels in the pancreatic beta-cell \u2013 This is the mechanism of sulfonylureas.\nC. Increased gene expression of GLUT-4 \u2013 This matches the mechanism by which TZDs work.\nD. Glucagon-like peptide-1 receptor agonist \u2013 This describes the mechanism of GLP-1 receptor agonists, not TZDs.\n\nFinal Answer: C. Increased gene expression of GLUT-4",
            "Step 1: Recognize that this 60-year-old woman with a history of diabetes is now presenting with signs of heart failure (shortness of breath on exertion, ascites, and lower-extremity edema). Thiazolidinediones (such as pioglitazone) are anti-diabetic agents known to cause fluid retention and may exacerbate heart failure.\n\nStep 2: Recall the mechanism of action of thiazolidinediones\u2014they act as peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) agonists. Activation of PPAR-\u03b3 increases the transcription of insulin-sensitive genes, including those for GLUT-4, enhancing peripheral (muscle and adipose) glucose uptake.\n\nStep 3: Evaluate the options:\nA. Binding to the alpha subunit of the insulin receptor \u2013 Not the mechanism for any common anti-diabetics.\nB. Closure of ATP-sensitive K-channels in the pancreatic beta-cell \u2013 This describes sulfonylureas.\nC. Increased gene expression of GLUT-4 \u2013 This is the mechanism of thiazolidinediones.\nD. Glucagon-like peptide-1 receptor agonist \u2013 This is the mechanism for GLP-1 analogs.\n\nStep 4: Since the patient's clinical picture is consistent with a side effect of thiazolidinediones and the mechanism of action matches option C, that is the correct answer.\n\nFinal answer: C. Increased gene expression of GLUT-4"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Recognize the Key Clinical Clues\n\u2022 The patient has type 2 diabetes and is on medication.\n\u2022 Her presentation (shortness of breath with exertion, ascites, and peripheral edema) suggests fluid retention and heart failure.\n\u2022 Thiazolidinediones (TZDs), such as pioglitazone, are known to cause fluid retention and worsening heart failure.\n\nStep 2: Connect the Side Effects to the Medication\n\u2022 In diabetic patients, TZDs are used to improve insulin sensitivity.\n\u2022 A notable adverse effect of TZDs is fluid retention, which can lead to or exacerbate heart failure.\n\u2022 Her physical findings (gross ascites, engorged periumbilical veins, and bilateral pitting edema) are consistent with this adverse effect.\n\nStep 3: Understand the Mechanism of Action of TZDs\n\u2022 TZDs work by binding to the peroxisome proliferator\u2010activated receptor gamma (PPAR-\u03b3) in the nucleus.\n\u2022 Activation of PPAR-\u03b3 increases the transcription of insulin-sensitive genes, including those that increase the expression of GLUT-4 transporters.\n\u2022 Increased GLUT-4 expression enhances glucose uptake in adipose tissue and muscle, thereby improving insulin sensitivity.\n\nStep 4: Evaluate the Options\nA. Binding to the alpha subunit of the insulin receptor \u2013 This is not the mechanism of TZDs.\nB. Closure of ATP-sensitive K-channels in the pancreatic beta-cell \u2013 This is the mechanism of sulfonylureas.\nC. Increased gene expression of GLUT-4 \u2013 This matches the mechanism by which TZDs work.\nD. Glucagon-like peptide-1 receptor agonist \u2013 This describes the mechanism of GLP-1 receptor agonists, not TZDs.\n\nFinal Answer: C. Increased gene expression of GLUT-4"
    },
    {
        "realidx": 231,
        "question": "A 59-year-old man comes to the emergency department because of excruciating left knee pain for 4 days. He underwent a total knee arthroplasty of his left knee joint 4 months ago. He has hypertension and osteoarthritis. Current medications include glucosamine, amlodipine, and meloxicam. His temperature is 38.1\u00b0C (100.6\u00b0F), pulse is 97/min, and blood pressure is 118/71 mm Hg. Examination shows a tender, swollen left knee joint; range of motion is limited by pain. Analysis of the synovial fluid confirms septic arthritis, and the prosthesis is removed. Which of the following is the most likely causal organism?",
        "answer": "Staphylococcus epidermidis",
        "options": {
            "A": "Staphylococcus epidermidis",
            "B": "Escherichia coli",
            "C": "Staphylococcus aureus",
            "D": "Pseudomonas aeruginosa"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "59 year old man",
            "emergency department",
            "of excruciating left knee pain",
            "4 days",
            "total knee arthroplasty",
            "left",
            "joint",
            "months",
            "hypertension",
            "osteoarthritis",
            "Current medications include glucosamine",
            "amlodipine",
            "meloxicam",
            "temperature",
            "100",
            "pulse",
            "97 min",
            "blood pressure",
            "71 mm Hg",
            "Examination shows",
            "tender",
            "swollen left knee joint",
            "range of motion",
            "limited",
            "pain",
            "Analysis",
            "synovial fluid confirms septic arthritis",
            "prosthesis",
            "removed",
            "following",
            "most likely causal organism"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4632,
            "completion_tokens": 2683
        },
        "time_elapsed": 24.18547487258911,
        "raw_responses": [
            "Step 1: Review Key Information\n\u2022 The patient underwent total knee arthroplasty 4 months ago.\n\u2022 He now presents with symptoms consistent with septic arthritis.\n\u2022 Prosthetic joint infections are often caused by organisms that can form biofilms on the prosthetic material.\n\nStep 2: Consider Organisms Associated with Prosthetic Joints\n\u2022 Staphylococcus aureus is a common cause of septic arthritis in native joints and can affect prosthetic joints, typically in early onset cases (<3 months).\n\u2022 Staphylococcus epidermidis, a coagulase-negative Staphylococcus, is notorious for its ability to adhere to prosthetic material and form a biofilm, making it a frequent cause of delayed prosthetic joint infections (3\u201312 months after surgery).\n\u2022 Escherichia coli and Pseudomonas aeruginosa are less commonly associated with prosthetic joint infections unless in specific high-risk population scenarios.\n\nStep 3: Eliminate Incorrect Choices\n\u2022 Escherichia coli (Option B) is not commonly implicated in prosthetic joint infections.\n\u2022 Pseudomonas aeruginosa (Option D) is less likely without risk factors such as immunocompromise or specific hospital setting exposures.\n\u2022 Although Staphylococcus aureus (Option C) is a common cause, the timing (4 months post-operation) makes Staphylococcus epidermidis more likely due to its ability to cause delayed infections on prosthetic surfaces.\n\nStep 4: Final Answer\nBased on the timing and the nature of prosthetic joint infections, the most likely causal organism is:\n\nA. Staphylococcus epidermidis",
            "Step 1 \u2013 Relevant Information:\n\u2022 This patient has a prosthetic joint from a knee arthroplasty performed 4 months ago.\n\u2022 He now presents with signs of septic arthritis.\n\u2022 Prosthetic joint infections are particularly associated with organisms capable of forming biofilms.\n\nStep 2 \u2013 Compare and Eliminate Incorrect Choices:\n\u2022 Escherichia coli \u2013 Typically associated with urinary tract and other intra-abdominal infections, not prosthetic joint infections.\n\u2022 Staphylococcus aureus \u2013 A common cause of septic arthritis in native joints but is less frequently the culprit in prosthetic joint infections compared to coagulase-negative staphylococci.\n\u2022 Pseudomonas aeruginosa \u2013 Although it can cause infections in certain settings (e.g., in patients with burns or immunocompromised individuals), it is not the typical organism in prosthetic joint infections.\n\u2022 Staphylococcus epidermidis \u2013 Known for its ability to form biofilms on prostheses, making it the most likely cause in this situation.\n\nStep 3 \u2013 Final Answer:\nA: Staphylococcus epidermidis",
            "Step 1: Consider the clinical context. The patient underwent a total knee arthroplasty 4 months ago and now presents with septic arthritis of the prosthetic joint. Prosthetic joint infections, especially those occurring months after surgery, are most commonly associated with infections by organisms that form biofilms.\n\nStep 2: Compare and eliminate incorrect choices.\n\u2022 Escherichia coli is not a common cause of prosthetic joint infections.\n\u2022 Staphylococcus aureus, while a common cause of septic arthritis, is less frequently implicated in prosthetic joint infections compared to coagulase-negative organisms when the prosthesis is involved.\n\u2022 Pseudomonas aeruginosa is typically associated with infections in immunocompromised patients or in settings related to contamination with water, not typical in this scenario.\n\nStep 3: Provide the final answer.\nThe most likely causal organism in a prosthetic joint infection presenting several months after surgery is a coagulase-negative staphylococcus, specifically Staphylococcus epidermidis.\n\nFinal answer: A: Staphylococcus epidermidis."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review Key Information\n\u2022 The patient underwent total knee arthroplasty 4 months ago.\n\u2022 He now presents with symptoms consistent with septic arthritis.\n\u2022 Prosthetic joint infections are often caused by organisms that can form biofilms on the prosthetic material.\n\nStep 2: Consider Organisms Associated with Prosthetic Joints\n\u2022 Staphylococcus aureus is a common cause of septic arthritis in native joints and can affect prosthetic joints, typically in early onset cases (<3 months).\n\u2022 Staphylococcus epidermidis, a coagulase-negative Staphylococcus, is notorious for its ability to adhere to prosthetic material and form a biofilm, making it a frequent cause of delayed prosthetic joint infections (3\u201312 months after surgery).\n\u2022 Escherichia coli and Pseudomonas aeruginosa are less commonly associated with prosthetic joint infections unless in specific high-risk population scenarios.\n\nStep 3: Eliminate Incorrect Choices\n\u2022 Escherichia coli (Option B) is not commonly implicated in prosthetic joint infections.\n\u2022 Pseudomonas aeruginosa (Option D) is less likely without risk factors such as immunocompromise or specific hospital setting exposures.\n\u2022 Although Staphylococcus aureus (Option C) is a common cause, the timing (4 months post-operation) makes Staphylococcus epidermidis more likely due to its ability to cause delayed infections on prosthetic surfaces.\n\nStep 4: Final Answer\nBased on the timing and the nature of prosthetic joint infections, the most likely causal organism is:\n\nA. Staphylococcus epidermidis"
    },
    {
        "realidx": 234,
        "question": "A 55-year-old man comes to the physician because of a 3-month history of a progressively growing mass in his axilla. During this period, he has had recurrent episodes of low-grade fever lasting for 7 to 10 days, and an 8-kg (18-lb) weight loss. His only medication is a multivitamin. Physical examination shows nontender, right axillary, cervical, and inguinal lymphadenopathy. His serum calcium concentration is 15.1 mg/dL and parathyroid hormone (PTH) concentration is 9 pg/mL. A lymph node biopsy shows granuloma formation and large CD15-positive, CD30-positive cells with bilobed nuclei. Which of the following is the most likely explanation for this patient's laboratory findings?",
        "answer": "Secretion of \u03b3-interferon by activated T-lymphocytes",
        "options": {
            "A": "Excessive intake of dietary ergocalciferol",
            "B": "Induction of focal osteolysis by tumor cells",
            "C": "Secretion of \u03b3-interferon by activated T-lymphocytes",
            "D": "Production of PTH-related peptide by malignant cells"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "55 year old man",
            "physician",
            "3 month history",
            "mass",
            "axilla",
            "period",
            "recurrent episodes of low-grade fever",
            "7",
            "10 days",
            "kg",
            "weight loss",
            "only medication",
            "multivitamin",
            "Physical examination shows nontender",
            "right axillary",
            "cervical",
            "inguinal lymphadenopathy",
            "serum concentration",
            "mg/dL",
            "parathyroid hormone",
            "concentration",
            "pg/mL",
            "lymph node biopsy shows granuloma formation",
            "large CD15 positive",
            "CD30-positive cells",
            "bilobed nuclei",
            "following",
            "most likely explanation",
            "patient's laboratory findings"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 6300,
            "completion_tokens": 4849
        },
        "time_elapsed": 37.97693085670471,
        "raw_responses": [
            "Step 1 \u2013 Identify the Key Findings:\n\u2022 The patient is a 55-year-old man with \u201cB\u201d symptoms (fever, weight loss) and widespread, non-tender lymphadenopathy.\n\u2022 The lymph node biopsy reveals large cells with bilobed nuclei that are CD15 and CD30 positive, which is characteristic of classical Hodgkin lymphoma.\n\u2022 His laboratory studies show a high serum calcium level (15.1 mg/dL) with a low parathyroid hormone (PTH) concentration, indicating hypercalcemia that is not due to primary hyperparathyroidism.\n\nStep 2 \u2013 Consider the Mechanism of Hypercalcemia in Hodgkin Lymphoma:\nIn Hodgkin lymphoma, hypercalcemia is often the result of increased production of calcitriol (the active form of vitamin D). In this context, activated macrophages in the granulomas produce 1\u03b1-hydroxylase, which converts 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D (calcitriol). The upregulation of 1\u03b1-hydroxylase is driven by cytokines, including \u03b3-interferon, secreted by activated T-lymphocytes.\n\nStep 3 \u2013 Evaluate the Answer Choices:\nA. Excessive intake of dietary ergocalciferol \u2013 Dietary vitamin D intake is not indicated in this patient and does not account for his lab abnormalities.\nB. Induction of focal osteolysis by tumor cells \u2013 While some malignancies cause hypercalcemia through osteolytic metastases, Hodgkin lymphoma typically does not work via this mechanism.\nC. Secretion of \u03b3-interferon by activated T-lymphocytes \u2013 \u03b3-interferon from T-lymphocytes stimulates macrophages to express 1\u03b1-hydroxylase, leading to excessive conversion of vitamin D to calcitriol, which increases calcium absorption and results in hypercalcemia.\nD. Production of PTH-related peptide by malignant cells \u2013 While PTHrP is a common cause of malignancy-associated hypercalcemia, it is most often seen in squamous cell carcinomas and is not the usual mechanism for Hodgkin lymphoma.\n\nStep 4 \u2013 Final Answer:\nThe explanation that best fits the patient\u2019s laboratory findings is that cytokines (\u03b3-interferon) from activated T-lymphocytes stimulate macrophages in the granulomas to produce excess calcitriol. This leads to increased calcium absorption and subsequent hypercalcemia.\n\nFinal answer: C. Secretion of \u03b3-interferon by activated T-lymphocytes.",
            "Step 1: Identify key details. The patient is a 55-year-old man with systemic \u201cB symptoms\u201d (fevers, weight loss) and widespread nontender lymphadenopathy. The biopsy shows large CD15-positive, CD30-positive cells with bilobed nuclei along with granulomas, consistent with Hodgkin lymphoma.\n\nStep 2: Recognize the hypercalcemia mechanism. His lab results show a high serum calcium and a low parathyroid hormone (PTH) level, indicating a PTH-independent hypercalcemia. In Hodgkin lymphoma, hypercalcemia is often due to increased production of calcitriol (1,25-dihydroxyvitamin D) by macrophages in granulomas. Activated T-lymphocytes secrete \u03b3-interferon, which stimulates these macrophages to convert vitamin D to its active form, thereby increasing calcium absorption.\n\nStep 3: Eliminate incorrect answer choices:\n\u2022 Excessive intake of dietary ergocalciferol (A) would not be secondary to cancer.\n\u2022 Induction of focal osteolysis by tumor cells (B) is more typical of conditions like multiple myeloma.\n\u2022 Production of PTH-related peptide by malignant cells (D) is seen in squamous cell carcinomas, not Hodgkin lymphoma.\n\nStep 4: Final answer. The best explanation for his hypercalcemia is the secretion of \u03b3-interferon by activated T-lymphocytes leading to increased calcitriol production by macrophages in granulomas.\n\nFinal Answer: C. Secretion of \u03b3-interferon by activated T-lymphocytes",
            "Step 1: Review the key clinical findings. The patient is a 55-year-old man with a 3-month history of a progressively enlarging axillary mass who also has B symptoms (fever, weight loss) and generalized lymphadenopathy. The lymph node biopsy reveals granuloma formation and Reed\u2013Sternberg cells that are CD15-positive and CD30-positive, which is characteristic of Hodgkin lymphoma.\n\nStep 2: Understand the laboratory findings. The patient\u2019s serum calcium is markedly elevated at 15.1 mg/dL while his parathyroid hormone (PTH) is low at 9 pg/mL. This indicates hypercalcemia that is not driven by PTH, suggesting another mechanism is responsible.\n\nStep 3: Connect the pathology to hypercalcemia. Hodgkin lymphoma is known to be associated with hypercalcemia. In this condition, activated T-lymphocytes within the tumor environment secrete cytokines such as \u03b3-interferon. This cytokine stimulates macrophages in the granulomas to increase the expression of 1-\u03b1 hydroxylase, which converts inactive vitamin D (25-hydroxyvitamin D) into its active form, 1,25-dihydroxyvitamin D (calcitriol). Elevated calcitriol increases intestinal calcium absorption and bone resorption, resulting in hypercalcemia with suppressed PTH levels.\n\nStep 4: Eliminate the other choices:\n\u2022 Option A (Excessive intake of dietary ergocalciferol) would involve vitamin D toxicity, but there is no history of excessive vitamin D intake.\n\u2022 Option B (Induction of focal osteolysis by tumor cells) is more typical of cancers with bone metastases (e.g., breast cancer or multiple myeloma), not Hodgkin lymphoma.\n\u2022 Option D (Production of PTH-related peptide by malignant cells) is seen with squamous cell carcinomas rather than Hodgkin lymphoma.\n\nFinal Answer: Option C: Secretion of \u03b3-interferon by activated T-lymphocytes."
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Review the key clinical findings. The patient is a 55-year-old man with a 3-month history of a progressively enlarging axillary mass who also has B symptoms (fever, weight loss) and generalized lymphadenopathy. The lymph node biopsy reveals granuloma formation and Reed\u2013Sternberg cells that are CD15-positive and CD30-positive, which is characteristic of Hodgkin lymphoma.\n\nStep 2: Understand the laboratory findings. The patient\u2019s serum calcium is markedly elevated at 15.1 mg/dL while his parathyroid hormone (PTH) is low at 9 pg/mL. This indicates hypercalcemia that is not driven by PTH, suggesting another mechanism is responsible.\n\nStep 3: Connect the pathology to hypercalcemia. Hodgkin lymphoma is known to be associated with hypercalcemia. In this condition, activated T-lymphocytes within the tumor environment secrete cytokines such as \u03b3-interferon. This cytokine stimulates macrophages in the granulomas to increase the expression of 1-\u03b1 hydroxylase, which converts inactive vitamin D (25-hydroxyvitamin D) into its active form, 1,25-dihydroxyvitamin D (calcitriol). Elevated calcitriol increases intestinal calcium absorption and bone resorption, resulting in hypercalcemia with suppressed PTH levels.\n\nStep 4: Eliminate the other choices:\n\u2022 Option A (Excessive intake of dietary ergocalciferol) would involve vitamin D toxicity, but there is no history of excessive vitamin D intake.\n\u2022 Option B (Induction of focal osteolysis by tumor cells) is more typical of cancers with bone metastases (e.g., breast cancer or multiple myeloma), not Hodgkin lymphoma.\n\u2022 Option D (Production of PTH-related peptide by malignant cells) is seen with squamous cell carcinomas rather than Hodgkin lymphoma.\n\nFinal Answer: Option C: Secretion of \u03b3-interferon by activated T-lymphocytes."
    },
    {
        "realidx": 237,
        "question": "A 65-year-old man presents to his primary care physician with a neck mass. He first noticed a firm mass on the anterior aspect of his neck approximately 4 months ago. The mass is painless and has not increased in size since then. He has also noticed occasional fatigue and has gained 10 pounds in the past 4 months despite no change in his diet or exercise frequency. His past medical history is notable for gout for which he takes allopurinol. He denies any prior thyroid disorder. He runs 4 times per week and eats a balanced diet of mostly fruits and vegetables. He does not smoke and drinks a glass of wine with dinner. His family history is notable for medullary thyroid cancer in his maternal uncle. His temperature is 97.8\u00b0F (36.6\u00b0C), blood pressure is 127/72 mmHg, pulse is 87/min, and respirations are 19/min. On exam, he has a firm, symmetric, and stone-firm thyroid. A biopsy of this patient's lesion would most likely demonstrate which of the following findings?",
        "answer": "Dense fibroinflammatory infiltrate",
        "options": {
            "A": "Diffuse infiltrate of lymphoid cells destroying thyroid follicles",
            "B": "Dense fibroinflammatory infiltrate",
            "C": "Pleomorphic undifferentiated infiltrative cells with necrosis",
            "D": "Stromal amyloid deposition"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "65 year old man presents",
            "primary care physician",
            "neck mass",
            "first",
            "firm mass",
            "anterior aspect of",
            "neck approximately",
            "months",
            "mass",
            "painless",
            "not increased in size",
            "then",
            "occasional fatigue",
            "gained 10 pounds",
            "past",
            "months",
            "change in",
            "diet",
            "exercise frequency",
            "past medical history",
            "notable",
            "gout",
            "takes allopurinol",
            "denies",
            "prior thyroid disorder",
            "runs 4 times per week",
            "eats",
            "balanced diet",
            "mostly fruits",
            "vegetables",
            "not smoke",
            "drinks",
            "glass",
            "wine",
            "dinner",
            "family history",
            "notable",
            "medullary thyroid cancer",
            "maternal uncle",
            "temperature",
            "97",
            "36",
            "blood pressure",
            "72 mmHg",
            "pulse",
            "87 min",
            "respirations",
            "min",
            "exam",
            "firm",
            "symmetric",
            "stone firm thyroid",
            "biopsy",
            "patient's lesion",
            "most likely",
            "following findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4668,
            "completion_tokens": 2413
        },
        "time_elapsed": 21.661052703857422,
        "raw_responses": [
            "Step 1: Consider relevant patient information. The patient is a 65-year-old man with a firm, \"stone-firm\" thyroid mass and a family history of medullary thyroid cancer. His symptoms of weight gain and fatigue, along with the neck mass, point toward a thyroid pathology.\n\nStep 2: Compare the options:\n\u2022 Option A (Diffuse infiltrate of lymphoid cells destroying thyroid follicles) describes Hashimoto's thyroiditis, which typically presents with hypothyroidism and a diffuse goiter, not a solitary, firm mass with a family history of medullary thyroid cancer.\n\u2022 Option B (Dense fibroinflammatory infiltrate) is characteristic of Riedel's thyroiditis, known for a \"woody,\" fixed thyroid, but this condition is less likely with the given family history.\n\u2022 Option C (Pleomorphic undifferentiated infiltrative cells with necrosis) is seen in anaplastic thyroid carcinoma, which is very aggressive and usually presents with rapid growth and compression symptoms, not a stable, firm mass.\n\u2022 Option D (Stromal amyloid deposition) is the classic histological finding in medullary thyroid carcinoma, where the stromal amyloid is derived from calcitonin deposits.\n\nStep 3: Provide the final answer.\nFinal Answer: D. Stromal amyloid deposition",
            "Step 1: Recognize that the patient has a thyroid mass with a family history of medullary thyroid cancer, which strongly suggests a diagnosis of medullary thyroid carcinoma.\n\nStep 2: Recall that medullary thyroid carcinoma arises from the parafollicular C cells and is classically associated with stromal amyloid deposition (derived from calcitonin).\n\nStep 3: Eliminate the other options:\n\u2022 Option A (Diffuse infiltrate of lymphoid cells destroying thyroid follicles) is characteristic of Hashimoto thyroiditis.\n\u2022 Option B (Dense fibroinflammatory infiltrate) is seen in Riedel thyroiditis.\n\u2022 Option C (Pleomorphic undifferentiated infiltrative cells with necrosis) corresponds to anaplastic thyroid carcinoma.\n\nFinal answer: D. Stromal amyloid deposition",
            "Step 1: Key details in the question include a neck mass in an elderly man, a firm, stone-firm thyroid on exam, associated weight gain, and a family history of medullary thyroid cancer. These features lead us to suspect medullary thyroid carcinoma.\n\nStep 2: Evaluate the answer choices:\n\u2022 Option A (Diffuse infiltrate of lymphoid cells destroying thyroid follicles) is characteristic of Hashimoto thyroiditis.\n\u2022 Option B (Dense fibroinflammatory infiltrate) describes Riedel thyroiditis.\n\u2022 Option C (Pleomorphic undifferentiated infiltrative cells with necrosis) is seen in anaplastic thyroid carcinoma.\n\u2022 Option D (Stromal amyloid deposition) is the hallmark histopathologic finding in medullary thyroid carcinoma, due to deposits of calcitonin.\n\nFinal Answer: D. Stromal amyloid deposition"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Consider relevant patient information. The patient is a 65-year-old man with a firm, \"stone-firm\" thyroid mass and a family history of medullary thyroid cancer. His symptoms of weight gain and fatigue, along with the neck mass, point toward a thyroid pathology.\n\nStep 2: Compare the options:\n\u2022 Option A (Diffuse infiltrate of lymphoid cells destroying thyroid follicles) describes Hashimoto's thyroiditis, which typically presents with hypothyroidism and a diffuse goiter, not a solitary, firm mass with a family history of medullary thyroid cancer.\n\u2022 Option B (Dense fibroinflammatory infiltrate) is characteristic of Riedel's thyroiditis, known for a \"woody,\" fixed thyroid, but this condition is less likely with the given family history.\n\u2022 Option C (Pleomorphic undifferentiated infiltrative cells with necrosis) is seen in anaplastic thyroid carcinoma, which is very aggressive and usually presents with rapid growth and compression symptoms, not a stable, firm mass.\n\u2022 Option D (Stromal amyloid deposition) is the classic histological finding in medullary thyroid carcinoma, where the stromal amyloid is derived from calcitonin deposits.\n\nStep 3: Provide the final answer.\nFinal Answer: D. Stromal amyloid deposition"
    },
    {
        "realidx": 238,
        "question": "A group of researchers decided to explore whether the estimates of incidence and prevalence rates of systemic lupus erythematosus (SLE) were influenced by the number of years it took to examine administrative data. These estimates were not only based on hospital discharges, but also on physician billing codes. For study purposes, the researchers labeled incident cases at the initial occurrence of SLE diagnosis in the hospital database, while prevalent cases were those that were coded as harboring SLE at any time, with patients maintaining their diagnosis until death. Which statement is true regarding the relationship between incidence and prevalence rates during the time period that might be chosen for this specific study?",
        "answer": "Incidence rates will be higher during shorter time periods than longer periods.",
        "options": {
            "A": "Incidence rates will be higher during shorter time periods than longer periods.",
            "B": "The prevalence of SLE during consecutively shorter time windows will be overestimated.",
            "C": "The inclusion of attack rates would increase incidence estimates in longer time periods.",
            "D": "The inclusion of attack rates would decrease incidence estimates in shorter time periods."
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "A group",
            "researchers",
            "to",
            "estimates",
            "incidence",
            "prevalence rates",
            "systemic lupus erythematosus",
            "influenced",
            "number",
            "years",
            "took to",
            "administrative data",
            "estimates",
            "not only based",
            "hospital discharges",
            "physician billing codes",
            "study purposes",
            "researchers labeled incident cases",
            "initial occurrence",
            "SLE diagnosis",
            "hospital database",
            "prevalent cases",
            "coded",
            "harboring SLE",
            "time",
            "patients maintaining",
            "diagnosis",
            "death",
            "statement",
            "true",
            "relationship",
            "incidence",
            "prevalence rates",
            "time period",
            "chosen",
            "specific study"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5895,
            "completion_tokens": 8600
        },
        "time_elapsed": 57.27003765106201,
        "raw_responses": [
            "We start by reviewing the definitions. Incidence is a measure of new cases arising in a given time period, whereas prevalence is the total number of cases (new and pre\u2010existing) at a given point in time (or over a period). In studies using administrative data, researchers must decide on a \u201clook\u2010back\u201d period to decide if a given case is truly \u201cnew\u201d (an incident case) or was already present (a prevalent case).\n\nIf only a short observational period is used, the researchers may lack the history needed to tell whether some patients had SLE prior to the study period. As a result, patients with pre\u2010existing SLE may be misclassified as incident when they are seen for the \u201cfirst\u201d time in the database. In contrast, using a longer time period (with adequate look\u2010back) would help filter out cases truly new to the database. Therefore, when using a shorter period, the incidence rate (number of new diagnoses per unit time) may be falsely elevated due to misclassification.\n\nLooking at the answer options:\n\nA. \u201cIncidence rates will be higher during shorter time periods than longer periods.\u201d  \n\u2022 This is the correct concept: with a short window, you risk misclassifying prevalent (but previously undocumented) cases as incident, thereby inflating the incidence rate.\n\nB. \u201cThe prevalence of SLE during consecutively shorter time windows will be overestimated.\u201d  \n\u2022 Prevalence \u2013 being the snapshot of total cases \u2013 is less susceptible to the problem of a short look\u2010back period in the same way; in fact, the chronic nature of the disease means that most true cases will eventually be captured regardless of window. This option is misleading.\n\nC. \u201cThe inclusion of attack rates would increase incidence estimates in longer time periods.\u201d  \n\u2022 Attack rate is a measure used primarily for acute outbreaks, not chronic diseases like SLE.\n\nD. \u201cThe inclusion of attack rates would decrease incidence estimates in shorter time periods.\u201d  \n\u2022 Again, attack rates are not applicable to chronic illnesses such as SLE and do not affect these estimates as described.\n\nThus, the best answer is:\n\nFinal answer: A",
            "The correct answer is A.\n\nStep\u2010by\u2010step explanation:\n\n\u2022 In epidemiologic studies using administrative data, there is a potential pitfall when defining \u201cincident\u201d cases. Incident cases ideally should be \u201cnew\u2010onset\u201d cases. However, if you use a short period of observation (i.e., a short \u201clook\u2010back\u201d or \u201cwashout\u201d period), you may capture persons who had the disease before but whose prior diagnosis isn\u2019t recorded in your study window. These \u201cprevalent\u201d cases will then be misclassified as \u201cincident.\u201d\n\n\u2022 Therefore, if a short time period is used, many cases that are simply recurrences or continued manifestations of an already present disease might be counted as new cases. When a longer period of data is examined, there is more opportunity to identify patients as already having had the diagnosis and thus avoid misclassification as incident.\n\n\u2022 This means that incidence rates tend to appear higher in shorter time periods (where misclassification occurs), whereas longer observation periods allow for more accurate classification and hence lower incidence rates (per unit time).\n\n\u2022 The other options either reference concepts (such as attack rates) that are more relevant to acute outbreaks or incorrectly describe how prevalence would be affected. In chronic diseases such as SLE (where patients maintain their diagnosis until death), prevalence is a cumulative \u201cstock\u201d that increases over time. Shorter windows are less likely to \u201coverestimate\u201d prevalence since they tend to miss cases rather than accumulate them.\n\nThus, the best answer is: A. Incidence rates will be higher during shorter time periods than longer periods.",
            "Let\u2019s break down the scenario:\n\n\u2022 In this study, \u201cincident cases\u201d are identified as the very first time a hospital record has a diagnosis of SLE. However, when using administrative data, if the period of observation (i.e., the look\u2010back period) is very short, many patients who already had SLE (but whose \u201ctrue\u201d diagnosis predated the study period) may be misclassified as incident because there isn\u2019t enough historical data to show they were \u201cpre\u2010existing\u201d (i.e., prevalent).\n\n\u2022 In a longer time window, researchers have a better chance of distinguishing patients who truly are new cases from those who have long\u2010standing disease. That means fewer prevalent cases are mistakenly placed in the incident category.\n\n\u2022 Thus, if you use a shorter time period to examine your administrative data, you are more likely to overestimate the incidence rate (counting some long\u2010standing cases as new) compared with using a longer look\u2010back period.\n\nEvaluating the answer choices:\nA. \u201cIncidence rates will be higher during shorter time periods than longer periods.\u201d \n\u2003\u2013 This is the correct relationship. With a short look\u2010back period, more patients may be misclassified as \u201cincident,\u201d leading to an inflated incidence rate.\n\nB. \u201cThe prevalence of SLE during consecutively shorter time windows will be overestimated.\u201d\n\u2003\u2013 Prevalence (the proportion of individuals living with a disease) is less subject to this misclassification bias; in fact, shorter windows may miss chronic cases that are not coded repeatedly, potentially underestimating true prevalence.\n\nC. \u201cThe inclusion of attack rates would increase incidence estimates in longer time periods.\u201d\n\u2003\u2013 The concept of attack rates applies to acute outbreaks, not to a chronic disease like SLE.\n\nD. \u201cThe inclusion of attack rates would decrease incidence estimates in shorter time periods.\u201d\n\u2003\u2013 Again, attack rates are not relevant for chronic diseases like SLE, so this is not applicable.\n\nThus, the best answer is:\n\nA: Incidence rates will be higher during shorter time periods than longer periods."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Let\u2019s break down the scenario:\n\n\u2022 In this study, \u201cincident cases\u201d are identified as the very first time a hospital record has a diagnosis of SLE. However, when using administrative data, if the period of observation (i.e., the look\u2010back period) is very short, many patients who already had SLE (but whose \u201ctrue\u201d diagnosis predated the study period) may be misclassified as incident because there isn\u2019t enough historical data to show they were \u201cpre\u2010existing\u201d (i.e., prevalent).\n\n\u2022 In a longer time window, researchers have a better chance of distinguishing patients who truly are new cases from those who have long\u2010standing disease. That means fewer prevalent cases are mistakenly placed in the incident category.\n\n\u2022 Thus, if you use a shorter time period to examine your administrative data, you are more likely to overestimate the incidence rate (counting some long\u2010standing cases as new) compared with using a longer look\u2010back period.\n\nEvaluating the answer choices:\nA. \u201cIncidence rates will be higher during shorter time periods than longer periods.\u201d \n\u2003\u2013 This is the correct relationship. With a short look\u2010back period, more patients may be misclassified as \u201cincident,\u201d leading to an inflated incidence rate.\n\nB. \u201cThe prevalence of SLE during consecutively shorter time windows will be overestimated.\u201d\n\u2003\u2013 Prevalence (the proportion of individuals living with a disease) is less subject to this misclassification bias; in fact, shorter windows may miss chronic cases that are not coded repeatedly, potentially underestimating true prevalence.\n\nC. \u201cThe inclusion of attack rates would increase incidence estimates in longer time periods.\u201d\n\u2003\u2013 The concept of attack rates applies to acute outbreaks, not to a chronic disease like SLE.\n\nD. \u201cThe inclusion of attack rates would decrease incidence estimates in shorter time periods.\u201d\n\u2003\u2013 Again, attack rates are not relevant for chronic diseases like SLE, so this is not applicable.\n\nThus, the best answer is:\n\nA: Incidence rates will be higher during shorter time periods than longer periods."
    },
    {
        "realidx": 239,
        "question": "A 48-year-old Caucasian female presents to her primary care physician for evaluation of progressive weakness and shortness of breath. She has had progressive shortness of breath over the last year with an intermittent non-productive cough. In addition, she complains of difficulty raising her arms to brush her hair. Her temperature is 99.6\u00b0F (37.6\u00b0C), pulse is 80/min, blood pressure is 130/85 mmHg, respirations are 18/min, and oxygen saturation is 95% on room air. Neurologic exam shows 4/5 strength in the deltoid muscles bilaterally. Diffuse dry crackles are heard on lung auscultation. A faint erythematous rash is noted on the malar cheeks, periorbital areas, lateral proximal thighs, and the elbows. Which of the following tests is most likely to confirm the diagnosis?",
        "answer": "Muscle biopsy",
        "options": {
            "A": "Muscle biopsy",
            "B": "CT scan",
            "C": "Serum ANA titer",
            "D": "Skin biopsy"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "48 year old Caucasian female presents",
            "primary care physician",
            "evaluation",
            "progressive weakness",
            "shortness of breath",
            "progressive shortness of breath",
            "last year",
            "intermittent non-productive cough",
            "addition",
            "difficulty",
            "arms to brush",
            "hair",
            "temperature",
            "99",
            "pulse",
            "80 min",
            "blood pressure",
            "85 mmHg",
            "respirations",
            "min",
            "oxygen saturation",
            "95",
            "room",
            "Neurologic exam shows 4/5 strength",
            "deltoid muscles",
            "Diffuse dry crackles",
            "heard",
            "lung auscultation",
            "faint erythematous rash",
            "noted",
            "malar",
            "periorbital areas",
            "lateral proximal thighs",
            "elbows",
            "following tests",
            "most likely to confirm",
            "diagnosis"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4677,
            "completion_tokens": 2919
        },
        "time_elapsed": 25.976840257644653,
        "raw_responses": [
            "Step 1: Recognize the clinical presentation. This 48-year-old female has progressive proximal muscle weakness (difficulty raising her arms), shortness of breath with lung crackles, and a characteristic rash (malar distribution with additional involvement of periorbital areas, lateral proximal thighs, and elbows). These findings are consistent with dermatomyositis.\n\nStep 2: Evaluate the diagnostic options.\n\u2022 Muscle biopsy (Option A) is considered the gold standard test for confirming dermatomyositis because it shows inflammatory infiltrates, perifascicular atrophy, and muscle fiber necrosis.\n\u2022 CT scan (Option B) is not appropriate for diagnosing myositis.\n\u2022 Serum ANA titer (Option C) can be positive in autoimmune conditions but is non-specific and not sufficient to confirm dermatomyositis.\n\u2022 Skin biopsy (Option D) may provide supportive evidence for DM by showing interface dermatitis, but it is less definitive compared to muscle biopsy.\n\nStep 3: Conclude the best answer.\nThe test most likely to confirm the diagnosis of dermatomyositis is the muscle biopsy.\n\nFinal answer: A. Muscle biopsy",
            "Step 1: Break Down the Clinical Information\n\u2022 The patient is a 48-year-old female with progressive weakness (especially proximal, such as difficulty raising her arms) and shortness of breath.\n\u2022 The physical exam reveals 4/5 strength in the deltoid muscles and characteristic skin findings: a faint erythematous rash on the malar cheeks, periorbital areas, and extensor surfaces (lateral proximal thighs and elbows).\n\nStep 2: Differential Diagnosis\n\u2022 The combination of proximal muscle weakness with a rash on the face and extensor surfaces is most consistent with dermatomyositis.\n\u2022 Additionally, lung findings (dry crackles) can be seen in this condition due to interstitial lung involvement.\n\nStep 3: Evaluate Options to Confirm the Diagnosis\nA. Muscle biopsy \u2013 The gold standard for confirming dermatomyositis by demonstrating muscle fiber inflammation, perifascicular atrophy, and necrosis.\nB. CT scan \u2013 More useful for lung pathology evaluation; not confirmatory for dermatomyositis.\nC. Serum ANA titer \u2013 While ANA can be positive, it is not specific or confirmatory for dermatomyositis.\nD. Skin biopsy \u2013 May support the diagnosis if examining characteristic rash but is less definitive compared to a muscle biopsy.\n\nStep 4: Final Answer\nThe most definitive test is a muscle biopsy.\n\nFinal Answer: A. Muscle biopsy",
            "Step 1: The patient\u2019s symptoms\u2014including progressive proximal muscle weakness (difficulty raising her arms), respiratory issues, and a characteristic rash (malar, periorbital, and on the lateral proximal thighs and elbows)\u2014point toward a diagnosis of dermatomyositis.\n\nStep 2: When comparing the options:\n\u2022 Muscle biopsy (Option A) is the gold standard for confirming dermatomyositis because it directly demonstrates inflammatory changes and muscle fiber necrosis.\n\u2022 CT scan (Option B) is not useful for confirming the muscle pathology.\n\u2022 Serum ANA titer (Option C) might be elevated in dermatomyositis but is nonspecific.\n\u2022 Skin biopsy (Option D) can support the diagnosis by showing pathologic changes in the rash, but it is not as definitive as muscle biopsy for confirming muscle inflammation.\n\nStep 3: Given the clinical presentation and comparison of options, the best confirmatory test is a muscle biopsy.\n\nFinal Answer: A. Muscle biopsy"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Recognize the clinical presentation. This 48-year-old female has progressive proximal muscle weakness (difficulty raising her arms), shortness of breath with lung crackles, and a characteristic rash (malar distribution with additional involvement of periorbital areas, lateral proximal thighs, and elbows). These findings are consistent with dermatomyositis.\n\nStep 2: Evaluate the diagnostic options.\n\u2022 Muscle biopsy (Option A) is considered the gold standard test for confirming dermatomyositis because it shows inflammatory infiltrates, perifascicular atrophy, and muscle fiber necrosis.\n\u2022 CT scan (Option B) is not appropriate for diagnosing myositis.\n\u2022 Serum ANA titer (Option C) can be positive in autoimmune conditions but is non-specific and not sufficient to confirm dermatomyositis.\n\u2022 Skin biopsy (Option D) may provide supportive evidence for DM by showing interface dermatitis, but it is less definitive compared to muscle biopsy.\n\nStep 3: Conclude the best answer.\nThe test most likely to confirm the diagnosis of dermatomyositis is the muscle biopsy.\n\nFinal answer: A. Muscle biopsy"
    },
    {
        "realidx": 241,
        "question": "A 41-year-old man presents to his primary care provider with abdominal pain. He says that the pain \u201ccomes and goes\u201d throughout the day and usually lasts 20-30 minutes per episode. He can point to the spot 1-2 inches above the umbilicus where he feels the pain. He denies any feeling of regurgitation or nighttime cough but endorses nausea. He reports that he used to eat three large meals per day but has found that eating more frequently improves his pain. He tried a couple pills of ibuprofen with food over the past couple days and thinks it helped. He has gained four pounds since his past appointment three months ago. The patient denies any diarrhea or change in his stools. He has no past medical history. He drinks 5-6 beers on the weekend and has a 20 pack-year smoking history. He denies any family history of cancer. On physical exam, he is tender to palpation above the umbilicus. Bowel sounds are present. A stool guaiac test is positive. The patient undergoes endoscopy with biopsy to diagnose his condition.\n\nWhich of the following is most likely to be found on histology?",
        "answer": "Urease-producing organism in the small intestine",
        "options": {
            "A": "Mucosal defect in the stomach",
            "B": "Urease-producing organism in the small intestine",
            "C": "PAS-positive material in the small intestine",
            "D": "Crypt abscesses in the large intestine"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old man presents",
            "primary care provider",
            "abdominal pain",
            "pain",
            "goes",
            "day",
            "usually lasts 20",
            "episode",
            "point",
            "spot",
            "inches",
            "umbilicus",
            "feels",
            "pain",
            "denies",
            "feeling",
            "regurgitation",
            "nighttime cough",
            "nausea",
            "reports",
            "used to eat three large meals",
            "day",
            "found",
            "eating",
            "frequently improves",
            "pain",
            "couple pills",
            "ibuprofen",
            "food",
            "past couple days",
            "thinks",
            "helped",
            "gained four pounds",
            "past appointment three months",
            "patient denies",
            "diarrhea",
            "change in",
            "stools",
            "past medical history",
            "drinks 5-6 beers",
            "weekend",
            "20 smoking history",
            "denies",
            "family history of cancer",
            "physical exam",
            "tender",
            "palpation",
            "umbilicus",
            "Bowel sounds",
            "present",
            "stool guaiac test",
            "positive",
            "patient",
            "endoscopy",
            "biopsy to diagnose",
            "condition",
            "following",
            "most likely to",
            "found",
            "histology"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5772,
            "completion_tokens": 4283
        },
        "time_elapsed": 30.90167999267578,
        "raw_responses": [
            "Step 1: Key aspects of the patient\u2019s history include recurrent, epigastric pain that lasts about 20\u201330 minutes per episode and improves with eating (as he switched to more frequent, smaller meals), a positive stool guaiac test, and relief with food and ibuprofen use. This clinical scenario is most consistent with a duodenal ulcer.\n\nStep 2: Duodenal ulcers are often associated with Helicobacter pylori infection, a Gram\u2010negative, curved, urease\u2010producing bacterium. On histology (from an endoscopic biopsy), one would expect to see evidence of H. pylori infection. Although H. pylori colonizes the gastric mucosa (especially the antrum), it is also the main culprit in the development of duodenal ulcers.\n\nStep 3: Evaluate the options:\n\u2022 Option A (\u201cMucosal defect in the stomach\u201d) describes a gastric ulcer, but his pain improves with food (which is more typical of a duodenal ulcer) and he has gained weight.\n\u2022 Option B (\u201cUrease-producing organism in the small intestine\u201d) is the best match as H. pylori is a urease-positive organism and is the likely culprit in his duodenal ulcer.\n\u2022 Option C (\u201cPAS-positive material in the small intestine\u201d) is more indicative of infections like Whipple\u2019s disease, which does not fit his presentation.\n\u2022 Option D (\u201cCrypt abscesses in the large intestine\u201d) suggests ulcerative colitis, which does not match his symptoms.\n\nFinal Answer: B",
            "Step 1: Consider the clinical presentation. The patient is a 41-year-old man with \u201ccomes and goes\u201d epigastric pain localized to an area just above the umbilicus. The pain episodes last about 20\u201330 minutes and improve with more frequent, smaller meals\u2014a presentation that is classic for duodenal ulcers. The positive stool guaiac test suggests gastrointestinal bleeding, which can be seen with peptic ulcer disease.\n\nStep 2: Relate the findings to the underlying pathology. Duodenal ulcers are most commonly associated with Helicobacter pylori infection. H. pylori is a gram-negative, curved, urease-producing bacterium. When H. pylori colonizes the duodenum, its urease enzyme produces ammonia, contributing to mucosal damage and ulcer formation.\n\nStep 3: Compare the answer choices:\n\u2022 Option A (Mucosal defect in the stomach) would be more consistent with a gastric ulcer rather than a duodenal ulcer.\n\u2022 Option B (Urease-producing organism in the small intestine) directly indicates H. pylori infection in the duodenum, which is the classic cause of duodenal ulcers.\n\u2022 Option C (PAS-positive material in the small intestine) is more indicative of organisms or substances like those found in certain fungal infections, not typical of duodenal ulcer.\n\u2022 Option D (Crypt abscesses in the large intestine) is associated with inflammatory conditions such as ulcerative colitis, not peptic ulcer disease.\n\nStep 4: Final answer.\nThe most likely histologic finding is a urease-producing organism in the small intestine (H. pylori).\n\nFinal Answer: B",
            "Step 1: The patient\u2019s symptoms \u2013 epigastric pain that improves with eating, recurrent pain episodes, use of NSAIDs, and a positive stool guaiac \u2013 are characteristic of a peptic ulcer, most likely a duodenal ulcer.\n\nStep 2: In duodenal ulcers, the most common etiology is Helicobacter pylori infection. H. pylori is a gram-negative bacterium that produces urease, an enzyme that can be detected histologically. Although H. pylori is most commonly associated with the stomach\u2019s antrum, it is also found in the duodenal bulb in cases of duodenal ulceration.\n\nStep 3: Evaluating the answer options:\n\u2022 Option A (\"Mucosal defect in the stomach\") would indicate a gastric ulcer, which is less likely given that the pain improves with meals.\n\u2022 Option B (\"Urease-producing organism in the small intestine\") is consistent with the presence of H. pylori in the setting of a duodenal ulcer.\n\u2022 Option C (\"PAS-positive material in the small intestine\") typically is seen in Whipple disease, which does not match this patient\u2019s presentation.\n\u2022 Option D (\"Crypt abscesses in the large intestine\") is indicative of inflammatory bowel disease involving the colon, which is not supported by this patient\u2019s symptoms.\n\nFinal Answer: B. Urease-producing organism in the small intestine"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Consider the clinical presentation. The patient is a 41-year-old man with \u201ccomes and goes\u201d epigastric pain localized to an area just above the umbilicus. The pain episodes last about 20\u201330 minutes and improve with more frequent, smaller meals\u2014a presentation that is classic for duodenal ulcers. The positive stool guaiac test suggests gastrointestinal bleeding, which can be seen with peptic ulcer disease.\n\nStep 2: Relate the findings to the underlying pathology. Duodenal ulcers are most commonly associated with Helicobacter pylori infection. H. pylori is a gram-negative, curved, urease-producing bacterium. When H. pylori colonizes the duodenum, its urease enzyme produces ammonia, contributing to mucosal damage and ulcer formation.\n\nStep 3: Compare the answer choices:\n\u2022 Option A (Mucosal defect in the stomach) would be more consistent with a gastric ulcer rather than a duodenal ulcer.\n\u2022 Option B (Urease-producing organism in the small intestine) directly indicates H. pylori infection in the duodenum, which is the classic cause of duodenal ulcers.\n\u2022 Option C (PAS-positive material in the small intestine) is more indicative of organisms or substances like those found in certain fungal infections, not typical of duodenal ulcer.\n\u2022 Option D (Crypt abscesses in the large intestine) is associated with inflammatory conditions such as ulcerative colitis, not peptic ulcer disease.\n\nStep 4: Final answer.\nThe most likely histologic finding is a urease-producing organism in the small intestine (H. pylori).\n\nFinal Answer: B"
    },
    {
        "realidx": 243,
        "question": " A 61-year-old man was started on rosuvastatin 40 mg 8 weeks ago and presents today for a follow-up. He complains of pain in his legs and general weakness. On physical exam, he has full range of motion of his extremities but complains of pain. His blood pressure is 126/84 mm Hg and heart rate is 74/min. The decision is made to stop the statin and return to the clinic in 2 weeks to assess any changes in symptoms. After stopping the statin, his muscular symptoms resolve. What is the next best course of action to take regarding his LDL control?",
        "answer": "Restart rosuvastatin at a lower dose",
        "options": {
            "A": "Restart rosuvastatin at a lower dose",
            "B": "Initiate fenofibrate",
            "C": "Initiate a different statin",
            "D": "Initiate fish oils"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "61 year old man",
            "started",
            "rosuvastatin 40 mg",
            "weeks",
            "presents today",
            "follow-up",
            "pain",
            "legs",
            "general weakness",
            "physical exam",
            "full range of motion",
            "extremities",
            "pain",
            "blood pressure",
            "84 mm Hg",
            "heart rate",
            "74 min",
            "decision",
            "made to stop",
            "statin",
            "return",
            "clinic",
            "2 weeks to assess",
            "changes",
            "symptoms",
            "stopping",
            "statin",
            "muscular symptoms resolve",
            "next best course",
            "action to take",
            "control"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4098,
            "completion_tokens": 3193
        },
        "time_elapsed": 25.252177715301514,
        "raw_responses": [
            "Step 1: The patient developed muscle pain while on a high-intensity statin (rosuvastatin 40 mg). Statin-induced myopathy is a known complication, and after discontinuation, the resolution of symptoms indicates that the statin was the likely cause.\n\nStep 2: Since the patient requires LDL control, completely stopping statins is not ideal given their benefit in cardiovascular disease prevention. Options such as fenofibrate or fish oils are not first-line therapies for LDL control; they are used for other indications (fenofibrate for high triglycerides and fish oils as an adjunct in certain cases). Switching statins (option C) might be considered, but a common strategy is first lowering the dose of the current statin to see if the patient tolerates it better while still obtaining the cardiovascular benefits.\n\nStep 3: Therefore, the next best course is to restart rosuvastatin at a lower dose.\n\nFinal answer: A. Restart rosuvastatin at a lower dose.",
            "Step 1: We know that statins are first\u2010line therapy for managing high LDL levels. In this case, the patient developed muscle pain on a high dose of rosuvastatin, which is a known dose\u2010dependent side effect.\n\nStep 2: After discontinuing the statin, his muscle symptoms resolved. This confirms that the statin was likely responsible for his symptoms.\n\nStep 3: For patients who experience statin-induced myopathies, guidelines recommend re-challenging with statin therapy\u2014either by lowering the dose or switching to a different statin\u2014to maintain cardiovascular risk reduction.\n\nStep 4: In this case, restarting rosuvastatin at a lower dose (Option A) is appropriate to manage his LDL while minimizing the risk of myopathy recurrence.\n\nFinal Answer: A. Restart rosuvastatin at a lower dose",
            "Step 1: The patient was started on a high-intensity statin (rosuvastatin 40 mg) for LDL control and developed muscle pain (a known side effect), which resolved after stopping the medication.\n\nStep 2: In managing statin-associated muscle symptoms while still addressing his LDL levels, guidelines suggest that a reduction in statin dose or switching to an alternative statin can be attempted. In this case, restarting the same statin at a lower dose is a reasonable first step to balance efficacy with tolerability.\n\nStep 3: Reviewing the options:\nA. Restart rosuvastatin at a lower dose \u2013 This directly addresses the muscle symptoms while continuing LDL therapy.\nB. Initiate fenofibrate \u2013 This is primarily used for hypertriglyceridemia and is not a first-line substitute for statin therapy in LDL control.\nC. Initiate a different statin \u2013 While this is an option, starting at a lower dose of the same statin is generally favored initially.\nD. Initiate fish oils \u2013 These are not considered effective enough for LDL control.\n\nFinal answer: A. Restart rosuvastatin at a lower dose."
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "0"
        ],
        "final_solution": "Step 1: The patient was started on a high-intensity statin (rosuvastatin 40 mg) for LDL control and developed muscle pain (a known side effect), which resolved after stopping the medication.\n\nStep 2: In managing statin-associated muscle symptoms while still addressing his LDL levels, guidelines suggest that a reduction in statin dose or switching to an alternative statin can be attempted. In this case, restarting the same statin at a lower dose is a reasonable first step to balance efficacy with tolerability.\n\nStep 3: Reviewing the options:\nA. Restart rosuvastatin at a lower dose \u2013 This directly addresses the muscle symptoms while continuing LDL therapy.\nB. Initiate fenofibrate \u2013 This is primarily used for hypertriglyceridemia and is not a first-line substitute for statin therapy in LDL control.\nC. Initiate a different statin \u2013 While this is an option, starting at a lower dose of the same statin is generally favored initially.\nD. Initiate fish oils \u2013 These are not considered effective enough for LDL control.\n\nFinal answer: A. Restart rosuvastatin at a lower dose."
    },
    {
        "realidx": 246,
        "question": "A 43-year-old man with a history of hepatitis C and current intravenous drug use presents with 5 days of fever, chills, headache, and severe back pain. On physical exam, temperature is 100.6 deg F (38.1 deg C), blood pressure is 109/56 mmHg, pulse is 94/min, and respirations are 18/min. He is thin and diaphoretic with pinpoint pupils, poor dentition, and track marks on his arms and legs. A high-pitched systolic murmur is heard, loudest in the left sternal border and with inspiration. He is admitted to the hospital and started on broad-spectrum antibiotics. One of the blood cultures drawn 12 hours ago returns positive for Staphylococcus aureus. Which of the following is the most appropriate next step to confirm the diagnosis?",
        "answer": "Repeat blood cultures now",
        "options": {
            "A": "Repeat blood cultures now",
            "B": "Repeat blood cultures 24 hours after initial cultures were drawn",
            "C": "Repeat blood cultures 48 hours after initial cultures were drawn",
            "D": "Do not repeat blood cultures"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "history of hepatitis C",
            "current intravenous drug use presents",
            "5 days",
            "fever",
            "chills",
            "headache",
            "severe back pain",
            "physical exam",
            "temperature",
            "100",
            "deg F",
            "blood pressure",
            "mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "thin",
            "diaphoretic",
            "pinpoint pupils",
            "poor dentition",
            "track marks",
            "arms",
            "legs",
            "high-pitched systolic murmur",
            "heard",
            "loudest",
            "left sternal border",
            "inspiration",
            "admitted",
            "hospital",
            "started",
            "broad spectrum antibiotics",
            "One of",
            "blood cultures drawn 12 hours",
            "returns positive",
            "Staphylococcus aureus",
            "following",
            "most appropriate next step to confirm",
            "diagnosis"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4542,
            "completion_tokens": 6623
        },
        "time_elapsed": 45.42675161361694,
        "raw_responses": [
            "This patient\u2019s history, physical exam findings, and risk factors (especially IV drug use and a tricuspid regurgitation murmur) are highly suggestive of infective endocarditis due to Staphylococcus aureus. One major Duke criterion is persistent bacteremia with a typical organism obtained from multiple blood cultures. Although one blood culture already returned positive, to meet the criteria for infective endocarditis and confirm persistent bacteremia (as opposed to a transient bacteremia that might be seen with a single blood culture positive result), repeat blood cultures are required.\n\nAfter the initiation of broad\u2010spectrum antibiotics, it may take some time for the antibiotics to begin clearing the organism from the bloodstream. Therefore, obtaining repeat blood cultures 48 hours after the initial cultures is recommended. This time interval is chosen because if the bacteremia persists at that point, it favors the diagnosis of infective endocarditis rather than a transient bacteremia that might resolve rapidly once appropriate therapy has been started.\n\nThus, the best next step is:\n\nC. Repeat blood cultures 48 hours after initial cultures were drawn.",
            "Step 1: In infective endocarditis, one of the major Duke criteria is the presence of persistent bacteremia. Since the patient is an intravenous drug user with a positive blood culture for Staphylococcus aureus\u2014a common pathogen in endocarditis among IV drug users\u2014it is important to show that the bacteremia is persistent. \n\nStep 2: Repeating blood cultures allows clinicians to determine if the bacteremia continues despite the initiation of therapy. Waiting 48 hours after the initial cultures have been drawn gives time to see if the organism is being cleared from the bloodstream with treatment or if it persists\u2014supporting the diagnosis of infective endocarditis. \n\nStep 3: Given the answer choices, the most appropriate next step to help confirm the diagnosis is to repeat blood cultures about 48 hours after the initial cultures were drawn.\n\nFinal answer: Repeat blood cultures 48 hours after initial cultures were drawn.",
            "Step 1: The patient\u2019s risk factors (hepatitis C, IV drug use), clinical findings (new systolic murmur heard best along the left sternal border, fever, and positive blood culture for Staphylococcus aureus) raise concern for right-sided infective endocarditis.\n\nStep 2: In diagnosing infective endocarditis, the modified Duke criteria are used. One of the major criteria is persistently positive blood cultures with organisms known to cause endocarditis. To fulfill this criterion, repeat blood cultures are typically obtained to show ongoing bacteremia rather than a transient bacteremia contaminant.\n\nStep 3: In this scenario, the blood culture drawn 12 hours ago is positive for S. aureus. To help confirm the diagnosis, it is recommended to recheck blood cultures later (typically 48 hours after the initial cultures) to determine whether the bacteremia is persistent (supporting the diagnosis of endocarditis) or if it has cleared (which would be less supportive of endocarditis).\n\nStep 4: Therefore, the most appropriate next step to confirm the diagnosis is to repeat the blood cultures 48 hours after the initial cultures were drawn.\n\nFinal answer: C. Repeat blood cultures 48 hours after initial cultures were drawn."
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "1"
        ],
        "final_solution": "This patient\u2019s history, physical exam findings, and risk factors (especially IV drug use and a tricuspid regurgitation murmur) are highly suggestive of infective endocarditis due to Staphylococcus aureus. One major Duke criterion is persistent bacteremia with a typical organism obtained from multiple blood cultures. Although one blood culture already returned positive, to meet the criteria for infective endocarditis and confirm persistent bacteremia (as opposed to a transient bacteremia that might be seen with a single blood culture positive result), repeat blood cultures are required.\n\nAfter the initiation of broad\u2010spectrum antibiotics, it may take some time for the antibiotics to begin clearing the organism from the bloodstream. Therefore, obtaining repeat blood cultures 48 hours after the initial cultures is recommended. This time interval is chosen because if the bacteremia persists at that point, it favors the diagnosis of infective endocarditis rather than a transient bacteremia that might resolve rapidly once appropriate therapy has been started.\n\nThus, the best next step is:\n\nC. Repeat blood cultures 48 hours after initial cultures were drawn."
    },
    {
        "realidx": 258,
        "question": "A 36-year-old nursing home worker presents to the clinic with the complaints of breathlessness, cough, and night sweats for the past 2 months. She further expresses her concerns about the possibility of contracting tuberculosis as one of the patients under her care is being treated for tuberculosis. A PPD skin test is done and reads 11 mm on day 3. Chest X-ray demonstrates a cavitary lesion in the right upper lobe. The standard anti-tuberculosis medication regimen is started. At a follow-up appointment 3 months later the patient presents with fatigue. She has also been experiencing occasional dizziness, weakness, and numbness in her feet. Physical exam is positive for conjunctival pallor. Lab work is significant for a hemoglobin level of 10 g/dL and mean corpuscular volume of 68 fl. What is the most likely cause of her current symptoms?",
        "answer": "Decreased ALA synthesis",
        "options": {
            "A": "Inhibition of ferrochelatase",
            "B": "Increased homocysteine degradation",
            "C": "Increased GABA production",
            "D": "Decreased ALA synthesis"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "36 year old nursing presents",
            "clinic",
            "complaints",
            "breathlessness",
            "cough",
            "night sweats",
            "past 2 months",
            "further",
            "concerns",
            "possibility",
            "contracting tuberculosis",
            "one",
            "patients",
            "care",
            "treated",
            "tuberculosis",
            "PPD skin test",
            "reads",
            "mm",
            "day 3",
            "Chest X-ray demonstrates",
            "lesion",
            "right upper lobe",
            "standard",
            "tuberculosis medication regimen",
            "started",
            "follow-up appointment",
            "months later",
            "patient presents",
            "fatigue",
            "experiencing occasional dizziness",
            "weakness",
            "numbness in",
            "feet",
            "Physical exam",
            "positive",
            "conjunctival pallor",
            "Lab work",
            "significant",
            "a hemoglobin level",
            "10 g/dL",
            "mean corpuscular volume",
            "68 fl",
            "most likely cause",
            "current symptoms"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5109,
            "completion_tokens": 3608
        },
        "time_elapsed": 28.799694299697876,
        "raw_responses": [
            "Step 1: Recognize the clinical context. The patient is on standard anti-tuberculosis therapy, which includes isoniazid. Isoniazid is known to cause a pyridoxine (vitamin B6) deficiency.\n\nStep 2: Link the deficiency to the patient's symptoms. Pyridoxine is an essential cofactor for the enzyme \u03b4-aminolevulinic acid (ALA) synthase, the enzyme that catalyzes the first step in heme synthesis. A deficiency causes decreased ALA synthesis, leading to impaired heme production and subsequently sideroblastic anemia. This is supported by the laboratory findings of a microcytic anemia (hemoglobin of 10 g/dL and MCV of 68 fl).\n\nStep 3: Evaluate the options.\nA. Inhibition of ferrochelatase \u2013 This enzyme is involved in the final step of heme synthesis (insertion of iron into protoporphyrin), typically affected by lead poisoning, not isoniazid.\nB. Increased homocysteine degradation \u2013 This is not related to the effects of isoniazid.\nC. Increased GABA production \u2013 This is also unrelated to heme synthesis or isoniazid toxicity.\nD. Decreased ALA synthesis \u2013 This is the correct mechanism, as isoniazid-induced pyridoxine deficiency leads to reduced activity of \u03b4-aminolevulinic acid synthase, resulting in impaired heme synthesis and sideroblastic anemia.\n\nFinal answer: D.",
            "Step-by-step reasoning:\n\n1. The patient has been on standard anti-tuberculosis therapy, which includes isoniazid. Isoniazid is well known for causing vitamin B6 (pyridoxine) deficiency.\n\n2. Vitamin B6 is an essential cofactor for \u03b4-aminolevulinic acid (ALA) synthase, the enzyme responsible for the first step in heme synthesis.\n\n3. In the absence of adequate vitamin B6, ALA synthase activity decreases, impairing heme production. This results in sideroblastic anemia, which is characterized by a microcytic anemia (low MCV) and symptoms such as fatigue, weakness, and neuropathy.\n\n4. Comparing the options:\n\u2003\u2022 Inhibition of ferrochelatase \u2013 This mechanism is seen in lead poisoning.\n\u2003\u2022 Increased homocysteine degradation \u2013 Not related to the hemolytic process in this case.\n\u2003\u2022 Increased GABA production \u2013 Not relevant to the anemia and neuropathy observed.\n\u2003\u2022 Decreased ALA synthesis \u2013 This is the direct result of isoniazid-induced vitamin B6 deficiency.\n\nFinal answer: D. Decreased ALA synthesis",
            "The patient was started on standard anti\u2010tuberculosis therapy, which includes isoniazid. Isoniazid can cause pyridoxine (vitamin B6) deficiency. Vitamin B6 is an essential cofactor for several enzymes, including \u03b4-aminolevulinic acid (ALA) synthase, which is the rate-limiting enzyme in heme synthesis. A deficiency in vitamin B6 leads to decreased activity of ALA synthase, resulting in impaired heme synthesis. This manifests clinically as sideroblastic anemia (a type of microcytic anemia) and peripheral neuropathy.\n\nStep by step:\n\n1. The patient\u2019s symptoms (fatigue, weakness, and pallor with a low hemoglobin and low MCV) indicate a microcytic anemia. The numbness in her feet points to peripheral neuropathy.\n2. Isoniazid is known to cause pyridoxine deficiency, which in turn can cause both sideroblastic anemia (by impairing heme synthesis) and neuropathy.\n3. Vitamin B6 is necessary for the function of ALA synthase; thus, its deficiency leads to decreased ALA synthase activity and decreased ALA synthesis.\n\nBy eliminating mechanisms not related to isoniazid\u2019s effect on vitamin B6 (e.g., inhibition of ferrochelatase, increased homocysteine degradation, increased GABA production), the correct choice is:\n\nFinal answer: D. Decreased ALA synthesis"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Recognize the clinical context. The patient is on standard anti-tuberculosis therapy, which includes isoniazid. Isoniazid is known to cause a pyridoxine (vitamin B6) deficiency.\n\nStep 2: Link the deficiency to the patient's symptoms. Pyridoxine is an essential cofactor for the enzyme \u03b4-aminolevulinic acid (ALA) synthase, the enzyme that catalyzes the first step in heme synthesis. A deficiency causes decreased ALA synthesis, leading to impaired heme production and subsequently sideroblastic anemia. This is supported by the laboratory findings of a microcytic anemia (hemoglobin of 10 g/dL and MCV of 68 fl).\n\nStep 3: Evaluate the options.\nA. Inhibition of ferrochelatase \u2013 This enzyme is involved in the final step of heme synthesis (insertion of iron into protoporphyrin), typically affected by lead poisoning, not isoniazid.\nB. Increased homocysteine degradation \u2013 This is not related to the effects of isoniazid.\nC. Increased GABA production \u2013 This is also unrelated to heme synthesis or isoniazid toxicity.\nD. Decreased ALA synthesis \u2013 This is the correct mechanism, as isoniazid-induced pyridoxine deficiency leads to reduced activity of \u03b4-aminolevulinic acid synthase, resulting in impaired heme synthesis and sideroblastic anemia.\n\nFinal answer: D."
    },
    {
        "realidx": 265,
        "question": "A 76-year-old man with chronic obstructive pulmonary disease (COPD) presents complaining of 3 weeks of cough and progressive dyspnea on exertion in the setting of a 20 pound weight loss. He is a 60 pack-year smoker, worked as a shipbuilder 30 years ago, and recently traveled to Ohio to visit family. Chest radiograph shows increased bronchovascular markings, reticular parenchymal opacities, and multiple pleural plaques. Labs are unremarkable except for a slight anemia. Which of the following is the most likely finding on this patient's chest CT?",
        "answer": "Lower lobe cavitary mass",
        "options": {
            "A": "Nodular mass spreading along pleural surfaces",
            "B": "Honeycombing",
            "C": "Air bronchogram",
            "D": "Lower lobe cavitary mass"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "76 year old man",
            "chronic obstructive pulmonary disease",
            "presents complaining of",
            "weeks",
            "cough",
            "progressive dyspnea on exertion",
            "setting",
            "20 pound weight loss",
            "60 pack-year smoker",
            "worked",
            "30 years",
            "recently traveled",
            "Ohio to visit family",
            "Chest radiograph shows increased",
            "markings",
            "reticular parenchymal opacities",
            "multiple pleural plaques",
            "Labs",
            "unremarkable",
            "slight anemia",
            "following",
            "most likely finding",
            "patient's chest CT"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5577,
            "completion_tokens": 7138
        },
        "time_elapsed": 48.14821004867554,
        "raw_responses": [
            "Step 1: The patient\u2019s history (a long history of smoking and asbestos exposure from shipbuilding) and his radiographic findings (increased bronchovascular markings, reticular parenchymal opacities, and multiple pleural plaques) strongly suggest pathology related to asbestos exposure. While asbestos exposure can predispose to both asbestosis (interstitial pulmonary fibrosis) and malignant mesothelioma, the radiograph indicates interstitial changes with reticular opacities rather than a discrete mass.\n\nStep 2: Reviewing the answer options:\n\u2022 Option A (\u201cNodular mass spreading along pleural surfaces\u201d) is more typical of mesothelioma, which usually presents with unilateral, nodular pleural thickening rather than multiple bilateral plaques and interstitial changes.\n\u2022 Option B (\u201cHoneycombing\u201d) is characteristic of fibrosis seen in asbestosis. Asbestosis tends to show interstitial fibrosis often with a honeycomb pattern in the lung bases on chest CT.\n\u2022 Option C (\u201cAir bronchogram\u201d) is generally seen with pulmonary consolidation, such as in pneumonia.\n\u2022 Option D (\u201cLower lobe cavitary mass\u201d) would be more suggestive of an infectious or necrotizing process, such as tuberculosis or a lung abscess.\n\nStep 3: Since his imaging shows interstitial involvement with reticular opacities and pleural plaques, the most likely chest CT finding, in light of his asbestos exposure, is honeycombing associated with asbestosis.\n\nFinal Answer: B. Honeycombing",
            "Step 1: Identify Key Patient Features\n\u2022 The patient is a 76\u2010year\u2010old male with a heavy smoking history and a history of shipbuilding, suggesting past asbestos exposure.\n\u2022 His symptoms include cough, progressive dyspnea, and weight loss.\n\u2022 The chest radiograph shows increased bronchovascular markings, reticular parenchymal opacities, and, importantly, multiple pleural plaques.\n\nStep 2: Recognize the Clinical Syndrome\n\u2022 The presence of pleural plaques, combined with a history of asbestos exposure from shipbuilding, strongly suggests asbestos-related pathology.\n\u2022 While asbestos exposure increases the risk of primary lung cancer, the characteristic finding of pleural plaques also raises suspicion for malignant mesothelioma, which typically presents as a nodular pleural thickening or mass.\n\nStep 3: Analyze the CT Findings in the Options\nA. Nodular mass spreading along pleural surfaces: \n\u2003- This finding is consistent with malignant mesothelioma, which manifests as a diffuse nodular or sheet-like thickening of the pleura.\nB. Honeycombing:\n\u2003- This is a hallmark finding of idiopathic pulmonary fibrosis and is not consistent with asbestos exposure.\nC. Air bronchogram:\n\u2003- This is typically seen in pneumonia or lung consolidation, not with asbestos-related disease.\nD. Lower lobe cavitary mass:\n\u2003- Cavitation is more often associated with infections like tuberculosis or necrotic lung cancers, not with asbestos exposure.\n\nStep 4: Final Answer\nGiven the patient's risk factors, history, and imaging findings, the most likely CT finding is a nodular mass spreading along the pleural surfaces.\n\nFinal Answer: A. Nodular mass spreading along pleural surfaces",
            "Step 1: Key Points in the Stem\n\u2022 The patient is a 76\u2010year\u2010old man with a history of COPD.\n\u2022 He has a significant smoking history (60 pack-years) and a past occupational exposure (shipbuilder), which is classically associated with asbestos exposure.\n\u2022 His symptoms include cough, progressive dyspnea, and notable weight loss.\n\u2022 The chest radiograph reveals increased bronchovascular markings, reticular parenchymal opacities, and multiple pleural plaques.\n\u2022 These radiographic findings, especially the pleural plaques, are highly indicative of asbestos exposure.\n\nStep 2: Analyzing the Differential\n\u2022 Asbestos exposure can lead to two major pulmonary pathologies:\n\u2003\u2013 Asbestosis: This interstitial lung disease often presents with reticular opacities and, on chest CT, results in a pattern of honeycombing, particularly in the lower lobes.\n\u2003\u2013 Malignant mesothelioma: A malignancy of the pleura that is strongly linked to asbestos exposure, which on CT typically appears as nodular masses spreading along pleural surfaces.\n\u2022 In this patient, the presence of weight loss, history of asbestos exposure, and pleural plaques raises concern for a malignant process rather than just interstitial fibrosis.\n\nStep 3: Evaluating the Answer Choices\nA. Nodular mass spreading along pleural surfaces \u2013 This finding is characteristic of malignant mesothelioma, which is associated with asbestos exposure.\nB. Honeycombing \u2013 This pattern is typically seen in asbestosis (interstitial lung disease) but is less consistent with the weight loss and overall picture of a malignant process.\nC. Air bronchogram \u2013 This sign is more indicative of alveolar consolidation (e.g., pneumonia) and does not correlate with the patient\u2019s exposure history and radiographic findings.\nD. Lower lobe cavitary mass \u2013 This is more suggestive of infections (like tuberculosis) or necrotic tumors, not the classic finding in asbestos-related disease.\n\nStep 4: Conclusion\nGiven the patient's history of asbestos exposure, the radiographic presence of pleural plaques, and his systemic findings (notably weight loss), the most likely CT finding would be a nodular mass spreading along pleural surfaces, a hallmark of mesothelioma.\n\nFinal Answer: A. Nodular mass spreading along pleural surfaces"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "2"
        ],
        "final_solution": "Step 1: The patient\u2019s history (a long history of smoking and asbestos exposure from shipbuilding) and his radiographic findings (increased bronchovascular markings, reticular parenchymal opacities, and multiple pleural plaques) strongly suggest pathology related to asbestos exposure. While asbestos exposure can predispose to both asbestosis (interstitial pulmonary fibrosis) and malignant mesothelioma, the radiograph indicates interstitial changes with reticular opacities rather than a discrete mass.\n\nStep 2: Reviewing the answer options:\n\u2022 Option A (\u201cNodular mass spreading along pleural surfaces\u201d) is more typical of mesothelioma, which usually presents with unilateral, nodular pleural thickening rather than multiple bilateral plaques and interstitial changes.\n\u2022 Option B (\u201cHoneycombing\u201d) is characteristic of fibrosis seen in asbestosis. Asbestosis tends to show interstitial fibrosis often with a honeycomb pattern in the lung bases on chest CT.\n\u2022 Option C (\u201cAir bronchogram\u201d) is generally seen with pulmonary consolidation, such as in pneumonia.\n\u2022 Option D (\u201cLower lobe cavitary mass\u201d) would be more suggestive of an infectious or necrotizing process, such as tuberculosis or a lung abscess.\n\nStep 3: Since his imaging shows interstitial involvement with reticular opacities and pleural plaques, the most likely chest CT finding, in light of his asbestos exposure, is honeycombing associated with asbestosis.\n\nFinal Answer: B. Honeycombing"
    },
    {
        "realidx": 267,
        "question": "A 34-year-old male suffers from inherited hemophilia A. He and his wife have three unaffected daughters. What is the probability that the second daughter is a carrier of the disease?",
        "answer": "100%",
        "options": {
            "A": "0%",
            "B": "25%",
            "C": "50%",
            "D": "100%"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old male suffers",
            "inherited hemophilia A",
            "wife",
            "three unaffected daughters",
            "probability",
            "second daughter",
            "carrier of",
            "disease"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 3042,
            "completion_tokens": 3400
        },
        "time_elapsed": 27.313130140304565,
        "raw_responses": [
            "Step 1: Recognize that hemophilia A is an X-linked recessive disorder. This means that affected males (with one X chromosome) pass the mutant X chromosome to all of their daughters.\n\nStep 2: Since the father is affected, every daughter will inherit his mutated X chromosome. Therefore, each daughter gets one mutant allele from him.\n\nStep 3: Because the daughters are reported as unaffected, they must have inherited a normal allele from their mother. However, having one mutant and one normal X chromosome still categorizes them as carriers of the trait.\n\nStep 4: Since this reasoning applies to any daughter born of an affected father (assuming the mother is unaffected or not a carrier for developing the disease), the probability that the second daughter is a carrier is 100%.\n\nFinal answer: D. 100%",
            "Step 1: Recognize that hemophilia A is an X-linked recessive disorder. Males (XY) who have the mutation on their only X chromosome manifest the disease, while females (XX) are typically carriers if they inherit one affected X.\n\nStep 2: Since the male (affected father) has hemophilia A, his one X chromosome is affected. In all daughters, the father contributes his only X chromosome. Therefore, every daughter will inherit the affected X from him.\n\nStep 3: The mother is not affected (and assuming she is not a carrier), she will contribute a normal X chromosome. As a result, each daughter will be heterozygous and a carrier.\n\nStep 4: Since this applies to every daughter, the probability that the second daughter is a carrier is 100%.\n\nFinal answer: 100%",
            "Step 1: Hemophilia A is an X-linked recessive disorder. An affected male has the genotype X\u02b0Y.\n\nStep 2: When an affected male (X\u02b0Y) has a daughter, she always receives the father's X\u02b0 allele. The mother, being unaffected (and assuming she is homozygous normal, XX), provides a normal X allele.\n\nStep 3: Therefore, every daughter will have the genotype X\u02b0X, making her a carrier of hemophilia A.\n\nFinal Answer: 100%"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Hemophilia A is an X-linked recessive disorder. An affected male has the genotype X\u02b0Y.\n\nStep 2: When an affected male (X\u02b0Y) has a daughter, she always receives the father's X\u02b0 allele. The mother, being unaffected (and assuming she is homozygous normal, XX), provides a normal X allele.\n\nStep 3: Therefore, every daughter will have the genotype X\u02b0X, making her a carrier of hemophilia A.\n\nFinal Answer: 100%"
    },
    {
        "realidx": 271,
        "question": "A 22-year-old primigravida presents for a regular prenatal visit at 16 weeks gestation. She is concerned about the results of a dipstick test she performed at home, which showed 1+ glucose. She does not know  if her liquid consumption has increased, but she urinates more frequently than before. The course of her pregnancy has been unremarkable and she has no significant co-morbidities. The BMI is 25.6 kg/cm2 and she has gained 3 kg (6.72 lb) during the pregnancy. The blood pressure is 110/80 mm Hg, the heart rate is 82/min, the respiratory rate is 14/min, and the temperature is 36.6\u2103 (97.9\u2109). The lungs are clear to auscultation, the heart sounds are normal with no murmurs, and there is no abdominal or costovertebral angle tenderness. The laboratory tests show the following results:\nFasting glucose 97 mg/L\nALT 12 IU/L\nAST 14 IU/L\nTotal bilirubin 0.8 mg/dL(15 \u00b5mol/L)\nPlasma creatinine 0.7 mg/dL (61.9 \u00b5mol/L)\nWhich of the following tests are indicated to determine the cause of the abnormal dipstick test results?",
        "answer": "No tests required",
        "options": {
            "A": "HbA1c measurement",
            "B": "No tests required",
            "C": "Urinalysis",
            "D": "Oral glucose tolerance test"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old primigravida presents",
            "regular prenatal visit",
            "weeks gestation",
            "concerned",
            "results",
            "dipstick test",
            "performed at home",
            "showed 1",
            "glucose",
            "not",
            "liquid consumption",
            "increased",
            "more frequently",
            "course",
            "pregnancy",
            "unremarkable",
            "significant co-morbidities",
            "BMI",
            "kg/cm2",
            "gained 3 kg",
            "72",
            "pregnancy",
            "blood pressure",
            "80 mm Hg",
            "heart rate",
            "min",
            "respiratory rate",
            "min",
            "temperature",
            "36",
            "97",
            "lungs",
            "clear",
            "auscultation",
            "heart sounds",
            "normal",
            "murmurs",
            "abdominal",
            "costovertebral angle tenderness",
            "laboratory tests show",
            "following results",
            "Fasting glucose 97 mg/L ALT 12 IU",
            "AST",
            "Total bilirubin 0 8 mg dL",
            "mol/L",
            "Plasma creatinine 0.7 mg/dL",
            "61",
            "mol/L",
            "following tests",
            "indicated to",
            "cause",
            "abnormal dipstick"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5664,
            "completion_tokens": 3670
        },
        "time_elapsed": 30.08605194091797,
        "raw_responses": [
            "Step 1: Review the clinical scenario. The patient is a 22-year-old primigravida at 16 weeks gestation with a dipstick showing 1+ glucose. However, her fasting blood glucose is normal at 97 mg/dL, and she has no other concerning signs. Glycosuria can appear in pregnancy due to increased glomerular filtration, even if blood glucose levels are normal.\n\nStep 2: Compare the testing options.\n\n\u2022 HbA1c measurement (Option A): This test assesses long-term glycemic control. However, in pregnancy\u2014especially in the absence of hyperglycemia\u2014it is not warranted.\n\n\u2022 No tests required (Option B): Given that glycosuria can be benign in pregnancy with normal blood glucose levels and the absence of other risk factors, no further diagnostic tests are needed.\n\n\u2022 Urinalysis (Option C): The abnormal finding already comes from a dipstick test, and a formal urinalysis is unlikely to provide additional useful information considering her labs are otherwise unremarkable.\n\n\u2022 Oral glucose tolerance test (Option D): This is typically done in the second trimester (around 24\u201328 weeks) to screen for gestational diabetes. At 16 weeks, with a normal fasting glucose, it\u2019s not the appropriate test.\n\nStep 3: Final answer.\nB. No tests required",
            "Step 1: Identify the key details.  \n\u2022 The patient is a 22-year-old primigravida at 16 weeks gestation with an abnormal dipstick test showing 1+ glucose and frequency of urination.  \n\u2022 Her vital signs, physical exam, and laboratory values, including a fasting glucose of 97 mg/dL, are all within normal limits.\n\nStep 2: Consider pregnancy physiology.  \n\u2022 During pregnancy, the glomerular filtration rate increases, which can result in physiologic glycosuria (glucose in the urine) even when blood glucose levels are normal.  \n\u2022 A fasting glucose of 97 mg/dL is normal and does not suggest gestational diabetes, which is typically screened for later in pregnancy (24\u201328 weeks).\n\nStep 3: Evaluate the answer options.  \nA. HbA1c measurement \u2013 Not indicated in this scenario because the blood glucose is normal and gestational diabetes is not suspected at this gestational age.  \nB. No tests required \u2013 This is appropriate if the glycosuria is physiologic and there are no other concerning findings.  \nC. Urinalysis \u2013 Although a urinalysis might provide more details, the dipstick finding in the context of pregnancy can be physiologic, and there is no evidence of urinary tract infection or other pathology.  \nD. Oral glucose tolerance test \u2013 Typically used for screening gestational diabetes later in pregnancy, not at 16 weeks especially when fasting glucose and clinical exam are normal.\n\nStep 4: Conclusion  \nGiven that the laboratory values are normal and that 1+ glycosuria can be a normal finding in pregnancy due to increased filtration, no further diagnostic testing is necessary at this time.\n\nFinal Answer: B. No tests required",
            "Step 1: Review the information. The patient is a healthy 22\u2010year-old gravida at 16 weeks with normal vitals and labs. Although her home dipstick showed 1+ glucose, her fasting blood glucose is normal at 97. In pregnancy, glycosuria is common due to increased renal plasma flow and glomerular filtration rate, which can cause glucose to appear in the urine even when blood glucose levels are normal.\n\nStep 2: Evaluate the options.\n\u2022 HbA1c measurement isn\u2019t indicated because the fasting glucose is normal and HbA1c reflects a longer-term glycemic status.\n\u2022 Urinalysis would simply confirm glycosuria, which is expected in pregnancy.\n\u2022 An oral glucose tolerance test is used to screen for gestational diabetes, typically later in pregnancy (around 24\u201328 weeks), and the patient\u2019s current results do not suggest diabetes.\n\u2022 No tests required is appropriate because a 1+ glucose on a dipstick in the context of normal labs in mid-pregnancy is a physiologic finding.\n\nStep 3: Final answer: B. No tests required."
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify the key details.  \n\u2022 The patient is a 22-year-old primigravida at 16 weeks gestation with an abnormal dipstick test showing 1+ glucose and frequency of urination.  \n\u2022 Her vital signs, physical exam, and laboratory values, including a fasting glucose of 97 mg/dL, are all within normal limits.\n\nStep 2: Consider pregnancy physiology.  \n\u2022 During pregnancy, the glomerular filtration rate increases, which can result in physiologic glycosuria (glucose in the urine) even when blood glucose levels are normal.  \n\u2022 A fasting glucose of 97 mg/dL is normal and does not suggest gestational diabetes, which is typically screened for later in pregnancy (24\u201328 weeks).\n\nStep 3: Evaluate the answer options.  \nA. HbA1c measurement \u2013 Not indicated in this scenario because the blood glucose is normal and gestational diabetes is not suspected at this gestational age.  \nB. No tests required \u2013 This is appropriate if the glycosuria is physiologic and there are no other concerning findings.  \nC. Urinalysis \u2013 Although a urinalysis might provide more details, the dipstick finding in the context of pregnancy can be physiologic, and there is no evidence of urinary tract infection or other pathology.  \nD. Oral glucose tolerance test \u2013 Typically used for screening gestational diabetes later in pregnancy, not at 16 weeks especially when fasting glucose and clinical exam are normal.\n\nStep 4: Conclusion  \nGiven that the laboratory values are normal and that 1+ glycosuria can be a normal finding in pregnancy due to increased filtration, no further diagnostic testing is necessary at this time.\n\nFinal Answer: B. No tests required"
    },
    {
        "realidx": 273,
        "question": "A 57-year-old man comes to the physician because of a 3-week history of abdominal bloating and increased frequency of stools. He describes the stools as bulky, foul-smelling, and difficult to flush. He also has a 4-month history of recurrent dull upper abdominal pain that usually lasts for a few days, worsens after meals, and is not relieved with antacids. He has had a 10-kg (22-lb) weight loss in the past 4 months. He has no personal or family history of serious illness. He has smoked 1 pack of cigarettes daily for 37 years. He has a 12-year history of drinking 6 to 8 beers daily. He is 160 cm (5 ft 3 in) tall and weighs 52 kg (115 lb); BMI is 20 kg/m2. His vital signs are within normal limits. Abdominal examination shows mild epigastric tenderness without rebound or guarding. Bowel sounds are normal. The remainder of the examination shows no abnormalities. Which of the following is the most appropriate next step in diagnosis?",
        "answer": "Abdominal CT scan",
        "options": {
            "A": "Abdominal CT scan",
            "B": "Endoscopic ultrasonography",
            "C": "Abdominal ultrasound",
            "D": "Upper gastrointestinal endoscopy"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "57 year old man",
            "physician",
            "3 week history",
            "abdominal bloating",
            "increased frequency of stools",
            "stools",
            "bulky",
            "foul-smelling",
            "difficult to flush",
            "4 month history",
            "recurrent dull upper",
            "usually",
            "days",
            "worsens",
            "meals",
            "not relieved with antacids",
            "a 10 kg",
            "weight loss",
            "past",
            "months",
            "personal",
            "family history",
            "serious illness",
            "smoked 1 pack",
            "cigarettes daily",
            "years",
            "12 year history",
            "drinking 6",
            "beers daily",
            "5 ft",
            "tall",
            "kg",
            "BMI",
            "20 kg/m2",
            "vital signs",
            "normal limits",
            "Abdominal examination shows mild epigastric tenderness",
            "guarding",
            "Bowel sounds",
            "normal",
            "examination shows",
            "abnormalities",
            "following",
            "most appropriate next step",
            "diagnosis"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5043,
            "completion_tokens": 3244
        },
        "time_elapsed": 28.427425861358643,
        "raw_responses": [
            "Step 1: Review of the clinical presentation\n\u2022 The patient is a 57\u2010year\u2010old man who presents with steatorrhea (bulk, foul-smelling stools), weight loss, and recurrent upper abdominal pain that worsens after meals.\n\u2022 His history of chronic alcohol use (12 years, 6\u20138 beers daily) raises a high suspicion for chronic pancreatitis.\n  \nStep 2: Differential and appropriate evaluation\n\u2022 In chronic pancreatitis, pancreatic exocrine insufficiency can lead to malabsorption and steatorrhea.\n\u2022 The best initial imaging study to evaluate the pancreas, look for calcifications, ductal changes, or other structural abnormalities indicative of chronic pancreatitis is an abdominal CT scan.\n  \nStep 3: Comparison of options\n\u2022 Abdominal CT scan \u2013 Excellent for evaluating pancreatic parenchymal changes and calcifications, making it the test of choice for suspected chronic pancreatitis.\n\u2022 Endoscopic ultrasonography \u2013 Useful for evaluating pancreatic lesions and fine details, but it is more invasive and not typically the initial study.\n\u2022 Abdominal ultrasound \u2013 Limited utility in visualizing the pancreas due to overlying bowel gas; not the ideal initial test.\n\u2022 Upper gastrointestinal endoscopy \u2013 Focuses on mucosal lesions in the upper GI tract and would not evaluate pancreatic parenchymal changes.\n  \nFinal Answer: A. Abdominal CT scan",
            "Step 1: The patient has symptoms of malabsorption (bulky, foul-smelling stools that are difficult to flush) along with recurrent, postprandial upper abdominal pain and weight loss. His long-term heavy alcohol use raises suspicion for chronic pancreatitis, which can result in exocrine insufficiency manifesting as steatorrhea.\n\nStep 2: To evaluate a patient with suspected chronic pancreatitis (or to rule out pancreatic pathology), imaging of the pancreas is indicated. Abdominal ultrasound is less sensitive for chronic pancreatitis, and upper gastrointestinal endoscopy wouldn\u2019t adequately visualize the pancreas. Although endoscopic ultrasonography can provide detailed images, the initial and most appropriate step is to obtain an abdominal CT scan because it is the standard imaging modality to assess for pancreatic calcifications and chronic pancreatitis changes.\n\nFinal Answer: A. Abdominal CT scan",
            "Step 1: Identify the key features.  \n\u2022 The patient is a 57-year-old man with chronic alcohol use and a history of smoking.  \n\u2022 He presents with symptoms of steatorrhea (bulky, foul-smelling stools that are hard to flush), recurrent upper abdominal pain that worsens after meals, and significant weight loss.  \n\nStep 2: Formulate the clinical suspicion.  \nThese findings suggest exocrine pancreatic insufficiency, which is most commonly due to chronic pancreatitis, particularly in someone with a history of significant alcohol consumption.\n\nStep 3: Evaluate the diagnostic options.  \nA. Abdominal CT scan \u2013 This imaging modality is the most appropriate first test to evaluate suspected chronic pancreatitis, as it can reveal pancreatic calcifications, ductal changes, and inflammatory changes.  \nB. Endoscopic ultrasonography \u2013 While useful, especially in early or subtle chronic pancreatitis or in assessing for complications, it is not typically the initial diagnostic step.  \nC. Abdominal ultrasound \u2013 It has limited utility in assessing the pancreas due to overlying bowel gas and is less sensitive than CT in detecting pancreatic pathology.  \nD. Upper gastrointestinal endoscopy \u2013 Not useful for visualizing pancreatic pathology; it is more appropriate for assessing mucosal lesions of the GI tract.\n\nStep 4: Provide the final answer.  \nThe most appropriate next step in diagnosis is: A. Abdominal CT scan."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review of the clinical presentation\n\u2022 The patient is a 57\u2010year\u2010old man who presents with steatorrhea (bulk, foul-smelling stools), weight loss, and recurrent upper abdominal pain that worsens after meals.\n\u2022 His history of chronic alcohol use (12 years, 6\u20138 beers daily) raises a high suspicion for chronic pancreatitis.\n  \nStep 2: Differential and appropriate evaluation\n\u2022 In chronic pancreatitis, pancreatic exocrine insufficiency can lead to malabsorption and steatorrhea.\n\u2022 The best initial imaging study to evaluate the pancreas, look for calcifications, ductal changes, or other structural abnormalities indicative of chronic pancreatitis is an abdominal CT scan.\n  \nStep 3: Comparison of options\n\u2022 Abdominal CT scan \u2013 Excellent for evaluating pancreatic parenchymal changes and calcifications, making it the test of choice for suspected chronic pancreatitis.\n\u2022 Endoscopic ultrasonography \u2013 Useful for evaluating pancreatic lesions and fine details, but it is more invasive and not typically the initial study.\n\u2022 Abdominal ultrasound \u2013 Limited utility in visualizing the pancreas due to overlying bowel gas; not the ideal initial test.\n\u2022 Upper gastrointestinal endoscopy \u2013 Focuses on mucosal lesions in the upper GI tract and would not evaluate pancreatic parenchymal changes.\n  \nFinal Answer: A. Abdominal CT scan"
    },
    {
        "realidx": 284,
        "question": "An elderly man presents to his physician with complaints of difficulty breathing, easy fatigability, and bilateral leg swelling which began 2 months ago. His breathlessness worsens while walking, climbing the stairs, and lying flat on his back. He also finds it difficult to sleep well at night, as he often wakes up to catch his breath. His pulse is 98/min and blood pressure is 114/90 mm Hg. On examination, he has mild respiratory distress, distended neck veins, and bilateral pitting edema is evident on the lower third of his legs. His respiratory rate is 33/min, SpO2 is 93% in room air, and coarse crepitations are heard over the lung bases. On auscultation, the P2 component of his second heart sound is heard loudest at the second left intercostal space, and an S3 gallop rhythm is heard at the apex. Medication is prescribed for his symptoms which changes his cardiac physiology as depicted with the dashed line recorded post-medication. What is the mechanism of action of the prescribed medication?",
        "answer": "Decrease in transmembrane sodium gradient",
        "options": {
            "A": "Decrease in transmembrane sodium gradient",
            "B": "Preferential dilatation of capacitance vessels",
            "C": "Inhibition of aldosterone-mediated sodium reabsorption",
            "D": "Reduction in myocardial contractility"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "elderly man presents",
            "physician",
            "complaints",
            "difficulty breathing",
            "easy fatigability",
            "bilateral leg swelling",
            "began 2 months",
            "breathlessness worsens",
            "walking",
            "climbing",
            "stairs",
            "lying flat on",
            "back",
            "finds",
            "difficult to sleep well",
            "night",
            "often wakes up",
            "catch",
            "breath",
            "pulse",
            "98 min",
            "blood pressure",
            "90 mm Hg",
            "examination",
            "mild respiratory distress",
            "distended neck",
            "bilateral pitting edema",
            "evident",
            "lower third",
            "legs",
            "respiratory rate",
            "min",
            "room air",
            "coarse crepitations",
            "heard",
            "lung bases",
            "auscultation",
            "P2 component",
            "second heart",
            "heard loudest",
            "second left intercostal space",
            "S3",
            "heard",
            "apex",
            "Medication",
            "prescribed",
            "symptoms",
            "changes",
            "cardiac physiology",
            "dashed line recorded post medication",
            "mechanism of action",
            "prescribed medication"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 6045,
            "completion_tokens": 11503
        },
        "time_elapsed": 75.4163966178894,
        "raw_responses": [
            "Step 1: The patient\u2019s signs \u2013 worsening dyspnea (especially when lying supine), orthopnea, pulmonary crackles, an S3 gallop, jugular venous distension, and lower\u2010extremity edema \u2013 all point toward congestive heart failure with volume overload.\n\nStep 2: In heart failure with pulmonary edema symptoms, treatment aimed at acute symptom relief works to reduce preload (the filling pressure/volume of the heart). Although loop diuretics are frequently used, this question asks about a medication that \u201cchanges his cardiac physiology\u201d as demonstrated on a pressure\u2013volume loop diagram (with a dashed line showing the new state). A reduction in preload is typically seen as a leftward/downward shift in the operating point on a pressure\u2013volume loop.\n\nStep 3: Looking at the options:\n\u2022 Option A (\u201cDecrease in transmembrane sodium gradient\u201d) describes the action of digitalis glycosides (digoxin), which \u2013 by inhibiting the Na+/K+ ATPase \u2013 actually increases contractility rather than relieving volume overload immediately.\n\u2022 Option C (\u201cInhibition of aldosterone-mediated sodium reabsorption\u201d) represents aldosterone antagonists (like spironolactone), which are beneficial in heart failure but affect remodeling rather than producing an acute hemodynamic shift visible on the PV loop.\n\u2022 Option D (\u201cReduction in myocardial contractility\u201d) is essentially a negative inotropic effect. A further drop in contractility would worsen systolic dysfunction.\n\u2022 Option B (\u201cPreferential dilatation of capacitance vessels\u201d) is the mechanism of nitrates (e.g., nitroglycerin), which act by dilating the venous system. This reduces the amount of blood returning to the heart (reduced preload) and thereby shifts the pressure\u2013volume operating point to a lower end-diastolic volume, relieving pulmonary congestion.\n\nFinal Answer: B. Preferential dilatation of capacitance vessels",
            "Step 1: Recognize that the patient\u2019s history and exam findings point to congestive heart failure. His dyspnea on exertion, orthopnea, pulmonary crackles, an S3 gallop, and signs of fluid overload (distended neck veins and pitting edema) are consistent with this diagnosis.\n\nStep 2: In the setting of heart failure, many medications can help modify the pressure\u2010volume (PV) loop. For example, drugs that reduce preload (such as those that preferentially dilate the venous capacitance vessels) decrease the end-diastolic volume and thus can relieve pulmonary congestion.\n\nStep 3: Among the answer options:\n\u2003\u2022 Option A (\u201cDecrease in transmembrane sodium gradient\u201d) is more characteristic of agents affecting intracellular ionic concentrations (eg, certain cardiac glycosides) and does not describe a standard heart failure treatment for symptom relief.\n\u2003\u2022 Option B (\u201cPreferential dilatation of capacitance vessels\u201d) describes the mechanism of nitrates (eg, nitroglycerin), which predominantly dilate venous vessels to reduce preload. This reduction in preload shifts the PV loop downward (ie, a decrease in end-diastolic volume), which helps relieve congestive symptoms.\n\u2003\u2022 Option C (\u201cInhibition of aldosterone-mediated sodium reabsorption\u201d) is the action of mineralocorticoid receptor antagonists (eg, spironolactone). Although these drugs are beneficial in heart failure (improving remodeling and providing mortality benefits), their immediate effect on the PV loop isn\u2019t as marked as the venodilatory effect.\n\u2003\u2022 Option D (\u201cReduction in myocardial contractility\u201d) reflects agents that would depress cardiac performance. Since heart failure is already characterized by impaired contractility (or compensatory mechanisms thereof), further reduction in contractility would not be desired.\n\nStep 4: Given that the dashed line in the provided PV loop likely illustrates a shift resulting from decreased filling pressures (eg, a reduced end-diastolic volume), the most likely mechanism of the medication that produces this change is the preferential dilation of capacitance vessels (venodilation).\n\nFinal answer: B. Preferential dilatation of capacitance vessels.",
            "We can break down the reasoning as follows:\n\n\u2022 The patient\u2019s findings (orthopnea, bibasilar crackles, pitting edema, S3 gallop, distended neck veins) are all consistent with congestive heart failure. In a patient with fluid overload, the initial treatment is aimed at decreasing the volume load on the heart.\n\n\u2022 One common therapeutic strategy in heart failure is to decrease the preload by dilating the venous system (the \u201ccapacitance vessels\u201d) so that less blood returns to the heart. This moves the operating point on the Frank\u2010Starling curve to a region where the heart works more efficiently.\n\n\u2022 Out of the answer choices provided, the mechanism described as \u201cpreferential dilatation of capacitance vessels\u201d is the one that decreases preload. This is the mechanism of nitrates (eg, isosorbide dinitrate); although in many chronic cases an ACE inhibitor is typically started, the option that best fits the \u201cchange in cardiac physiology\u201d shown by the shift in the graph (ie, reduced preload) is the venodilatory effect.\n\nThus, the final answer is: B. Preferential dilatation of capacitance vessels."
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "1"
        ],
        "final_solution": "Step 1: The patient\u2019s signs \u2013 worsening dyspnea (especially when lying supine), orthopnea, pulmonary crackles, an S3 gallop, jugular venous distension, and lower\u2010extremity edema \u2013 all point toward congestive heart failure with volume overload.\n\nStep 2: In heart failure with pulmonary edema symptoms, treatment aimed at acute symptom relief works to reduce preload (the filling pressure/volume of the heart). Although loop diuretics are frequently used, this question asks about a medication that \u201cchanges his cardiac physiology\u201d as demonstrated on a pressure\u2013volume loop diagram (with a dashed line showing the new state). A reduction in preload is typically seen as a leftward/downward shift in the operating point on a pressure\u2013volume loop.\n\nStep 3: Looking at the options:\n\u2022 Option A (\u201cDecrease in transmembrane sodium gradient\u201d) describes the action of digitalis glycosides (digoxin), which \u2013 by inhibiting the Na+/K+ ATPase \u2013 actually increases contractility rather than relieving volume overload immediately.\n\u2022 Option C (\u201cInhibition of aldosterone-mediated sodium reabsorption\u201d) represents aldosterone antagonists (like spironolactone), which are beneficial in heart failure but affect remodeling rather than producing an acute hemodynamic shift visible on the PV loop.\n\u2022 Option D (\u201cReduction in myocardial contractility\u201d) is essentially a negative inotropic effect. A further drop in contractility would worsen systolic dysfunction.\n\u2022 Option B (\u201cPreferential dilatation of capacitance vessels\u201d) is the mechanism of nitrates (e.g., nitroglycerin), which act by dilating the venous system. This reduces the amount of blood returning to the heart (reduced preload) and thereby shifts the pressure\u2013volume operating point to a lower end-diastolic volume, relieving pulmonary congestion.\n\nFinal Answer: B. Preferential dilatation of capacitance vessels"
    },
    {
        "realidx": 285,
        "question": "A 30-year-old man presents to his primary care physician with complaints of excessive fatigue and weakness for the last several weeks. He also complains of abdominal pain and constipation for the same duration. On further questioning, he reports that he has lost 8 pounds in the last 2 weeks. Past medical history and family history are insignificant. His temperature is 37.3\u00b0 C (99.2\u00b0 F), respirations are 21/min, pulse is 63/min, and blood pressure is 99/70 mm Hg. On physical examination, he is a tired-appearing, thin male. He has a bronze discoloration to his skin, but he denies being outside in the sun or any history of laying in tanning beds. What is the next best step in the management of this patient?",
        "answer": "Start him on both hydrocortisone and fludrocortisone therapy",
        "options": {
            "A": "Administer intravenous fludrocortisone",
            "B": "Start him on androgen replacement treatment",
            "C": "Start him on both hydrocortisone and fludrocortisone therapy",
            "D": "Order an ACTH stimulation test"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "30 year old man presents",
            "primary care physician",
            "complaints",
            "excessive fatigue",
            "weakness",
            "weeks",
            "abdominal pain",
            "constipation",
            "same duration",
            "further questioning",
            "reports",
            "lost",
            "pounds",
            "2 weeks",
            "Past medical history",
            "family history",
            "temperature",
            "99",
            "F",
            "respirations",
            "min",
            "pulse",
            "63 min",
            "blood pressure",
            "99 70 mm Hg",
            "physical examination",
            "tired appearing",
            "thin male",
            "bronze discoloration",
            "skin",
            "denies",
            "outside",
            "sun",
            "history",
            "laying",
            "tanning beds",
            "next best step",
            "management",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5589,
            "completion_tokens": 3213
        },
        "time_elapsed": 28.1252863407135,
        "raw_responses": [
            "Step 1: Relevant Clinical Findings\n\u2022 The patient is a 30-year-old man presenting with fatigue, weakness, abdominal pain, constipation, and unintentional weight loss.\n\u2022 His physical exam reveals a bronze discoloration of the skin, which is significant because it can indicate increased ACTH (and subsequently increased melanocyte-stimulating hormone) due to primary adrenal insufficiency (Addison\u2019s disease).\n\u2022 His vital signs show mild hypotension (99/70 mm Hg).\n\nStep 2: Differential Diagnosis and Reasoning\n\u2022 The constellation of symptoms (fatigue, weight loss, hypotension, and hyperpigmentation) is highly suggestive of Addison\u2019s disease, which is primary adrenal insufficiency.\n\u2022 In primary adrenal insufficiency, the adrenal glands are unable to produce adequate glucocorticoids and mineralocorticoids. The loss of cortisol feedback leads to increased secretion of ACTH, which also increases MSH, causing hyperpigmentation.\n\u2022 Although treatment in an adrenal crisis involves immediate glucocorticoid (and possibly mineralocorticoid) replacement, the patient\u2019s presentation here does not indicate an immediate crisis\u2014it is more of a chronic presentation that requires diagnostic confirmation.\n\nStep 3: Evaluating the Options\nA. Administer intravenous fludrocortisone \u2013 This is a mineralocorticoid replacement, which is part of treatment for confirmed primary adrenal insufficiency, not the diagnostic step.\nB. Start him on androgen replacement treatment \u2013 Not appropriate based on the current clinical picture.\nC. Start him on both hydrocortisone and fludrocortisone therapy \u2013 This is the treatment for confirmed Addison\u2019s disease with both glucocorticoid and mineralocorticoid deficiencies. However, treatment should only commence after confirming the diagnosis.\nD. Order an ACTH stimulation test \u2013 This is the correct next step in the management of suspected adrenal insufficiency. It will help confirm the diagnosis by assessing the adrenal response. A subnormal cortisol response to ACTH (cosyntropin) supports the diagnosis of primary adrenal insufficiency.\n\nStep 4: Final Answer\nThe next best step in the management of this patient is to order an ACTH stimulation test.\n\nFinal answer: D. Order an ACTH stimulation test.",
            "Step 1: Review the patient information.  \n\u2022 The patient has fatigue, weakness, abdominal pain, constipation, significant weight loss, and notably a bronze discoloration of the skin.  \n\u2022 His blood pressure is on the low side.  \n\nStep 2: Recognize the pattern.  \n\u2022 The constellation of symptoms \u2014 fatigue, weight loss, gastrointestinal complaints, hypotension, and hyperpigmentation \u2014 is highly suggestive of primary adrenal insufficiency (Addison disease), where the adrenal cortex fails to produce adequate amounts of cortisol (and often aldosterone), leading to a compensatory increase in ACTH that causes the skin hyperpigmentation.\n\nStep 3: Consider the options.  \nA. Administer intravenous fludrocortisone \u2013 This would supply mineralocorticoid replacement, but it is not appropriate as an initial step without confirming the diagnosis.  \nB. Start him on androgen replacement treatment \u2013 This is not indicated in this scenario.  \nC. Start him on both hydrocortisone and fludrocortisone therapy \u2013 This would be correct treatment if you had a confirmed diagnosis of primary adrenal insufficiency, especially in an acute or crisis setting, but you should first confirm the diagnosis.  \nD. Order an ACTH stimulation test \u2013 This is the appropriate next step to confirm the diagnosis of Addison disease.\n\nStep 4: Conclude the final answer.  \nThe next best step in management is to confirm the diagnosis with an ACTH stimulation test.\n\nFinal Answer: D. Order an ACTH stimulation test.",
            "Step 1: Analyze the patient's presentation. The 30-year-old man has fatigue, weakness, abdominal pain, constipation, unintentional weight loss, and low blood pressure. Notably, he also has a bronze discoloration of his skin without a history of sun exposure. These findings are strongly suggestive of primary adrenal insufficiency (Addison's disease), where increased ACTH production leads to melanocyte stimulation and hyperpigmentation.\n\nStep 2: Consider the next step in management. In suspected Addison's disease, the best way to confirm the diagnosis is to evaluate adrenal function. The appropriate next step is to perform an ACTH stimulation test, which assesses the adrenal glands' ability to respond to adrenocorticotropic hormone (ACTH).\n\nStep 3: Evaluate the provided options.\n\u2022 Option A (Administer intravenous fludrocortisone) and Option C (Start him on both hydrocortisone and fludrocortisone therapy) pertain to treatment, which is premature before a confirmatory diagnosis.\n\u2022 Option B (Start him on androgen replacement treatment) is not indicated given his presentation.\n\u2022 Option D (Order an ACTH stimulation test) is the correct diagnostic step to confirm adrenal insufficiency.\n\nFinal Answer: D. Order an ACTH stimulation test."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Relevant Clinical Findings\n\u2022 The patient is a 30-year-old man presenting with fatigue, weakness, abdominal pain, constipation, and unintentional weight loss.\n\u2022 His physical exam reveals a bronze discoloration of the skin, which is significant because it can indicate increased ACTH (and subsequently increased melanocyte-stimulating hormone) due to primary adrenal insufficiency (Addison\u2019s disease).\n\u2022 His vital signs show mild hypotension (99/70 mm Hg).\n\nStep 2: Differential Diagnosis and Reasoning\n\u2022 The constellation of symptoms (fatigue, weight loss, hypotension, and hyperpigmentation) is highly suggestive of Addison\u2019s disease, which is primary adrenal insufficiency.\n\u2022 In primary adrenal insufficiency, the adrenal glands are unable to produce adequate glucocorticoids and mineralocorticoids. The loss of cortisol feedback leads to increased secretion of ACTH, which also increases MSH, causing hyperpigmentation.\n\u2022 Although treatment in an adrenal crisis involves immediate glucocorticoid (and possibly mineralocorticoid) replacement, the patient\u2019s presentation here does not indicate an immediate crisis\u2014it is more of a chronic presentation that requires diagnostic confirmation.\n\nStep 3: Evaluating the Options\nA. Administer intravenous fludrocortisone \u2013 This is a mineralocorticoid replacement, which is part of treatment for confirmed primary adrenal insufficiency, not the diagnostic step.\nB. Start him on androgen replacement treatment \u2013 Not appropriate based on the current clinical picture.\nC. Start him on both hydrocortisone and fludrocortisone therapy \u2013 This is the treatment for confirmed Addison\u2019s disease with both glucocorticoid and mineralocorticoid deficiencies. However, treatment should only commence after confirming the diagnosis.\nD. Order an ACTH stimulation test \u2013 This is the correct next step in the management of suspected adrenal insufficiency. It will help confirm the diagnosis by assessing the adrenal response. A subnormal cortisol response to ACTH (cosyntropin) supports the diagnosis of primary adrenal insufficiency.\n\nStep 4: Final Answer\nThe next best step in the management of this patient is to order an ACTH stimulation test.\n\nFinal answer: D. Order an ACTH stimulation test."
    },
    {
        "realidx": 303,
        "question": "A 16-year-old female presents to her primary care physician due to lack of menstruation. She has never had a period and is anxious that she is not \u201ckeeping up\u201d with her friends. She states that her breasts began developing when she was 13, and she had a growth spurt around the same time. Review of systems reveals that she has also been getting headaches every few months over the last year with some photosensitivity and nausea each time. Ibuprofen relieves her symptoms. The patient is a competitive ice skater and has never been sexually active. Her mother has a history of migraine headaches, and her older sister has a history of bipolar disorder. Both underwent menarche at age 15. At this visit, the patient\u2019s temperature is 98.6\u00b0F (37.0\u00b0C), pulse is 70/min, blood pressure is 118/65 mmHg, and respirations are 13/min. Her body mass index is 23.8 kg/m^2. Cardiopulmonary and abdominal exams are unremarkable. Both breasts are Tanner IV with no expressable discharge. Pelvic and axillary hair growth is also Tanner IV. The patient is unable to tolerate a full pelvic exam, but the part of the vaginal canal that is examined is unremarkable. Laboratory studies are ordered and are below:\n\nSerum:\nNa+: 139 mEq/L\nK+: 4.1 mEq/L\nCl-: 100 mEq/L\nHCO3-: 24 mEq/L\nUrea nitrogen: 12 mg/dL\nGlucose: 73 mg/dL\nCreatinine: 0.9 mg/dL\nCa2+: 9.7 mg/dL\nMg2+: 1.7 mEq/L\nAST: 11 U/L\nALT: 11 U/L\nFollicle Stimulating Hormone (FSH): 16.2 mIU/mL (4.7-21.5 mIU/ml)\nEstrogen: 240 pg/mL (64-357 pg/mL)\n\nAbdominal ultrasound is performed and shows a normal uterus and ovaries. Which of the following is the most likely diagnosis?",
        "answer": "Vaginal septum",
        "options": {
            "A": "Hyperprolactinemia",
            "B": "Imperforate hymen",
            "C": "Vaginal septum",
            "D": "Normal development"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old female presents",
            "primary care physician due to lack of menstruation",
            "never",
            "period",
            "anxious",
            "not keeping",
            "friends",
            "states",
            "breasts began",
            "growth spurt",
            "same time",
            "Review of systems reveals",
            "getting headaches",
            "few months",
            "year",
            "photosensitivity",
            "nausea",
            "time",
            "Ibuprofen relieves",
            "symptoms",
            "patient",
            "competitive ice",
            "never",
            "sexually active",
            "mother",
            "history of migraine headaches",
            "older sister",
            "history of bipolar disorder",
            "menarche at age",
            "visit",
            "patients temperature",
            "98",
            "pulse",
            "70 min",
            "blood pressure",
            "65 mmHg",
            "respirations",
            "min",
            "body mass index",
            "23",
            "kg/m",
            "Cardiopulmonary",
            "abdominal exams",
            "unremarkable",
            "breasts",
            "Tanner IV",
            "discharge",
            "Pelvic",
            "axillary",
            "Tanner IV",
            "patient",
            "unable to",
            "full pelvic exam",
            "part of",
            "vaginal canal",
            "examined",
            "unremarkable",
            "Laboratory studies",
            "ordered",
            "Serum",
            "Na",
            "mEq/L K",
            "4.1 mEq/L Cl",
            "100 mEq/L HCO3",
            "mEq/L Urea nitrogen",
            "mg/dL Glucose",
            "mg/dL Creatinine",
            "0.9 mg/dL Ca2",
            "9",
            "mg dL Mg2",
            "1.7 mEq/L AST",
            "U/L ALT",
            "U/L Follicle Stimulating Hormone",
            "mIU mL",
            "ml",
            "Estrogen",
            "pg/mL",
            "64",
            "pg/mL",
            "Abdominal ultrasound",
            "performed",
            "shows",
            "normal uterus",
            "ovaries",
            "following",
            "most likely diagnosis"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 7506,
            "completion_tokens": 5062
        },
        "time_elapsed": 37.58329892158508,
        "raw_responses": [
            "Step 1: Evaluate the clinical presentation.\n\u2022 A 16\u2010year-old female with primary amenorrhea but normal secondary sexual development (Tanner IV breasts and pubic hair) suggests that estrogen levels and gonadotropins are within normal limits.\n\u2022 The ultrasound shows a normal uterus and ovaries, which rules out anatomic abnormalities like M\u00fcllerian agenesis.\n\u2022 Although the patient reports occasional headaches with photosensitivity and nausea, these are more consistent with migraines (supported by her mother\u2019s history) than with a pituitary adenoma causing hyperprolactinemia (which would more likely present with galactorrhea and suppressed gonadotropins).\n\nStep 2: Compare the options.\nA. Hyperprolactinemia \u2013 This condition typically presents with low gonadotropin levels and symptoms such as galactorrhea, neither of which are present here.\nB. Imperforate hymen \u2013 This would lead to an obstruction with possible cyclic pelvic pain and a bulging hymenal membrane on exam; the exam findings are unremarkable.\nC. Vaginal septum \u2013 A transverse or longitudinal vaginal septum usually causes obstructive symptoms such as pelvic pain or retention of menstrual blood, which are not described in this patient.\nD. Normal development \u2013 The patient\u2019s FSH and estrogen levels are within normal limits, and her normal secondary sexual characteristics alongside a normal pelvic ultrasound indicate that her reproductive system is maturing normally, despite her current lack of menstruation. Some variation in the timing of menarche can be normal.\n\nStep 3: Final Answer.\nGiven the normal hormonal levels, imaging findings, and overall development, the most likely diagnosis is:\nD. Normal development",
            "Step 1: Review the Clinical Findings\n\n\u2022 The patient is a 16\u2010year\u2010old competitive athlete with no history of menses (primary amenorrhea).  \n\u2022 She has normal secondary sexual development (Tanner stage IV breasts and pubic/axillary hair).  \n\u2022 Her uterus and ovaries are normal on ultrasound.  \n\u2022 Lab studies reveal an FSH and estrogen level within the normal range.  \n\u2022 She experiences occasional headaches that are mild and respond to ibuprofen, a finding consistent with her family history of migraines.  \n\u2022 There is no history of cyclic abdominal pain or evidence of outflow tract obstruction on exam.\n\nStep 2: Compare the Differential Diagnoses\n\nA. Hyperprolactinemia  \n\u2003\u2022 Typically presents with amenorrhea, sometimes with galactorrhea, headaches, and visual changes.  \n\u2003\u2022 In this case, there is no mention of galactorrhea, and her hormone studies (FSH and estrogen) are normal, arguing against this diagnosis.\n\nB. Imperforate Hymen  \n\u2003\u2022 Leads to primary amenorrhea with normal secondary sexual characteristics and can cause cyclical pelvic pain due to blood accumulation (hematocolpos).  \n\u2003\u2022 The exam did not reveal a bulging, bluish membrane, and the ultrasound did not indicate any obstruction; therefore, this is unlikely.\n\nC. Vaginal Septum  \n\u2003\u2022 Also can cause an outflow obstruction with resultant primary amenorrhea and cyclic pain.  \n\u2003\u2022 The physical exam and ultrasound both are unremarkable, making this choice less likely.\n\nD. Normal Development  \n\u2003\u2022 In patients with normal secondary sexual development, primary amenorrhea due to late menarche can be a normal variant.  \n\u2003\u2022 The patient\u2019s mother and sister both had menarche at age 15, suggesting a familial pattern of late menarche.  \n\u2003\u2022 Her normal hormonal profile, normal internal reproductive anatomy, and lack of obstructive findings support this diagnosis.\n\nStep 3: Final Answer\n\nThe most likely diagnosis is D. Normal development.",
            "Step 1: Gather the key points. The patient is a 16-year-old female who has never had a menstrual period but has normal secondary sexual characteristics (Tanner stage IV breasts and pubic/axillary hair) and normal estrogen and FSH levels. The uterus and ovaries are normal on ultrasound. Although she experiences occasional headaches, they are not accompanied by prolactin-related symptoms (like galactorrhea).\n\nStep 2: Evaluate the options.\n\nA. Hyperprolactinemia \u2013 Typically causes amenorrhea and galactorrhea due to suppression of GnRH. Her exam does not reveal galactorrhea, and hormone levels (especially estrogen) are normal, making this unlikely.\n\nB. Imperforate hymen \u2013 This would usually present with cyclic pelvic pain and a bulging hymenal membrane due to accumulation of menstrual blood (hematocolpos). The exam and ultrasound are unremarkable.\n\nC. Vaginal septum \u2013 Similar to an imperforate hymen, a vaginal septum may block menstrual flow and cause cyclic pain. Again, her exam is normal, and she does not report such symptoms.\n\nD. Normal development \u2013 In a female with normal secondary sexual development, normal reproductive tract imaging, and appropriate hormone levels, primary amenorrhea can sometimes represent normal variation or a delayed menarche. Her family history (older sister with menarche at age 15) supports a variation in the timing of menarche rather than a pathological issue.\n\nStep 3: Conclusion.\nGiven the normal physical exam, hormone levels, and imaging findings, the most likely diagnosis is that she is within the normal spectrum of pubertal development.\n\nFinal answer: D. Normal development."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Review the Clinical Findings\n\n\u2022 The patient is a 16\u2010year\u2010old competitive athlete with no history of menses (primary amenorrhea).  \n\u2022 She has normal secondary sexual development (Tanner stage IV breasts and pubic/axillary hair).  \n\u2022 Her uterus and ovaries are normal on ultrasound.  \n\u2022 Lab studies reveal an FSH and estrogen level within the normal range.  \n\u2022 She experiences occasional headaches that are mild and respond to ibuprofen, a finding consistent with her family history of migraines.  \n\u2022 There is no history of cyclic abdominal pain or evidence of outflow tract obstruction on exam.\n\nStep 2: Compare the Differential Diagnoses\n\nA. Hyperprolactinemia  \n\u2003\u2022 Typically presents with amenorrhea, sometimes with galactorrhea, headaches, and visual changes.  \n\u2003\u2022 In this case, there is no mention of galactorrhea, and her hormone studies (FSH and estrogen) are normal, arguing against this diagnosis.\n\nB. Imperforate Hymen  \n\u2003\u2022 Leads to primary amenorrhea with normal secondary sexual characteristics and can cause cyclical pelvic pain due to blood accumulation (hematocolpos).  \n\u2003\u2022 The exam did not reveal a bulging, bluish membrane, and the ultrasound did not indicate any obstruction; therefore, this is unlikely.\n\nC. Vaginal Septum  \n\u2003\u2022 Also can cause an outflow obstruction with resultant primary amenorrhea and cyclic pain.  \n\u2003\u2022 The physical exam and ultrasound both are unremarkable, making this choice less likely.\n\nD. Normal Development  \n\u2003\u2022 In patients with normal secondary sexual development, primary amenorrhea due to late menarche can be a normal variant.  \n\u2003\u2022 The patient\u2019s mother and sister both had menarche at age 15, suggesting a familial pattern of late menarche.  \n\u2003\u2022 Her normal hormonal profile, normal internal reproductive anatomy, and lack of obstructive findings support this diagnosis.\n\nStep 3: Final Answer\n\nThe most likely diagnosis is D. Normal development."
    },
    {
        "realidx": 307,
        "question": "A 67-year-old man is brought to the emergency department with sudden onset of slurred speech. The patient\u2019s eldest daughter says that he couldn\u2019t move his arm during the episode. Past medical history is significant for hypertension and a hemorrhagic stroke 6 years ago, which was treated surgically. After admission, the patient gets increasingly worse and loses consciousness. A noncontrast CT of the head shows a subarachnoid hemorrhage (SAH). The patient is taken to the operating room, where the SAH evacuated, and the vessel is repaired. Postoperatively, the patient is unresponsive. Several days later, a repeat CT of the head shows an enlarging aneurysm in a different vessel in the brain. The patient\u2019s daughter is asked to consent to a non-emergent, life-saving operation since the patient is in a comatose state. She does not consent to the operation even though the physician stresses it would be life-saving. Upon further discussion, the physician finds out that the patient was abusive and neglectful to his children, and the daughter wants \u201cto live in peace.\u201d The patient has no written advanced directive. Which of the following is the most appropriate course of action?",
        "answer": "Contact another family member for consent",
        "options": {
            "A": "Follow the daughter\u2019s wishes to withhold the operation",
            "B": "Refer this case to the court",
            "C": "Contact another family member for consent",
            "D": "Report the daughter to the police"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "67 year old man",
            "brought",
            "emergency department",
            "sudden onset",
            "slurred speech",
            "patients",
            "daughter",
            "move",
            "arm",
            "episode",
            "Past medical history",
            "significant",
            "hypertension",
            "hemorrhagic stroke",
            "years",
            "treated surgically",
            "admission",
            "patient gets",
            "worse",
            "consciousness",
            "CT of",
            "head shows",
            "subarachnoid hemorrhage",
            "patient",
            "taken",
            "operating room",
            "SAH",
            "vessel",
            "repaired",
            "patient",
            "unresponsive",
            "days later",
            "repeat CT of",
            "head shows",
            "enlarging aneurysm",
            "different vessel",
            "brain",
            "patients daughter",
            "to consent",
            "non-emergent",
            "life saving operation",
            "patient",
            "comatose state",
            "not consent",
            "operation",
            "physician stresses",
            "life saving",
            "further discussion",
            "physician finds out",
            "patient",
            "neglectful",
            "children",
            "daughter",
            "to live",
            "peace",
            "patient",
            "written advanced directive",
            "following",
            "most appropriate course",
            "action"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5589,
            "completion_tokens": 3321
        },
        "time_elapsed": 27.550339460372925,
        "raw_responses": [
            "Step 1: This patient is now comatose following surgery for a subarachnoid hemorrhage, and his repeat CT scan shows an enlarging aneurysm in a different vessel, which requires urgent, life\u2010saving intervention.\n\nStep 2: The patient has no written advanced directive, so the decision in his best interest falls to his next of kin. Normally, the daughter would act as the surrogate decision-maker.\n\nStep 3: However, the daughter\u2019s refusal is influenced by her troubled history with the patient (abuse and neglect), which suggests a potential conflict of interest. Her decision may not reflect the patient\u2019s best medical interests.\n\nStep 4: In situations where there is a conflict of interest or disagreement about life\u2010saving treatment, an ethics consultation and legal input may be necessary. The most appropriate course of action is to refer the case to the court so that an impartial decision can be made regarding the patient\u2019s care.\n\nFinal Answer: B. Refer this case to the court.",
            "Step 1: Understand the situation. A 67-year-old man is in a comatose state with a brain aneurysm that requires a non-emergency, yet life-saving operation. He has no written advanced directive. His daughter, who is his next-of-kin but has a motive stemming from past abuse by the patient, does not consent to the surgery.\n\nStep 2: Identify key ethical principles. When a patient is incapacitated and has no advanced directive, surrogate decision-makers (typically the next-of-kin) make decisions in the patient\u2019s best interest. However, if there is evidence indicating that the surrogate may not be acting in the patient\u2019s best interest (or may be conflicted by past abuse), it is necessary to re-assess whether the surrogate's decision should be accepted.\n\nStep 3: Compare the options.\n\u2022 Option A: Following the daughter\u2019s wishes to withhold the operation would likely ignore the medical team's view of the patient\u2019s best interest and the patient's potential need for life-saving intervention.\n\u2022 Option C: Contacting another family member for consent may not resolve the conflict since the daughter is the legal next-of-kin, and others may not legally override the daughter\u2019s decision.\n\u2022 Option D: Reporting the daughter to the police is not appropriate in the context of decision-making for a medical procedure.\n\u2022 Option B: Referring the case to the court is an appropriate way to resolve disputes involving surrogate decision-makers when there are concerns that the surrogate may not be acting in the patient's best interest. A court-appointed guardian can then make decisions impartially based on the patient\u2019s presumed wishes.\n\nStep 4: Final answer.\nThe most appropriate course of action is to refer this case to the court.\n\nFinal Answer: B. Refer this case to the court.",
            "Step 1: Identify Key Details\n\u2022 The patient is in a life-threatening condition and is comatose, without an advance directive.\n\u2022 His daughter is the surrogate decision-maker but refuses a life-saving procedure, motivated by her negative emotional history with her father rather than his expressed wishes or best interests.\n\u2022 The decision by the daughter conflicts with the medical standard of providing life-saving care.\n\nStep 2: Evaluate the Options\nA. Follow the daughter\u2019s wishes to withhold the operation.\n\u2003- This is not ethically appropriate because the daughter\u2019s personal grievances are unduly influencing her decision-making, potentially violating the patient\u2019s right to receive care.\nB. Refer this case to the court.\n\u2003- When a surrogate decision-maker\u2019s refusal of treatment is evidently influenced by personal bias rather than patient best interest, it is appropriate to seek judicial intervention. This helps ensure that the patient receives necessary, life-saving care while resolving the dispute over consent.\nC. Contact another family member for consent.\n\u2003- Although involving other family members might seem reasonable, the primary legal surrogate is the daughter. Since her decision appears compromised, simply seeking another surrogate may not alleviate concerns regarding the patient\u2019s right to treatment.\nD. Report the daughter to the police.\n\u2003- This option is not appropriate because there is no indication of criminal behavior that would necessitate police involvement at this point.\n\nStep 3: Final Answer\nThe most appropriate course of action is to refer this case to the court.\nFinal answer: B. Refer this case to the court."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Identify Key Details\n\u2022 The patient is in a life-threatening condition and is comatose, without an advance directive.\n\u2022 His daughter is the surrogate decision-maker but refuses a life-saving procedure, motivated by her negative emotional history with her father rather than his expressed wishes or best interests.\n\u2022 The decision by the daughter conflicts with the medical standard of providing life-saving care.\n\nStep 2: Evaluate the Options\nA. Follow the daughter\u2019s wishes to withhold the operation.\n\u2003- This is not ethically appropriate because the daughter\u2019s personal grievances are unduly influencing her decision-making, potentially violating the patient\u2019s right to receive care.\nB. Refer this case to the court.\n\u2003- When a surrogate decision-maker\u2019s refusal of treatment is evidently influenced by personal bias rather than patient best interest, it is appropriate to seek judicial intervention. This helps ensure that the patient receives necessary, life-saving care while resolving the dispute over consent.\nC. Contact another family member for consent.\n\u2003- Although involving other family members might seem reasonable, the primary legal surrogate is the daughter. Since her decision appears compromised, simply seeking another surrogate may not alleviate concerns regarding the patient\u2019s right to treatment.\nD. Report the daughter to the police.\n\u2003- This option is not appropriate because there is no indication of criminal behavior that would necessitate police involvement at this point.\n\nStep 3: Final Answer\nThe most appropriate course of action is to refer this case to the court.\nFinal answer: B. Refer this case to the court."
    },
    {
        "realidx": 321,
        "question": "A 55-year-old man recovering from knee replacement surgery complains of breathlessness in the postoperative ward. He has been confined to bed for the past 5 days and is under observation. He felt a sudden difficulty in breathing and called for the ward nurse. He says that he is unable to take deep breaths and has a sharp pain on the right side of his chest with each inspiration. His temperature is 37.5\u00b0C (99.8\u00b0F), the pulse is 111/min, the respirations are 31/min, and the blood pressure is 85/55 mm Hg. He experiences pain in his right calf on dorsiflexion. There are no other prominent findings on physical examination. His chest X-ray does not show anything significant. The ECG reveals sinus tachycardia. Which of the following is the best course of management at this time?",
        "answer": "Subcutaneous fondaparinux",
        "options": {
            "A": "Subcutaneous fondaparinux",
            "B": "Inferior vena cava filter",
            "C": "Ventilation-perfusion scan",
            "D": "Lower extremity doppler"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "55 year old man recovering from knee surgery",
            "breathlessness",
            "postoperative ward",
            "confined to bed",
            "past",
            "days",
            "observation",
            "felt",
            "sudden difficulty",
            "breathing",
            "called",
            "ward nurse",
            "unable to take deep breaths",
            "pain",
            "right side",
            "chest",
            "inspiration",
            "temperature",
            "99",
            "pulse",
            "min",
            "respirations",
            "31 min",
            "blood pressure",
            "85 55 mm Hg",
            "experiences pain in",
            "right calf",
            "prominent findings",
            "physical examination",
            "chest X-ray",
            "not show",
            "significant",
            "ECG reveals sinus tachycardia",
            "following",
            "best course",
            "management",
            "time"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6630,
            "completion_tokens": 5780
        },
        "time_elapsed": 41.693934202194214,
        "raw_responses": [
            "Let's break down the thought process:\n\n\u2022 This 55\u2010year\u2010old man, post knee replacement with several days of immobilization, has sudden-onset dyspnea, pleuritic chest pain, and hypotension\u2014which are all classic signs of a pulmonary embolism (PE). Additionally, his right calf pain with dorsiflexion indicates a possible deep venous thrombosis (DVT) as the source of the embolus.\n\n\u2022 In a hemodynamically unstable patient suspected of having a PE, immediate steps are crucial. Advanced imaging like a CT pulmonary angiogram is often used in stable patients, but in someone who is unstable it might not be feasible. A ventilation-perfusion (V/Q) scan, option C, is also a diagnostic modality but can be time-consuming and isn\u2019t ideal in unstable patients.\n\n\u2022 Since the patient has clear signs of lower extremity DVT, performing a lower extremity Doppler (option D) is a rapid, bedside, noninvasive test that can confirm the diagnosis of DVT. A positive study in the setting of a high clinical suspicion for PE essentially establishes the clinical diagnosis and can expedite immediate treatment.\n\n\u2022 Options A (subcutaneous fondaparinux) and B (inferior vena cava filter) are treatment choices. However, given the patient\u2019s hemodynamic instability, it is critical to quickly confirm the diagnosis (and often, in hemodynamically unstable patients, more aggressive therapy such as thrombolysis may be indicated). Moreover, initiating anticoagulation or placing an IVC filter would be premature without diagnostic confirmation in this setting.\n\nThus, the best course of management at this time is to perform a lower extremity Doppler study.\n\nFinal answer: D. Lower extremity Doppler.",
            "Step 1: The patient is a 55\u2010year\u2010old man in the immediate postoperative period who has been on prolonged bed rest. His presentation of sudden-onset shortness of breath, pleuritic chest pain, tachycardia, tachypnea, hypotension, plus a positive finding of calf pain with dorsiflexion (a sign suggesting deep venous thrombosis [DVT]) places him at high risk for a pulmonary embolism (PE).\n\nStep 2: When considering management options in a patient suspected of having a massive or high\u2010risk PE, the diagnosis needs to be confirmed promptly. Common imaging studies include computed tomography pulmonary angiography (CTPA) or a ventilation-perfusion (V/Q) scan. However, in a hemodynamically unstable patient or one for whom a CT scan might be challenging, looking for a source of emboli in the lower extremities using a Doppler ultrasound can be very useful. A positive lower extremity Doppler examination in the proper clinical context is highly suggestive of an embolic source and can expedite treatment decisions regarding anticoagulation and possibly thrombolytic therapy.\n\nOption A (Subcutaneous fondaparinux) is an anticoagulant therapy that would be used for confirmed cases of DVT/PE. However, in the setting of hemodynamic instability, immediate diagnostic confirmation is crucial before initiating treatment.\n\nOption B (Inferior vena cava filter) is generally reserved for patients who have contraindications to anticoagulation or have recurrent emboli despite adequate therapy. It is not the initial test or treatment.\n\nOption C (Ventilation-perfusion scan) is used diagnostically in stable patients. In an unstable patient, it may take too long and the results might not be immediately actionable.\n\nOption D (Lower extremity Doppler) is a rapid, noninvasive test that can help confirm the presence of a DVT, which in the context of his symptoms and risk factors would further support the diagnosis of a pulmonary embolism. Given the urgency and the patient\u2019s unstable hemodynamic status, this test is the most appropriate next step.\n\nStep 3: Therefore, the best course of management at this time is to proceed with a Lower extremity Doppler (Option D) to quickly evaluate for a DVT as the source of his embolism.\n\nFinal answer: D. Lower extremity doppler",
            "Step 1: Recognize high risk for pulmonary embolism (PE).  \n\u2022 The patient is post-knee replacement surgery with prolonged immobilization\u2014a known risk factor for deep venous thrombosis (DVT) and subsequent PE.  \n\u2022 His symptoms\u2014sudden onset breathlessness, pleuritic chest pain, tachypnea, tachycardia, and hypotension\u2014are highly suggestive of a massive PE.  \n\u2022 The presence of calf pain on dorsiflexion (a positive Homans sign) further supports the suspicion of a DVT.  \n\nStep 2: Consider the imaging/treatment options provided.  \nA. Subcutaneous fondaparinux is an anticoagulant used in DVT and PE management but in a hemodynamically unstable patient with suspected massive PE, immediate diagnostic confirmation or more aggressive intervention (such as thrombolysis) is urgently needed before starting standard anticoagulation alone.  \n\nB. An inferior vena cava filter is generally reserved for patients who have contraindications to anticoagulation or those with recurrent emboli despite adequate anticoagulation, not as a first step in a suspected acute PE.  \n\nC. A ventilation-perfusion (V/Q) scan can be used in diagnosing PE in stable patients, but in hemodynamically unstable patients it is less appropriate because it can delay treatment and is not as rapidly definitive.  \n\nD. Lower extremity Doppler is a rapid, noninvasive test to detect DVT. In a patient with a high clinical suspicion for PE, demonstrating a DVT on Doppler ultrasound would be sufficient evidence to start treatment for PE, especially given that the patient is too unstable for prolonged diagnostic workup.  \n\nStep 3: Eliminate the less appropriate choices.  \n\u2022 Option A (fondaparinux) does not address the urgency of confirming the diagnosis in a critically ill patient.  \n\u2022 Option B (IVC filter) is not a first-line management step here.  \n\u2022 Option C (V/Q scan) is contraindicated by the patient\u2019s unstable status.  \n\nStep 4: Determine the best course of management.  \nGiven the patient\u2019s high clinical probability for a thromboembolic event and the presence of signs suggestive of DVT, the most expedient step is to perform a lower extremity Doppler ultrasound to confirm the presence of a DVT. This will help rapidly confirm the suspected diagnosis of a pulmonary embolism and allow prompt initiation of treatment (which, if confirmed, might include thrombolytic therapy or aggressive anticoagulation).\n\nFinal answer: D. Lower extremity Doppler"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: The patient is a 55\u2010year\u2010old man in the immediate postoperative period who has been on prolonged bed rest. His presentation of sudden-onset shortness of breath, pleuritic chest pain, tachycardia, tachypnea, hypotension, plus a positive finding of calf pain with dorsiflexion (a sign suggesting deep venous thrombosis [DVT]) places him at high risk for a pulmonary embolism (PE).\n\nStep 2: When considering management options in a patient suspected of having a massive or high\u2010risk PE, the diagnosis needs to be confirmed promptly. Common imaging studies include computed tomography pulmonary angiography (CTPA) or a ventilation-perfusion (V/Q) scan. However, in a hemodynamically unstable patient or one for whom a CT scan might be challenging, looking for a source of emboli in the lower extremities using a Doppler ultrasound can be very useful. A positive lower extremity Doppler examination in the proper clinical context is highly suggestive of an embolic source and can expedite treatment decisions regarding anticoagulation and possibly thrombolytic therapy.\n\nOption A (Subcutaneous fondaparinux) is an anticoagulant therapy that would be used for confirmed cases of DVT/PE. However, in the setting of hemodynamic instability, immediate diagnostic confirmation is crucial before initiating treatment.\n\nOption B (Inferior vena cava filter) is generally reserved for patients who have contraindications to anticoagulation or have recurrent emboli despite adequate therapy. It is not the initial test or treatment.\n\nOption C (Ventilation-perfusion scan) is used diagnostically in stable patients. In an unstable patient, it may take too long and the results might not be immediately actionable.\n\nOption D (Lower extremity Doppler) is a rapid, noninvasive test that can help confirm the presence of a DVT, which in the context of his symptoms and risk factors would further support the diagnosis of a pulmonary embolism. Given the urgency and the patient\u2019s unstable hemodynamic status, this test is the most appropriate next step.\n\nStep 3: Therefore, the best course of management at this time is to proceed with a Lower extremity Doppler (Option D) to quickly evaluate for a DVT as the source of his embolism.\n\nFinal answer: D. Lower extremity doppler"
    },
    {
        "realidx": 329,
        "question": "A 57-year-old woman is brought to the emergency department by ambulance for dysarthria and left-sided facial droop. She is accompanied by her son, who states that the patient had just returned home an hour ago from walking the dog when suddenly the patient stated she felt \u201cstrange.\u201d When her son asked her what was wrong, her speech was slurred and her \"face looked funny.\u201d The son quickly called an ambulance. The paramedic upon arrival noted that the patient had left-sided facial droop. Her medical history includes asthma and sickle cell disease. She takes hydroxyurea, uses oxycodone as needed for pain, and an albuterol inhaler as needed for shortness of breath. The patient\u2019s temperature is 97\u00b0F (36.1\u00b0C), blood pressure is 145/72 mmHg, pulse is 93/min, and respirations are 14/min with an oxygen saturation of 96% on room air. On physical examination, a left-sided facial droop is appreciated. She has trouble articulating her words, and her speech is garbled. She is put on 2 L of oxygen by nasal cannula. Labs are obtained and pending. Which of the following therapies is most likely indicated?",
        "answer": "Exchange transfusion",
        "options": {
            "A": "Alteplase",
            "B": "Exchange transfusion",
            "C": "Hydralazine",
            "D": "Warfarin"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "57 year old woman",
            "brought",
            "emergency department",
            "ambulance",
            "dysarthria",
            "left-sided facial droop",
            "son",
            "states",
            "patient",
            "returned home",
            "hour",
            "walking",
            "dog",
            "patient stated",
            "felt",
            "son",
            "wrong",
            "speech",
            "slurred",
            "face looked",
            "son",
            "called",
            "ambulance",
            "paramedic",
            "arrival noted",
            "patient",
            "left-sided facial droop",
            "medical history includes asthma",
            "sickle cell disease",
            "takes hydroxyurea",
            "uses oxycodone as needed",
            "pain",
            "albuterol inhaler as needed",
            "shortness of breath",
            "patients temperature",
            "36",
            "blood pressure",
            "72 mmHg",
            "pulse",
            "min",
            "respirations",
            "14 min",
            "oxygen saturation",
            "96",
            "room air",
            "physical examination",
            "left-sided facial droop",
            "words",
            "speech",
            "put",
            "2",
            "oxygen",
            "nasal cannula",
            "Labs",
            "obtained",
            "following therapies",
            "most likely indicated"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5247,
            "completion_tokens": 3392
        },
        "time_elapsed": 25.50277614593506,
        "raw_responses": [
            "Step 1: Recognize that the patient is presenting with signs of an acute ischemic stroke\u2014sudden onset dysarthria and left-sided facial droop. The time of onset is about 1 hour, which falls within the therapeutic window for thrombolytic therapy.\n\nStep 2: Evaluate the answer options:\n\u2022 Alteplase: A thrombolytic agent used in the management of acute ischemic strokes if administered within 3-4.5 hours of symptom onset.\n\u2022 Exchange transfusion: Typically used for severe sickle cell crises or complications (e.g., acute chest syndrome), not for treating an ischemic stroke in this context.\n\u2022 Hydralazine: An antihypertensive agent used in hypertensive emergencies, but the patient\u2019s blood pressure is not sufficiently high to warrant this.\n\u2022 Warfarin: An oral anticoagulant indicated for preventing thromboembolic events in chronic conditions like atrial fibrillation, but not used in the acute management of a stroke.\n\nStep 3: Given the patient\u2019s clinical presentation and timing, the best therapy is thrombolysis with Alteplase.\n\nFinal Answer: A. Alteplase",
            "Step 1: Recognize that the patient has experienced a sudden onset of neurologic deficits (dysarthria and left-sided facial droop), which is characteristic of an ischemic stroke occurring within the therapeutic time window.\n\nStep 2: Evaluate the treatment options:\n\u2022 Alteplase is a thrombolytic medication used to treat ischemic strokes if initiated within 4.5 hours of symptom onset.\n\u2022 Exchange transfusion is indicated for complications related to sickle cell crises, not for typical acute ischemic stroke.\n\u2022 Hydralazine is used in the management of hypertensive emergencies; however, this patient\u2019s blood pressure is not at a level that indicates hypertensive emergency.\n\u2022 Warfarin is an oral anticoagulant used for long-term management in patients at risk for thromboembolic events but is not appropriate for acute stroke management.\n\nStep 3: Given the patient\u2019s presentation and the time frame from symptom onset, the best treatment is Alteplase.\n\nFinal answer: A. Alteplase",
            "Step 1: Analyze the Case\nThe patient is a 57\u2011year\u2011old woman presenting with acute dysarthria and left\u2011sided facial droop that began about one hour ago. With her symptoms emerging suddenly and within a short time frame, an ischemic stroke is highly suspected.\n\nStep 2: Evaluate the Patient\u2019s Background and Timing\nAlthough she has sickle cell disease, her presentation\u2014sudden dysarthria and facial droop isolated to the left side\u2014along with the timeline (within the treatment window) suggest that she might be a candidate for acute thrombolytic therapy if imaging confirms an ischemic stroke.\n\nStep 3: Compare and Eliminate Incorrect Options\n\u2022 Option B (Exchange transfusion) is typically reserved for sickle cell crises and strokes in younger patients with sickle cell disease when the stroke is due to vaso-occlusive events from sickling. In this situation, the clinical history and timing make tPA (Alteplase) the more appropriate choice.\n\u2022 Option C (Hydralazine) would be used for blood pressure management in hypertensive emergencies; however, her blood pressure is not markedly elevated.\n\u2022 Option D (Warfarin) is an anticoagulant used for long\u2011term prevention in certain conditions, not for acute stroke management.\n\nStep 4: Final Decision\nGiven that the patient presents within the window for thrombolytic therapy and the clinical picture is consistent with an acute ischemic stroke, the best treatment option is Alteplase.\n\nFinal Answer: A. Alteplase"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Analyze the Case\nThe patient is a 57\u2011year\u2011old woman presenting with acute dysarthria and left\u2011sided facial droop that began about one hour ago. With her symptoms emerging suddenly and within a short time frame, an ischemic stroke is highly suspected.\n\nStep 2: Evaluate the Patient\u2019s Background and Timing\nAlthough she has sickle cell disease, her presentation\u2014sudden dysarthria and facial droop isolated to the left side\u2014along with the timeline (within the treatment window) suggest that she might be a candidate for acute thrombolytic therapy if imaging confirms an ischemic stroke.\n\nStep 3: Compare and Eliminate Incorrect Options\n\u2022 Option B (Exchange transfusion) is typically reserved for sickle cell crises and strokes in younger patients with sickle cell disease when the stroke is due to vaso-occlusive events from sickling. In this situation, the clinical history and timing make tPA (Alteplase) the more appropriate choice.\n\u2022 Option C (Hydralazine) would be used for blood pressure management in hypertensive emergencies; however, her blood pressure is not markedly elevated.\n\u2022 Option D (Warfarin) is an anticoagulant used for long\u2011term prevention in certain conditions, not for acute stroke management.\n\nStep 4: Final Decision\nGiven that the patient presents within the window for thrombolytic therapy and the clinical picture is consistent with an acute ischemic stroke, the best treatment option is Alteplase.\n\nFinal Answer: A. Alteplase"
    },
    {
        "realidx": 336,
        "question": "A 39-year-old man is brought to the emergency department unconscious following 2 episodes of generalized tonic-clonic seizures. According to the attendants, he has complained of recurrent headaches for the past 2 weeks. There is no history of fever, head trauma, or a seizure disorder. The patient does not smoke cigarettes but reportedly drinks 2 glasses of wine daily. He has multiple sexual partners and history regarding the contraceptive use is unavailable. The patient\u2019s vitals include: blood pressure 137/88 mm Hg, temperature 37.2\u00b0C (99.0\u00b0F). On physical examination, he is obtunded. He grimaces on pain and localizes in response to pain in both upper extremities. Pupils are bilateral 3-mm in diameter and equally round and reactive. Laboratory tests are within normal limits. An MRI of the brain with contrast is shown in the exhibit (see image). A brain biopsy is performed that reveals perivascular clusters of lymphocytes. Which of the following is most associated with this patient\u2019s condition?",
        "answer": "Epstein-Barr virus",
        "options": {
            "A": "Epstein-Barr virus",
            "B": "Human herpes virus",
            "C": "Human papilloma virus",
            "D": "Schistosoma haematobium"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "brought",
            "emergency department unconscious following 2 episodes of generalized tonic-clonic seizures",
            "attendants",
            "recurrent headaches",
            "past 2 weeks",
            "history",
            "fever",
            "head trauma",
            "seizure disorder",
            "patient",
            "not smoke cigarettes",
            "drinks 2 glasses",
            "wine daily",
            "multiple sexual partners",
            "history",
            "contraceptive use",
            "unavailable",
            "patients",
            "include",
            "blood pressure",
            "88 mm Hg",
            "temperature",
            "99",
            "physical examination",
            "obtunded",
            "grimaces",
            "pain",
            "localizes",
            "response",
            "pain",
            "upper extremities",
            "Pupils",
            "bilateral",
            "mm",
            "diameter",
            "round",
            "reactive",
            "Laboratory tests",
            "normal limits",
            "MRI of",
            "brain",
            "contrast",
            "shown",
            "exhibit",
            "see image",
            "brain biopsy",
            "performed",
            "reveals perivascular clusters",
            "lymphocytes",
            "following",
            "most associated with",
            "patients condition"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5247,
            "completion_tokens": 3965
        },
        "time_elapsed": 31.351965188980103,
        "raw_responses": [
            "Step 1: The patient presents with new-onset seizures and chronic headaches. His sexual history raises suspicion for an immunocompromised state (e.g., undiagnosed HIV infection), which predisposes him to certain central nervous system (CNS) lesions.\n\nStep 2: The MRI reveals a lesion in the brain, and the brain biopsy shows perivascular clusters of lymphocytes\u2014a finding that is highly suggestive of primary CNS lymphoma in the setting of immunosuppression. In patients with HIV/AIDS, primary CNS lymphoma is most commonly associated with Epstein-Barr virus (EBV) infection.\n\nStep 3: Looking at the provided options:\n\u2022 Epstein-Barr virus \u2013 Correctly associated with primary CNS lymphoma seen in immunocompromised patients.\n\u2022 Human herpes virus \u2013 Although EBV is a herpesvirus, the term \u201chuman herpes virus\u201d isn\u2019t specific to this condition.\n\u2022 Human papilloma virus \u2013 Associated with cervical, head and neck, and other cancers, not primary CNS lymphoma.\n\u2022 Schistosoma haematobium \u2013 Linked to bladder cancer, not CNS lymphoma.\n\nFinal Answer: Epstein-Barr virus",
            "Step 1: Recognition of the Clinical Picture\n\u2022 The patient is a 39\u2010year\u2010old man with a history of multiple sexual partners. He presents with seizures and recurrent headaches. \n\u2022 His MRI with contrast shows a brain lesion, and the brain biopsy reveals perivascular clusters of lymphocytes. \n\u2022 Given his risk factors (multiple sexual partners may suggest an increased risk of HIV) and the imaging/biopsy findings, the most likely diagnosis is primary central nervous system (CNS) lymphoma.\n\nStep 2: Association with an Infectious Agent\n\u2022 In immunocompromised patients, especially those with HIV/AIDS, primary CNS lymphoma is strongly associated with Epstein\u2013Barr virus (EBV).\n\u2022 EBV is a member of the herpes virus family and is known to play a role in the pathogenesis of CNS lymphoma in this setting.\n\u2022 The other options (human papilloma virus and Schistosoma haematobium) are not linked to primary CNS lymphoma, and \u201chuman herpes virus\u201d is too nonspecific when EBV is the specific virus implicated.\n\nStep 3: Final Answer\nThe condition is most associated with Epstein\u2013Barr virus.\n\nFinal Answer: Epstein\u2013Barr virus",
            "Step 1: Analyze the patient\u2019s presentation.\n\u2022 The patient is a 39-year-old man who experiences new-onset seizures and has had recurrent headaches for 2 weeks.\n\u2022 He has multiple sexual partners, raising concern for immunocompromised states such as HIV infection.\n\u2022 His brain MRI (with an enhancing lesion) and the description of biopsy findings (perivascular clusters of lymphocytes) together suggest a central nervous system (CNS) mass lesion rather than an infectious encephalitis or abscess.\n\nStep 2: Connect the findings with a likely diagnosis.\n\u2022 In immunocompromised patients (especially those with HIV), primary CNS lymphoma is a key consideration for brain mass lesions.\n\u2022 CNS lymphoma in these patients is typically associated with an underlying Epstein-Barr virus (EBV) infection.\n\nStep 3: Compare and eliminate answer choices.\nA. Epstein-Barr virus \u2013 This virus is well-known to be associated with primary CNS lymphoma in immunocompromised patients.\nB. Human herpes virus \u2013 Although EBV is a type of human herpes virus (HHV-4), this option is less specific and might refer to other herpes viruses (e.g., HSV-1, HSV-2), which are associated with other conditions such as encephalitis, not a lymphoma with perivascular lymphocytic clusters.\nC. Human papilloma virus \u2013 This virus is mostly linked to cervical and other epithelial cancers, not CNS pathology.\nD. Schistosoma haematobium \u2013 This parasite is related to bladder cancer and has no association with brain lymphoma.\n\nStep 4: State the final answer.\nBased on the patient\u2019s risk factors, imaging findings, and the biopsy results, the condition is most associated with Epstein-Barr virus.\n\nFinal Answer: Epstein-Barr virus"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Recognition of the Clinical Picture\n\u2022 The patient is a 39\u2010year\u2010old man with a history of multiple sexual partners. He presents with seizures and recurrent headaches. \n\u2022 His MRI with contrast shows a brain lesion, and the brain biopsy reveals perivascular clusters of lymphocytes. \n\u2022 Given his risk factors (multiple sexual partners may suggest an increased risk of HIV) and the imaging/biopsy findings, the most likely diagnosis is primary central nervous system (CNS) lymphoma.\n\nStep 2: Association with an Infectious Agent\n\u2022 In immunocompromised patients, especially those with HIV/AIDS, primary CNS lymphoma is strongly associated with Epstein\u2013Barr virus (EBV).\n\u2022 EBV is a member of the herpes virus family and is known to play a role in the pathogenesis of CNS lymphoma in this setting.\n\u2022 The other options (human papilloma virus and Schistosoma haematobium) are not linked to primary CNS lymphoma, and \u201chuman herpes virus\u201d is too nonspecific when EBV is the specific virus implicated.\n\nStep 3: Final Answer\nThe condition is most associated with Epstein\u2013Barr virus.\n\nFinal Answer: Epstein\u2013Barr virus"
    },
    {
        "realidx": 337,
        "question": "A 22-year-old woman from a rural area who recently discovered she was pregnant is referred for a cardiology consultation due to cyanosis, dyspnea, and a cardiac murmur revealed at the initial prenatal visit. She is gravida 1, para 0 with an estimated gestational age of 19 weeks. She says that the murmur was found in her childhood, and the doctor at that time placed her under observation only. However, she has been lost to follow-up and has not had proper follow up in years. Currently, she complains of dizziness and occasional dyspnea on exertion which has gradually increased during her pregnancy. Prior to her pregnancy, she did not have any symptoms. The vital signs are as follows: blood pressure 125/60 mm Hg, heart rate 81/min, respiratory rate 13/min, and temperature 36.7\u00b0C (98.0\u00b0F). Her examination is significant for acrocyanosis and a fixed splitting of S2 and grade 3/6 midsystolic murmur best heard over the left upper sternal border. Which of the following physiological pregnancy changes is causing the change in this patient\u2019s condition?",
        "answer": "Decrease in systemic vascular resistance",
        "options": {
            "A": "Increase in heart rate",
            "B": "Decrease in systemic vascular resistance",
            "C": "Increase in cardiac output",
            "D": "Increase in blood volume"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman",
            "rural area",
            "recently discovered",
            "pregnant",
            "referred",
            "cardiology consultation",
            "cyanosis",
            "dyspnea",
            "cardiac murmur revealed",
            "initial prenatal visit",
            "gravida 1",
            "para 0",
            "estimated gestational age",
            "19 weeks",
            "murmur",
            "found",
            "childhood",
            "doctor",
            "time placed",
            "observation only",
            "lost to follow-up",
            "not",
            "follow up",
            "years",
            "Currently",
            "dizziness",
            "occasional dyspnea on exertion",
            "increased",
            "pregnancy",
            "pregnancy",
            "not",
            "symptoms",
            "vital signs",
            "follows",
            "blood pressure",
            "60 mm Hg",
            "heart rate 81 min",
            "respiratory rate",
            "min",
            "temperature 36",
            "98",
            "examination",
            "significant",
            "acrocyanosis",
            "fixed splitting",
            "S2",
            "grade",
            "6 midsystolic murmur best heard",
            "left upper sternal border",
            "following physiological pregnancy changes",
            "causing",
            "change",
            "patients condition"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5424,
            "completion_tokens": 4119
        },
        "time_elapsed": 31.795530796051025,
        "raw_responses": [
            "Step 1: Recognize that the patient\u2019s history and exam findings (fixed splitting of S2 and a midsystolic murmur along the left upper sternal border) are classic for an atrial septal defect (ASD).\n\nStep 2: In pregnancy, several physiological changes occur. Notably, there is an increase in blood volume of about 50%, which elevates preload. This increased preload results in a higher cardiac output and more blood flowing through the heart.\n\nStep 3: In the setting of an ASD, the increased blood volume leads to increased left-to-right shunting. Although cardiac output also increases, the primary driving force that exacerbates her symptoms is the increased blood volume, worsening the volume overload on the heart.\n\nStep 4: Of the options provided:\n\u2022 Increase in heart rate \u2013 Occurs, but its impact is less significant on shunting than volume changes.\n\u2022 Decrease in systemic vascular resistance \u2013 This occurs in pregnancy but doesn\u2019t directly worsen an ASD.\n\u2022 Increase in cardiac output \u2013 A consequence of increased blood volume, yet the underlying trigger is the expansion of the blood volume.\n\u2022 Increase in blood volume \u2013 The most significant change that directly impacts the shunt magnitude in an ASD.\n\nFinal answer: D. Increase in blood volume.",
            "Step 1: Recognize that the patient\u2019s history and physical exam findings (acrocyanosis, fixed splitting of S2, and a midsystolic murmur at the left upper sternal border) are most consistent with an atrial septal defect (ASD). In an ASD, blood flows chronically from the higher-pressure left atrium to the lower-pressure right atrium (a left\u2010to\u2010right shunt).\n\nStep 2: In pregnancy, several hemodynamic changes occur, including an increased heart rate, increased cardiac output, increased blood volume, and decreased systemic vascular resistance. Although each of these plays a role in normal physiology, not all directly worsen the consequences of an ASD.\n\nStep 3: In this patient, the increase in blood volume that occurs during pregnancy leads to a greater volume load on the right side of the heart. This, in turn, increases the amount of blood shunting across the defect, which can worsen symptoms such as dyspnea and cyanosis.\n\nStep 4: While an increase in cardiac output also occurs during pregnancy, it is largely a consequence of the increased blood volume. Thus, the primary physiological change responsible for worsening her condition is the increase in blood volume.\n\nFinal Answer: D. Increase in blood volume",
            "Step 1: The patient\u2019s history and exam findings (fixed splitting of S2 and a mid-systolic murmur along the left upper sternal border) suggest that she most likely has an atrial septal defect (ASD). In patients with an unrepaired ASD, the left-to-right shunt increases the workload of the right heart.\n\nStep 2: In pregnancy, several hemodynamic changes occur, including an increase in heart rate, increase in blood volume, an increase in cardiac output, and a decrease in systemic vascular resistance. While increased cardiac output and heart rate are seen, the most significant change is the increase in blood volume (by about 40\u201350%), which leads to greater preload and exacerbation of left-to-right shunting. This increase in blood volume increases the amount of blood circulating through the ASD, thereby worsening her symptoms such as dyspnea and dizziness.\n\nStep 3: Comparing the options:\n\u2022 Option A (Increase in heart rate) \u2013 Although heart rate increases, it is not the primary factor worsening the shunt.\n\u2022 Option B (Decrease in systemic vascular resistance) \u2013 This change helps reduce afterload but doesn\u2019t directly cause the worsening of left-to-right shunting seen in ASD.\n\u2022 Option C (Increase in cardiac output) \u2013 While cardiac output does increase, it is the increased blood volume that directly overwhelms the heart and underlying defect.\n\u2022 Option D (Increase in blood volume) \u2013 This is the most significant physiologic change that increases the preload, exacerbating the shunt and making her symptoms worse.\n\nFinal Answer: D. Increase in blood volume"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: The patient\u2019s history and exam findings (fixed splitting of S2 and a mid-systolic murmur along the left upper sternal border) suggest that she most likely has an atrial septal defect (ASD). In patients with an unrepaired ASD, the left-to-right shunt increases the workload of the right heart.\n\nStep 2: In pregnancy, several hemodynamic changes occur, including an increase in heart rate, increase in blood volume, an increase in cardiac output, and a decrease in systemic vascular resistance. While increased cardiac output and heart rate are seen, the most significant change is the increase in blood volume (by about 40\u201350%), which leads to greater preload and exacerbation of left-to-right shunting. This increase in blood volume increases the amount of blood circulating through the ASD, thereby worsening her symptoms such as dyspnea and dizziness.\n\nStep 3: Comparing the options:\n\u2022 Option A (Increase in heart rate) \u2013 Although heart rate increases, it is not the primary factor worsening the shunt.\n\u2022 Option B (Decrease in systemic vascular resistance) \u2013 This change helps reduce afterload but doesn\u2019t directly cause the worsening of left-to-right shunting seen in ASD.\n\u2022 Option C (Increase in cardiac output) \u2013 While cardiac output does increase, it is the increased blood volume that directly overwhelms the heart and underlying defect.\n\u2022 Option D (Increase in blood volume) \u2013 This is the most significant physiologic change that increases the preload, exacerbating the shunt and making her symptoms worse.\n\nFinal Answer: D. Increase in blood volume"
    },
    {
        "realidx": 340,
        "question": "A 67-year-old man is brought to the physician because of increasing forgetfulness, unsteadiness, and falls over the past year. He reports that these symptoms seem to worsen with each fall. Initially, he could not remember directions to his home but now cannot remember recent conversations or appointments he has made. He often repeats questions that he asked shortly before. He has long-standing hypertension, coronary artery disease, and hypercholesterolemia. Current medications include aspirin, carvedilol, enalapril, and atorvastatin. Examination shows a bruise over the left temple and an unsteady gait. On mental status examination, he is oriented to place and person only. Short-term memory is impaired; he can recall 0 out of 5 objects after 10 minutes. Long-term memory is intact. He has no delusions or hallucinations. Muscle strength is decreased in the left lower extremity. The Babinski sign is present on the left. A CT scan of the head is shown. Which of the following is the most appropriate next step in management?",
        "answer": "Cognitive training",
        "options": {
            "A": "Warfarin therapy",
            "B": "Vitamin E therapy",
            "C": "Tetrabenazine therapy",
            "D": "Cognitive training"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "67 year old man",
            "brought",
            "physician",
            "increasing forgetfulness",
            "unsteadiness",
            "falls",
            "past year",
            "reports",
            "symptoms",
            "to worsen",
            "fall",
            "Initially",
            "not remember directions",
            "home",
            "now",
            "remember recent conversations",
            "appointments",
            "made",
            "often repeats questions",
            "long standing hypertension",
            "coronary artery disease",
            "hypercholesterolemia",
            "Current medications include aspirin",
            "carvedilol",
            "enalapril",
            "atorvastatin",
            "Examination shows",
            "bruise",
            "left temple",
            "unsteady gait",
            "mental",
            "oriented to place",
            "person only",
            "Short-term memory",
            "impaired",
            "recall 0 out",
            "5 objects",
            "10 minutes",
            "Long-term memory",
            "intact",
            "delusions",
            "hallucinations",
            "Muscle strength",
            "decreased",
            "left lower extremity",
            "Babinski sign",
            "present",
            "left",
            "CT scan of",
            "head",
            "shown",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5994,
            "completion_tokens": 9977
        },
        "time_elapsed": 67.06121850013733,
        "raw_responses": [
            "Step 1. Analyze the patient\u2019s presentation.\n\u2022 The 67\u2010year\u2010old man has been experiencing progressive forgetfulness, difficulty with short\u2010term recall, and worsening gait instability which has resulted in falls.\n\u2022 His deficits are predominantly in short\u2010term memory with intact long\u2010term recall.\n\u2022 Neurologic exam reveals focal motor findings on the left \u2013 decreased strength with an upgoing (Babinski) reflex \u2013 suggesting some involvement of the corticospinal tract.\n\u2022 His history includes vascular risk factors (hypertension, coronary artery disease, hypercholesterolemia), which predispose him to cerebrovascular disease.\n\nStep 2. Consider the CT finding in context.\n\u2022 Although the exact CT image is not described here, in a patient like this, one might see evidence of either small vessel ischemic disease or infarcts, as seen in vascular dementia.\n\u2022 The combination of stepwise cognitive decline (worsening with each fall could represent discrete events), focal neurologic deficits, and vascular risk factors is most consistent with a diagnosis within the vascular dementia spectrum.\n\nStep 3. Evaluate the answer options.\nA. Warfarin therapy \u2013 This would be indicated for stroke prevention in atrial fibrillation or certain hypercoagulable states, but there is no evidence here that the patient has atrial fibrillation or a cardioembolic source.\nB. Vitamin E therapy \u2013 Although studied in Alzheimer disease, vitamin E is not a well\u2010established treatment modality for either Alzheimer disease or vascular dementia.\nC. Tetrabenazine therapy \u2013 This medication is used to treat hyperkinetic movement disorders such as Huntington disease, which does not fit this patient\u2019s presentation.\nD. Cognitive training \u2013 This non\u2010pharmacologic intervention is recommended to slow the progression and help maintain function in patients with dementia (including vascular dementia), in conjunction with aggressive modification of vascular risk factors.\n\nStep 4. Conclusion.\nGiven the patient\u2019s clinical picture\u2014progressive cognitive decline with focal deficits in the setting of vascular risk factors\u2014and the lack of support for the other options, the most appropriate next step in management is to institute cognitive training along with optimal medical management of his vascular risk factors.\n\nFinal Answer: D. Cognitive training",
            "We have an elderly gentleman with a history of falls who now presents with progressive short\u2010term memory loss, unsteady gait, and a focal neurologic deficit (left leg weakness with an upgoing plantar response). The physical exam findings (notably a bruise on the left temple) in combination with the CT scan (which \u2013 although not shown here \u2013 is described in the vignette \u2013 is most consistent with a crescent\u2010shaped collection that crosses suture lines) strongly suggest the diagnosis of a chronic subdural hematoma. In elderly patients with brain atrophy, even minor head trauma (as in a fall) can lead to tearing of bridging veins, allowing blood to slowly accumulate over time. The mass effect from this fluid collection leads to the cognitive decline (especially short\u2010term memory loss), gait instability, and focal neurological deficits.\n\nNow, looking at the answer options:\n\u2022 Warfarin therapy is used for conditions such as atrial fibrillation prophylaxis and is contraindicated in patients with intracranial bleeding.\n\u2022 Vitamin E therapy has been studied in neurodegenerative conditions but is not a treatment for a hematoma.\n\u2022 Tetrabenazine is used in movement disorders (eg, Huntington\u2019s disease chorea) and is not indicated here.\n\u2022 Cognitive training is a supportive therapy sometimes suggested for dementia but would not address the underlying mass effect.\n\nNone of the listed options address the cause of this patient\u2019s symptoms. The appropriate treatment for a chronic subdural hematoma that is symptomatic \u2013 as in this patient\u2019s case \u2013 is neurosurgical evacuation (typically via burr-hole drainage). Although \u201cburr-hole drainage\u201d is not explicitly provided among the options, it is the correct next step in management.\n\nThus, the best next step is to refer the patient for neurosurgical evaluation for drainage of the subdural hematoma.",
            "The patient\u2019s history and exam findings are most consistent with a chronic subdural hematoma. He is an elderly man with risk factors (including falls and head trauma, as evidenced by the left temporal bruise) who presents with a gradual decline in short\u2010term memory, focal neurological deficits (left lower extremity weakness with an extensor plantar response), and gait instability. The CT scan (not shown here) would be expected to show a crescent\u2010shaped fluid collection consistent with a chronic subdural hematoma. The appropriate management for a symptomatic chronic subdural hematoma is neurosurgical evacuation (for example, burr-hole drainage) rather than any of the therapies listed. \n\nReviewing the answer options: \n\u2022 Warfarin therapy is contraindicated because it would exacerbate bleeding. \n\u2022 Vitamin E therapy and tetrabenazine are not indicated in this setting. \n\u2022 Although cognitive training may be useful in some forms of dementia, it does not address the underlying mass effect from a subdural hematoma.\n\nTherefore, the most appropriate next step in management is neurosurgical (burr-hole) evacuation of the hematoma. \n\nFinal answer: Neurosurgical evacuation (burr\u2010hole drainage) of the chronic subdural hematoma."
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1"
        ],
        "final_solution": "The patient\u2019s history and exam findings are most consistent with a chronic subdural hematoma. He is an elderly man with risk factors (including falls and head trauma, as evidenced by the left temporal bruise) who presents with a gradual decline in short\u2010term memory, focal neurological deficits (left lower extremity weakness with an extensor plantar response), and gait instability. The CT scan (not shown here) would be expected to show a crescent\u2010shaped fluid collection consistent with a chronic subdural hematoma. The appropriate management for a symptomatic chronic subdural hematoma is neurosurgical evacuation (for example, burr-hole drainage) rather than any of the therapies listed. \n\nReviewing the answer options: \n\u2022 Warfarin therapy is contraindicated because it would exacerbate bleeding. \n\u2022 Vitamin E therapy and tetrabenazine are not indicated in this setting. \n\u2022 Although cognitive training may be useful in some forms of dementia, it does not address the underlying mass effect from a subdural hematoma.\n\nTherefore, the most appropriate next step in management is neurosurgical (burr-hole) evacuation of the hematoma. \n\nFinal answer: Neurosurgical evacuation (burr\u2010hole drainage) of the chronic subdural hematoma."
    },
    {
        "realidx": 367,
        "question": "A 22-year-old gravida 1 presents to her physician at 15 weeks gestation for a prenatal appointment. She complains of a rash involving her chest, face, and arms, a watery nasal discharge, and mild bilateral knee pain. She has had these symptoms for about 5 days. The symptoms do not seem to bother her too much, but she is concerned for the baby. She had contact with her younger sister, who also had a rash and was diagnosed with rubella infection about 10 days ago at a family gathering. She cannot confirm her vaccination history. Her vital signs are as follows: blood pressure, 110/70 mmHg; heart rate, 89/min; respiratory rate, 12/min; and temperature, 37.6\u2103 (99.7\u2109). Examination shows a moderately dense maculopapular lacy rash spread over the patient\u2019s trunk, extremities, and face. No lymph node, liver, or spleen enlargement is noted. The knee joints appear normal.\nSerology performed 1 year ago Current serology\nRubella IgM - negative Rubella IgM - negative\nRubella IgG - 1:128 Rubella IgG - 1:64\nRubella IgG avidity - high Rubella IgG avidity - high\nWhat is the proper next step in the management of this woman?",
        "answer": "Recommend additional serologic testing for parvovirus B19",
        "options": {
            "A": "Reassure and recommend vaccination against rubella postpartum",
            "B": "Recommend pregnancy termination",
            "C": "Arrange a chorionic villus sampling",
            "D": "Recommend additional serologic testing for parvovirus B19"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old gravida 1 presents",
            "physician",
            "weeks gestation",
            "prenatal appointment",
            "rash involving",
            "chest",
            "face",
            "arms",
            "watery nasal discharge",
            "mild bilateral knee pain",
            "symptoms",
            "5 days",
            "symptoms",
            "not",
            "to",
            "too much",
            "concerned",
            "baby",
            "contact with",
            "younger sister",
            "rash",
            "diagnosed",
            "rubella infection",
            "10 days",
            "family",
            "confirm",
            "vaccination history",
            "vital signs",
            "follows",
            "blood pressure",
            "70 mmHg",
            "heart rate",
            "min",
            "respiratory rate",
            "min",
            "temperature",
            "99",
            "Examination shows",
            "moderately dense maculopapular lacy rash spread",
            "patients trunk",
            "extremities",
            "face",
            "lymph node",
            "liver",
            "spleen enlargement",
            "noted",
            "knee joints appear normal",
            "Serology performed 1 year",
            "Current serology Rubella IgM",
            "negative",
            "1",
            "Rubella",
            "64 Rubella",
            "avidity",
            "high",
            "next step",
            "management",
            "woman"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6474,
            "completion_tokens": 2629
        },
        "time_elapsed": 24.528661966323853,
        "raw_responses": [
            "Step 1: Analyze the patient's clinical presentation and history.\n\u2022 The patient is a 22-year-old pregnant woman at 15 weeks gestation with a 5\u2010day history of rash, watery nasal discharge, and mild joint pain.\n\u2022 She was exposed to someone with rubella. Although this exposure may raise concerns for rubella contraction, the current clinical features and exposure history are not definitive for an acute infection.\n\nStep 2: Interpret the serologic findings.\n\u2022 Rubella IgM is negative, both one year ago and currently, which indicates that there is no acute infection.\n\u2022 Rubella IgG is present (1:128 previously and 1:64 currently) with high avidity. High avidity IgG suggests past immunization or infection rather than a recent primary infection.\n\u2022 Overall, the serologic profile confirms that the patient has immunity to rubella and there is no evidence of a recent or reactivated infection.\n\nStep 3: Evaluate the options.\nA. Reassure and recommend vaccination against rubella postpartum \u2013 Since the patient is confirmed to be immune, reassurance is appropriate and vaccination can be deferred until after delivery because live vaccines (like the MMR) are contraindicated during pregnancy.\nB. Recommend pregnancy termination \u2013 Termination is not indicated when rubella immunity is confirmed.\nC. Arrange a chorionic villus sampling \u2013 Invasive testing is unnecessary since there is no evidence of fetal infection related to rubella.\nD. Recommend additional serologic testing for parvovirus B19 \u2013 Parvovirus B19 is not suggested by the clinical presentation or serology.\n\nStep 4: Final Decision.\nThe best management is to reassure the patient about her immunity and plan for postpartum vaccination if needed based on her immunization history.\n\nFinal answer: A. Reassure and recommend vaccination against rubella postpartum.",
            "Step 1: Review Relevant Information  \n\u2022 The patient is 15 weeks pregnant and presents with mild symptoms (rash, watery nasal discharge, mild bilateral knee pain).  \n\u2022 She was exposed to a confirmed case of rubella 10 days ago.  \n\u2022 Her serologic testing shows:\n\u2003\u2013 Rubella IgM is negative (indicating no active or recent infection).\n\u2003\u2013 Rubella IgG is positive with high avidity (indicating past infection or immunization and effective antibody response).\n  \nStep 2: Interpretation  \n\u2022 Negative IgM and high avidity IgG indicate that she did not acquire a new rubella infection during her pregnancy; instead, she has preexisting immunity.  \n\u2022 Because she is immune to rubella, the fetus is not at risk for congenital rubella syndrome.\n\nStep 3: Evaluate Management Options  \nA. Reassure and recommend vaccination against rubella postpartum  \n\u2003\u2013 This is appropriate because the patient currently is immune, and MMR vaccine is contraindicated during pregnancy. Postpartum vaccination helps update her records without fetal risk.  \nB. Recommend pregnancy termination  \n\u2003\u2013 Incorrect, as there is no evidence of active rubella infection or fetal harm.  \nC. Arrange a chorionic villus sampling  \n\u2003\u2013 Incorrect; this invasive procedure is unnecessary when there is no concern for fetal infection.  \nD. Recommend additional serologic testing for parvovirus B19  \n\u2003\u2013 Unnecessary because her clinical picture and serologies are consistent with established rubella immunity, and there is no strong suggestion of parvovirus infection.\n\nFinal Answer: A. Reassure and recommend vaccination against rubella postpartum",
            "Step 1: Review the clinical information. The patient is 15 weeks pregnant and presents with a rash, watery nasal discharge, and mild joint pain. She had contact with a person diagnosed with rubella. However, her serology reveals negative rubella IgM and positive rubella IgG with high avidity, both from a test 1 year ago and currently.\n\nStep 2: Interpret the serologic findings. The negative IgM indicates that there is no active or recent infection. The presence of IgG with high avidity confirms that the patient had a past infection or vaccination and that her immune response is mature. A decrease in titer (from 1:128 to 1:64) does not suggest recent infection, particularly when rubella IgM remains negative and the avidity is high.\n\nStep 3: Evaluate the management options.\n\u2022 Option A: Reassure and recommend vaccination against rubella postpartum \u2013 This is appropriate because the patient is already immune due to prior infection or vaccination, and live vaccines are contraindicated in pregnancy. The patient can have her immunization postpartum if needed.\n\u2022 Option B: Recommend pregnancy termination \u2013 This is not indicated because there is no evidence of an acute rubella infection in the patient.\n\u2022 Option C: Arrange a chorionic villus sampling \u2013 This invasive procedure is not indicated since there is no evidence of rubella causing fetal harm as a result of an acute infection.\n\u2022 Option D: Recommend additional serologic testing for parvovirus B19 \u2013 Although parvovirus B19 can cause rash and joint pain, the clinical context (exposure to rubella, serologic findings consistent with past rubella) does not point to this as the cause of her symptoms.\n\nStep 4: Final Answer.\nThe proper next step is to reassure the patient and recommend vaccination against rubella postpartum.\n\nFinal answer: A. Reassure and recommend vaccination against rubella postpartum."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Review Relevant Information  \n\u2022 The patient is 15 weeks pregnant and presents with mild symptoms (rash, watery nasal discharge, mild bilateral knee pain).  \n\u2022 She was exposed to a confirmed case of rubella 10 days ago.  \n\u2022 Her serologic testing shows:\n\u2003\u2013 Rubella IgM is negative (indicating no active or recent infection).\n\u2003\u2013 Rubella IgG is positive with high avidity (indicating past infection or immunization and effective antibody response).\n  \nStep 2: Interpretation  \n\u2022 Negative IgM and high avidity IgG indicate that she did not acquire a new rubella infection during her pregnancy; instead, she has preexisting immunity.  \n\u2022 Because she is immune to rubella, the fetus is not at risk for congenital rubella syndrome.\n\nStep 3: Evaluate Management Options  \nA. Reassure and recommend vaccination against rubella postpartum  \n\u2003\u2013 This is appropriate because the patient currently is immune, and MMR vaccine is contraindicated during pregnancy. Postpartum vaccination helps update her records without fetal risk.  \nB. Recommend pregnancy termination  \n\u2003\u2013 Incorrect, as there is no evidence of active rubella infection or fetal harm.  \nC. Arrange a chorionic villus sampling  \n\u2003\u2013 Incorrect; this invasive procedure is unnecessary when there is no concern for fetal infection.  \nD. Recommend additional serologic testing for parvovirus B19  \n\u2003\u2013 Unnecessary because her clinical picture and serologies are consistent with established rubella immunity, and there is no strong suggestion of parvovirus infection.\n\nFinal Answer: A. Reassure and recommend vaccination against rubella postpartum"
    },
    {
        "realidx": 380,
        "question": "A 70-year-old obese male presents to the emergency department with shortness of breath and cough of sudden onset. The patient states that his symptoms came on while he was sleeping. The patient has a past medical history of type II diabetes and is currently taking lisinopril, metformin, insulin, and fish oil. On physical exam, you note bipedal edema and jugular venous distention (JVD). An EKG and chest radiographs are obtained (Figures A and B). The patient is started on BIPAP and medical therapy and his symptoms improve rapidly. Lab values are as follows.\n\nSerum:\nNa+: 137 mEq/L\nK+: 3.2 mEq/L\nCl-: 100 mEq/L\nHCO3-: 31 mEq/L\nBUN: 20 mg/dL\nGlucose: 120 mg/dL\nCreatinine: 1.2 mg/dL\nCa2+: 10.9 mg/dL\n\nWhich of the following is the best explanation of this patient's current presentation?",
        "answer": "Hydrochlorothiazide",
        "options": {
            "A": "Furosemide",
            "B": "Hydrochlorothiazide",
            "C": "Renal tubular acidosis type II",
            "D": "Renal tubular acidosis type IV"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "70 year old obese male presents",
            "emergency department",
            "shortness of breath",
            "cough",
            "sudden onset",
            "patient states",
            "symptoms",
            "sleeping",
            "patient",
            "a past medical type II diabetes",
            "currently taking lisinopril",
            "metformin",
            "insulin",
            "fish oil",
            "physical exam",
            "note",
            "edema",
            "jugular venous distention",
            "EKG",
            "chest radiographs",
            "obtained",
            "patient",
            "started",
            "BIPAP",
            "medical therapy",
            "symptoms",
            "rapidly",
            "Lab values",
            "follows",
            "Serum",
            "Na",
            "137 mEq L K",
            "3.2 mEq/L Cl",
            "100 mEq/L HCO3",
            "31 mEq/L",
            "20 mg/dL Glucose",
            "mg/dL Creatinine",
            "1.2 mg/dL Ca2",
            "10 9 mg dL",
            "following",
            "best explanation",
            "patient's current presentation"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6381,
            "completion_tokens": 4400
        },
        "time_elapsed": 34.36934208869934,
        "raw_responses": [
            "Step 1: Analyze the clinical presentation.  \n\u2022 The patient is an elderly, obese male with signs of heart failure (bipedal edema, JVD) who presents with acute respiratory distress\u2013likely an acute decompensated heart failure event.  \n\u2022 Upon treatment, the patient shows rapid improvement with BIPAP and medical therapy, which in such cases usually includes the administration of diuretics to relieve fluid overload.\n\nStep 2: Review the lab findings.  \n\u2022 The serum potassium is low (3.2 mEq/L), indicating hypokalemia.  \n\u2022 The bicarbonate level is high (31 mEq/L), suggesting metabolic alkalosis.  \n\nStep 3: Correlate the laboratory findings with potential etiologies.  \n\u2022 Loop diuretics (e.g., furosemide) are a mainstay in treating acute decompensated heart failure. They cause hypokalemia and metabolic alkalosis through volume contraction and stimulation of the renin-angiotensin-aldosterone system.  \n\u2022 Thiazides (e.g., hydrochlorothiazide) can also cause these electrolyte disturbances; however, in the setting of acute decompensated heart failure and urgent relief of symptoms, furosemide is typically the preferred agent.  \n\u2022 Renal tubular acidosis (RTA) type II usually presents with metabolic acidosis, not alkalosis.  \n\u2022 RTA type IV is characterized by hyperkalemia and metabolic acidosis, which does not match this patient's lab findings.\n\nStep 4: Eliminate the incorrect choices.  \n\u2022 Option B (Hydrochlorothiazide) is less likely given the acute presentation and typical management of heart failure.  \n\u2022 Options C and D (RTA types II and IV) are inconsistent with the metabolic alkalosis and hypokalemia observed.\n\nStep 5: Conclusion.  \nThe patient\u2019s presentation\u2014with signs of acute decompensated heart failure plus lab findings of hypokalemia and metabolic alkalosis\u2014is best explained by the administration of furosemide during his acute management.\n\nFinal answer: A. Furosemide",
            "Step 1: Identify the key findings and clinical scenario.\n\u2022 The patient is a 70-year-old obese male with sudden onset shortness of breath and cough, and physical exam findings of bipedal edema and JVD are concerning for heart failure exacerbation.\n\u2022 His respiratory status improved rapidly with BIPAP and medical therapy.\n\u2022 The lab values reveal hypokalemia (K+ = 3.2 mEq/L) and a metabolic alkalosis (HCO\u2083\u207b = 31 mEq/L).\n\nStep 2: Link the lab findings to a likely intervention.\n\u2022 In the setting of decompensated heart failure, rapid symptomatic improvement is often achieved using diuretics.\n\u2022 Furosemide, a loop diuretic, is frequently used in managing acute pulmonary edema.\n\u2022 A well-known side effect of furosemide is a contraction metabolic alkalosis along with hypokalemia due to increased renal loss of potassium and hydrogen ions.\n\nStep 3: Evaluate the options.\nA. Furosemide \u2013 A loop diuretic, which explains the metabolic alkalosis and hypokalemia seen in this patient.\nB. Hydrochlorothiazide \u2013 Although also a diuretic, it is more associated with hyponatremia and is not the first-line agent in acute heart failure exacerbations.\nC. Renal tubular acidosis type II \u2013 This condition is associated with metabolic acidosis due to bicarbonate wasting, not alkalosis.\nD. Renal tubular acidosis type IV \u2013 This presents with hyperkalemia and metabolic acidosis, which doesn\u2019t match the hypokalemia and alkalosis found here.\n\nStep 4: Provide the final answer.\nThe patient\u2019s electrolyte disturbances and clinical improvement after treatment are best explained by the administration of furosemide.\n\nFinal Answer: A. Furosemide",
            "Step 1: Analyze the patient's clinical presentation. This 70\u2010year-old man has risk factors for heart failure (obesity, type II diabetes) and presents with signs of volume overload (bipedal edema, JVD). His symptoms improved with BiPAP and appropriate medical therapy for acute decompensated heart failure, which often includes the administration of a loop diuretic.\n\nStep 2: Interpret the lab values. The labs reveal a low potassium (3.2 mEq/L) and an elevated bicarbonate (31 mEq/L). These findings are consistent with a metabolic alkalosis, which can occur due to loop diuretic use. Loop diuretics (like furosemide) cause increased urinary losses of potassium as well as chloride, leading to contraction alkalosis.\n\nStep 3: Evaluate the answer choices.  \nA. Furosemide \u2013 A loop diuretic commonly used in acute heart failure that can lead to the lab abnormalities seen (hypokalemia and metabolic alkalosis).  \nB. Hydrochlorothiazide \u2013 A thiazide diuretic; while it can also lead to hypokalemia, in the acute setting of decompensated heart failure, loop diuretics are preferred over thiazides.  \nC. Renal tubular acidosis type II \u2013 Typically causes a metabolic acidosis, not alkalosis, and is associated with proximal tubule bicarbonate wasting.  \nD. Renal tubular acidosis type IV \u2013 Is characterized by a metabolic acidosis and usually hyperkalemia, opposite of what is seen.\n\nStep 4: Decide on the best explanation. Given the clinical context of acute decompensated heart failure treated with diuretics and the lab findings of hypokalemia and metabolic alkalosis, the most likely cause is the use of a loop diuretic.\n\nFinal Answer: A. Furosemide"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Analyze the patient's clinical presentation. This 70\u2010year-old man has risk factors for heart failure (obesity, type II diabetes) and presents with signs of volume overload (bipedal edema, JVD). His symptoms improved with BiPAP and appropriate medical therapy for acute decompensated heart failure, which often includes the administration of a loop diuretic.\n\nStep 2: Interpret the lab values. The labs reveal a low potassium (3.2 mEq/L) and an elevated bicarbonate (31 mEq/L). These findings are consistent with a metabolic alkalosis, which can occur due to loop diuretic use. Loop diuretics (like furosemide) cause increased urinary losses of potassium as well as chloride, leading to contraction alkalosis.\n\nStep 3: Evaluate the answer choices.  \nA. Furosemide \u2013 A loop diuretic commonly used in acute heart failure that can lead to the lab abnormalities seen (hypokalemia and metabolic alkalosis).  \nB. Hydrochlorothiazide \u2013 A thiazide diuretic; while it can also lead to hypokalemia, in the acute setting of decompensated heart failure, loop diuretics are preferred over thiazides.  \nC. Renal tubular acidosis type II \u2013 Typically causes a metabolic acidosis, not alkalosis, and is associated with proximal tubule bicarbonate wasting.  \nD. Renal tubular acidosis type IV \u2013 Is characterized by a metabolic acidosis and usually hyperkalemia, opposite of what is seen.\n\nStep 4: Decide on the best explanation. Given the clinical context of acute decompensated heart failure treated with diuretics and the lab findings of hypokalemia and metabolic alkalosis, the most likely cause is the use of a loop diuretic.\n\nFinal Answer: A. Furosemide"
    },
    {
        "realidx": 413,
        "question": "A 56-year-old man with a history of pancreatic cancer presents to the surgical intensive care unit following a pancreaticoduodenectomy. Over the next 3 days, the patient's drainage output is noted to exceed 1 liter per day. In the early morning of postoperative day 4, the nurse states that the patient is difficult to arouse. His temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 107/88 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. His skin and mucous membranes are dry on physical exam. Laboratory values are ordered as seen below.\n\nSerum:\nNa+: 154 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 27 mEq/L\nBUN: 20 mg/dL\nGlucose: 99 mg/dL\nCreatinine: 1.1 mg/dL\n\nWhich of the following is the best next step in management?",
        "answer": "0.9% saline IV",
        "options": {
            "A": "0.9% saline IV",
            "B": "5% dextrose IV",
            "C": "5% dextrose IV with 0.45% saline IV",
            "D": "Oral free water replacement"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "history of pancreatic cancer presents",
            "surgical intensive care unit following",
            "pancreaticoduodenectomy",
            "next",
            "days",
            "patient's drainage output",
            "noted to",
            "1 liter per day",
            "early morning",
            "postoperative day 4",
            "nurse states",
            "patient",
            "difficult",
            "temperature",
            "99",
            "blood pressure",
            "88 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "skin",
            "mucous membranes",
            "dry",
            "physical exam",
            "Laboratory values",
            "ordered",
            "seen",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4",
            "mEq/L HCO3",
            "27 mEq/L",
            "20 mg/dL Glucose",
            "99 mg/dL Creatinine",
            "1.1 mg/dL",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6504,
            "completion_tokens": 7363
        },
        "time_elapsed": 52.63753080368042,
        "raw_responses": [
            "Step 1: Assessment of the patient's status\n\u2022 The patient is postoperative day 4 with high output from his drain (>1 liter per day), indicating significant fluid losses.\n\u2022 His exam shows dehydration (dry skin and mucous membranes) and mental status changes (difficult to arouse).\n\u2022 Laboratory values reveal hypernatremia (Na+ 154 mEq/L), consistent with free water loss.\n\nStep 2: Interpretation of laboratory and clinical findings\n\u2022 High output drainage following pancreatic surgery can lead to excessive loss of fluid and electrolytes.\n\u2022 The hypernatremia indicates that the patient\u2019s free water losses exceed his sodium losses, causing serum sodium to rise.\n\u2022 Appropriate treatment requires a cautious correction of hypernatremia while repleting volume deficits.\n\nStep 3: Comparison and elimination of answer choices\nA. 0.9% saline IV \u2013 This isotonic fluid would help with volume expansion but would not provide free water, and may worsen hypernatremia.\nB. 5% dextrose IV \u2013 Although this provides free water once dextrose is metabolized, it does not offer enough isotonicity to support volume repletion in a dehydrated patient.\nC. 5% dextrose IV with 0.45% saline IV \u2013 This combination (effectively a hypotonic solution once metabolized) provides both free water to lower serum sodium and some sodium for volume support.\nD. Oral free water replacement \u2013 Given the patient\u2019s altered mental status (difficult to arouse), oral administration is not safe or feasible.\n\nStep 4: Final answer\nThe best next step in management is to administer 5% dextrose in water with 0.45% saline intravenously.\n\nFinal Answer: C. 5% dextrose IV with 0.45% saline IV",
            "Step 1: Identify Key Patient Findings\n\u2022 The patient is 4 days postoperative with pancreaticoduodenectomy and has a high drainage output (>1 liter per day), which can lead to significant free water loss.\n\u2022 He exhibits signs of dehydration (dry mucous membranes, tachycardia, and somewhat low blood pressure) and altered mental status, likely due to hypovolemia.\n\u2022 His laboratory studies reveal hypernatremia (Na\u207a 154 mEq/L), indicating a free water deficit.\n\nStep 2: Determine the Underlying Problem and Management Priorities\n\u2022 The hypernatremia is most likely due to the loss of hypotonic fluid via the surgical drain.\n\u2022 The patient is volume-depleted, so the first priority is to restore intravascular volume and correct dehydration.\n\u2022 In cases of hypovolemic hypernatremia, the standard approach is to begin with isotonic fluids to address the volume deficit. After stabilization of volume status, one can then correct the free water deficit with hypotonic fluids over a prolonged period.\n\nStep 3: Evaluate the Management Options\nA. 0.9% Saline IV \u2013 Isotonic fluid that will restore intravascular volume without rapidly shifting serum sodium. This is the appropriate initial step in treating hypovolemic hypernatremia.\nB. 5% Dextrose IV \u2013 Although it eventually supplies free water once metabolized, it does not provide adequate intravascular volume support in a hypovolemic patient.\nC. 5% Dextrose IV with 0.45% Saline IV \u2013 This combination is more hypotonic and might be used later to replace the free water deficit, but it's not ideal for immediate volume repletion.\nD. Oral Free Water Replacement \u2013 Not appropriate in a patient with altered mental status who is difficult to arouse, due to the risk of aspiration and inadequate correction of hypovolemia.\n\nStep 4: Final Answer\nThe best next step in management for this patient is to initiate 0.9% saline IV.\n\nFinal Answer: A. 0.9% saline IV",
            "Step 1: Analyze the patient\u2019s presentation and lab values.\n\u2022 The patient is 4 days postoperative from a pancreaticoduodenectomy, with large-volume (>1 liter/day) drainage output causing significant fluid losses.\n\u2022 His exam shows signs of dehydration (dry mucous membranes, tachycardia), and his labs demonstrate hypernatremia (Na+ 154 mEq/L), indicating a free water deficit.\n\nStep 2: Determine the goal of management.\n\u2022 The patient\u2019s dehydration with hypernatremia needs correction by replacing free water. In a patient with volume depletion and an ongoing free water deficit, hypotonic fluids (which provide water without excess sodium) are appropriate.\n\u2022 Oral water replacement is unsafe given his altered mental status.\n\nStep 3: Evaluate the fluid options.\nA. 0.9% saline IV has a sodium content similar to his serum and does not supply free water \u2013 it would not correct his hypernatremia.\nB. 5% dextrose IV (D5W) essentially provides free water once the dextrose is metabolized. However, if the patient is hypovolemic, pure free water might not adequately restore intravascular volume.\nC. 5% dextrose IV with 0.45% saline IV offers both hypotonic free water replacement and a small amount of sodium to help restore intravascular volume and correct dehydration gradually.\nD. Oral free water replacement is contraindicated given his altered mental status (difficulty to arouse).\n\nStep 4: Conclude the best next step.\n\u2022 Since the patient is dehydrated and hypernatremic due to high-volume losses, and given his altered mental status precluding safe oral intake, the best next step is to begin intravenous fluid therapy with a hypotonic solution that also helps with volume repletion. Option C \u2013 5% dextrose IV with 0.45% saline IV \u2013 accomplishes both.\n\nFinal Answer: C. 5% dextrose IV with 0.45% saline IV"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Identify Key Patient Findings\n\u2022 The patient is 4 days postoperative with pancreaticoduodenectomy and has a high drainage output (>1 liter per day), which can lead to significant free water loss.\n\u2022 He exhibits signs of dehydration (dry mucous membranes, tachycardia, and somewhat low blood pressure) and altered mental status, likely due to hypovolemia.\n\u2022 His laboratory studies reveal hypernatremia (Na\u207a 154 mEq/L), indicating a free water deficit.\n\nStep 2: Determine the Underlying Problem and Management Priorities\n\u2022 The hypernatremia is most likely due to the loss of hypotonic fluid via the surgical drain.\n\u2022 The patient is volume-depleted, so the first priority is to restore intravascular volume and correct dehydration.\n\u2022 In cases of hypovolemic hypernatremia, the standard approach is to begin with isotonic fluids to address the volume deficit. After stabilization of volume status, one can then correct the free water deficit with hypotonic fluids over a prolonged period.\n\nStep 3: Evaluate the Management Options\nA. 0.9% Saline IV \u2013 Isotonic fluid that will restore intravascular volume without rapidly shifting serum sodium. This is the appropriate initial step in treating hypovolemic hypernatremia.\nB. 5% Dextrose IV \u2013 Although it eventually supplies free water once metabolized, it does not provide adequate intravascular volume support in a hypovolemic patient.\nC. 5% Dextrose IV with 0.45% Saline IV \u2013 This combination is more hypotonic and might be used later to replace the free water deficit, but it's not ideal for immediate volume repletion.\nD. Oral Free Water Replacement \u2013 Not appropriate in a patient with altered mental status who is difficult to arouse, due to the risk of aspiration and inadequate correction of hypovolemia.\n\nStep 4: Final Answer\nThe best next step in management for this patient is to initiate 0.9% saline IV.\n\nFinal Answer: A. 0.9% saline IV"
    },
    {
        "realidx": 423,
        "question": "A 27-year-old woman presents to the emergency department with acute onset bloody diarrhea. The patient has had severe abdominal pain throughout her entire life with occasional episodes of bloody diarrhea. She has recently lost 7 pounds and has felt generally ill for the past 2 days. She has a past medical history of generalized seizures with her most recent one having occurred 5 days ago. One month ago, the patient was treated for impetigo. The patient admits to occasional cocaine use and binge drinking. Her temperature is 98.7\u00b0F (37.1\u00b0C), blood pressure is 107/58 mmHg, pulse is 127/min, respirations are 16/min, and oxygen saturation is 99% on room air. Physical exam is notable for diffuse abdominal tenderness and guaiac positive stools. Laboratory values are ordered as seen below.\n\nHemoglobin: 9 g/dL\nHematocrit: 30%\nLeukocyte count: 9,400/mm^3 with normal differential\nPlatelet count: 199,000/mm^3\n\nSerum:\nNa+: 139 mEq/L\nCl-: 101 mEq/L\nK+: 4.9 mEq/L\nHCO3-: 25 mEq/L\nBUN: 37 mg/dL\nGlucose: 99 mg/dL\nCreatinine: 1.8 mg/dL\nAST: 62 U/L\nALT: 80 U/L\nBlood alcohol: .15 g/dL\n\nUrine:\nColor: Yellow\nProtein: Positive\nCocaine: Positive\nMarijuana: Positive\n\nWhich of the following is the best explanation for this patient's laboratory findings?",
        "answer": "Protein deposition",
        "options": {
            "A": "Alcohol-induced liver injury",
            "B": "Immune response to streptococcal infection",
            "C": "Intestinal IgA deficiency",
            "D": "Protein deposition"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "27 year old woman presents",
            "emergency department",
            "acute onset bloody diarrhea",
            "patient",
            "severe abdominal",
            "entire life",
            "occasional episodes of bloody diarrhea",
            "recently lost",
            "pounds",
            "felt",
            "ill",
            "past 2 days",
            "past medical generalized seizures",
            "most recent one",
            "occurred 5 days",
            "One month",
            "patient",
            "treated",
            "impetigo",
            "patient admits",
            "occasional cocaine use",
            "binge drinking",
            "temperature",
            "98",
            "blood pressure",
            "58 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "99",
            "room air",
            "Physical exam",
            "notable",
            "diffuse abdominal tenderness",
            "guaiac positive stools",
            "Laboratory values",
            "ordered",
            "seen",
            "Hemoglobin",
            "g/dL Hematocrit",
            "30",
            "Leukocyte count",
            "400 mm",
            "normal differential Platelet count",
            "mm",
            "Serum",
            "Na",
            "mEq/L Cl",
            "mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L",
            "mg/dL Glucose",
            "99 mg/dL Creatinine",
            "1.8 mg/dL AST",
            "62 U/L ALT",
            "80 U/L Blood alcohol",
            "g/dL",
            "Urine",
            "Color",
            "Yellow Protein",
            "Positive Cocaine",
            "Positive Marijuana",
            "Positive",
            "following",
            "best explanation",
            "patient's laboratory findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 7134,
            "completion_tokens": 8425
        },
        "time_elapsed": 58.82889723777771,
        "raw_responses": [
            "Let\u2019s break down the case step by step:\n\n\u2022 The patient is a 27\u2010year\u2010old woman with life\u2010long severe abdominal pain and intermittent bouts of bloody diarrhea. This history raises suspicion for an inflammatory bowel disease (IBD) such as ulcerative colitis.\n\u2022 She now presents with an acute exacerbation (weight loss, malaise, bloody diarrhea) and has laboratory evidence of renal dysfunction\u2014elevated BUN and creatinine\u2014and proteinuria.\n\u2022 In patients with a long history of chronic inflammatory conditions like ulcerative colitis, one possible complication is secondary (AA) amyloidosis. In AA amyloidosis, chronic inflammation leads to increased serum amyloid A, which in turn can deposit as amyloid protein in various organs, including the kidneys. When amyloid deposits in the renal glomeruli, it can lead to proteinuria and progressive renal impairment.\n\u2022 Although she had impetigo a month ago, an immune response to streptococcal infection (i.e., post-streptococcal glomerulonephritis) would not account for her lifelong gastrointestinal symptoms. Similarly, alcohol-induced liver injury or an intestinal IgA deficiency do not explain the combination of chronic bloody diarrhea with renal findings.\n  \nThus, the best explanation for the patient\u2019s laboratory findings is that her long-standing inflammatory condition (ulcerative colitis) has led to amyloid deposition in the kidneys.\n\nFinal answer: D. Protein deposition",
            "Step 1. Summarize the case details:\n\u2022 A 27\u2010year\u2010old woman with a history of lifelong severe abdominal pain and occasional episodes of bloody diarrhea now presents acutely with bloody diarrhea, 7\u2010lb weight loss, and a feeling of general malaise.\n\u2022 She has a history of seizures and was treated for impetigo about 1 month ago. Also, she admits to occasional cocaine use and binge drinking.\n\u2022 Vital signs reveal tachycardia and otherwise normal parameters.\n\u2022 Laboratory studies show anemia (hemoglobin 9 g/dL), evidence of renal dysfunction (BUN 37 mg/dL, creatinine 1.8 mg/dL), mild transaminase elevation, and a urine analysis positive for protein.\n\nStep 2. Analyzing the clinical picture:\n\u2022 The patient\u2019s chronic history of abdominal pain with recurrent bloody diarrhea raises the suspicion for an inflammatory bowel disorder such as ulcerative colitis.\n\u2022 In patients with ulcerative colitis, there is a known association with IgA nephropathy. IgA nephropathy is characterized by the deposition of IgA immune complexes in the glomeruli\u2014this deposition can lead to hematuria and proteinuria and eventually to renal dysfunction, as seen in this patient.\n\u2022 Although the patient\u2019s recent history of impetigo might raise concerns for post-streptococcal glomerulonephritis, that condition classically presents with complement consumption, edema, and a different timeline, and it does not explain her long\u2010standing gastrointestinal symptoms.\n\u2022 The other options (alcohol-induced liver injury and intestinal IgA deficiency) do not account for the proteinuria and renal dysfunction in context with her chronic gastrointestinal complaints.\n\nStep 3. Analyze the answer choices:\nA. Alcohol-induced liver injury \u2013 The mildly elevated AST and ALT are not sufficient to suggest liver injury from alcohol, and this doesn\u2019t explain the kidney findings.\nB. Immune response to streptococcal infection \u2013 Although the patient had impetigo treated a month ago, post-streptococcal glomerulonephritis is typically seen after pharyngitis or in a slightly younger population and would not account for her longstanding GI symptoms.\nC. Intestinal IgA deficiency \u2013 Deficiency in IgA predisposes to infections but does not cause immune complex deposition or the findings noted on this patient\u2019s renal workup.\nD. Protein deposition \u2013 This option is referring to the deposition of protein complexes in the kidney (i.e., IgA in IgA nephropathy), which is associated with chronic inflammatory conditions such as ulcerative colitis and can account for the renal dysfunction and proteinuria observed.\n\nStep 4. Final Answer:\nThe best explanation for this patient\u2019s laboratory findings is the deposition of immune complexes (specifically IgA) in the glomeruli, making the correct answer:\n\nD. Protein deposition",
            "Step 1: Key details in the case include the patient's lifelong history of severe abdominal pain with recurrent episodes of bloody diarrhea (suggestive of an underlying inflammatory bowel disease, such as ulcerative colitis), recent weight loss and malaise, and laboratory findings showing renal impairment with an elevated BUN/creatinine and proteinuria.\n\nStep 2: In patients with inflammatory bowel disease (IBD), especially ulcerative colitis, there is an increased risk for extraintestinal manifestations such as IgA nephropathy. This renal condition is caused by IgA immune complex deposition in the glomeruli, damaging the kidneys and leading to proteinuria and renal dysfunction.\n\nStep 3: Now, compare the options:\n\u2022 Option A (Alcohol-induced liver injury) does not account for the renal findings nor the chronic gastrointestinal symptoms.\n\u2022 Option B (Immune response to streptococcal infection) is characteristic of post-streptococcal glomerulonephritis, but the patient\u2019s long history of abdominal symptoms and the timeline after her impetigo do not fit this picture.\n\u2022 Option C (Intestinal IgA deficiency) is not known to cause immune complex deposition in the kidney; it more typically predisposes to infections.\n\u2022 Option D (Protein deposition) is best interpreted as referring to the deposition of IgA-containing immune complexes within the renal glomeruli, which provides the link between chronic inflammation (as seen in ulcerative colitis) and the patient\u2019s renal signs.\n\nFinal Answer: D. Protein deposition"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "1"
        ],
        "final_solution": "Step 1: Key details in the case include the patient's lifelong history of severe abdominal pain with recurrent episodes of bloody diarrhea (suggestive of an underlying inflammatory bowel disease, such as ulcerative colitis), recent weight loss and malaise, and laboratory findings showing renal impairment with an elevated BUN/creatinine and proteinuria.\n\nStep 2: In patients with inflammatory bowel disease (IBD), especially ulcerative colitis, there is an increased risk for extraintestinal manifestations such as IgA nephropathy. This renal condition is caused by IgA immune complex deposition in the glomeruli, damaging the kidneys and leading to proteinuria and renal dysfunction.\n\nStep 3: Now, compare the options:\n\u2022 Option A (Alcohol-induced liver injury) does not account for the renal findings nor the chronic gastrointestinal symptoms.\n\u2022 Option B (Immune response to streptococcal infection) is characteristic of post-streptococcal glomerulonephritis, but the patient\u2019s long history of abdominal symptoms and the timeline after her impetigo do not fit this picture.\n\u2022 Option C (Intestinal IgA deficiency) is not known to cause immune complex deposition in the kidney; it more typically predisposes to infections.\n\u2022 Option D (Protein deposition) is best interpreted as referring to the deposition of IgA-containing immune complexes within the renal glomeruli, which provides the link between chronic inflammation (as seen in ulcerative colitis) and the patient\u2019s renal signs.\n\nFinal Answer: D. Protein deposition"
    },
    {
        "realidx": 448,
        "question": "A 69-year-old male with a longstanding history of hypertension and high cholesterol presents with abdominal pain and \u2018bruising on his feet\u2019. The patient states that his symptoms started about a week ago and have steadily worsened. He describes the abdominal pain as mild to moderate, dull, and deeply localized to the umbilical region. Past medical history is significant for 2 transient ischemic attacks 6 months prior, characterized by a sudden right-sided weakness and trouble speaking but recovered fully within 30 minutes. Current medications are sildenafil 100 mg orally as needed. Patient reports a 30-pack-year smoking history and heavy alcohol use on the weekends. Review of systems is significant for decreased appetite and feeling easily full. Vitals are temperature 37\u00b0C (98.6\u00b0F), blood pressure 155/89 mm Hg, pulse 89/min, respirations 16/min, and oxygen saturation 98% on room air. On physical examination, the patient is alert and cooperative. The cardiac exam is normal. Lungs are clear to auscultation. Carotid bruit present on the right. The abdomen is soft and nontender. Bowel sounds present. A pulsatile abdominal mass is felt in the lower umbilical region. Patient\u2019s feet have the following appearance seen in the picture. Abdominal ultrasound reveals the presence of an abdominal aortic aneurysm (AAA). Contrast CT reveals a small, unruptured AAA (diameter 4.1 cm). High flow supplemental oxygen and fluid resuscitation are initiated. Morphine sulfate and metoprolol are administered. Which of the following is the best course of treatment for this patient?\n ",
        "answer": "Emergency open surgical repair",
        "options": {
            "A": "Discharge with clinical surveillance and ultrasound every 6 months",
            "B": "Elective endovascular repair",
            "C": "Elective open surgical repair",
            "D": "Emergency open surgical repair"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "69 year old male",
            "history of hypertension",
            "high cholesterol presents",
            "abdominal pain",
            "bruising",
            "feet",
            "patient states",
            "symptoms started",
            "week",
            "worsened",
            "abdominal",
            "mild to moderate",
            "dull",
            "deeply localized",
            "umbilical region",
            "Past medical history",
            "significant",
            "transient ischemic attacks",
            "months prior",
            "characterized",
            "sudden right-sided weakness",
            "speaking",
            "recovered",
            "30 minutes",
            "Current medications",
            "sildenafil 100 mg orally",
            "needed",
            "Patient reports",
            "30 pack-year smoking history",
            "heavy alcohol use",
            "weekends",
            "Review of systems",
            "significant",
            "decreased appetite",
            "feeling easily full",
            "temperature",
            "98",
            "blood pressure",
            "mm Hg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation 98",
            "room air",
            "physical examination",
            "patient",
            "alert",
            "cooperative",
            "cardiac exam",
            "normal",
            "Lungs",
            "clear",
            "auscultation",
            "Carotid bruit present",
            "right",
            "abdomen",
            "soft",
            "nontender",
            "Bowel sounds present",
            "pulsatile abdominal mass",
            "felt",
            "lower umbilical region",
            "Patients feet",
            "following appearance seen",
            "picture",
            "Abdominal ultrasound reveals",
            "presence of",
            "abdominal aortic aneurysm",
            "Contrast CT reveals",
            "small",
            "diameter",
            "High flow supplemental oxygen",
            "fluid resuscitation",
            "initiated",
            "Morphine sulfate",
            "metoprolol",
            "administered",
            "following",
            "best course",
            "treatment",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6399,
            "completion_tokens": 3651
        },
        "time_elapsed": 30.686800479888916,
        "raw_responses": [
            "Step 1: Identify the key details of the case. The patient is a 69\u2010year\u2010old male with risk factors (hypertension, hypercholesterolemia, smoking history) and symptoms concerning for an abdominal aortic aneurysm (AAA). A pulsatile abdominal mass was noted in the umbilical region, and imaging revealed a small, unruptured AAA measuring 4.1 cm. His present complaints include mild, dull, localized abdominal pain and peripheral signs on his feet, but there are no signs of rupture or acute hemodynamic instability.\n\nStep 2: Review AAA management guidelines. For male patients, elective repair is typically considered when the aneurysm exceeds 5.5 cm in diameter. In aneurysms smaller than this threshold, especially if asymptomatic or minimally symptomatic, the standard management is conservative with periodic surveillance (typically ultrasound every 6 to 12 months).\n\nStep 3: Evaluate the treatment options.\n\u2022 Option A (Discharge with clinical surveillance and ultrasound every 6 months) is most consistent with the management of an unruptured, small (<5.5 cm) AAA in a stable patient.\n\u2022 Option B (Elective endovascular repair) and Option C (Elective open surgical repair) are reserved for larger or rapidly enlarging aneurysms or those that cause significant symptoms; this patient does not meet these criteria.\n\u2022 Option D (Emergency open surgical repair) is indicated in the setting of a ruptured AAA, which is not the case here.\n\nStep 4: Final Answer.\nThe best course of treatment is:\nA. Discharge with clinical surveillance and ultrasound every 6 months.",
            "Step 1: Identify the Key Findings\n\u2022 The patient is a 69\u2010year-old male with cardiovascular risk factors (hypertension, dyslipidemia, smoking, alcohol).\n\u2022 He has a pulsatile abdominal mass palpated in the lower umbilical region.\n\u2022 Abdominal ultrasound confirms the presence of an abdominal aortic aneurysm (AAA), and contrast CT measures it as 4.1 cm in diameter.\n\u2022 The patient is hemodynamically stable and his AAA is unruptured.\n\nStep 2: Apply AAA Management Guidelines\n\u2022 For male patients, surgical repair is typically recommended when an AAA reaches 5.5 cm in diameter.\n\u2022 Since this patient\u2019s AAA is 4.1 cm, it falls below the surgical repair threshold.\n\u2022 The standard management for an AAA of this size is periodic surveillance with imaging, along with risk factor modification (e.g., blood pressure control, smoking cessation).\n\nStep 3: Evaluate the Answer Choices\nA. Discharge with clinical surveillance and ultrasound every 6 months \u2013 This is appropriate because the AAA is below the 5.5 cm threshold.\nB. Elective endovascular repair \u2013 This is considered for aneurysms \u22655.5 cm in men or if there are other concerning features; not indicated here.\nC. Elective open surgical repair \u2013 Same rationale as B.\nD. Emergency open surgical repair \u2013 Reserved for ruptured or rapidly expanding aneurysms; not applicable here.\n\nStep 4: Final Answer\nThe best course of treatment is to discharge the patient with clinical surveillance, including ultrasound monitoring every 6 months.\n\nFinal Answer: A. Discharge with clinical surveillance and ultrasound every 6 months",
            "Step 1: Key details in the case include the patient's age, risk factors (hypertension, high cholesterol, smoking, alcohol use), the pulsatile abdominal mass noted on exam, and imaging findings showing an abdominal aortic aneurysm (AAA) with a diameter of 4.1 cm. Despite the patient\u2019s symptoms (mild to moderate, dull, periumbilical pain and bruising on his feet), there are no signs of rupture or impending rupture.\n\nStep 2: Management of AAA is largely determined by the aneurysm size and symptomatology. For men, elective repair is generally recommended when the aneurysm reaches a diameter of 5.5 cm or more, or if the aneurysm is symptomatic or rapidly enlarging. In this case, the AAA is unruptured and measures only 4.1 cm, which is below the threshold for surgical repair.\n\nStep 3: Comparing the options:\n\u2022 Option A (Discharge with clinical surveillance and ultrasound every 6 months) is appropriate for an AAA of this size.\n\u2022 Options B (Elective endovascular repair) and C (Elective open surgical repair) are not indicated based on the current size.\n\u2022 Option D (Emergency open surgical repair) is reserved for ruptured or unstable aneurysms, which is not the situation here.\n\nFinal Answer: A. Discharge with clinical surveillance and ultrasound every 6 months."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Identify the Key Findings\n\u2022 The patient is a 69\u2010year-old male with cardiovascular risk factors (hypertension, dyslipidemia, smoking, alcohol).\n\u2022 He has a pulsatile abdominal mass palpated in the lower umbilical region.\n\u2022 Abdominal ultrasound confirms the presence of an abdominal aortic aneurysm (AAA), and contrast CT measures it as 4.1 cm in diameter.\n\u2022 The patient is hemodynamically stable and his AAA is unruptured.\n\nStep 2: Apply AAA Management Guidelines\n\u2022 For male patients, surgical repair is typically recommended when an AAA reaches 5.5 cm in diameter.\n\u2022 Since this patient\u2019s AAA is 4.1 cm, it falls below the surgical repair threshold.\n\u2022 The standard management for an AAA of this size is periodic surveillance with imaging, along with risk factor modification (e.g., blood pressure control, smoking cessation).\n\nStep 3: Evaluate the Answer Choices\nA. Discharge with clinical surveillance and ultrasound every 6 months \u2013 This is appropriate because the AAA is below the 5.5 cm threshold.\nB. Elective endovascular repair \u2013 This is considered for aneurysms \u22655.5 cm in men or if there are other concerning features; not indicated here.\nC. Elective open surgical repair \u2013 Same rationale as B.\nD. Emergency open surgical repair \u2013 Reserved for ruptured or rapidly expanding aneurysms; not applicable here.\n\nStep 4: Final Answer\nThe best course of treatment is to discharge the patient with clinical surveillance, including ultrasound monitoring every 6 months.\n\nFinal Answer: A. Discharge with clinical surveillance and ultrasound every 6 months"
    },
    {
        "realidx": 452,
        "question": "A 37-year-old man comes to the emergency department with the chief complaint of a high fever for several days. In addition to the fever, he has had malaise, chest pain, and a dry cough. He recently went on vacation to South America but has returned to his job delivering packages. He has several friends who recently had influenza. Hi temperature is 102.8\u00b0F (39.3 \u00b0C), blood pressure is 137/80 mmHg, pulse is 104/min, respirations are 19/min, and oxygen saturation is 98%. Chest exam reveals a deep noise found bilaterally in the lung bases. Chest radiograph reveals a wider area of opacity near the heart and bilateral lung infiltrates. Which of the following is characteristic of the most likely organism responsible for this patient's symptoms?",
        "answer": "D-glutamate capsule",
        "options": {
            "A": "Cultured on charcoal and yeast",
            "B": "D-glutamate capsule",
            "C": "Found in desert sand",
            "D": "Polyribosyl-ribitol-phosphate capsule"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old man",
            "emergency department",
            "chief complaint",
            "high fever",
            "several days",
            "fever",
            "malaise",
            "chest pain",
            "dry cough",
            "recently",
            "vacation",
            "South America",
            "returned",
            "job delivering packages",
            "several friends",
            "recently",
            "influenza",
            "Hi temperature",
            "blood pressure",
            "80 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "Chest exam reveals",
            "deep noise found",
            "lung bases",
            "Chest radiograph reveals",
            "wider area",
            "opacity",
            "heart",
            "bilateral lung infiltrates",
            "following",
            "characteristic",
            "likely organism responsible",
            "patient's symptoms"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5808,
            "completion_tokens": 7762
        },
        "time_elapsed": 51.085453271865845,
        "raw_responses": [
            "Step 1: Analyze the patient\u2019s presentation. The 37-year-old man has a high fever, malaise, chest pain, and a dry cough. His chest radiograph shows an opacity in the perihilar area with bilateral infiltrates. His travel history (recent vacation in South America) can be associated with exposure to environmental sources, and his symptoms are consistent with an atypical pneumonia.\n\nStep 2: Consider the likely organisms. Although his friends had influenza, his presentation (high fever, cough, and radiographic findings) is more in line with a bacterial pneumonia. Among the atypical pneumonia pathogens, Legionella pneumophila is notable for:\n\u2022 Association with travel/hotel stays (often from contaminated water sources)\n\u2022 High fevers and pulmonary infiltrates\n\nStep 3: Match the organism to the answer choices. Option A (\u201cCultured on charcoal and yeast\u201d) is a well\u2010known characteristic of Legionella pneumophila, which requires buffered charcoal yeast extract agar supplemented with iron and cysteine for culture. Other options refer to features of other organisms:\n\u2022 Option B (D-glutamate capsule) pertains to Bacillus anthracis.\n\u2022 Option C (Found in desert sand) is associated with certain fungal infections (e.g., Coccidioides) but not typical for this presentation.\n\u2022 Option D (Polyribosyl\u2010ribitol\u2010phosphate capsule) describes Haemophilus influenzae type b.\n\nStep 4: Provide the final answer. Based on the clinical scenario and the characteristics provided:\n\nFinal answer: A. Cultured on charcoal and yeast.",
            "Step 1: Analyze the clinical presentation. The patient is a 37\u2010year\u2010old man with high fever, malaise, chest pain, and a dry cough. His chest X\u2010ray shows bilateral infiltrates with a widened opacity near the heart. He also has a recent travel history to South America, which may hint at exposure to unusual pathogens in hotel water systems.\n\nStep 2: Consider likely pathogens. The description of an atypical pneumonia with a dry cough and bilateral infiltrates points toward organisms like Legionella pneumophila. Legionella is classically associated with contaminated water sources (e.g., hotels, cruise ships) and can present with high fever and systemic symptoms.\n\nStep 3: Evaluate the options.\n\u2022 Option A \u2013 \"Cultured on charcoal and yeast\": This describes the growth requirements of Legionella pneumophila on buffered charcoal yeast extract (BCYE) agar.\n\u2022 Option B \u2013 \"D-glutamate capsule\": This is not characteristic of Legionella; it more typically pertains to the capsule of Streptococcus pneumoniae, which usually presents with a productive cough and lobar pneumonia.\n\u2022 Option C \u2013 \"Found in desert sand\": This is suggestive of pathogens like Coccidioides immitis, associated with the American Southwest.\n\u2022 Option D \u2013 \"Polyribosyl\u2010ribitol\u2010phosphate capsule\": This is the capsule of Haemophilus influenzae type b, which is not implicated in this scenario.\n\nStep 4: Conclusion. The clinical findings and setting are most consistent with Legionella pneumophila, whose growth on buffered charcoal yeast extract agar is characteristic.\n\nFinal Answer: A. Cultured on charcoal and yeast",
            "Step 1: Analyze the clinical scenario. The patient is a 37\u2010year\u2010old man with high fever, malaise, chest pain, and a dry cough. His chest radiograph shows bilateral lung infiltrates with an opacity near the heart. In addition, he has a recent travel history to South America and possible community exposure through his work. Although several pathogens cause pneumonia, you must use the clues provided in the vignette to narrow down the organism.\n\nStep 2: Consider the likely pathogens and their characteristics.\n\u2022 Streptococcus pneumoniae is the most common cause of community-acquired pneumonia and is characterized by a polyribosyl\u2010ribitol\u2010phosphate capsule. However, it typically produces a productive (\u201crust-colored\u201d) cough and lobar consolidation rather than a widespread dry cough with bilateral infiltrates.\n\u2022 Legionella pneumophila, on the other hand, is considered an atypical pneumonia. It often presents with high fever, dry cough, and sometimes chest pain\u2014with radiographs showing patchy or bilateral infiltrates. It also has been associated with exposures during travel (e.g., in hotel water systems). A key laboratory characteristic is that it grows on buffered charcoal yeast extract media.\n\u2022 The other options are associated with different organisms: a D\u2011glutamate capsule is seen in Bacillus anthracis; \u201cfound in desert sand\u201d points towards Coccidioides immitis.\n  \nStep 3: Compare and eliminate.\n\u2022 Option D (Polyribosyl\u2010ribitol\u2010phosphate capsule) describes S. pneumoniae, which is more typically associated with a productive cough and lobar pneumonia.\n\u2022 Options B and C refer to organisms that do not match this clinical picture.\n\u2022 Option A (\u201cCultured on charcoal and yeast\u201d) is the classic description for Legionella pneumophila.\n\nStep 4: Conclusion.\nGiven the patient\u2019s presentation of high fever, dry cough, chest pain, bilateral infiltrates on chest radiograph, and the travel history, Legionella pneumophila is the most likely cause. Its characteristic culture on buffered charcoal yeast extract media supports this diagnosis.\n\nFinal answer: A. Cultured on charcoal and yeast"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "1"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation. The patient is a 37\u2010year\u2010old man with high fever, malaise, chest pain, and a dry cough. His chest X\u2010ray shows bilateral infiltrates with a widened opacity near the heart. He also has a recent travel history to South America, which may hint at exposure to unusual pathogens in hotel water systems.\n\nStep 2: Consider likely pathogens. The description of an atypical pneumonia with a dry cough and bilateral infiltrates points toward organisms like Legionella pneumophila. Legionella is classically associated with contaminated water sources (e.g., hotels, cruise ships) and can present with high fever and systemic symptoms.\n\nStep 3: Evaluate the options.\n\u2022 Option A \u2013 \"Cultured on charcoal and yeast\": This describes the growth requirements of Legionella pneumophila on buffered charcoal yeast extract (BCYE) agar.\n\u2022 Option B \u2013 \"D-glutamate capsule\": This is not characteristic of Legionella; it more typically pertains to the capsule of Streptococcus pneumoniae, which usually presents with a productive cough and lobar pneumonia.\n\u2022 Option C \u2013 \"Found in desert sand\": This is suggestive of pathogens like Coccidioides immitis, associated with the American Southwest.\n\u2022 Option D \u2013 \"Polyribosyl\u2010ribitol\u2010phosphate capsule\": This is the capsule of Haemophilus influenzae type b, which is not implicated in this scenario.\n\nStep 4: Conclusion. The clinical findings and setting are most consistent with Legionella pneumophila, whose growth on buffered charcoal yeast extract agar is characteristic.\n\nFinal Answer: A. Cultured on charcoal and yeast"
    },
    {
        "realidx": 454,
        "question": "A 42-year-old man presents to a neurologist for evaluation of severe headache. He started experiencing episodic headaches and palpitations 3 months ago; however, he thought that these symptoms were simply related to the stress of moving and starting a new job. He has continued to experience these intermittent headaches and has also noticed that he sweats profusely during these episodes. On presentation his temperature is 99.1\u00b0F (37.3\u00b0C), blood pressure is 163/112 mmHg, pulse is 112/min, and respirations are 15/min. Physical exam reveals pallor and perspiration but is otherwise unremarkable. The most likely cause of this patient's symptoms is produced by cells located in which region of the histology slide shown in figure A?",
        "answer": "E",
        "options": {
            "A": "A",
            "B": "B",
            "C": "C",
            "D": "E"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man presents",
            "neurologist",
            "evaluation",
            "severe headache",
            "started experiencing episodic headaches",
            "palpitations",
            "months",
            "thought",
            "symptoms",
            "related",
            "stress",
            "moving",
            "starting",
            "new job",
            "continued to experience",
            "intermittent headaches",
            "sweats",
            "episodes",
            "presentation",
            "temperature",
            "99",
            "3C",
            "blood pressure",
            "mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "Physical exam reveals pallor",
            "perspiration",
            "unremarkable",
            "most likely cause",
            "patient's symptoms",
            "cells",
            "region",
            "histology slide shown"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 3735,
            "completion_tokens": 3074
        },
        "time_elapsed": 25.682703256607056,
        "raw_responses": [
            "The patient\u2019s episodic headaches, palpitations, sweating, and hypertension are classic signs of a pheochromocytoma\u2014a tumor that arises from the chromaffin cells of the adrenal medulla, which are derived from neural crest cells. The histologic slide (Figure A) labels different regions of the adrenal gland, with one region representing the adrenal cortex and another representing the adrenal medulla. Given that pheochromocytomas originate in the medulla (where the chromaffin cells reside), the answer is the region on the slide corresponding to the medulla.\n\nAfter reviewing and eliminating the regions corresponding to other parts of the adrenal gland (i.e., the cortex, which does not produce catecholamines), the best answer is:\n\nFinal answer: C",
            "Step 1: Recognize that the patient\u2019s symptoms\u2014episodic headaches, palpitations, sweating, hypertension, and pallor\u2014are classic for a pheochromocytoma. These tumors secrete catecholamines (epinephrine and norepinephrine).\n\nStep 2: Recall that pheochromocytomas arise from chromaffin cells. These cells are embryologically derived from neural crest cells and are located in the adrenal medulla.\n\nStep 3: In the histology slide provided (labeled with regions A\u2013E), the region that corresponds to the adrenal medulla is the one where the chromaffin cells reside.\n\nStep 4: By matching this information with the options given, the correct answer is the label for the adrenal medulla. (In this question the adrenal medulla is represented by option C.)\n\nFinal answer: C",
            "Step 1: Recognize that the patient's episodic headache, palpitations, sweating, and hypertension are classic signs of a pheochromocytoma, a tumor originating from chromaffin cells that release catecholamines.\n\nStep 2: Recall that chromaffin cells are found in the adrenal medulla, which is the central portion of the adrenal gland on a histologic slide.\n\nStep 3: Comparing the regions described in figure A, the region that corresponds to the adrenal medulla (where the chromaffin cells reside) is option C.\n\nFinal answer: C"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Recognize that the patient\u2019s symptoms\u2014episodic headaches, palpitations, sweating, hypertension, and pallor\u2014are classic for a pheochromocytoma. These tumors secrete catecholamines (epinephrine and norepinephrine).\n\nStep 2: Recall that pheochromocytomas arise from chromaffin cells. These cells are embryologically derived from neural crest cells and are located in the adrenal medulla.\n\nStep 3: In the histology slide provided (labeled with regions A\u2013E), the region that corresponds to the adrenal medulla is the one where the chromaffin cells reside.\n\nStep 4: By matching this information with the options given, the correct answer is the label for the adrenal medulla. (In this question the adrenal medulla is represented by option C.)\n\nFinal answer: C"
    },
    {
        "realidx": 461,
        "question": "A 58-year-old man comes to the physician because he is unable to achieve erections during sexual intercourse. He first noticed the problem 8 months ago, when he became sexually active with a new girlfriend. He states that his relationship with his girlfriend is good, but his inability to engage in sexual intercourse has been frustrating. He has hyperlipidemia and was diagnosed with major depressive disorder 3 years ago. He works as a lawyer and enjoys his job, but he has had a great deal of stress lately. He had not been sexually active for the previous 3 years, since the death of his wife. He does not smoke. He drinks 4\u20136 beers on weekends. Current medications include simvastatin and citalopram. His temperature is 37.5\u00b0C (99.5\u00b0F), pulse is 80/min, and blood pressure is 135/82 mm Hg. BMI is 30 kg/m2. Pedal pulses are difficult to palpate. The remainder of the physical examination shows no abnormalities. Which of the following is the most appropriate next step in management?",
        "answer": "Nocturnal penile tumescence testing",
        "options": {
            "A": "Psychotherapy",
            "B": "Penile prosthesis insertion",
            "C": "Nocturnal penile tumescence testing",
            "D": "Switch citalopram to bupropion"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "58 year old man",
            "physician",
            "unable to",
            "erections",
            "sexual intercourse",
            "first",
            "problem",
            "months",
            "sexually active",
            "new girlfriend",
            "states",
            "relationship",
            "girlfriend",
            "good",
            "sexual intercourse",
            "hyperlipidemia",
            "diagnosed",
            "major depressive disorder",
            "years",
            "works",
            "lawyer",
            "job",
            "great",
            "stress",
            "not",
            "sexually active",
            "previous",
            "years",
            "death",
            "wife",
            "not smoke",
            "drinks",
            "beers",
            "weekends",
            "Current medications include simvastatin",
            "citalopram",
            "temperature",
            "99",
            "pulse",
            "80 min",
            "blood pressure",
            "mm Hg",
            "BMI",
            "30 kg/m2",
            "Pedal pulses",
            "difficult to palpate",
            "physical examination shows",
            "abnormalities",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5616,
            "completion_tokens": 4009
        },
        "time_elapsed": 30.511411428451538,
        "raw_responses": [
            "Step 1: Analyze the Patient\u2019s History and Findings\n\u2022 The patient is a 58\u2010year\u2010old man with difficulty achieving erections, beginning 8 months ago when he resumed sexual activity after a prolonged period. \n\u2022 He has vascular risk factors (hyperlipidemia, obesity, and diminished pedal pulses suggesting peripheral vascular disease) that predispose him to organic erectile dysfunction.\n\u2022 He also has major depressive disorder and is taking citalopram, an SSRI known to cause sexual dysfunction.\n\u2022 The onset of his erectile dysfunction with a new partner raises the possibility of a psychogenic component as well.\n\nStep 2: Weighing the Management Options\nA. Psychotherapy \u2013 While it can be helpful in psychogenic erectile dysfunction, his risk factors and medication effects make an organic cause at least partly likely.\nB. Penile prosthesis insertion \u2013 This is a treatment option reserved for patients who are refractory to other interventions. It would be premature without further evaluation.\nD. Switching citalopram to bupropion \u2013 Although SSRIs can cause sexual dysfunction, it\u2019s important first to determine whether the dysfunction is predominantly organic or psychogenic before altering his psychiatric regimen.\n\nStep 3: The Role of Nocturnal Penile Tumescence Testing\n\u2022 Nocturnal penile tumescence testing helps differentiate between organic and psychogenic causes of erectile dysfunction. Normal nocturnal erections suggest a psychogenic component, whereas their absence points toward an organic etiology.\n\u2022 Given this patient\u2019s mixed risk factors, this test is essential to clarify whether his erectile dysfunction is primarily due to vascular/medication-related (organic) factors or if a psychogenic component is present, which will then guide subsequent treatment.\n\nFinal Answer:\nC. Nocturnal penile tumescence testing",
            "Step 1: Analyze the Patient's History and Exam Findings\n\u2022 The patient is a 58\u2010year\u2010old man with hyperlipidemia, obesity (BMI 30), and signs of possible vascular disease (difficult-to-palpate pedal pulses). These factors predispose him to atherosclerosis, a common cause of erectile dysfunction (ED).\n\u2022 He has been on citalopram for major depressive disorder, and SSRIs can contribute to sexual dysfunction.\n\u2022 Despite his new relationship, his physical exam suggests an organic cause due to vascular insufficiency.\n\nStep 2: Compare the Options\nA. Psychotherapy \u2013 More appropriate if the suspected etiology is primarily psychological. Although his depression is noted, his examination findings lean toward an organic cause.\nB. Penile prosthesis insertion \u2013 This is considered a last resort for patients with refractory ED who have not responded to other treatments.\nC. Nocturnal penile tumescence (NPT) testing \u2013 This test helps distinguish between a psychogenic and an organic etiology of ED by assessing spontaneous erections during sleep.\nD. Switch citalopram to bupropion \u2013 While SSRIs like citalopram can cause sexual dysfunction, his physical exam findings (poor pedal pulses) suggest that vascular issues are likely contributing to his ED. Changing medications might be helpful in some cases, but it doesn\u2019t address the possibility of underlying organic pathology suggested by his exam.\n\nStep 3: Final Answer\nThe next appropriate step is to perform nocturnal penile tumescence testing to help differentiate an organic cause from a psychogenic one.\n\nFinal answer: C. Nocturnal penile tumescence testing",
            "Step 1: Review the patient's history and exam. This 58-year-old man has several risk factors for organic erectile dysfunction (ED) including hyperlipidemia, obesity (BMI of 30), and signs of possible vascular disease (poor pedal pulses). Although he is on citalopram, which can also impair sexual function, his physical exam findings point more toward an organic cause.\n\nStep 2: Consider the options. Psychotherapy (A) would be more appropriate for strictly psychogenic ED, which is less likely given his risk factors. Penile prosthesis insertion (B) is invasive and reserved for refractory cases that do not respond to medical therapy. Switching citalopram to bupropion (D) could be considered if his ED were believed to be primarily medication-induced, but his exam findings make an organic cause more likely.\n\nStep 3: Determine the next step. Nocturnal penile tumescence testing (C) is used to differentiate organic from psychogenic ED. Given his risk factors and exam findings suggesting an organic etiology, this test would help confirm the diagnosis and further guide management.\n\nFinal Answer: C. Nocturnal penile tumescence testing"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Analyze the Patient\u2019s History and Findings\n\u2022 The patient is a 58\u2010year\u2010old man with difficulty achieving erections, beginning 8 months ago when he resumed sexual activity after a prolonged period. \n\u2022 He has vascular risk factors (hyperlipidemia, obesity, and diminished pedal pulses suggesting peripheral vascular disease) that predispose him to organic erectile dysfunction.\n\u2022 He also has major depressive disorder and is taking citalopram, an SSRI known to cause sexual dysfunction.\n\u2022 The onset of his erectile dysfunction with a new partner raises the possibility of a psychogenic component as well.\n\nStep 2: Weighing the Management Options\nA. Psychotherapy \u2013 While it can be helpful in psychogenic erectile dysfunction, his risk factors and medication effects make an organic cause at least partly likely.\nB. Penile prosthesis insertion \u2013 This is a treatment option reserved for patients who are refractory to other interventions. It would be premature without further evaluation.\nD. Switching citalopram to bupropion \u2013 Although SSRIs can cause sexual dysfunction, it\u2019s important first to determine whether the dysfunction is predominantly organic or psychogenic before altering his psychiatric regimen.\n\nStep 3: The Role of Nocturnal Penile Tumescence Testing\n\u2022 Nocturnal penile tumescence testing helps differentiate between organic and psychogenic causes of erectile dysfunction. Normal nocturnal erections suggest a psychogenic component, whereas their absence points toward an organic etiology.\n\u2022 Given this patient\u2019s mixed risk factors, this test is essential to clarify whether his erectile dysfunction is primarily due to vascular/medication-related (organic) factors or if a psychogenic component is present, which will then guide subsequent treatment.\n\nFinal Answer:\nC. Nocturnal penile tumescence testing"
    },
    {
        "realidx": 477,
        "question": "A 32-year-old man comes to the physician because of a 2-day history of a tingling sensation in his right forearm. He reports that his symptoms started after he lifted heavy weights at the gym. Physical examination shows loss of sensation on the lateral side of the right forearm. Sensation over the thumb is intact. Range of motion of the neck is normal. His symptoms do not worsen with axial compression or distraction of the neck. Further examination of this patient is most likely to show weakness of which of the following actions?",
        "answer": "Elbow flexion",
        "options": {
            "A": "Elbow flexion",
            "B": "Forearm pronation",
            "C": "Index finger flexion",
            "D": "Wrist extension"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old man",
            "physician",
            "2-day history",
            "tingling sensation",
            "right forearm",
            "reports",
            "symptoms started",
            "lifted heavy weights",
            "Physical examination shows loss of sensation",
            "lateral side",
            "right forearm",
            "Sensation",
            "thumb",
            "intact",
            "Range of motion",
            "neck",
            "normal",
            "symptoms",
            "not worsen",
            "axial compression",
            "distraction of",
            "neck",
            "Further examination",
            "patient",
            "most likely to show weakness",
            "following actions"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5064,
            "completion_tokens": 4330
        },
        "time_elapsed": 38.81078481674194,
        "raw_responses": [
            "Step 1: Identify the nerve involvement. The patient complains of tingling in the right forearm and has lost sensation on the lateral side of the forearm, which corresponds to the distribution of the lateral antebrachial cutaneous nerve. This nerve is the sensory continuation of the musculocutaneous nerve.\n\nStep 2: Connect the nerve to motor function. The musculocutaneous nerve not only provides the lateral forearm sensation but also innervates the muscles responsible for elbow flexion (biceps brachii, brachialis, and coracobrachialis).\n\nStep 3: Evaluate the options.\n\u2022 Option A: Elbow flexion \u2013 This is directly controlled by the muscles innervated by the musculocutaneous nerve.\n\u2022 Option B: Forearm pronation \u2013 This action is mainly mediated by the pronator teres, innervated by the median nerve.\n\u2022 Option C: Index finger flexion \u2013 This is primarily controlled by flexor digitorum superficialis and profundus, which are innervated by the median nerve.\n\u2022 Option D: Wrist extension \u2013 This function is under the control of the radial nerve.\n  \nStep 4: The findings point toward an injury affecting the musculocutaneous nerve due to heavy weight lifting, such as possible traction or compression injury. With an injury to this nerve, motor weakness would most notably affect elbow flexion.\n\nFinal Answer: A. Elbow flexion",
            "Step 1: Identify the nerve involved.  \n\u2022 The patient has sensory loss over the lateral aspect of his forearm, which is served by the lateral antebrachial cutaneous nerve. This nerve is the terminal sensory branch of the musculocutaneous nerve.  \n\u2022 His history of heavy weight lifting suggests that the musculocutaneous nerve may have been injured.\n\nStep 2: Determine the function of the musculocutaneous nerve.  \n\u2022 The musculocutaneous nerve innervates the biceps brachii, brachialis, and coracobrachialis muscles.  \n\u2022 These muscles primarily function in elbow flexion and, in the case of the biceps brachii, also contribute to forearm supination.\n\nStep 3: Compare the options.  \nA. Elbow flexion \u2013 This action is primarily performed by the biceps brachii and brachialis muscles (both innervated by the musculocutaneous nerve).  \nB. Forearm pronation \u2013 This is mainly mediated by the pronator teres and pronator quadratus (innervated by the median nerve).  \nC. Index finger flexion \u2013 This is controlled by flexor digitorum superficialis and profundus (median and ulnar nerves).  \nD. Wrist extension \u2013 This is controlled by the extensor carpi radialis and extensor carpi ulnaris (innervated by the radial nerve).\n\nStep 4: Conclude the most likely weakness.  \n\u2022 Because the musculocutaneous nerve is affected, the most likely observed weakness would be in elbow flexion.\n\nFinal answer: A. Elbow flexion",
            "Step 1: Key information from the question\n\u2022 The patient has numbness/tingling on the lateral side of the right forearm.\n\u2022 Sensation over the thumb is intact.\n\u2022 Symptoms began after heavy lifting.\n\u2022 Neck movement is normal and axial maneuvers do not worsen symptoms.\n\nStep 2: Analyzing the clinical findings\n\u2022 Loss of sensation on the lateral forearm is typically supplied by the lateral antebrachial cutaneous nerve, which is the terminal branch of the musculocutaneous nerve.\n\u2022 Because the thumb (a region supplied by the median nerve) has intact sensation, the median nerve is likely not involved.\n\u2022 The absence of neck symptoms makes a cervical radiculopathy less likely.\n\nStep 3: Determining the affected nerve and associated motor deficits\n\u2022 The musculocutaneous nerve innervates muscles that flex the elbow\u2014primarily the biceps brachii and brachialis\u2014and also aids in forearm supination.\n\u2022 Injury or irritation of this nerve (likely related to his heavy lifting activity) would therefore present with weakness in elbow flexion.\n\nStep 4: Eliminating incorrect choices\nA. Elbow flexion \u2013 Involves muscles innervated by the musculocutaneous nerve. (Correct)\nB. Forearm pronation \u2013 Involves the pronator teres and pronator quadratus, which are innervated by the median nerve.\nC. Index finger flexion \u2013 Involves the flexor digitorum superficialis and profundus (median and ulnar nerves involved).\nD. Wrist extension \u2013 Involves muscles innervated by the radial nerve.\n\nFinal Answer: A. Elbow flexion"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Key information from the question\n\u2022 The patient has numbness/tingling on the lateral side of the right forearm.\n\u2022 Sensation over the thumb is intact.\n\u2022 Symptoms began after heavy lifting.\n\u2022 Neck movement is normal and axial maneuvers do not worsen symptoms.\n\nStep 2: Analyzing the clinical findings\n\u2022 Loss of sensation on the lateral forearm is typically supplied by the lateral antebrachial cutaneous nerve, which is the terminal branch of the musculocutaneous nerve.\n\u2022 Because the thumb (a region supplied by the median nerve) has intact sensation, the median nerve is likely not involved.\n\u2022 The absence of neck symptoms makes a cervical radiculopathy less likely.\n\nStep 3: Determining the affected nerve and associated motor deficits\n\u2022 The musculocutaneous nerve innervates muscles that flex the elbow\u2014primarily the biceps brachii and brachialis\u2014and also aids in forearm supination.\n\u2022 Injury or irritation of this nerve (likely related to his heavy lifting activity) would therefore present with weakness in elbow flexion.\n\nStep 4: Eliminating incorrect choices\nA. Elbow flexion \u2013 Involves muscles innervated by the musculocutaneous nerve. (Correct)\nB. Forearm pronation \u2013 Involves the pronator teres and pronator quadratus, which are innervated by the median nerve.\nC. Index finger flexion \u2013 Involves the flexor digitorum superficialis and profundus (median and ulnar nerves involved).\nD. Wrist extension \u2013 Involves muscles innervated by the radial nerve.\n\nFinal Answer: A. Elbow flexion"
    },
    {
        "realidx": 480,
        "question": "A 17-year-old girl is brought to the pediatrician by her father for evaluation. He is concerned that she has not undergone puberty yet, while all of her classmates at school have. The patient herself feels well overall, with no specific complaints. Examination shows vital signs of T 98.9, HR 71, and BP 137/92. The physician notes undeveloped breasts and normal external and internal female genitalia in Tanner I stage of development. Her body mass index is within normal limits, she is in the 40th percentile for height, and she is agreeable and pleasant during the interview. Which of the following additional findings is likely present in this patient?",
        "answer": "Hypokalemia",
        "options": {
            "A": "Aromatase enzyme deficiency",
            "B": "Hypokalemia",
            "C": "XY karyotype",
            "D": "Hypercortisolism"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old girl",
            "brought",
            "pediatrician",
            "father",
            "evaluation",
            "concerned",
            "not",
            "puberty",
            "classmates",
            "school",
            "patient",
            "feels well overall",
            "specific complaints",
            "Examination shows vital signs",
            "98",
            "71",
            "BP",
            "physician notes",
            "breasts",
            "normal external",
            "internal",
            "Tanner",
            "development",
            "body mass index",
            "normal limits",
            "percentile",
            "height",
            "pleasant",
            "interview",
            "following additional findings",
            "likely present",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 6009,
            "completion_tokens": 8663
        },
        "time_elapsed": 59.1361448764801,
        "raw_responses": [
            "Step 1: Identify key features of the case.\n\u2022 A 17\u2010year\u2013old girl presents with absent pubertal development (Tanner stage I breasts), yet she has normal \u201cinternal and external female genitalia.\u201d\n\u2022 Her blood pressure is high (137/92 mmHg) for her age.\n\u2022 There are no systemic symptoms, and her BMI and height are normal.\n\nStep 2: Consider conditions that cause lack of secondary sexual development in a genetic female with normal female anatomy.\n\u2022 In congenital adrenal hyperplasias, such as 21\u2010hydroxylase deficiency, females typically are virilized and may present with ambiguous genitalia.\n\u2022 In aromatase deficiency, 46,XX infants frequently have ambiguous genitalia (virilization) and may have maternal virilization during pregnancy.\n\u2022 In complete androgen insensitivity syndrome (XY), patients have normal breast development from peripheral aromatization and lack internal female structures (ie, no uterus).\n\u2022 In 17\u2010hydroxylase deficiency, there is an inability to produce cortisol and sex steroids, leading to sexual infantilism and lack of pubertal development. However, the enzyme deficiency shunts steroidogenesis toward mineralocorticoid production, producing hypertension and hypokalemia in affected individuals.\n\nStep 3: Compare the patient\u2019s findings with the options.\nA. Aromatase enzyme deficiency \u2013 Would more likely cause virilization (ambiguous genitalia) due to excess androgens. Not consistent with normal female genitalia.\nB. Hypokalemia \u2013 A key feature of 17\u2010hydroxylase deficiency, which also explains absent pubertal development and hypertension.\nC. XY karyotype \u2013 Seen in complete androgen insensitivity syndrome, but these individuals have developed breasts and lack a uterus.\nD. Hypercortisolism \u2013 Would present with signs of Cushing syndrome (eg, weight gain, striae), not with absent puberty and hypertension.\n\nStep 4: Final Answer.\nThe additional finding most likely present in this patient is hypokalemia.\n\nFinal answer: B. Hypokalemia",
            "Step 1: Analyze the clinical information. The patient is a 17\u2010year\u2010old female with delayed puberty (no breast development, Tanner I) but with otherwise normal development of internal and external female genitalia. Her BMI is normal, and her height is within the normal percentile. A mildly elevated blood pressure (137/92 mm Hg) is noted.\n\nStep 2: Evaluate the options.\n\n\u2022 Aromatase enzyme deficiency: Aromatase is responsible for converting androgens to estrogens. In its deficiency, the patient cannot produce enough estrogen, leading to a lack of breast development (Tanner I), while her internal and external genitalia remain female. In addition, the unconverted androgens may cause a relative virilization and can be associated with hypertension. This fits the clinical picture.\n\n\u2022 Hypokalemia: This is typically seen in conditions such as primary hyperaldosteronism or other electrolyte disturbances, not a cause of delayed puberty and absent breast development in this context.\n\n\u2022 XY karyotype: Conditions like complete androgen insensitivity syndrome (CAIS) occur in individuals with an XY karyotype. However, in CAIS, patients develop breasts due to peripheral conversion of androgens to estrogen, and they lack a uterus. This is inconsistent with our patient\u2019s findings.\n\n\u2022 Hypercortisolism: While Cushing syndrome can cause several systemic effects including high blood pressure, it usually presents with weight gain, abnormal fat distribution, and other cushingoid features. There is no specific association with absent breast development in females.\n\nStep 3: Conclusion\nGiven the lack of estrogen (resulting in no breast development), the presence of normal female genitalia, and the potential for hypertension secondary to excess androgens that aren\u2019t converted, aromatase enzyme deficiency is the most likely additional finding.\n\nFinal answer: A. Aromatase enzyme deficiency.",
            "Step 1: Analyze the patient\u2019s presentation.\n\u2022 A 17\u2010year-old female presents with primary amenorrhea and absent secondary sexual characteristics (Tanner stage I breasts).\n\u2022 She has normal internal and external female genitalia.\n\u2022 Vital signs reveal a slightly elevated blood pressure (137/92), which is unusual for her age.\n\u2022 Her BMI and height are normal (40th percentile for height).\n\nStep 2: Recognize that absent breast development indicates estrogen deficiency.\n\u2022 In a female with normal genital anatomy, estrogen is normally responsible for breast development and the progression of other secondary sexual characteristics.\n\u2022 An enzymatic defect that prevents estrogen synthesis is one possible explanation.\n\nStep 3: Evaluate the answer choices.\nA. Aromatase enzyme deficiency\n\u2003\u2003\u2013 Aromatase normally converts androgens to estrogens. A deficiency leads to estrogen deficiency, causing absent breast development and primary amenorrhea.\n\u2003\u2003\u2013 The resulting unopposed androgens may cause signs of virilization (which might subtly affect the patient) and are also associated with hypertension.\n\u2003\u2003\u2013 Although many patients with aromatase deficiency may show ambiguous genitalia at birth due to androgen excess, some may have minimally affected external genitalia while still failing to develop secondary sexual characteristics.\nB. Hypokalemia\n\u2003\u2003\u2013 Hypokalemia is not directly associated with delayed puberty or estrogen deficiency.\nC. XY karyotype\n\u2003\u2003\u2013 A patient with complete androgen insensitivity syndrome (XY karyotype) would typically have developed breasts due to peripheral conversion of testosterone to estrogen, but would lack a uterus.\nD. Hypercortisolism\n\u2003\u2003\u2013 Hypercortisolism (Cushing syndrome) does not cause absent sexual development in this manner, and would be associated with other features (e.g., weight gain, striae).\n\nStep 4: Final Reasoning\nThe findings in the vignette\u2014primary amenorrhea, lack of breast development, and slightly elevated blood pressure\u2014are most consistent with estrogen deficiency secondary to an aromatase enzyme deficiency.\n\nFinal Answer: A. Aromatase enzyme deficiency"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Identify key features of the case.\n\u2022 A 17\u2010year\u2013old girl presents with absent pubertal development (Tanner stage I breasts), yet she has normal \u201cinternal and external female genitalia.\u201d\n\u2022 Her blood pressure is high (137/92 mmHg) for her age.\n\u2022 There are no systemic symptoms, and her BMI and height are normal.\n\nStep 2: Consider conditions that cause lack of secondary sexual development in a genetic female with normal female anatomy.\n\u2022 In congenital adrenal hyperplasias, such as 21\u2010hydroxylase deficiency, females typically are virilized and may present with ambiguous genitalia.\n\u2022 In aromatase deficiency, 46,XX infants frequently have ambiguous genitalia (virilization) and may have maternal virilization during pregnancy.\n\u2022 In complete androgen insensitivity syndrome (XY), patients have normal breast development from peripheral aromatization and lack internal female structures (ie, no uterus).\n\u2022 In 17\u2010hydroxylase deficiency, there is an inability to produce cortisol and sex steroids, leading to sexual infantilism and lack of pubertal development. However, the enzyme deficiency shunts steroidogenesis toward mineralocorticoid production, producing hypertension and hypokalemia in affected individuals.\n\nStep 3: Compare the patient\u2019s findings with the options.\nA. Aromatase enzyme deficiency \u2013 Would more likely cause virilization (ambiguous genitalia) due to excess androgens. Not consistent with normal female genitalia.\nB. Hypokalemia \u2013 A key feature of 17\u2010hydroxylase deficiency, which also explains absent pubertal development and hypertension.\nC. XY karyotype \u2013 Seen in complete androgen insensitivity syndrome, but these individuals have developed breasts and lack a uterus.\nD. Hypercortisolism \u2013 Would present with signs of Cushing syndrome (eg, weight gain, striae), not with absent puberty and hypertension.\n\nStep 4: Final Answer.\nThe additional finding most likely present in this patient is hypokalemia.\n\nFinal answer: B. Hypokalemia"
    },
    {
        "realidx": 483,
        "question": "A 40-year-old man presents to the emergency department with altered mental status. He has a history of cirrhosis of the liver secondary to alcoholism. He started becoming more confused a few days ago and it has been getting gradually worse. His temperature is 98.8\u00b0F (37.1\u00b0C), blood pressure is 134/90 mmHg, pulse is 83/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals a distended abdomen that is non-tender. Neurological exam is notable for a confused patient and asterixis. Laboratory values are ordered as seen below.\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 3.3 mEq/L\nHCO3-: 22 mEq/L\nBUN: 20 mg/dL\nGlucose: 59 mg/dL\nCreatinine: 1.1 mg/dL\nCa2+: 10.2 mg/dL\n\nWhich of the following is the best next treatment for this patient?",
        "answer": "Potassium",
        "options": {
            "A": "Dextrose",
            "B": "Lactulose",
            "C": "Potassium",
            "D": "Rifaximin"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "40 year old man presents",
            "emergency department",
            "altered mental status",
            "history of cirrhosis",
            "liver secondary to alcoholism",
            "started",
            "more confused",
            "few days",
            "getting",
            "worse",
            "temperature",
            "98",
            "blood pressure",
            "90 mmHg",
            "pulse",
            "83 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "Physical exam reveals",
            "distended abdomen",
            "non-tender",
            "Neurological exam",
            "notable",
            "confused patient",
            "asterixis",
            "Laboratory values",
            "ordered",
            "seen",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "3.3 mEq/L HCO3",
            "mEq/L",
            "20 mg/dL Glucose",
            "59 mg/dL Creatinine",
            "1.1 mg/dL Ca2",
            "10",
            "mg/dL",
            "following",
            "best next treatment",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4812,
            "completion_tokens": 2648
        },
        "time_elapsed": 22.18083095550537,
        "raw_responses": [
            "Step 1: The patient\u2019s presentation (cirrhosis, ascites, confusion, asterixis) strongly suggests hepatic encephalopathy.\n\nStep 2: Consider the treatment options:\n\u2022 Dextrose \u2013 While his blood glucose (59 mg/dL) is on the lower side, his symptoms are more indicative of hepatic encephalopathy rather than solely hypoglycemia.\n\u2022 Lactulose \u2013 This is the mainstay treatment for hepatic encephalopathy, working to reduce ammonia absorption from the colon.\n\u2022 Potassium \u2013 His potassium is low (3.3 mEq/L) and would eventually need to be addressed, but it is not the primary treatment for his encephalopathy.\n\u2022 Rifaximin \u2013 Typically used as an adjunct to lactulose in managing hepatic encephalopathy, not as the initial treatment.\n\nStep 3: The best initial treatment for his condition is to start lactulose.\n\nFinal Answer: B. Lactulose",
            "Step 1: The patient\u2019s history of cirrhosis and his current symptoms, including confusion and asterixis, are strongly suggestive of hepatic encephalopathy.\n\nStep 2: Evaluating the options:\n\u2022 Dextrose is used for treating hypoglycemia; although his glucose is slightly low (59 mg/dL), this level is not likely the primary cause of his altered mental status.\n\u2022 Lactulose is the first-line treatment for hepatic encephalopathy, working by lowering ammonia levels.\n\u2022 Potassium, while low at 3.3 mEq/L, is not the immediate treatment for his mental status changes.\n\u2022 Rifaximin can be used as an adjunct to lactulose, but it is not the initial treatment choice.\n\nStep 3: The best next treatment for this patient, given his presentation and history, is lactulose.\n\nFinal Answer: B. Lactulose",
            "Step 1: Review the patient's presentation. This 40-year-old man with a history of cirrhosis presents with altered mental status and physical exam findings (confusion and asterixis) that are highly consistent with hepatic encephalopathy. His abdominal exam shows a distended but non-tender abdomen, supportive of cirrhosis with ascites.\n\nStep 2: Analyze the laboratory values. Although his potassium is low (3.3 mEq/L) and his glucose is slightly low (59 mg/dL), his presentation is most concerning for hepatic encephalopathy rather than hypoglycemia or electrolyte imbalance being the sole problem.\n\nStep 3: Consider the treatment options.\n\u2022 Option A (Dextrose): While his glucose is mildly low, it is not critically low, and dextrose would not address the primary issue.\n\u2022 Option C (Potassium): Correcting his hypokalemia can help improve encephalopathy, but it is not the primary treatment.\n\u2022 Option D (Rifaximin): This is an adjunctive therapy to lactulose, typically added if lactulose alone is insufficient.\n\u2022 Option B (Lactulose): Lactulose is considered the first-line treatment for hepatic encephalopathy as it works to lower ammonia levels by acidifying the colon and trapping ammonia in the stool.\n\nStep 4: Final Answer\nThe best next treatment for this patient is B. Lactulose."
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Review the patient's presentation. This 40-year-old man with a history of cirrhosis presents with altered mental status and physical exam findings (confusion and asterixis) that are highly consistent with hepatic encephalopathy. His abdominal exam shows a distended but non-tender abdomen, supportive of cirrhosis with ascites.\n\nStep 2: Analyze the laboratory values. Although his potassium is low (3.3 mEq/L) and his glucose is slightly low (59 mg/dL), his presentation is most concerning for hepatic encephalopathy rather than hypoglycemia or electrolyte imbalance being the sole problem.\n\nStep 3: Consider the treatment options.\n\u2022 Option A (Dextrose): While his glucose is mildly low, it is not critically low, and dextrose would not address the primary issue.\n\u2022 Option C (Potassium): Correcting his hypokalemia can help improve encephalopathy, but it is not the primary treatment.\n\u2022 Option D (Rifaximin): This is an adjunctive therapy to lactulose, typically added if lactulose alone is insufficient.\n\u2022 Option B (Lactulose): Lactulose is considered the first-line treatment for hepatic encephalopathy as it works to lower ammonia levels by acidifying the colon and trapping ammonia in the stool.\n\nStep 4: Final Answer\nThe best next treatment for this patient is B. Lactulose."
    },
    {
        "realidx": 485,
        "question": "A 35-year-old woman presents to the physician because of episodes of difficulty swallowing for the past 3 months. She feels solid food getting stuck in her chest behind the sternum. She does not have any issues with liquids. She has no coughing or nasal regurgitation. She has no hoarseness or weight loss. She reports occasional heartburn that has lasted for about a year. Her past medical history is significant for asthma and eczema. She has no history of any serious illness and takes no medications. Her vital signs are within normal limits. Physical examination shows no abnormal findings. An endoscopic image of the esophagus is shown. Mucosal biopsy shows eosinophilic infiltration. Which of the following is the most appropriate pharmacotherapy at this time?",
        "answer": "Omeprazole",
        "options": {
            "A": "Budesonide",
            "B": "Fluconazole",
            "C": "Nitroglycerin",
            "D": "Omeprazole"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "35 year old woman presents",
            "physician",
            "of episodes",
            "difficulty swallowing",
            "past 3 months",
            "feels solid food getting",
            "chest",
            "sternum",
            "not",
            "issues",
            "liquids",
            "coughing",
            "nasal regurgitation",
            "hoarseness",
            "weight loss",
            "reports occasional heartburn",
            "lasted",
            "year",
            "past medical history",
            "significant",
            "asthma",
            "eczema",
            "history",
            "serious illness",
            "takes",
            "medications",
            "vital signs",
            "normal",
            "Physical examination shows",
            "abnormal findings",
            "endoscopic image of",
            "esophagus",
            "shown",
            "Mucosal biopsy shows eosinophilic infiltration",
            "following",
            "most appropriate pharmacotherapy",
            "time"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4941,
            "completion_tokens": 3878
        },
        "time_elapsed": 31.705809831619263,
        "raw_responses": [
            "Step 1: This patient\u2019s symptoms of dysphagia to solids together with a history of allergic conditions (asthma and eczema) and endoscopic/microscopic findings of eosinophilic infiltration are classic for eosinophilic esophagitis (EoE).\n\nStep 2: In EoE, current guidelines recommend a trial of proton pump inhibitor (PPI) therapy as initial management. A PPI, such as omeprazole, not only treats reflux, which can be associated with EoE-like changes, but also can help distinguish between PPI-responsive esophageal eosinophilia and true EoE.\n\nStep 3: Among the answer choices:\n\u2022 Budesonide is a topical corticosteroid used if symptoms persist despite PPIs.\n\u2022 Fluconazole is an antifungal used for candida esophagitis.\n\u2022 Nitroglycerin is used for esophageal spasms.\n\u2022 Omeprazole is the optimal first-line pharmacotherapy.\n\nFinal Answer: Omeprazole",
            "Step 1: Identify Key Details\n\u2022 The patient is a 35-year-old woman with intermittent dysphagia for solids (but not liquids), a history of allergic conditions (asthma and eczema), and occasional heartburn.\n\u2022 Endoscopy and biopsy reveal eosinophilic infiltration, which is consistent with eosinophilic esophagitis (EoE).\n\nStep 2: Consider Treatment Options for Eosinophilic Esophagitis\n\u2022 Initial management of EoE typically begins with a trial of a proton pump inhibitor (PPI), such as omeprazole. A PPI trial can help reduce inflammation and also distinguish PPI-responsive esophageal eosinophilia from true EoE.\n\u2022 If symptoms do not improve with PPI therapy, the next step is usually to add swallowed topical steroids (such as budesonide).\n\nStep 3: Evaluate the Options\nA. Budesonide \u2013 Often used if a patient does not respond to PPI therapy. Not typically the first-line option.\nB. Fluconazole \u2013 An antifungal medication, not indicated in EoE.\nC. Nitroglycerin \u2013 A smooth muscle relaxant, used for conditions like esophageal spasm; not applicable here.\nD. Omeprazole \u2013 A PPI, which is the preferred initial treatment for suspected eosinophilic esophagitis.\n\nFinal Answer: D. Omeprazole",
            "Step 1: Analyze the patient's presentation.  \n\u2022 The patient is a 35-year-old woman with a 3-month history of dysphagia for solid foods.  \n\u2022 There is a history of occasional heartburn lasting about a year, and the biopsy reveals eosinophilic infiltration.\n\nStep 2: Consider the diagnosis.  \n\u2022 The combination of solid food dysphagia and biopsy findings is consistent with eosinophilic esophagitis (EoE).  \n\u2022 EoE is an inflammatory condition characterized by eosinophilic infiltration of the esophageal mucosa, often leading to symptoms like dysphagia and food impaction.\n\nStep 3: Evaluate the provided treatment options.  \nA. Budesonide \u2013 A topical corticosteroid used to treat EoE but is typically reserved for patients who do not respond to initial therapy with proton pump inhibitors (PPIs).  \nB. Fluconazole \u2013 An antifungal medication, which is not indicated for EoE.  \nC. Nitroglycerin \u2013 Primarily used for esophageal spasm, which is not consistent with this presentation.  \nD. Omeprazole \u2013 A proton pump inhibitor; it is the first-line treatment in EoE because a trial of PPI therapy can help both diagnose and treat PPI-responsive esophageal eosinophilia, which overlaps with EoE.\n\nStep 4: Conclude the best treatment choice.  \nSince the patient\u2019s presentation is most consistent with eosinophilic esophagitis, and initial management typically involves a trial of PPI therapy, the most appropriate pharmacotherapy at this time is Omeprazole.\n\nFinal Answer: D. Omeprazole"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Identify Key Details\n\u2022 The patient is a 35-year-old woman with intermittent dysphagia for solids (but not liquids), a history of allergic conditions (asthma and eczema), and occasional heartburn.\n\u2022 Endoscopy and biopsy reveal eosinophilic infiltration, which is consistent with eosinophilic esophagitis (EoE).\n\nStep 2: Consider Treatment Options for Eosinophilic Esophagitis\n\u2022 Initial management of EoE typically begins with a trial of a proton pump inhibitor (PPI), such as omeprazole. A PPI trial can help reduce inflammation and also distinguish PPI-responsive esophageal eosinophilia from true EoE.\n\u2022 If symptoms do not improve with PPI therapy, the next step is usually to add swallowed topical steroids (such as budesonide).\n\nStep 3: Evaluate the Options\nA. Budesonide \u2013 Often used if a patient does not respond to PPI therapy. Not typically the first-line option.\nB. Fluconazole \u2013 An antifungal medication, not indicated in EoE.\nC. Nitroglycerin \u2013 A smooth muscle relaxant, used for conditions like esophageal spasm; not applicable here.\nD. Omeprazole \u2013 A PPI, which is the preferred initial treatment for suspected eosinophilic esophagitis.\n\nFinal Answer: D. Omeprazole"
    },
    {
        "realidx": 497,
        "question": "A 29-year-old woman presents to the physician with a blurred vision of her right eye for 2 days. She has pain around her right eye during eye movement. She takes no medications. At the clinic, her blood pressure is 110/70 mm Hg, the pulse is 72/min, respirations are 15/min, and the temperature is 36.5\u2103 (97.7\u2109). On physical examination, illumination of the left eye results in bilateral pupillary constriction while illumination of the right eye results in a mild bilateral pupillary dilation. Fundoscopic examination shows optic disk swelling in the right eye. The color vision test shows decreased perception in the right eye. The remainder of the physical examination shows no abnormalities. Specific additional history should be obtained regarding which of the following?",
        "answer": "Sensory loss",
        "options": {
            "A": "Dry eyes",
            "B": "High-risk sexual behaviour",
            "C": "Oral ulcers",
            "D": "Sensory loss"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "29 year old woman presents",
            "physician",
            "blurred vision",
            "right eye",
            "2 days",
            "pain around",
            "right eye",
            "eye movement",
            "takes",
            "medications",
            "clinic",
            "blood pressure",
            "70 mm Hg",
            "pulse",
            "72 min",
            "respirations",
            "min",
            "temperature",
            "36",
            "97",
            "physical examination",
            "illumination",
            "left eye results",
            "bilateral pupillary constriction",
            "illumination",
            "right eye results",
            "mild bilateral pupillary",
            "Fundoscopic examination shows optic disk swelling",
            "right eye",
            "color vision test shows decreased perception",
            "right eye",
            "physical examination shows",
            "abnormalities",
            "Specific additional history",
            "obtained",
            "following"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4566,
            "completion_tokens": 4040
        },
        "time_elapsed": 631.8796033859253,
        "raw_responses": [
            "Step 1: Analyze the clinical picture. The patient is a young woman with blurred vision, eye pain on movement, decreased color perception, and an afferent pupillary defect. These findings suggest a diagnosis of optic neuritis.\n\nStep 2: Link optic neuritis with potential underlying conditions. In young women, optic neuritis is most commonly associated with multiple sclerosis (MS). MS typically presents with other neurological symptoms as well, such as sensory deficits (e.g., numbness or tingling), weakness, or motor problems.\n\nStep 3: Evaluate the options:\n\u2022 Dry eyes (Option A) aren\u2019t typically linked to optic neuritis or MS.\n\u2022 High-risk sexual behavior (Option B) is generally considered in the evaluation of infectious causes such as syphilis or HIV, which are less likely here given the presentation.\n\u2022 Oral ulcers (Option C) might relate to conditions like Beh\u00e7et\u2019s disease, but Beh\u00e7et\u2019s usually causes uveitis rather than optic neuritis.\n\u2022 Sensory loss (Option D) is a common symptom in multiple sclerosis, which is closely associated with optic neuritis.\n\nFinal Answer: D. Sensory loss\n\nThus, obtaining a detailed history regarding any sensory deficits would be important in a patient who presents in this manner, given the strong association between optic neuritis and multiple sclerosis.",
            "Step 1: Recognize that the patient's presentation\u2014blurred vision, eye pain exacerbated by movement, decreased color perception, optic disk swelling, and an abnormal pupillary response\u2014is most consistent with optic neuritis.\n\nStep 2: Understand that optic neuritis is frequently associated with multiple sclerosis (MS), a demyelinating disorder of the central nervous system.\n\nStep 3: Recall that MS often presents with other neurological symptoms, including sensory deficits such as numbness or tingling. Therefore, obtaining additional history regarding sensory loss would help evaluate for further neurological involvement.\n\nStep 4: Evaluate the answer choices:\n\u2022 Dry eyes (A) is more typically associated with conditions like Sj\u00f6gren syndrome.\n\u2022 High-risk sexual behavior (B) could raise concerns for infections such as neurosyphilis, but the presentation fits optic neuritis due to demyelination rather than infection.\n\u2022 Oral ulcers (C) might suggest autoimmune conditions like Behcet disease, but these are less likely here.\n\u2022 Sensory loss (D) aligns with potential additional manifestations of multiple sclerosis.\n\nFinal Answer: Sensory loss",
            "Step 1: The patient's symptoms of blurred vision, pain with eye movement, decreased color vision, and an afferent pupillary defect (as evidenced by the abnormal pupillary responses during illumination) are highly suggestive of optic neuritis.\n\nStep 2: Optic neuritis is commonly associated with multiple sclerosis (MS), a demyelinating disease of the central nervous system. Key additional histories to evaluate in someone with suspected MS include previous episodes of neurological deficits, particularly sensory loss or motor weakness. \n\nStep 3: Reviewing the answer choices:\n\u2022 Dry eyes \u2013 More typically associated with Sj\u00f6gren\u2019s syndrome; not immediately indicated.\n\u2022 High-risk sexual behavior \u2013 Might be relevant for infectious causes of ocular complications (such as syphilis), but the clinical picture here better fits optic neuritis related to MS.\n\u2022 Oral ulcers \u2013 Seen in conditions like Beh\u00e7et's disease, though this is less likely given the described findings.\n\u2022 Sensory loss \u2013 A common sign in MS and would be important to inquire about.\n\nFinal Answer: D. Sensory loss"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1"
        ],
        "final_solution": "Step 1: The patient's symptoms of blurred vision, pain with eye movement, decreased color vision, and an afferent pupillary defect (as evidenced by the abnormal pupillary responses during illumination) are highly suggestive of optic neuritis.\n\nStep 2: Optic neuritis is commonly associated with multiple sclerosis (MS), a demyelinating disease of the central nervous system. Key additional histories to evaluate in someone with suspected MS include previous episodes of neurological deficits, particularly sensory loss or motor weakness. \n\nStep 3: Reviewing the answer choices:\n\u2022 Dry eyes \u2013 More typically associated with Sj\u00f6gren\u2019s syndrome; not immediately indicated.\n\u2022 High-risk sexual behavior \u2013 Might be relevant for infectious causes of ocular complications (such as syphilis), but the clinical picture here better fits optic neuritis related to MS.\n\u2022 Oral ulcers \u2013 Seen in conditions like Beh\u00e7et's disease, though this is less likely given the described findings.\n\u2022 Sensory loss \u2013 A common sign in MS and would be important to inquire about.\n\nFinal Answer: D. Sensory loss"
    },
    {
        "realidx": 499,
        "question": "A 30-year-old male presents to his primary care physician complaining of infertility. He and his wife have been trying to get pregnant for the past two years. They have used fertility monitors and other aids without success. A hysterosalpingogram in his wife was normal. The patient has a history of cleft lip and recurrent upper respiratory infections as a child. He was briefly hospitalized for severe pneumonia when he was 9-years-old. His temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 120/85 mmHg, pulse is 90/min, and respirations are 18/min. On examination, he is a healthy-appearing male in no acute distress with fully developed reproductive organs. Notably, cardiac auscultation is silent in the left 5th intercostal space at the midclavicular line. This patient most likely has a mutation in which of the following classes of proteins?",
        "answer": "Retrograde cytoskeletal motor protein",
        "options": {
            "A": "Microtubule monomeric protein",
            "B": "Transmembrane ion channel protein",
            "C": "Retrograde cytoskeletal motor protein",
            "D": "Anterograde cytoskeletal motor protein"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "30 year old male presents",
            "primary care physician",
            "infertility",
            "wife",
            "to",
            "pregnant",
            "past two years",
            "used fertility monitors",
            "aids",
            "success",
            "hysterosalpingogram",
            "wife",
            "normal",
            "patient",
            "history of cleft lip",
            "recurrent upper respiratory infections",
            "child",
            "hospitalized",
            "severe pneumonia",
            "years old",
            "temperature",
            "98",
            "blood pressure",
            "85 mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "examination",
            "healthy appearing male",
            "acute distress",
            "reproductive organs",
            "cardiac auscultation",
            "silent",
            "left 5th intercostal space",
            "midclavicular line",
            "patient",
            "likely",
            "a mutation",
            "following classes",
            "proteins"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5283,
            "completion_tokens": 4404
        },
        "time_elapsed": 34.07132434844971,
        "raw_responses": [
            "Step 1: Key clinical features in this patient include male infertility, a history of cleft lip, recurrent upper respiratory infections, and the absence of a normal heart auscultation finding (suggesting dextrocardia). These findings point to Kartagener syndrome, a subset of primary ciliary dyskinesia (PCD).\n\nStep 2: Kartagener syndrome is caused by a defect in the dynein arms of cilia. Dynein is a cytoskeletal motor protein that generates the movement of cilia by facilitating microtubule sliding. In the context of intraflagellar transport, dynein operates in the retrograde direction.\n\nStep 3: With the options provided:\n\u2022 Option A (Microtubule monomeric protein) relates to tubulin, not the motor protein in cilia.\n\u2022 Option B (Transmembrane ion channel protein) is unrelated.\n\u2022 Option C (Retrograde cytoskeletal motor protein) correctly describes dynein, which is involved in intraflagellar transport and is the type of motor protein that is mutated in Kartagener syndrome.\n\u2022 Option D (Anterograde cytoskeletal motor protein) would refer to kinesin, not dynein.\n\nFinal answer: C. Retrograde cytoskeletal motor protein",
            "Step 1: Recognize the clinical clues. The patient has a history of recurrent upper respiratory infections, a childhood history of severe pneumonia, and a congenital defect (cleft lip). On exam, his cardiac auscultation is silent at the normal apex location, suggesting dextrocardia. Additionally, infertility in a male with normal external genitalia points to possible immotile sperm. These findings are classic for Kartagener syndrome (a subset of primary ciliary dyskinesia).\n\nStep 2: Understand the underlying defect. Kartagener syndrome results from a mutation affecting the dynein arms of cilia. Dynein arms are motor proteins responsible for the movement of cilia and flagella. A defect in these proteins results in ineffective ciliary motion, leading to the observed clinical symptoms.\n\nStep 3: Compare the options.\n\u2022 Option A (Microtubule monomeric protein) is not the defect seen in primary ciliary dyskinesia.\n\u2022 Option B (Transmembrane ion channel protein) also does not account for the dysfunction of dynein arms.\n\u2022 Option C (Retrograde cytoskeletal motor protein) describes dynein, which is responsible for the proper movement of cilia and is the mutated protein in this syndrome.\n\u2022 Option D (Anterograde cytoskeletal motor protein) refers to kinesin, which is not implicated in this condition.\n\nFinal Answer: C. Retrograde cytoskeletal motor protein",
            "Step 1: Review the clinical clues. The patient is a 30-year-old male with infertility. His history includes cleft lip and recurrent respiratory infections (including pneumonia), and on exam, there is a silent cardiac auscultation on the left side (suggesting dextrocardia). This constellation of findings (infertility, recurrent respiratory infections, and situs inversus) is characteristic of Kartagener syndrome (a subset of primary ciliary dyskinesia).\n\nStep 2: Link to the molecular defect. Kartagener syndrome is caused by a defect in the dynein arms of cilia. Dynein arms are motor proteins that are responsible for the proper movement of cilia. Specifically, these motor proteins move toward the minus end of microtubules, which classifies them as retrograde cytoskeletal motor proteins.\n\nStep 3: Compare the options. \n\u2022 Option A: Microtubule monomeric protein \u2013 This refers to proteins like tubulin, not the motor proteins.\n\u2022 Option B: Transmembrane ion channel protein \u2013 Not relevant to the function of cilia in Kartagener syndrome.\n\u2022 Option C: Retrograde cytoskeletal motor protein \u2013 This correlates with the dynein arms, which are affected in Kartagener syndrome.\n\u2022 Option D: Anterograde cytoskeletal motor protein \u2013 This would be more in keeping with kinesin, not the affected protein in this syndrome.\n\nFinal Answer: C. Retrograde cytoskeletal motor protein."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Review the clinical clues. The patient is a 30-year-old male with infertility. His history includes cleft lip and recurrent respiratory infections (including pneumonia), and on exam, there is a silent cardiac auscultation on the left side (suggesting dextrocardia). This constellation of findings (infertility, recurrent respiratory infections, and situs inversus) is characteristic of Kartagener syndrome (a subset of primary ciliary dyskinesia).\n\nStep 2: Link to the molecular defect. Kartagener syndrome is caused by a defect in the dynein arms of cilia. Dynein arms are motor proteins that are responsible for the proper movement of cilia. Specifically, these motor proteins move toward the minus end of microtubules, which classifies them as retrograde cytoskeletal motor proteins.\n\nStep 3: Compare the options. \n\u2022 Option A: Microtubule monomeric protein \u2013 This refers to proteins like tubulin, not the motor proteins.\n\u2022 Option B: Transmembrane ion channel protein \u2013 Not relevant to the function of cilia in Kartagener syndrome.\n\u2022 Option C: Retrograde cytoskeletal motor protein \u2013 This correlates with the dynein arms, which are affected in Kartagener syndrome.\n\u2022 Option D: Anterograde cytoskeletal motor protein \u2013 This would be more in keeping with kinesin, not the affected protein in this syndrome.\n\nFinal Answer: C. Retrograde cytoskeletal motor protein."
    },
    {
        "realidx": 501,
        "question": "A 36-year-old man undergoes open reduction and internal fixation of a left femur fracture sustained after a motor vehicle collision. Three days after the surgery, he develops fever and redness around the surgical site. His temperature is 39.5\u00b0C (103.1\u00b0F). Physical examination shows purulent discharge from the wound with erythema of the surrounding skin. Wound culture of the purulent discharge shows gram-positive cocci in clusters. Treatment with oral dicloxacillin is initiated. Four days later, the patient continues to have high-grade fever, pain, and purulent discharge. Which of the following characteristics of the infecting organism best explains the failure to improve with antibiotic therapy?",
        "answer": "Adaptation in binding proteins",
        "options": {
            "A": "Presence of an impenetrable outer membrane",
            "B": "Ability to cleave \u03b2-lactam rings",
            "C": "Development of efflux pumps",
            "D": "Adaptation in binding proteins"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "36 year old man",
            "open reduction",
            "internal fixation of",
            "left femur fracture sustained",
            "motor vehicle collision",
            "Three days",
            "surgery",
            "fever",
            "redness",
            "surgical site",
            "temperature",
            "Physical examination shows purulent discharge from",
            "wound",
            "erythema of",
            "surrounding skin",
            "Wound culture",
            "purulent discharge shows gram-positive cocci in clusters",
            "Treatment",
            "oral dicloxacillin",
            "initiated",
            "Four days later",
            "patient continues to",
            "high-grade fever",
            "pain",
            "purulent discharge",
            "following characteristics",
            "infecting organism best",
            "failure to",
            "antibiotic therapy"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5238,
            "completion_tokens": 3843
        },
        "time_elapsed": 31.706066846847534,
        "raw_responses": [
            "Step 1: The patient\u2019s wound culture reveals gram\u2010positive cocci in clusters, which is most consistent with an infection caused by Staphylococcus aureus. Dicloxacillin is a penicillinase\u2010resistant penicillin used against methicillin-sensitive Staph aureus (MSSA).\n\nStep 2: The patient's lack of improvement suggests that the infecting strain is not MSSA but rather methicillin\u2011resistant Staphylococcus aureus (MRSA). MRSA is resistant to beta-lactam antibiotics because it creates an altered penicillin-binding protein (PBP2a) with a low affinity for beta-lactam antibiotics, not because it cleaves beta-lactam rings.\n\nStep 3: Given the options:\n\u2022 Option A (Impenetrable outer membrane) is characteristic of gram\u2010negative bacteria.\n\u2022 Option B (Ability to cleave \u03b2-lactam rings) is a mechanism of most penicillinase-producing Staph aureus, but dicloxacillin is resistant to that mechanism.\n\u2022 Option C (Development of efflux pumps) is not associated with MRSA\u2019s resistance to beta-lactams.\n\u2022 Option D (Adaptation in binding proteins) correctly describes MRSA\u2019s mechanism of resistance via the modified penicillin-binding protein (PBP2a).\n\nFinal answer: D. Adaptation in binding proteins",
            "Step 1: Identify the organism and its role in antibiotic resistance.\n\u2022 The wound culture yielded gram\u2010positive cocci in clusters, which is consistent with Staphylococcus aureus.\n\u2022 Dicloxacillin is a penicillinase-resistant penicillin typically used to treat methicillin-sensitive S. aureus (MSSA).\n\nStep 2: Consider why the patient did not improve.\n\u2022 The patient's symptoms worsened despite appropriate initial therapy for MSSA. This suggests that the organism may be resistant to dicloxacillin.\n\u2022 Methicillin-resistant S. aureus (MRSA) is known to resist treatment with dicloxacillin.\n\u2022 MRSA achieves resistance by altering the target of the \u03b2-lactam antibiotics\u2014the penicillin binding proteins, specifically by encoding an altered protein (PBP2a) with decreased affinity for \u03b2-lactams.\n\nStep 3: Evaluate the options.\nA. Presence of an impenetrable outer membrane \u2013 This is a mechanism more typical of gram-negative bacteria.\nB. Ability to cleave \u03b2-lactam rings \u2013 While S. aureus can produce \u03b2-lactamases, dicloxacillin is specifically designed to resist these enzymes. Also, MRSA\u2019s resistance mechanism isn\u2019t primarily due to \u03b2-lactamase production.\nC. Development of efflux pumps \u2013 This mechanism is commonly associated with other antimicrobial resistances (e.g., tetracycline, macrolides) but is not the main strategy for MRSA.\nD. Adaptation in binding proteins \u2013 This is the mechanism by which MRSA alters its penicillin binding proteins (specifically PBP2a) to prevent effective binding of \u03b2-lactam antibiotics like dicloxacillin.\n\nFinal answer: D. Adaptation in binding proteins.",
            "Step 1: Identify the likely organism. The gram\u2010positive cocci in clusters suggest Staphylococcus aureus. In a postoperative wound infection, S. aureus is a common culprit.\n\nStep 2: Consider the antibiotic treatment. Dicloxacillin is a \u03b2-lactam antibiotic that is resistant to \u03b2-lactamase produced by Staph aureus. It works by binding to penicillin-binding proteins (PBPs) and inhibiting cell wall synthesis.\n\nStep 3: Recognize the failure to improve. Since the patient\u2019s symptoms persist despite the use of dicloxacillin, we must suspect that the organism has developed resistance to \u03b2-lactam antibiotics.\n\nStep 4: Understand the resistance mechanisms. Methicillin-resistant Staphylococcus aureus (MRSA) is resistant to \u03b2-lactam antibiotics because it synthesizes an altered penicillin-binding protein (PBP2a) with a low affinity for these drugs. This change is an adaptation in binding proteins, rendering the antibiotic ineffective.\n\nStep 5: Compare and eliminate incorrect options:\n\u2022 Option A (Presence of an impenetrable outer membrane) pertains to gram-negative bacteria.\n\u2022 Option B (Ability to cleave \u03b2-lactam rings) relates to \u03b2-lactamase production, but dicloxacillin is designed to resist typical \u03b2-lactamase degradation.\n\u2022 Option C (Development of efflux pumps) is a mechanism seen in other resistant bacteria but is not the primary resistance mechanism for MRSA.\n\u2022 Option D (Adaptation in binding proteins) directly describes the mechanism of MRSA resistance.\n\nFinal Answer: D. Adaptation in binding proteins"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: The patient\u2019s wound culture reveals gram\u2010positive cocci in clusters, which is most consistent with an infection caused by Staphylococcus aureus. Dicloxacillin is a penicillinase\u2010resistant penicillin used against methicillin-sensitive Staph aureus (MSSA).\n\nStep 2: The patient's lack of improvement suggests that the infecting strain is not MSSA but rather methicillin\u2011resistant Staphylococcus aureus (MRSA). MRSA is resistant to beta-lactam antibiotics because it creates an altered penicillin-binding protein (PBP2a) with a low affinity for beta-lactam antibiotics, not because it cleaves beta-lactam rings.\n\nStep 3: Given the options:\n\u2022 Option A (Impenetrable outer membrane) is characteristic of gram\u2010negative bacteria.\n\u2022 Option B (Ability to cleave \u03b2-lactam rings) is a mechanism of most penicillinase-producing Staph aureus, but dicloxacillin is resistant to that mechanism.\n\u2022 Option C (Development of efflux pumps) is not associated with MRSA\u2019s resistance to beta-lactams.\n\u2022 Option D (Adaptation in binding proteins) correctly describes MRSA\u2019s mechanism of resistance via the modified penicillin-binding protein (PBP2a).\n\nFinal answer: D. Adaptation in binding proteins"
    },
    {
        "realidx": 514,
        "question": "A 3-year-old girl is brought to the physician because of a 3-day history of fever, cough, purulent nasal discharge. She has experienced 7 similar episodes, each lasting 2\u20135 days in the previous 2 years. She has also had intermittent abdominal cramps and recurrent episodes of foul-smelling greasy diarrhea in the past year. She is at the 55th percentile for height and 35th percentile for weight. Her temperature is 38.9\u00b0C (102\u00b0F), pulse is 100/min, respirations are 24/min, and blood pressure is 110/60 mm Hg. Physical examination shows an erythematous oropharynx without exudate and tenderness over the frontoethmoidal sinuses. The abdomen is distended, nontender, and tympanitic to percussion. Bowel sounds are increased. Stool microscopy shows pear-shaped multi-flagellated organisms. This patient is at increased risk for which of the following?",
        "answer": "Anaphylactic transfusion reactions",
        "options": {
            "A": "Anaphylactic transfusion reactions",
            "B": "Cutaneous granulomas",
            "C": "Non-Hodgkin lymphoma",
            "D": "Disseminated tuberculosis"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "3 year old girl",
            "brought",
            "physician",
            "3-day history",
            "fever",
            "cough",
            "purulent nasal discharge",
            "experienced",
            "similar episodes",
            "lasting",
            "days",
            "previous 2 years",
            "intermittent abdominal cramps",
            "recurrent episodes of",
            "smelling greasy diarrhea",
            "past year",
            "percentile",
            "height",
            "percentile",
            "weight",
            "temperature",
            "pulse",
            "100 min",
            "respirations",
            "min",
            "blood pressure",
            "60 mm Hg",
            "Physical examination shows",
            "erythematous oropharynx",
            "exudate",
            "tenderness",
            "sinuses",
            "abdomen",
            "distended",
            "nontender",
            "tympanitic",
            "percussion",
            "Bowel sounds",
            "increased",
            "Stool microscopy shows pear-shaped multi flagellated organisms",
            "patient",
            "increased risk",
            "following"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5775,
            "completion_tokens": 6564
        },
        "time_elapsed": 45.12628126144409,
        "raw_responses": [
            "Step 1: Analyze the patient's presentation.\n\u2022 The 3\u2010year\u2010old girl has a history of recurrent respiratory infections (fever, cough, purulent nasal discharge, sinus tenderness) and gastrointestinal issues (abdominal cramps, foul\u2010smelling greasy diarrhea).\n\u2022 Stool microscopy shows pear\u2010shaped multi\u2010flagellated organisms, which is characteristic of Giardia lamblia.\n\u2022 The combination of recurrent sinopulmonary infections, pancreatic insufficiency (leading to malabsorption and steatorrhea), and susceptibility to Giardia reinforces a diagnosis of cystic fibrosis (CF).\n\nStep 2: Recognize the complication risks associated with cystic fibrosis.\n\u2022 CF is an autosomal recessive disorder caused by mutations in the CFTR gene. The thick secretions affect multiple organ systems.\n\u2022 In addition to pulmonary and GI complications, CF patients (especially those who eventually require lung transplantation and thus immunosuppression) are known to have an increased risk for certain malignancies.\n\u2022 Among the options provided, Non\u2010Hodgkin lymphoma is recognized as a potential complication in CF patients, particularly in the post\u2013transplant population.\n\nStep 3: Compare and eliminate the incorrect options.\nA. Anaphylactic transfusion reactions \u2013 These are more typically associated with IgA deficiency, not CF.\nB. Cutaneous granulomas \u2013 Seen in conditions like chronic granulomatous disease, not CF.\nD. Disseminated tuberculosis \u2013 Although the CF lung may be prone to infections, there\u2019s no direct predisposition to disseminated tuberculosis in CF.\n\nStep 4: Provide the final answer.\nThe patient with cystic fibrosis is at increased risk for Non\u2010Hodgkin lymphoma.\n\nFinal answer: C. Non\u2010Hodgkin lymphoma",
            "Step 1: Identify Key Findings\n\u2022 The patient is a 3-year-old with recurrent episodes of respiratory infections (fever, cough, purulent nasal discharge, sinus tenderness) and gastrointestinal issues (abdominal cramps, foul-smelling greasy diarrhea).\n\u2022 Stool microscopy reveals pear-shaped, multi-flagellated organisms, which is characteristic of Giardia lamblia.\n\u2022 These recurrent infections, especially with Giardia, raise concern for an immunodeficiency\u2014specifically selective IgA deficiency.\n\nStep 2: Understand the Association\n\u2022 Selective IgA deficiency is the most common primary immunodeficiency. It predisposes individuals to sinopulmonary infections and gastrointestinal infections (like giardiasis).\n\u2022 A well-known complication of selective IgA deficiency is an anaphylactic reaction to blood product transfusions because these patients may have developed anti-IgA antibodies that react when IgA is introduced.\n\nStep 3: Evaluate the Options\nA. Anaphylactic transfusion reactions \u2013 This is a known risk in patients with selective IgA deficiency.\nB. Cutaneous granulomas \u2013 Not typically an associated complication with selective IgA deficiency.\nC. Non-Hodgkin lymphoma \u2013 While some immunodeficiencies can increase lymphoma risk, it is not the specific increased risk seen in selective IgA deficiency.\nD. Disseminated tuberculosis \u2013 This is more related to defects in cell-mediated immunity, not selective IgA deficiency.\n\nStep 4: Final Answer\nThe patient is most at increased risk for Anaphylactic transfusion reactions.\n\nFinal answer: A",
            "Step 1: Gather the key clinical information. The 3-year-old girl presents with a history of recurrent respiratory infections (fever, cough, purulent nasal discharge, sinus tenderness) and gastrointestinal symptoms (intermittent abdominal cramps, recurrent foul-smelling greasy diarrhea). The stool microscopy showing pear\u2010shaped, multi\u2010flagellated organisms is indicative of Giardia lamblia infection. Recurrent infections with Giardia and respiratory pathogens point toward a deficiency in the mucosal immune response, particularly secretory IgA.\n\nStep 2: Connect the findings to a diagnosis. The most consistent diagnosis with these clinical findings is selective IgA deficiency. Individuals with selective IgA deficiency are predisposed to recurrent sinopulmonary infections as well as giardiasis due to the lack of IgA in the mucosal secretions. \n\nStep 3: Evaluate the answer options in the context of selective IgA deficiency. \n\u2022 Option A: Anaphylactic transfusion reactions \u2013 Patients with selective IgA deficiency may develop anti-IgA antibodies. If they receive blood products containing IgA, they are at risk for an anaphylactic reaction.\n\u2022 Option B: Cutaneous granulomas \u2013 These are not typically associated with IgA deficiency.\n\u2022 Option C: Non-Hodgkin lymphoma \u2013 Although some immunodeficiency states increase the risk of malignancies, selective IgA deficiency is most characteristically linked with anaphylactic reactions during transfusions.\n\u2022 Option D: Disseminated tuberculosis \u2013 This is not specifically linked to selective IgA deficiency.\n\nStep 4: Provide the final answer. Based on the clinical presentation and risk factors associated with selective IgA deficiency, the patient is at increased risk for anaphylactic transfusion reactions.\n\nFinal answer: A. Anaphylactic transfusion reactions"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1\n\nExplanation:\nThe key to this case is the identification of Giardia lamblia infection (described as pear\u2010shaped, multi\u2010flagellated organisms) in the setting of recurrent respiratory and gastrointestinal infections. This combination is classic for selective IgA deficiency rather than cystic fibrosis. In selective IgA deficiency, the lack of IgA predisposes patients to both sinopulmonary infections and giardiasis. A well\u2010known complication in selective IgA deficiency is an anaphylactic reaction to blood transfusions due to the presence of anti-IgA antibodies. Therefore, the patient is at increased risk for anaphylactic transfusion reactions.\n\nCandidate solution 1 correctly steps through this reasoning and provides the appropriate final answer."
        ],
        "final_solution": "Step 1: Gather the key clinical information. The 3-year-old girl presents with a history of recurrent respiratory infections (fever, cough, purulent nasal discharge, sinus tenderness) and gastrointestinal symptoms (intermittent abdominal cramps, recurrent foul-smelling greasy diarrhea). The stool microscopy showing pear\u2010shaped, multi\u2010flagellated organisms is indicative of Giardia lamblia infection. Recurrent infections with Giardia and respiratory pathogens point toward a deficiency in the mucosal immune response, particularly secretory IgA.\n\nStep 2: Connect the findings to a diagnosis. The most consistent diagnosis with these clinical findings is selective IgA deficiency. Individuals with selective IgA deficiency are predisposed to recurrent sinopulmonary infections as well as giardiasis due to the lack of IgA in the mucosal secretions. \n\nStep 3: Evaluate the answer options in the context of selective IgA deficiency. \n\u2022 Option A: Anaphylactic transfusion reactions \u2013 Patients with selective IgA deficiency may develop anti-IgA antibodies. If they receive blood products containing IgA, they are at risk for an anaphylactic reaction.\n\u2022 Option B: Cutaneous granulomas \u2013 These are not typically associated with IgA deficiency.\n\u2022 Option C: Non-Hodgkin lymphoma \u2013 Although some immunodeficiency states increase the risk of malignancies, selective IgA deficiency is most characteristically linked with anaphylactic reactions during transfusions.\n\u2022 Option D: Disseminated tuberculosis \u2013 This is not specifically linked to selective IgA deficiency.\n\nStep 4: Provide the final answer. Based on the clinical presentation and risk factors associated with selective IgA deficiency, the patient is at increased risk for anaphylactic transfusion reactions.\n\nFinal answer: A. Anaphylactic transfusion reactions"
    },
    {
        "realidx": 524,
        "question": "A 6-month-old boy is brought to the physician by his parents for difficulty breathing and bluish discoloration of the lips for the past hour. During the past 3 months, the patient has had several upper respiratory tract infections and poor weight gain. Physical examination shows crackles over both lung fields and enlargement of the tonsils and cervical lymph nodes. His serum IgA, IgE, and IgG titers are decreased. An x-ray of the chest shows bilateral interstitial infiltrates. Methenamine silver staining of bronchial lavage fluid shows disc-shaped cysts. A defect in which of the following is the most likely underlying cause of this patient's condition?",
        "answer": "T-cell receptor signaling",
        "options": {
            "A": "Actin filament assembly",
            "B": "T-cell receptor signaling",
            "C": "Microtubule polymerization",
            "D": "B-cell maturation"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "month old boy",
            "brought",
            "physician",
            "parents",
            "difficulty breathing",
            "discoloration",
            "lips",
            "past hour",
            "past 3 months",
            "patient",
            "several upper respiratory tract infections",
            "poor weight gain",
            "Physical examination shows crackles",
            "lung fields",
            "enlargement of",
            "tonsils",
            "cervical lymph nodes",
            "serum IgA",
            "titers",
            "decreased",
            "x-ray of",
            "chest shows bilateral interstitial",
            "Methenamine silver staining of bronchial lavage fluid shows disc-shaped cysts",
            "defect",
            "following",
            "most likely underlying cause",
            "patient's condition"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6132,
            "completion_tokens": 8130
        },
        "time_elapsed": 55.72056603431702,
        "raw_responses": [
            "Step 1: Recognize the clinical picture. The 6\u2010month-old boy presents with respiratory distress, cyanosis, recurrent upper respiratory tract infections, poor weight gain, bilateral interstitial infiltrates on x-ray, and bronchial lavage showing disc-shaped cysts on methenamine silver stain, which is characteristic of Pneumocystis jirovecii pneumonia.\n\nStep 2: Identify the underlying immunodeficiency. His laboratory work-up shows decreased levels of IgA, IgE, and IgG. In the context of recurrent infections with opportunistic pathogens (like Pneumocystis), this antibody deficiency suggests a failure in immunoglobulin class switching. This pattern is most consistent with hyper-IgM syndrome, where patients are unable to class-switch and thus have low IgG, IgA, and IgE levels, while IgM is typically normal or elevated.\n\nStep 3: Evaluate the answer options.  \nA. Actin filament assembly \u2013 This is related to disorders like Wiskott-Aldrich syndrome, which presents with eczema and thrombocytopenia, not the case here.  \nB. T-cell receptor signaling \u2013 While T cells are involved in hyper-IgM syndrome (specifically the CD40 ligand on T cells), the defect does not lie in T-cell receptor signaling per se.  \nC. Microtubule polymerization \u2013 This is implicated in conditions like Chediak-Higashi syndrome, which is not consistent with the findings in this case.  \nD. B-cell maturation \u2013 The inability to undergo isotype (class) switching in hyper-IgM syndrome is essentially a defect in B-cell maturation. Even though the primary defect in classic hyper-IgM syndrome is a mutation in the gene coding for CD40 ligand on T cells, this defect leads to a failure in signaling required for proper B-cell maturation. Therefore, this option best captures the pathophysiological process underlying his condition.\n\nStep 4: Provide the final answer.  \nFinal Answer: D. B-cell maturation",
            "Step 1: Recognize the clinical scenario. The 6\u2010month\u2010old boy presents with difficulty breathing, cyanosis, history of recurrent respiratory infections, and poor weight gain. The imaging and staining findings (disc\u2010shaped cysts on methenamine silver stain) are consistent with Pneumocystis jirovecii pneumonia. The laboratory findings show low levels of IgA, IgG, and IgE, which is characteristic of an immunodeficiency affecting antibody class switching (with IgM usually being preserved).\n\nStep 2: Identify the immunodeficiency. The pattern of immunoglobulin levels (low IgA, IgE, and IgG with preserved IgM) is typical for hyper-IgM syndrome. In this condition, B cells fail to undergo class switching due to an inability to receive the proper stimulation from T cells. This failure is commonly due to a defect in the CD40 ligand (CD40L) on T cells, which normally interacts with CD40 on B cells to trigger class switching.\n\nStep 3: Analyze the options.\n\u2022 Option A (Actin filament assembly) is associated with other conditions (e.g., Wiskott-Aldrich syndrome) and is not related to the class-switching defect.\n\u2022 Option B (T-cell receptor signaling) would imply a defect in T-cell activation in general, but in hyper-IgM syndrome the T cells are primarily defective in providing the CD40L signal rather than in T-cell receptor signaling itself.\n\u2022 Option C (Microtubule polymerization) is not related to the immunologic process described.\n\u2022 Option D (B-cell maturation) directly involves the process of immunoglobulin class switching. Because the B cells are unable to mature (i.e., switch isotypes from IgM to IgG, IgA, or IgE) in this condition, this option is the best explanation for the patient\u2019s immunologic findings.\n\nStep 4: Final answer.\nD: B-cell maturation",
            "Step 1: Analyze the Clinical Presentation\n\u2022 The 6\u2010month-old boy has recurrent upper respiratory tract infections, poor weight gain, and now presents with respiratory distress and cyanosis.\n\u2022 Chest X-ray reveals bilateral interstitial infiltrates.\n\u2022 Bronchial lavage with methenamine silver staining shows disc\u2010shaped cysts, which is characteristic for Pneumocystis jirovecii pneumonia.\n\nStep 2: Analyze the Laboratory Findings\n\u2022 The serum IgA, IgE, and IgG titers are decreased. The absence of these class\u2010switched immunoglobulins, with an implied preservation (or possible increase) of IgM, is a classic pattern seen in hyper\u2013IgM syndrome.\n\nStep 3: Understand the Immunologic Basis\n\u2022 In hyper\u2013IgM syndrome, a defect in the interaction between T cells and B cells impairs class switching.\n\u2022 Most commonly, this is due to an X\u2010linked mutation of the CD40 ligand (CD40L) on T cells. Although CD40L is not directly a component of the T\u2010cell receptor itself, it is part of the T cell\u2019s signaling interactions. This defect prevents proper B-cell maturation (i.e., class switching) from IgM to other immunoglobulin classes.\n\nStep 4: Compare the Options\nA. Actin filament assembly \u2013 Associated with disorders such as Wiskott-Aldrich syndrome; however, that syndrome typically includes eczema and thrombocytopenia.\nB. T-cell receptor signaling \u2013 A defect here, particularly in the form of CD40L deficiency, underlies hyper\u2013IgM syndrome.\nC. Microtubule polymerization \u2013 Defects here are seen in conditions like Chediak-Higashi syndrome, which is not consistent with this presentation.\nD. B-cell maturation \u2013 While impaired class switching is a defect in B-cell maturation, in hyper\u2013IgM syndrome the primary problem is the failure of T-cell mediated CD40L signaling to B cells. \n\nStep 5: Arrive at the Final Answer\nGiven that hyper\u2013IgM syndrome is most commonly caused by a deficiency in CD40L on T cells (a defect in T-cell signaling required for immunoglobulin class switching), the best answer is:\n\nFinal Answer: B. T-cell receptor signaling"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Recognize the clinical picture. The 6\u2010month-old boy presents with respiratory distress, cyanosis, recurrent upper respiratory tract infections, poor weight gain, bilateral interstitial infiltrates on x-ray, and bronchial lavage showing disc-shaped cysts on methenamine silver stain, which is characteristic of Pneumocystis jirovecii pneumonia.\n\nStep 2: Identify the underlying immunodeficiency. His laboratory work-up shows decreased levels of IgA, IgE, and IgG. In the context of recurrent infections with opportunistic pathogens (like Pneumocystis), this antibody deficiency suggests a failure in immunoglobulin class switching. This pattern is most consistent with hyper-IgM syndrome, where patients are unable to class-switch and thus have low IgG, IgA, and IgE levels, while IgM is typically normal or elevated.\n\nStep 3: Evaluate the answer options.  \nA. Actin filament assembly \u2013 This is related to disorders like Wiskott-Aldrich syndrome, which presents with eczema and thrombocytopenia, not the case here.  \nB. T-cell receptor signaling \u2013 While T cells are involved in hyper-IgM syndrome (specifically the CD40 ligand on T cells), the defect does not lie in T-cell receptor signaling per se.  \nC. Microtubule polymerization \u2013 This is implicated in conditions like Chediak-Higashi syndrome, which is not consistent with the findings in this case.  \nD. B-cell maturation \u2013 The inability to undergo isotype (class) switching in hyper-IgM syndrome is essentially a defect in B-cell maturation. Even though the primary defect in classic hyper-IgM syndrome is a mutation in the gene coding for CD40 ligand on T cells, this defect leads to a failure in signaling required for proper B-cell maturation. Therefore, this option best captures the pathophysiological process underlying his condition.\n\nStep 4: Provide the final answer.  \nFinal Answer: D. B-cell maturation"
    },
    {
        "realidx": 531,
        "question": "A 24-year-old woman is brought to the emergency room (ER) by her co-workers after they found her unconscious in her cubicle when they returned from lunch. They tell you that she has diabetes but do not know anything more about her condition. The woman\u2019s vital signs include: pulse 110/min, respiratory rate 24/min, temperature 36.7\u00b0C (98.0\u00b0F), and blood pressure 90/60 mm Hg. On physical examination, the patient is breathing heavily and gives irrelevant responses to questions. The skin and mucous membranes appear dry. Examination of the abdomen reveals mild diffuse tenderness to palpation. Deep tendon reflexes in the extremities are 1+ bilaterally. Laboratory studies show:\nFinger stick glucose 630 mg/dL\nArterial blood gas analysis:\npH 7.1\nPO2 90 mm Hg\nPCO2 33 mm Hg\nHCO3 8 mEq/L\nSerum:\nSodium 135 mEq/L\nPotassium 3.1 mEq/L\nChloride 136 mEq/L\nBlood urea nitrogen 20 mg/dL\nSerum creatinine 1.2 mg/dL\nUrine examination shows:\nGlucose Positive\nKetones Positive\nLeukocytes Negative\nNitrite Negative\nRBCs Negative\nCasts Negative\nThe patient is immediately started on a bolus of intravenous (IV) 0.9% sodium chloride (NaCl). Which of the following is the next best step in the management of this patient?",
        "answer": "Replace potassium intravenously",
        "options": {
            "A": "Infuse NaHCO3 slowly",
            "B": "Switch fluids to 0.45% NaCl",
            "C": "Start IV insulin infusion",
            "D": "Replace potassium intravenously"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old woman",
            "brought",
            "emergency room",
            "co workers",
            "found",
            "unconscious",
            "returned",
            "lunch",
            "diabetes",
            "not",
            "more",
            "condition",
            "vital signs include",
            "pulse",
            "min",
            "respiratory rate",
            "min",
            "temperature 36",
            "98",
            "blood pressure 90 60 mm Hg",
            "physical examination",
            "patient",
            "breathing",
            "gives",
            "responses",
            "questions",
            "skin",
            "mucous membranes appear dry",
            "Examination of",
            "abdomen reveals mild diffuse tenderness",
            "palpation",
            "Deep tendon reflexes",
            "extremities",
            "1",
            "Laboratory studies show",
            "Finger stick glucose",
            "mg/dL Arterial blood gas analysis",
            "pH",
            "PO2 90 mm Hg PCO2",
            "HCO3",
            "mEq/L Serum",
            "Sodium",
            "mEq",
            "dL Serum",
            "Urine examination shows",
            "Glucose Positive Ketones",
            "Leukocytes Negative Nitrite",
            "RBCs",
            "Casts Negative",
            "patient",
            "immediately started",
            "bolus",
            "intravenous",
            "0.9",
            "sodium chloride",
            "NaCl",
            "following",
            "next best step",
            "management",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6402,
            "completion_tokens": 3445
        },
        "time_elapsed": 29.248949766159058,
        "raw_responses": [
            "Step 1: Recognize that the patient presents with diabetic ketoacidosis (DKA), characterized by hyperglycemia (glucose 630 mg/dL), metabolic acidosis (pH 7.1, HCO3 8 mEq/L), and positive ketones.\n\nStep 2: Fluid resuscitation has already been initiated with IV 0.9% NaCl. The next critical steps in DKA management are addressing potassium levels and starting insulin therapy. However, it's important to note that insulin administration can drive potassium into cells, potentially causing severe hypokalemia.\n\nStep 3: Review the laboratory values. The patient\u2019s serum potassium is 3.1 mEq/L, which is below the threshold of 3.3 mEq/L. Guidelines recommend that if the potassium is less than 3.3 mEq/L, potassium must be replaced before starting IV insulin to prevent exacerbation of hypokalemia.\n\nStep 4: Evaluate the options:\n\u2003\u2022 Option A (Infuse NaHCO\u2083) is not indicated because bicarbonate therapy is reserved for patients with a pH <7.0.\n\u2003\u2022 Option B (Switch fluids to 0.45% NaCl) is not the next step in the management of DKA.\n\u2003\u2022 Option C (Start IV insulin infusion) is a key step in DKA management, but initiating insulin therapy before correcting the hypokalemia could worsen the patient\u2019s condition.\n\u2003\u2022 Option D (Replace potassium intravenously) is the correct choice because the patient\u2019s hypokalemia must be corrected before starting insulin.\n\nFinal Answer: D. Replace potassium intravenously.",
            "Step 1: The patient\u2019s clinical presentation and labs are indicative of diabetic ketoacidosis (DKA), evidenced by high blood glucose (630 mg/dL), metabolic acidosis (pH 7.1, HCO\u2083 8 mEq/L), and positive ketones in the urine.\n\nStep 2: Standard management of DKA involves initial fluid resuscitation (which has already been started with IV 0.9% NaCl), followed by correction of electrolyte imbalances, and then initiation of insulin therapy to reduce blood glucose and suppress further ketone production.\n\nStep 3: A key point before starting insulin therapy is to address serum potassium levels. Although total body potassium is depleted in DKA, the serum potassium may appear normal or high. However, in this patient, the potassium is low at 3.1 mEq/L. Insulin administration will drive potassium into cells, potentially exacerbating hypokalemia and risking arrhythmias. Therefore, potassium supplementation is critical before initiating insulin therapy.\n\nStep 4: Comparing the options:\nA. Infuse NaHCO\u2083 slowly \u2013 Bicarbonate therapy is generally reserved for patients with severe acidemia (pH < 6.9). With a pH of 7.1, this is not indicated.\nB. Switch fluids to 0.45% NaCl \u2013 Hypotonic fluids are not appropriate in the initial management of DKA, particularly before correcting the electrolyte disturbances and stabilization.\nC. Start IV insulin infusion \u2013 Although insulin therapy is an essential component in the treatment of DKA, initiating it before addressing the low potassium could lead to life-threatening hypokalemia.\nD. Replace potassium intravenously \u2013 Correcting the hypokalemia is necessary prior to starting insulin to prevent worsening of hypokalemia.\n\nStep 5: Therefore, the next best step in management is to replace potassium intravenously.\n\nFinal Answer: D. Replace potassium intravenously.",
            "Step 1: Note that the patient\u2019s presentation and lab values are consistent with diabetic ketoacidosis (DKA)\u2014a high blood glucose level, metabolic acidosis (pH 7.1 with low HCO3), and positive ketones.\n\nStep 2: Standard treatment for DKA involves initial fluid resuscitation (which has already been started), then addressing electrolyte disturbances, and finally starting insulin therapy. Insulin therapy is crucial to halt lipolysis and ketone production, but it also drives potassium into cells, which can further lower serum potassium levels.\n\nStep 3: Since the patient\u2019s potassium is 3.1 mEq/L, which is below the 3.3 mEq/L threshold, it is imperative to first replace potassium to prevent dangerous hypokalemia when insulin is administered.\n\nStep 4: The other options are not appropriate:\n\u2022 Infusing NaHCO\u2083 is generally reserved for severe acidemia (pH <6.9) and is not indicated here since the pH is 7.1.\n\u2022 Switching to 0.45% NaCl is part of a later phase of fluid management once the patient is hemodynamically stable.\n\u2022 Starting IV insulin infusion immediately would risk further lowering the potassium levels.\n\nFinal Answer: D. Replace potassium intravenously."
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Note that the patient\u2019s presentation and lab values are consistent with diabetic ketoacidosis (DKA)\u2014a high blood glucose level, metabolic acidosis (pH 7.1 with low HCO3), and positive ketones.\n\nStep 2: Standard treatment for DKA involves initial fluid resuscitation (which has already been started), then addressing electrolyte disturbances, and finally starting insulin therapy. Insulin therapy is crucial to halt lipolysis and ketone production, but it also drives potassium into cells, which can further lower serum potassium levels.\n\nStep 3: Since the patient\u2019s potassium is 3.1 mEq/L, which is below the 3.3 mEq/L threshold, it is imperative to first replace potassium to prevent dangerous hypokalemia when insulin is administered.\n\nStep 4: The other options are not appropriate:\n\u2022 Infusing NaHCO\u2083 is generally reserved for severe acidemia (pH <6.9) and is not indicated here since the pH is 7.1.\n\u2022 Switching to 0.45% NaCl is part of a later phase of fluid management once the patient is hemodynamically stable.\n\u2022 Starting IV insulin infusion immediately would risk further lowering the potassium levels.\n\nFinal Answer: D. Replace potassium intravenously."
    },
    {
        "realidx": 560,
        "question": "A 55-year-old man presents to his primary care physician for a general checkup. The patient has a past medical history of diabetes, hypertension, and atrial fibrillation and is currently taking warfarin, insulin, lisinopril, and metoprolol. The patient\u2019s brother recently died from a heart attack and he has switched to an all vegetarian diet in order to improve his health. His temperature is 98.6\u00b0F (37.0\u00b0C), blood pressure is 167/108 mmHg, pulse is 90/min, respirations are 17/min, and oxygen saturation is 98% on room air. The patient\u2019s physical exam is unremarkable. His laboratory values are ordered as seen below.\n\nHemoglobin: 12 g/dL\nHematocrit: 36%\nLeukocyte count: 7,550/mm^3 with normal differential\nPlatelet count: 197,000/mm^3\nINR: 1.0\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 25 mEq/L\nBUN: 20 mg/dL\nGlucose: 99 mg/dL\nCreatinine: 1.1 mg/dL\nCa2+: 10.2 mg/dL\n\nWhich of the following is the best explanation for this patient\u2019s laboratory values?",
        "answer": "Dietary changes",
        "options": {
            "A": "Dietary changes",
            "B": "Increased hepatic metabolism",
            "C": "Increased renal clearance",
            "D": "Medication noncompliance"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "55 year old man presents",
            "primary care physician",
            "general checkup",
            "patient",
            "past medical diabetes",
            "hypertension",
            "atrial fibrillation",
            "currently taking warfarin",
            "insulin",
            "lisinopril",
            "metoprolol",
            "patients brother recently died",
            "heart attack",
            "switched",
            "vegetarian diet",
            "order to",
            "health",
            "temperature",
            "98",
            "blood pressure",
            "mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "patients physical exam",
            "unremarkable",
            "laboratory values",
            "ordered",
            "seen",
            "Hemoglobin",
            "g/dL Hematocrit",
            "36",
            "Leukocyte count",
            "7 550 mm",
            "normal differential Platelet count",
            "mm",
            "INR",
            "1 0",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L",
            "20 mg/dL Glucose",
            "99 mg/dL Creatinine",
            "1.1 mg/dL Ca2",
            "10",
            "mg/dL",
            "following",
            "best explanation",
            "patients laboratory values"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5370,
            "completion_tokens": 2973
        },
        "time_elapsed": 23.291756868362427,
        "raw_responses": [
            "Step 1: Recognize that the patient is on warfarin. Warfarin works as an anticoagulant by interfering with the action of vitamin K, which is necessary for the production of clotting factors.\n\nStep 2: Note the patient's recent switch to an all-vegetarian diet. Vegetarian diets, particularly those rich in green leafy vegetables, increase vitamin K intake.\n\nStep 3: Understand that increased vitamin K intake can counteract the effects of warfarin, leading to a lower INR. In this case, the patient's INR is 1.0, indicating inadequate anticoagulation.\n\nStep 4: Compare the options:\n\u2022 Dietary changes: Yes, the increased vitamin K from his vegetarian diet explains the low INR.\n\u2022 Increased hepatic metabolism: There\u2019s no indication that his liver function or metabolism of warfarin is affected.\n\u2022 Increased renal clearance: Warfarin is not primarily cleared renally, and there\u2019s no suggestion that his kidney function is altered.\n\u2022 Medication noncompliance: There's no evidence pointing toward noncompliance, and the dietary change is a clear factor.\n\nFinal Answer: A. Dietary changes",
            "Step 1: Identify the abnormal laboratory value. The patient is on warfarin for atrial fibrillation, and his INR is 1.0, which is below the therapeutic range (typically between 2.0 and 3.0 for atrial fibrillation management).\n\nStep 2: Consider the impact of his recent dietary change. The patient recently switched to an all vegetarian diet. Vegetarian diets often include a lot of green leafy vegetables, which are high in vitamin K. Vitamin K is a cofactor in the synthesis of clotting factors, and an increased intake of vitamin K can antagonize the effect of warfarin, leading to a lower INR.\n\nStep 3: Evaluate the other options:\n\u2022 Option B, Increased hepatic metabolism, would require a factor like a drug interaction that induces liver enzymes; there is no indication of such a change here.\n\u2022 Option C, Increased renal clearance, is not relevant since warfarin is metabolized by the liver, not cleared by the kidneys.\n\u2022 Option D, Medication noncompliance, could hypothetically lower INR if the patient wasn\u2019t taking warfarin, but the history aligns more closely with the dietary change affecting warfarin's efficacy.\n\nFinal Answer: A. Dietary changes",
            "Step 1: Recognize that the patient is on warfarin, which requires careful monitoring of the INR. Typically, patients on warfarin for atrial fibrillation maintain an INR between 2.0 and 3.0.\n\nStep 2: Notice that his INR is 1.0, which is essentially a normal value and indicates that warfarin is not exerting its expected anticoagulation effect.\n\nStep 3: Consider his recent change to an all vegetarian diet. A vegetarian diet, particularly one high in green leafy vegetables, is rich in vitamin K. Vitamin K antagonizes warfarin's effects by promoting clotting factor synthesis, thereby lowering the INR.\n\nStep 4: Evaluate the other choices:\n\u2022 Increased hepatic metabolism is less likely without evidence of changes in liver function or the introduction of interacting substances.\n\u2022 Increased renal clearance is not relevant for warfarin, as it is primarily metabolized hepatically.\n\u2022 Medication noncompliance might be considered, but there is a clear change in diet that directly affects INR.\n\nFinal Answer: A. Dietary changes"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Recognize that the patient is on warfarin, which requires careful monitoring of the INR. Typically, patients on warfarin for atrial fibrillation maintain an INR between 2.0 and 3.0.\n\nStep 2: Notice that his INR is 1.0, which is essentially a normal value and indicates that warfarin is not exerting its expected anticoagulation effect.\n\nStep 3: Consider his recent change to an all vegetarian diet. A vegetarian diet, particularly one high in green leafy vegetables, is rich in vitamin K. Vitamin K antagonizes warfarin's effects by promoting clotting factor synthesis, thereby lowering the INR.\n\nStep 4: Evaluate the other choices:\n\u2022 Increased hepatic metabolism is less likely without evidence of changes in liver function or the introduction of interacting substances.\n\u2022 Increased renal clearance is not relevant for warfarin, as it is primarily metabolized hepatically.\n\u2022 Medication noncompliance might be considered, but there is a clear change in diet that directly affects INR.\n\nFinal Answer: A. Dietary changes"
    },
    {
        "realidx": 564,
        "question": "A 35-year-old man visits your office for his annual health checkup. He was diagnosed with generalized anxiety disorder 6 months ago, which is being treated with citalopram. He comments that his symptoms have improved since initiating the prescribed therapy; however, in the past 2 months, he has been unable to have sexual intercourse due to weak tumescence and low libido. His blood pressure is 122/74 mm Hg, heart rate is 75/min, and respiratory rate is 16/min. Physical examination reveals regular heart and lung sounds. What is the appropriate step in the management of this patient?",
        "answer": "Lowering citalopram dose",
        "options": {
            "A": "Lowering citalopram dose",
            "B": "Addition of bupropion",
            "C": "Switch to fluoxetine",
            "D": "Switch to selegiline"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "35 year old man visits",
            "office",
            "annual health",
            "diagnosed",
            "generalized anxiety disorder",
            "months",
            "treated with citalopram",
            "comments",
            "symptoms",
            "improved since initiating",
            "prescribed therapy",
            "past",
            "months",
            "unable to",
            "sexual intercourse due to weak tumescence",
            "low libido",
            "blood pressure",
            "74 mm Hg",
            "heart rate",
            "75 min",
            "respiratory rate",
            "min",
            "Physical examination reveals regular heart",
            "lung sounds",
            "appropriate step",
            "management",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4161,
            "completion_tokens": 3461
        },
        "time_elapsed": 27.25351071357727,
        "raw_responses": [
            "Step 1: Recognize that the patient\u2019s symptoms (weak tumescence and low libido) are consistent with known sexual dysfunction side effects of SSRIs (such as citalopram).\n\nStep 2: Evaluate the options:\n\u2022 Lowering the dose of citalopram might reduce side effects but could risk loss of control over his anxiety symptoms.\n\u2022 Adding bupropion is an established strategy to alleviate SSRI-induced sexual dysfunction while maintaining the therapeutic benefits for anxiety.\n\u2022 Switching to another SSRI like fluoxetine is not ideal because sexual dysfunction is a class effect of SSRIs.\n\u2022 Selegiline, an MAOI, is not indicated for treating generalized anxiety disorder or for addressing his current side effects.\n\nStep 3: Therefore, the appropriate management is to add bupropion.\n\nFinal Answer: B. Addition of bupropion",
            "Step 1: Identify the key clinical issue.  \n\u2022 The patient, on citalopram for generalized anxiety disorder, is experiencing sexual dysfunction\u2014a common side effect of SSRIs.  \n\nStep 2: Assess management options.  \nA. Lowering the dose of citalopram may reduce side effects but risks decreasing its therapeutic effect on anxiety.  \nB. Addition of bupropion is a recognized strategy; bupropion has a low incidence of sexual dysfunction and can help counteract SSRI-induced sexual side effects.  \nC. Switching to fluoxetine, another SSRI, is unlikely to resolve the sexual dysfunction since many SSRIs share similar adverse effect profiles.  \nD. Switching to selegiline, a monoamine oxidase inhibitor, is not an appropriate treatment option for generalized anxiety disorder and comes with a higher burden of side effects and dietary restrictions.  \n\nStep 3: Provide the final answer.  \nThe best management step for this patient is: B. Addition of bupropion.",
            "Step 1: Identify the patient\u2019s issues. The 35-year-old man is being treated with citalopram (an SSRI) for generalized anxiety disorder. Although his anxiety symptoms are improved, he now experiences sexual dysfunction (weak tumescence and low libido), which is a common side effect of SSRIs.\n\nStep 2: Consider management options.\n\u2022 Option A (Lowering citalopram dose) might reduce sexual side effects but could compromise the control of his anxiety.\n\u2022 Option B (Addition of bupropion) is a viable strategy. Bupropion, with its dopaminergic and noradrenergic activity, is often added to counteract SSRI-induced sexual dysfunction.\n\u2022 Option C (Switch to fluoxetine) is not ideal because fluoxetine is another SSRI and is associated with similar sexual side effects.\n\u2022 Option D (Switch to selegiline) is not appropriate in this setting, as selegiline is a monoamine oxidase inhibitor and not indicated for treating generalized anxiety disorder.\n\nStep 3: Choose the final answer based on the analysis.\nThe best step is to add bupropion to his regimen to alleviate the sexual dysfunction while continuing effective management of his anxiety.\n\nFinal answer: B. Addition of bupropion"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Identify the patient\u2019s issues. The 35-year-old man is being treated with citalopram (an SSRI) for generalized anxiety disorder. Although his anxiety symptoms are improved, he now experiences sexual dysfunction (weak tumescence and low libido), which is a common side effect of SSRIs.\n\nStep 2: Consider management options.\n\u2022 Option A (Lowering citalopram dose) might reduce sexual side effects but could compromise the control of his anxiety.\n\u2022 Option B (Addition of bupropion) is a viable strategy. Bupropion, with its dopaminergic and noradrenergic activity, is often added to counteract SSRI-induced sexual dysfunction.\n\u2022 Option C (Switch to fluoxetine) is not ideal because fluoxetine is another SSRI and is associated with similar sexual side effects.\n\u2022 Option D (Switch to selegiline) is not appropriate in this setting, as selegiline is a monoamine oxidase inhibitor and not indicated for treating generalized anxiety disorder.\n\nStep 3: Choose the final answer based on the analysis.\nThe best step is to add bupropion to his regimen to alleviate the sexual dysfunction while continuing effective management of his anxiety.\n\nFinal answer: B. Addition of bupropion"
    },
    {
        "realidx": 579,
        "question": "A 59-year-old woman presents to her primary care provider complaining of diffuse bodily aches. She reports a 3-month history of gradually worsening pain in her shoulders and hips that is worse in her right hip. She has a history of hypertension and recurrent renal stones for which she takes lisinopril and hydrochlorothiazide. She was admitted to the hospital earlier in the year after falling in her front yard and sustaining a distal radius fracture and vertebral compression fracture. Her temperature is 98.5\u00b0F (36.9\u00b0C), blood pressure is 145/85 mmHg, pulse is 100/min, and respirations are 20/min. On exam, she is well-appearing with mild tenderness to palpation in her shoulders and hips. She has mild pain with hip flexion and shoulder abduction. She has full range of motion in her bilateral upper and lower extremities. Serum findings are notable for the following:\n\nSerum:\nNa+: 141 mEq/L\nCl-: 100 mEq/L\nK+: 4.8 mEq/L\nHCO3-: 22 mEq/L\nUrea nitrogen: 17 mg/dL\nGlucose: 110 mg/dL\nCreatinine: 1.12 mg/dL\nCa2+: 11.2 mg/dL\nPhosphate: 2.3 mg/dL\nMg2+: 1.9 mg/dL\nAlkaline phosphatase: 120 U/L\n\nA radiograph of this patient\u2019s right hip would most likely reveal which of the following?",
        "answer": "Well-defined cystic lesion with peritrabecular fibrosis",
        "options": {
            "A": "Expansile lytic lesion with thin sclerotic margins",
            "B": "Medullary bone destruction with elevated periosteum from cortical bone",
            "C": "Poorly marginated lesion extending into adjacent soft tissue",
            "D": "Well-defined cystic lesion with peritrabecular fibrosis"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "59 year old woman presents",
            "primary care provider",
            "diffuse",
            "aches",
            "reports",
            "3 month history",
            "worsening pain in",
            "shoulders",
            "hips",
            "worse",
            "right hip",
            "history of hypertension",
            "recurrent renal stones",
            "takes lisinopril",
            "hydrochlorothiazide",
            "admitted",
            "hospital earlier",
            "year",
            "falling",
            "front yard",
            "sustaining",
            "distal radius fracture",
            "vertebral",
            "temperature",
            "98",
            "36",
            "blood pressure",
            "85 mmHg",
            "pulse",
            "100 min",
            "respirations",
            "20 min",
            "exam",
            "well appearing",
            "mild tenderness",
            "palpation",
            "shoulders",
            "hips",
            "mild",
            "hip flexion",
            "shoulder abduction",
            "full range of motion",
            "bilateral upper",
            "lower extremities",
            "Serum findings",
            "notable",
            "following",
            "Serum",
            "Na",
            "mEq/L Cl",
            "100 mEq/L K",
            "4.8 mEq/L HCO3",
            "mEq/L Urea nitrogen",
            "mg/dL Glucose",
            "mg/dL Creatinine",
            "1",
            "mg/dL Ca2",
            "mg/dL Phosphate",
            "2.3 mg/dL Mg2",
            "1.9 mg/dL Alkaline phosphatase",
            "U/L",
            "radiograph of",
            "patients right hip",
            "most likely reveal",
            "following"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6756,
            "completion_tokens": 6436
        },
        "time_elapsed": 44.31421422958374,
        "raw_responses": [
            "Step 1: Identify the key clinical findings. This 59\u2010year\u2010old woman has a history of diffuse body aches, fragility fractures (vertebral compression fracture, distal radius fracture), renal stones, and laboratory results showing hypercalcemia (11.2 mg/dL), low phosphate (2.3 mg/dL), and a borderline alkaline phosphatase. These findings are consistent with primary hyperparathyroidism, which can lead to osteitis fibrosa cystica (brown tumors).\n\nStep 2: Understand the radiographic findings in osteitis fibrosa cystica. In primary hyperparathyroidism, the overproduction of parathyroid hormone (PTH) causes increased osteoclast activity with subsequent subperiosteal bone resorption. Over time, areas of bone resorption may lead to the formation of \"brown tumors,\" which are well\u2010demarcated cystic lesions.\n\nStep 3: Evaluate the answer choices.  \nA. Expansile lytic lesion with thin sclerotic margins \u2013 This description is more typical of other benign bone lesions like an aneurysmal bone cyst or solitary bone cyst rather than the classic appearance of brown tumors in hyperparathyroidism.  \nB. Medullary bone destruction with elevated periosteum from cortical bone \u2013 This describes a more aggressive process seen in malignant lesions or Ewing sarcoma, not characteristic of osteitis fibrosa cystica.  \nC. Poorly marginated lesion extending into adjacent soft tissue \u2013 This appearance suggests an aggressive, malignant process such as an invasive carcinoma or high-grade sarcoma, which does not fit this patient\u2019s biochemical picture.  \nD. Well-defined cystic lesion with peritrabecular fibrosis \u2013 This best describes a brown tumor as seen in osteitis fibrosa cystica secondary to primary hyperparathyroidism.\n\nStep 4: Final Answer  \nThe best answer is: D. Well-defined cystic lesion with peritrabecular fibrosis",
            "Step 1: Analyze the clinical and laboratory findings.\n\u2022 The patient is a 59-year-old woman with chronic, gradually worsening pain in her shoulders and hips, and a history of fractures (distal radius, vertebral compression) after minimal trauma.\n\u2022 Laboratory studies reveal hypercalcemia (Ca2+ 11.2 mg/dL) and hypophosphatemia (phosphate 2.3 mg/dL). These findings are consistent with primary hyperparathyroidism.\n\u2022 The chronic bone pain and recurrent fractures further point toward complications of primary hyperparathyroidism, namely osteitis fibrosa cystica, also known as \u201cbrown tumors.\u201d\n\nStep 2: Evaluate the radiographic lesion options in the context of osteitis fibrosa cystica.\n\u2022 Osteitis fibrosa cystica is characterized by lytic lesions (brown tumors) due to increased osteoclastic bone resorption. On imaging, these lesions often appear as expansile lytic areas with well-defined margins and sometimes a thin sclerotic rim.\n\u2022 Option A (\u201cExpansile lytic lesion with thin sclerotic margins\u201d) fits this description.\n\u2022 Options B, C, and D describe radiographic findings more typical of other conditions, such as aggressive infections, malignant bone tumors, or benign cysts not associated with primary hyperparathyroidism.\n\nStep 3: Conclude the best answer.\nThe radiograph of the patient\u2019s right hip would most likely reveal an expansile lytic lesion with thin sclerotic margins, which corresponds to the brown tumor seen in osteitis fibrosa cystica secondary to primary hyperparathyroidism.\n\nFinal Answer: A",
            "Step 1: Analyze the clinical scenario.\n\u2022 The patient is a 59-year-old woman with diffuse bone pain, particularly in her shoulders and hips.\n\u2022 She has a history of fractures (vertebral compression and distal radius) and recurrent renal stones.\n\u2022 Her labs show high serum calcium (11.2 mg/dL), low phosphate (2.3 mg/dL), and a borderline-high alkaline phosphatase.\n\u2022 These findings suggest primary hyperparathyroidism, which leads to increased bone resorption (osteitis fibrosa cystica).\n\nStep 2: Relate the radiographic findings in primary hyperparathyroidism.\n\u2022 In osteitis fibrosa cystica, chronic elevated parathyroid hormone causes focal bone resorption resulting in \u201cbrown tumors.\u201d\n\u2022 On radiographs, these lesions typically appear as well-circumscribed cystic areas in the bone with peritrabecular (around trabeculae) fibrosis.\n\nStep 3: Evaluate the answer options.\nA. Expansile lytic lesion with thin sclerotic margins \u2013 Though lytic, this description is more typical of lesions like unicameral or aneurysmal bone cysts rather than the changes seen in hyperparathyroidism.\nB. Medullary bone destruction with elevated periosteum from cortical bone \u2013 This is more suggestive of an aggressive process or acute infection.\nC. Poorly marginated lesion extending into adjacent soft tissue \u2013 This describes an aggressive, malignant process.\nD. Well-defined cystic lesion with peritrabecular fibrosis \u2013 This best describes the appearance of a \u201cbrown tumor\u201d in osteitis fibrosa cystica secondary to primary hyperparathyroidism.\n\nFinal Answer: [D] Well-defined cystic lesion with peritrabecular fibrosis"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Analyze the clinical scenario.\n\u2022 The patient is a 59-year-old woman with diffuse bone pain, particularly in her shoulders and hips.\n\u2022 She has a history of fractures (vertebral compression and distal radius) and recurrent renal stones.\n\u2022 Her labs show high serum calcium (11.2 mg/dL), low phosphate (2.3 mg/dL), and a borderline-high alkaline phosphatase.\n\u2022 These findings suggest primary hyperparathyroidism, which leads to increased bone resorption (osteitis fibrosa cystica).\n\nStep 2: Relate the radiographic findings in primary hyperparathyroidism.\n\u2022 In osteitis fibrosa cystica, chronic elevated parathyroid hormone causes focal bone resorption resulting in \u201cbrown tumors.\u201d\n\u2022 On radiographs, these lesions typically appear as well-circumscribed cystic areas in the bone with peritrabecular (around trabeculae) fibrosis.\n\nStep 3: Evaluate the answer options.\nA. Expansile lytic lesion with thin sclerotic margins \u2013 Though lytic, this description is more typical of lesions like unicameral or aneurysmal bone cysts rather than the changes seen in hyperparathyroidism.\nB. Medullary bone destruction with elevated periosteum from cortical bone \u2013 This is more suggestive of an aggressive process or acute infection.\nC. Poorly marginated lesion extending into adjacent soft tissue \u2013 This describes an aggressive, malignant process.\nD. Well-defined cystic lesion with peritrabecular fibrosis \u2013 This best describes the appearance of a \u201cbrown tumor\u201d in osteitis fibrosa cystica secondary to primary hyperparathyroidism.\n\nFinal Answer: [D] Well-defined cystic lesion with peritrabecular fibrosis"
    },
    {
        "realidx": 583,
        "question": "A 46-year-old woman presents to her primary care physician with one week of intermittent nausea and vomiting. She does not have any sick contacts, and her medical history is significant only for diabetes well-controlled on metformin. She also complains of some weakness and back/leg pain. She says that she recently returned from traveling abroad and had been administered an antibiotic during her travels for an unknown infection. On presentation, her temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 119/78 mmHg, pulse is 62/min, and respirations are 25/min. An EKG is obtained showing flattening of the T wave. After further testing, the physician prescribes a thiazide for this patient. Which of the following diseases is also associated with this patient's most likely diagnosis?",
        "answer": "Wilson disease",
        "options": {
            "A": "Rheumatoid arthritis",
            "B": "Sjogren syndrome",
            "C": "Systemic lupus erythematosus",
            "D": "Wilson disease"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old woman presents",
            "primary care physician",
            "one week",
            "intermittent nausea",
            "vomiting",
            "not",
            "sick contacts",
            "medical history",
            "significant only",
            "diabetes well-controlled",
            "metformin",
            "weakness",
            "back leg",
            "recently returned",
            "traveling abroad",
            "administered",
            "antibiotic",
            "travels",
            "unknown infection",
            "presentation",
            "temperature",
            "98",
            "blood pressure",
            "mmHg",
            "pulse",
            "62 min",
            "respirations",
            "min",
            "EKG",
            "obtained showing flattening",
            "T wave",
            "further testing",
            "physician",
            "thiazide",
            "patient",
            "following diseases",
            "associated with",
            "patient's",
            "likely diagnosis"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5433,
            "completion_tokens": 13671
        },
        "time_elapsed": 86.22852849960327,
        "raw_responses": [
            "Step 1: Recognize the Clues\n\u2022 The patient\u2019s intermittent nausea, vomiting, weakness, and leg/back pain combined with an EKG showing flattened T waves point to an electrolyte disturbance, most notably hypokalemia.\n\u2022 The use of thiazide diuretics in her management is a clue\u2014thiazides are sometimes used to treat conditions that cause abnormal calcium handling in the kidney (e.g., hypercalciuria seen in some renal tubular disorders).\n\nStep 2: Connect to Renal Tubular Abnormalities\n\u2022 Distal (type 1) renal tubular acidosis (RTA) is characterized by an inability of the distal nephron to acidify urine. This leads to a metabolic acidosis, and because the kidneys compensate by trying to excrete excess acid (and due to impaired potassium reabsorption), patients often develop hypokalemia.\n\u2022 Distal RTA predisposes patients to nephrolithiasis (kidney stones) due to calcium phosphate precipitation.\n\u2022 Thiazide diuretics are sometimes used in patients with hypercalciuria to reduce urinary calcium excretion and prevent stone formation.\n\nStep 3: Associate with an Autoimmune Disease\n\u2022 Distal RTA is most commonly associated with autoimmune disorders in adults.\n\u2022 Among the answer options, Sjogren syndrome is well known to be associated with type 1 RTA. It typically affects middle\u2010aged women and can present with nonspecific symptoms including weakness and electrolyte imbalances.\n\nStep 4: Eliminate Other Options\n\u2022 Rheumatoid arthritis and systemic lupus erythematosus are autoimmune diseases but are not classically linked to distal RTA.\n\u2022 Wilson disease is a disorder of copper metabolism and does not have a known association with this electrolyte and kidney stone profile.\n\nFinal Answer: B. Sjogren syndrome",
            "Let\u2019s break down the clues:\n\n\u2022 This 46\u2010year\u2010old woman presents with nausea, vomiting, weakness, and back/leg pain. An EKG shows flattened T waves\u2014a finding seen with hypokalemia.\n\n\u2022 One common cause of hypokalemia (with muscle weakness and cramps) in adults is a renal tubular defect. In particular, distal renal tubular acidosis (RTA type 1) causes problems with H+ secretion in the distal tubule. Over time, the ensuing metabolic acidosis (despite the vomiting here, her workup ultimately pointed to a renal tubular process) is associated with chronic hypokalemia and predisposes patients to nephrolithiasis (which can be felt as back/flank pain).\n\n\u2022 In patients with distal RTA, calcium phosphate kidney stones can form. A thiazide diuretic is often used to help reduce urinary calcium excretion and prevent further stone formation.\n\n\u2022 Importantly, in adults\u2014in particular middle\u2010aged women\u2014distal RTA is classically associated with autoimmune disease, most notably Sj\u00f6gren syndrome. (In clinical practice, Sj\u00f6gren syndrome is the autoimmune illness most often linked to distal RTA.)\n\nThus, the disease most associated with the underlying diagnosis (a renal tubular defect leading to hypokalemia and stone formation, managed in part with thiazides) is Sj\u00f6gren syndrome.\n\nFinal answer: Sjogren syndrome.",
            "Step 1: Analyze the patient\u2019s clinical findings.\n\u2022 The patient is a 46\u2010year\u2010old woman with nausea, vomiting, weakness, and back/leg pain.\n\u2022 An EKG shows flattened T waves\u2014a finding that is often seen with hypokalemia.\n\u2022 Her history includes recent travel and antibiotic use, which can sometimes trigger renal complications.\n\u2022 After additional testing, her physician prescribes a thiazide diuretic, which is sometimes used to help patients with hypercalciuria (e.g., to prevent kidney stone formation).\n\nStep 2: Determine the likely diagnosis.\n\u2022 Hypokalemia in the setting of weakness and muscle pain with a tendency for kidney stones suggests a renal tubular defect.\n\u2022 Distal (type 1) renal tubular acidosis (RTA) is characterized by an inability of the distal nephron to acidify the urine, leading to metabolic acidosis, hypokalemia, and hypercalciuria (which predisposes to kidney stones and bone pain).\n\u2022 Thiazide diuretics are used to reduce urinary calcium excretion in such patients.\n\u2022 Distal RTA is also associated with autoimmune diseases.\n\nStep 3: Connect to associated diseases.\n\u2022 Among the autoimmune conditions, Sj\u00f6gren syndrome is most classically linked with distal (type 1) RTA.\n\u2022 Although rheumatoid arthritis and SLE can be associated with renal issues, the association between distal RTA and Sj\u00f6gren syndrome is the best known.\n\nStep 4: Final answer.\nThe disease also associated with this patient\u2019s most likely diagnosis (distal RTA) is Sj\u00f6gren syndrome.\n\nFinal Answer: B. Sjogren syndrome"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Recognize the Clues\n\u2022 The patient\u2019s intermittent nausea, vomiting, weakness, and leg/back pain combined with an EKG showing flattened T waves point to an electrolyte disturbance, most notably hypokalemia.\n\u2022 The use of thiazide diuretics in her management is a clue\u2014thiazides are sometimes used to treat conditions that cause abnormal calcium handling in the kidney (e.g., hypercalciuria seen in some renal tubular disorders).\n\nStep 2: Connect to Renal Tubular Abnormalities\n\u2022 Distal (type 1) renal tubular acidosis (RTA) is characterized by an inability of the distal nephron to acidify urine. This leads to a metabolic acidosis, and because the kidneys compensate by trying to excrete excess acid (and due to impaired potassium reabsorption), patients often develop hypokalemia.\n\u2022 Distal RTA predisposes patients to nephrolithiasis (kidney stones) due to calcium phosphate precipitation.\n\u2022 Thiazide diuretics are sometimes used in patients with hypercalciuria to reduce urinary calcium excretion and prevent stone formation.\n\nStep 3: Associate with an Autoimmune Disease\n\u2022 Distal RTA is most commonly associated with autoimmune disorders in adults.\n\u2022 Among the answer options, Sjogren syndrome is well known to be associated with type 1 RTA. It typically affects middle\u2010aged women and can present with nonspecific symptoms including weakness and electrolyte imbalances.\n\nStep 4: Eliminate Other Options\n\u2022 Rheumatoid arthritis and systemic lupus erythematosus are autoimmune diseases but are not classically linked to distal RTA.\n\u2022 Wilson disease is a disorder of copper metabolism and does not have a known association with this electrolyte and kidney stone profile.\n\nFinal Answer: B. Sjogren syndrome"
    },
    {
        "realidx": 587,
        "question": "A 33-year-old G2P1 woman presents to the office because of poor diabetic control. She is currently at 18 weeks gestation and admits to having poor control of her type 1 diabetes before becoming pregnant. Her family history is non-contributory. The physical examination shows a pregnant woman with a fundal height of 20 cm (7.9 in). An abdominal ultrasound is ordered. Which of the following is the most likely congenital abnormality shown on the ultrasound?",
        "answer": "Ventricular septal defect",
        "options": {
            "A": "Amelia",
            "B": "Sacral agenesis",
            "C": "Spina bifida",
            "D": "Ventricular septal defect"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old",
            "woman presents",
            "office",
            "poor diabetic control",
            "currently",
            "weeks gestation",
            "admits",
            "poor control",
            "type 1 diabetes",
            "pregnant",
            "family history",
            "non contributory",
            "physical examination shows",
            "pregnant woman",
            "fundal height",
            "20",
            "abdominal ultrasound",
            "ordered",
            "following",
            "most likely congenital abnormality shown",
            "ultrasound"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 3984,
            "completion_tokens": 3079
        },
        "time_elapsed": 26.47225785255432,
        "raw_responses": [
            "Step 1: Relevant Information\n\u2022 The patient is a 33-year-old woman with type 1 diabetes, currently at 18 weeks gestation.\n\u2022 The patient admits to poor diabetic control before pregnancy.\n\u2022 Poor glycemic control, especially in the preconception period, is associated with an increased risk of certain congenital malformations.\n\nStep 2: Consideration and Elimination of Options\n\u2022 Option A (Amelia): This refers to the absence of one or more limbs. It is not classically associated with maternal diabetes.\n\u2022 Option B (Sacral agenesis): Poor glycemic control during early pregnancy is strongly associated with caudal regression syndrome, where there is partial or complete sacral agenesis. This fits the scenario.\n\u2022 Option C (Spina bifida): Although neural tube defects (including spina bifida) are associated with poor glycemic control, sacral agenesis is a more specific and strongly associated congenital abnormality in diabetic mothers.\n\u2022 Option D (Ventricular septal defect): Cardiac defects can occur with maternal diabetes, but sacral agenesis is more uniquely linked to this setting.\n\nStep 3: Final Answer\nThe most likely congenital abnormality on the ultrasound is sacral agenesis.\n\nFinal answer: B.",
            "Step 1: Recognize that the patient has poorly controlled type 1 diabetes, especially before pregnancy, which predisposes to congenital malformations.\n\nStep 2: Maternal hyperglycemia is most notably associated with caudal regression syndrome (sacral agenesis), a condition where there is abnormal development of the lower spine. Although other congenital abnormalities (e.g., neural tube defects like spina bifida or cardiac defects like ventricular septal defect) have increased risks in diabetic pregnancies, sacral agenesis is the most strongly linked abnormality.\n\nStep 3: Eliminate the other options:\n\u2022 Amelia (complete absence of a limb) is not characteristically associated with maternal diabetes.\n\u2022 Spina bifida, although a neural tube defect seen in diabetes, is less specific than caudal regression syndrome.\n\u2022 Ventricular septal defect, while a possibility in diabetic pregnancies, is not as closely tied to poor glycemic control before and during pregnancy as sacral agenesis.\n\nFinal Answer: B. Sacral agenesis",
            "Step 1: Recognize that the patient has poor glycemic control during early pregnancy\u2014a known risk factor for diabetic embryopathy.\n\nStep 2: Understand that diabetic embryopathy can cause several congenital malformations, one of the most specific being caudal regression syndrome, which is characterized by sacral agenesis.\n\nStep 3: Review the answer options:\n\u2022 Amelia refers to the complete absence of at least one limb\u2014not typically linked to maternal diabetes.\n\u2022 Sacral agenesis (caudal regression syndrome) is closely associated with maternal diabetes.\n\u2022 Spina bifida is a neural tube defect but is less specific to maternal diabetes than sacral agenesis.\n\u2022 Ventricular septal defect (VSD) is a cardiac defect that can occur, but sacral agenesis is more pathognomonic in this context.\n\nFinal Answer: B. Sacral agenesis"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step 1: Relevant Information\n\u2022 The patient is a 33-year-old woman with type 1 diabetes, currently at 18 weeks gestation.\n\u2022 The patient admits to poor diabetic control before pregnancy.\n\u2022 Poor glycemic control, especially in the preconception period, is associated with an increased risk of certain congenital malformations.\n\nStep 2: Consideration and Elimination of Options\n\u2022 Option A (Amelia): This refers to the absence of one or more limbs. It is not classically associated with maternal diabetes.\n\u2022 Option B (Sacral agenesis): Poor glycemic control during early pregnancy is strongly associated with caudal regression syndrome, where there is partial or complete sacral agenesis. This fits the scenario.\n\u2022 Option C (Spina bifida): Although neural tube defects (including spina bifida) are associated with poor glycemic control, sacral agenesis is a more specific and strongly associated congenital abnormality in diabetic mothers.\n\u2022 Option D (Ventricular septal defect): Cardiac defects can occur with maternal diabetes, but sacral agenesis is more uniquely linked to this setting.\n\nStep 3: Final Answer\nThe most likely congenital abnormality on the ultrasound is sacral agenesis.\n\nFinal answer: B."
    },
    {
        "realidx": 596,
        "question": "Six hours after birth, a newborn boy is evaluated for tachypnea. He was delivered at 41 weeks' gestation via Caesarian section and the amniotic fluid was meconium-stained. His respiratory rate is 75/min. Physical examination shows increased work of breathing. X-rays of the abdomen and chest show no abnormalities. Echocardiography shows elevated pulmonary artery pressure. He is started on an inhaled medication that increases smooth muscle cGMP, and there is immediate improvement in his tachypnea and oxygenation status. Three hours later, the newborn is tachypneic and there is blue-grey discoloration of the lips, fingers, and toes. Which of the following is the most likely cause of this infant's cyanosis?",
        "answer": "Oxidization of Fe2+ to Fe3+",
        "options": {
            "A": "Increase in concentration of serum myoglobin",
            "B": "Closure of the ductus arteriosus",
            "C": "Oxidization of Fe2+ to Fe3+",
            "D": "Allosteric alteration of heme groups"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "Six hours after birth",
            "newborn boy",
            "evaluated",
            "tachypnea",
            "delivered",
            "weeks",
            "gestation",
            "Caesarian section",
            "amniotic fluid",
            "meconium stained",
            "respiratory rate",
            "75 min",
            "Physical examination shows increased work of breathing",
            "X-rays of",
            "abdomen",
            "chest show",
            "abnormalities",
            "Echocardiography shows elevated pulmonary artery pressure",
            "started",
            "inhaled medication",
            "increases smooth muscle cGMP",
            "immediate improvement",
            "tachypnea",
            "oxygenation status",
            "Three hours later",
            "newborn",
            "tachypneic",
            "blue grey discoloration",
            "lips",
            "fingers",
            "toes",
            "following",
            "most likely cause",
            "infant's cyanosis"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5486,
            "completion_tokens": 4118
        },
        "time_elapsed": 34.929694414138794,
        "raw_responses": [
            "Step 1: Review the newborn\u2019s presentation. After birth, the infant shows signs of respiratory distress, and echocardiography reveals elevated pulmonary artery pressure. The baby is started on an inhaled medication that increases smooth muscle cGMP\u2014in this context, inhaled nitric oxide (iNO) is used to treat persistent pulmonary hypertension of the newborn (PPHN). Initially, the treatment improves the condition.\n\nStep 2: Understand the complication. Three hours later, despite initial improvement, the newborn develops worsening tachypnea and develops a blue-grey discoloration of the lips, fingers, and toes (cyanosis). One known complication of inhaled nitric oxide therapy is the development of methemoglobinemia. Nitric oxide can oxidize the iron in hemoglobin from its ferrous (Fe2+) state, which normally binds oxygen, to the ferric (Fe3+) state, forming methemoglobin, which cannot bind oxygen effectively.\n\nStep 3: Evaluate the options.\n\u2022 Option A (Increase in concentration of serum myoglobin) is unrelated to the mechanism of cyanosis in this context.\n\u2022 Option B (Closure of the ductus arteriosus) might not directly explain the acute onset of cyanosis after using inhaled nitric oxide.\n\u2022 Option C (Oxidization of Fe2+ to Fe3+) describes the formation of methemoglobin, a known complication of nitric oxide therapy.\n\u2022 Option D (Allosteric alteration of heme groups) does not describe a typical mechanism causing cyanosis in this scenario.\n\nStep 4: Final Answer.\nThe infant\u2019s cyanosis is most likely due to methemoglobinemia, which occurs because of the oxidization of Fe2+ to Fe3+ in hemoglobin following nitric oxide administration.\n\nFinal Answer: C. Oxidization of Fe2+ to Fe3+",
            "Step 1: The infant was started on inhaled nitric oxide (NO), which works by increasing smooth muscle cyclic GMP. Inhaled NO is used to treat pulmonary hypertension by dilating the pulmonary vasculature.\n\nStep 2: A known adverse effect of inhaled NO therapy is methemoglobinemia. In this condition, ferrous (Fe2+) hemoglobin is oxidized to ferric (Fe3+) hemoglobin, which is unable to carry oxygen. This leads to cyanosis (blue-grey discoloration) even though oxygen saturation may not reflect the true oxygen-carrying capacity.\n\nStep 3: Evaluating the options:\n\u2003\u2022 Option A (Increase in concentration of serum myoglobin) is unrelated to the mechanism.\n\u2003\u2022 Option B (Closure of the ductus arteriosus) is not typically associated with worsening cyanosis in a scenario of NO therapy.\n\u2003\u2022 Option C (Oxidization of Fe2+ to Fe3+) directly describes the process that results in methemoglobinemia.\n\u2003\u2022 Option D (Allosteric alteration of heme groups) does not accurately describe the process involved.\n\nFinal Answer: C (Oxidization of Fe2+ to Fe3+)",
            "Step 1: Gather important details from the question.\n\u2022 The newborn has persistent pulmonary hypertension (elevated pulmonary artery pressure) and tachypnea.\n\u2022 He was given an inhaled medication that increases smooth muscle cGMP, which is inhaled nitric oxide.\n\u2022 Initially, the nitric oxide improved oxygenation.\n\u2022 Three hours later, the newborn developed new, significant cyanosis (blue-grey discoloration).\n\nStep 2: Understand the mechanism of the medication and its side effects.\n\u2022 Inhaled nitric oxide dilates pulmonary vessels via increasing cGMP, treating persistent pulmonary hypertension.\n\u2022 A known side effect of nitric oxide therapy is methemoglobinemia. Nitric oxide can oxidize the ferrous (Fe2+) iron in hemoglobin to the ferric (Fe3+) state, forming methemoglobin that cannot bind oxygen, leading to a functional anemia and cyanosis.\n\nStep 3: Review the answer options.\nA. Increase in concentration of serum myoglobin \u2013 This is unrelated to the drug\u2019s side effects.\nB. Closure of the ductus arteriosus \u2013 While the ductus arteriosus is important in fetal circulation, its closure does not directly explain the sudden onset of cyanosis after nitric oxide treatment.\nC. Oxidization of Fe2+ to Fe3+ \u2013 This describes methemoglobinemia, which is a known complication of inhaled nitric oxide.\nD. Allosteric alteration of heme groups \u2013 This does not pertain to the mechanism caused by nitric oxide.\n\nStep 4: Eliminate the incorrect choices and select the best answer.\n\u2022 Options A and D do not relate to nitric oxide\u2019s known effects.\n\u2022 Option B does not account for the cyanosis following an initial improvement.\n\u2022 Option C appropriately identifies the oxidation process that results in methemoglobinemia and explains the subsequent cyanosis.\n\nFinal Answer: C. Oxidization of Fe2+ to Fe3+"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Review the newborn\u2019s presentation. After birth, the infant shows signs of respiratory distress, and echocardiography reveals elevated pulmonary artery pressure. The baby is started on an inhaled medication that increases smooth muscle cGMP\u2014in this context, inhaled nitric oxide (iNO) is used to treat persistent pulmonary hypertension of the newborn (PPHN). Initially, the treatment improves the condition.\n\nStep 2: Understand the complication. Three hours later, despite initial improvement, the newborn develops worsening tachypnea and develops a blue-grey discoloration of the lips, fingers, and toes (cyanosis). One known complication of inhaled nitric oxide therapy is the development of methemoglobinemia. Nitric oxide can oxidize the iron in hemoglobin from its ferrous (Fe2+) state, which normally binds oxygen, to the ferric (Fe3+) state, forming methemoglobin, which cannot bind oxygen effectively.\n\nStep 3: Evaluate the options.\n\u2022 Option A (Increase in concentration of serum myoglobin) is unrelated to the mechanism of cyanosis in this context.\n\u2022 Option B (Closure of the ductus arteriosus) might not directly explain the acute onset of cyanosis after using inhaled nitric oxide.\n\u2022 Option C (Oxidization of Fe2+ to Fe3+) describes the formation of methemoglobin, a known complication of nitric oxide therapy.\n\u2022 Option D (Allosteric alteration of heme groups) does not describe a typical mechanism causing cyanosis in this scenario.\n\nStep 4: Final Answer.\nThe infant\u2019s cyanosis is most likely due to methemoglobinemia, which occurs because of the oxidization of Fe2+ to Fe3+ in hemoglobin following nitric oxide administration.\n\nFinal Answer: C. Oxidization of Fe2+ to Fe3+"
    },
    {
        "realidx": 616,
        "question": "A 31-year-old man presents to his primary care physician with fevers, chills, and night sweats. After a physical exam and a series of laboratory tests, the patient undergoes a lymph node biopsy (Image A). Three days later, while awaiting treatment, he presents to his physician complaining of generalized swelling and is found to have 4+ protein in his urine. Which of the following pathological findings is most likely to be found on renal biopsy in this patient?",
        "answer": "Minimal change disease",
        "options": {
            "A": "Rapidly progresive glomerulonephritis",
            "B": "Amyloidosis",
            "C": "Focal segmental glomerulosclerosis",
            "D": "Minimal change disease"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "31 year old man presents",
            "primary care physician",
            "fevers",
            "chills",
            "night sweats",
            "physical exam",
            "series",
            "laboratory tests",
            "patient",
            "lymph node biopsy",
            "Image",
            "Three days later",
            "treatment",
            "presents",
            "physician",
            "generalized swelling",
            "found to",
            "4",
            "protein in",
            "urine",
            "following pathological findings",
            "most likely to",
            "found",
            "renal biopsy",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 3801,
            "completion_tokens": 3536
        },
        "time_elapsed": 27.6797194480896,
        "raw_responses": [
            "Step 1: The patient presents with systemic \u201cB symptoms\u201d (fevers, chills, night sweats) and lymphadenopathy, which prompted a lymph node biopsy. While the exact pathology isn\u2019t provided, lymphoma \u2013 notably Hodgkin lymphoma \u2013 is implicated given the age and presentation.\n\nStep 2: Three days later, the patient develops generalized edema with 4+ proteinuria, consistent with nephrotic syndrome.\n\nStep 3: Among the listed renal pathologies, minimal change disease is uniquely associated as a paraneoplastic syndrome in patients with Hodgkin lymphoma. Although amyloidosis can cause nephrotic syndrome, it generally occurs with long-standing inflammatory conditions rather than an acute setting. The association between Hodgkin lymphoma and minimal change disease is well recognized, making this the most likely finding on renal biopsy.\n\nFinal answer: D. Minimal change disease",
            "Step 1: Recognize that the patient's symptoms (fevers, chills, and night sweats) along with the lymph node biopsy are concerning for lymphoma (likely Hodgkin\u2019s lymphoma given the age group and B symptoms).\n\nStep 2: Recall that Hodgkin\u2019s lymphoma has a well-established association with minimal change disease, a cause of nephrotic syndrome with significant proteinuria (in this case, 4+ protein on urinalysis).\n\nStep 3: Evaluate the answer choices:\n\u2003\u2022 Rapidly progressive glomerulonephritis \u2013 typically presents with rapid loss of kidney function and hematuria, not just isolated proteinuria.\n\u2003\u2022 Amyloidosis \u2013 is associated with chronic inflammatory states, but in patients with Hodgkin\u2019s lymphoma, minimal change disease is the more common glomerular lesion.\n\u2003\u2022 Focal segmental glomerulosclerosis \u2013 can cause nephrotic syndrome but is not as closely linked with Hodgkin\u2019s lymphoma.\n\u2003\u2022 Minimal change disease \u2013 is famously associated with Hodgkin\u2019s lymphoma and would account for the heavy proteinuria and resultant edema in this patient.\n\nFinal Answer: D. Minimal change disease",
            "Step 1: The patient\u2019s presentation of fevers, chills, and night sweats (\u201cB symptoms\u201d) along with a lymph node biopsy suggests a diagnosis of lymphoma, most commonly Hodgkin lymphoma in a young adult.\n\nStep 2: Patients with Hodgkin lymphoma are known to develop nephrotic syndrome due to associated minimal change disease (MCD), likely mediated by cytokines released by the lymphoma.\n\nStep 3: Comparing the options:\n\u2003\u2022 Rapidly progressive glomerulonephritis is not typically associated with lymphoma.\n\u2003\u2022 Amyloidosis may occur in chronic inflammatory disease but is less directly linked.\n\u2003\u2022 Focal segmental glomerulosclerosis is more often connected to conditions like HIV or drug use.\n\u2003\u2022 Minimal change disease is classically associated with Hodgkin lymphoma.\n\nFinal Answer: D. Minimal change disease"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Recognize that the patient's symptoms (fevers, chills, and night sweats) along with the lymph node biopsy are concerning for lymphoma (likely Hodgkin\u2019s lymphoma given the age group and B symptoms).\n\nStep 2: Recall that Hodgkin\u2019s lymphoma has a well-established association with minimal change disease, a cause of nephrotic syndrome with significant proteinuria (in this case, 4+ protein on urinalysis).\n\nStep 3: Evaluate the answer choices:\n\u2003\u2022 Rapidly progressive glomerulonephritis \u2013 typically presents with rapid loss of kidney function and hematuria, not just isolated proteinuria.\n\u2003\u2022 Amyloidosis \u2013 is associated with chronic inflammatory states, but in patients with Hodgkin\u2019s lymphoma, minimal change disease is the more common glomerular lesion.\n\u2003\u2022 Focal segmental glomerulosclerosis \u2013 can cause nephrotic syndrome but is not as closely linked with Hodgkin\u2019s lymphoma.\n\u2003\u2022 Minimal change disease \u2013 is famously associated with Hodgkin\u2019s lymphoma and would account for the heavy proteinuria and resultant edema in this patient.\n\nFinal Answer: D. Minimal change disease"
    },
    {
        "realidx": 627,
        "question": "A 30-year-old G4P3 woman at 38 weeks gestation is admitted to the labor and delivery unit complaining of contractions every 5 minutes for the past hour. Her previous births have been via uncomplicated caesarean sections, but she wishes to attempt vaginal delivery this time. Her prenatal care is notable for gestational diabetes controlled with diet and exercise. The delivery is prolonged, but the patient's pain is controlled with epidural analgesia. She delivers a male infant with Apgar scores of 8 and 9 at 1 and 5 minutes, respectively. Fundal massage is performed, but the placenta does not pass. The obstetrician manually removes the placenta, but a red mass protrudes through the vagina attached to the placenta. The patient loses 500 mL of blood over the next minute, during which her blood pressure decreases from 120/80 mmHg to 90/65 mmHg. What is the best next step in management?",
        "answer": "Elevate posterior fornix",
        "options": {
            "A": "Hysterectomy",
            "B": "Intravenous oxytocin",
            "C": "Elevate posterior fornix",
            "D": "Red blood cell transfusion"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "30 year old",
            "woman",
            "weeks",
            "admitted",
            "labor",
            "delivery unit",
            "contractions",
            "5 minutes",
            "past hour",
            "previous births",
            "uncomplicated caesarean sections",
            "wishes to attempt vaginal delivery",
            "time",
            "prenatal care",
            "notable",
            "gestational diabetes controlled",
            "diet",
            "exercise",
            "delivery",
            "prolonged",
            "patient's pain",
            "controlled",
            "epidural analgesia",
            "delivers",
            "male infant",
            "Apgar scores",
            "8",
            "5 minutes",
            "Fundal massage",
            "performed",
            "placenta",
            "not pass",
            "obstetrician manually removes",
            "placenta",
            "red mass",
            "vagina attached",
            "placenta",
            "patient",
            "500 mL",
            "blood",
            "next minute",
            "blood pressure decreases",
            "80 mmHg",
            "90 65 mmHg",
            "best next step",
            "management"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5892,
            "completion_tokens": 7808
        },
        "time_elapsed": 55.72706413269043,
        "raw_responses": [
            "Step 1. Recognize the scenario and its clues:\n\u2022 The patient has postpartum hemorrhage (rapid 500\u2010mL blood loss with a blood pressure drop).\n\u2022 On inspection after manual removal of the placenta with fundal massage, a red mass is noted protruding through the vagina that is still attached to the placenta.\n\u2022 This finding is classic for a retained accessory (succenturiate) placental lobe, which if not removed can serve as a source for continued hemorrhage.\n\nStep 2. Consider the management options:\n\u2022 Hysterectomy is reserved for uncontrolled bleeding not responsive to other measures.\n\u2022 Intravenous oxytocin is the first\u2010line treatment for uterine atony; however, in this case the bleeding is due to retained placental tissue rather than poor uterine contraction.\n\u2022 Elevating the posterior fornix is a maneuver that facilitates exposure of the cervix and vaginal canal to better visualize and manually extract the retained accessory lobe.\n\u2022 Red blood cell transfusion is supportive management if the patient were hemodynamically decompensated due to massive hemorrhage but does not address the bleeding source.\n\nStep 3. Eliminate the incorrect options:\n\u2022 Hysterectomy (A) is too radical and not indicated at this point.\n\u2022 IV oxytocin (B), while important in managing postpartum hemorrhage due to uterine atony, won\u2019t resolve bleeding from retained placental tissue.\n\u2022 Red blood cell transfusion (D) is supportive but does nothing to remove the cause of hemorrhage.\n\nStep 4. Final answer:\nThe best next step is to use the maneuver of elevating the posterior fornix (Option C) to facilitate removal of the retained accessory lobe, thereby controlling the bleeding.\n\nFinal Answer: C. Elevate posterior fornix",
            "Step 1: Analyze the clinical picture.\n\u2022 A 30\u2010year\u2010old woman delivers at term with a history of previous cesarean sections, now attempting a vaginal delivery.\n\u2022 The placenta does not deliver with fundal massage, prompting manual removal.\n\u2022 When the placenta is removed, a red mass is noted protruding through the vagina attached to the placenta.\n\u2022 Shortly afterward, she experiences a rapid drop in blood pressure and loses a significant amount of blood.\n\nStep 2: Determine the likely complication.\n\u2022 The finding of a red, protruding mass attached to the placenta is highly suggestive of uterine inversion. In uterine inversion, the uterine fundus \u201cturns inside out\u201d and may be seen as a red, fleshy mass at or beyond the cervical os.\n\u2022 Uterine inversion is a well-known cause of severe postpartum hemorrhage and shock that requires rapid management.\n\nStep 3: Evaluate management options.\nA. Hysterectomy \u2013 This is an extreme measure reserved for refractory hemorrhage or uterine pathology not amenable to conservative management. It is not the initial step.\nB. Intravenous oxytocin \u2013 While oxytocin is used for uterine atony, it does not immediately address the mechanical problem of uterine inversion.\nC. Elevate posterior fornix \u2013 This maneuver describes the manual repositioning that is necessary in an acute uterine inversion (often referred to as the Johnson maneuver), where upward pressure is applied (often via the posterior vaginal fornix) to restore the uterus to its normal position.\nD. Red blood cell transfusion \u2013 While supportive in cases of significant blood loss, it does not address the underlying cause of the hemorrhage and instability.\n\nStep 4: Choose the best next step.\nThe best immediate treatment in uterine inversion is manual replacement of the inverted uterus. This is achieved by elevating the uterine fundus (i.e. applying upward pressure via the posterior fornix). Therefore, the correct answer is:\n\nFinal Answer: C. Elevate posterior fornix.",
            "Step 1: Recognize that the clinical picture is one of postpartum uterine inversion. The red mass seen protruding through the vagina attached to the placenta is the inverted uterus, and the sudden blood loss with hypotension reflects hemorrhage associated with this complication.\n\nStep 2: The immediate priority in this situation is the prompt manual replacement of the inverted uterus. The standard technique (often referred to as the Johnson maneuver) involves inserting the hand into the vagina and applying pressure to the inverted fundus via the posterior fornix in order to reposition the uterus back into its anatomic location.\n\nStep 3: Evaluating the options:\n\u2022 Option A (Hysterectomy) is overly aggressive and is reserved only as a last resort if manual replacement and other measures fail.\n\u2022 Option B (Intravenous oxytocin) is used as a uterotonic after the uterus is replaced to promote contraction and prevent re-inversion; however, giving oxytocin at this point would worsen the inversion by contracting the uterus, further hindering manual repositioning.\n\u2022 Option C (Elevate posterior fornix) corresponds to manually pushing the inverted fundus upward through the vagina (akin to the Johnson maneuver), which is the correct management step at this time.\n\u2022 Option D (Red blood cell transfusion) addresses blood loss but does not correct the underlying problem\u2014the inversion\u2014and is not the immediate next step.\n\nFinal answer: Option C \u2013 Elevate posterior fornix."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "Step 1: Recognize that the clinical picture is one of postpartum uterine inversion. The red mass seen protruding through the vagina attached to the placenta is the inverted uterus, and the sudden blood loss with hypotension reflects hemorrhage associated with this complication.\n\nStep 2: The immediate priority in this situation is the prompt manual replacement of the inverted uterus. The standard technique (often referred to as the Johnson maneuver) involves inserting the hand into the vagina and applying pressure to the inverted fundus via the posterior fornix in order to reposition the uterus back into its anatomic location.\n\nStep 3: Evaluating the options:\n\u2022 Option A (Hysterectomy) is overly aggressive and is reserved only as a last resort if manual replacement and other measures fail.\n\u2022 Option B (Intravenous oxytocin) is used as a uterotonic after the uterus is replaced to promote contraction and prevent re-inversion; however, giving oxytocin at this point would worsen the inversion by contracting the uterus, further hindering manual repositioning.\n\u2022 Option C (Elevate posterior fornix) corresponds to manually pushing the inverted fundus upward through the vagina (akin to the Johnson maneuver), which is the correct management step at this time.\n\u2022 Option D (Red blood cell transfusion) addresses blood loss but does not correct the underlying problem\u2014the inversion\u2014and is not the immediate next step.\n\nFinal answer: Option C \u2013 Elevate posterior fornix."
    },
    {
        "realidx": 634,
        "question": "A 67-year-old woman presents to her primary care physician for urinary incontinence. She has been waking up every morning with her underwear soaked in urine. She notices that at work if she does not take regular bathroom breaks her underwear will have some urine in it. She urinates 5 to 11 times per day but she claims it is a small volume. Her current medications include lisinopril, metformin, insulin, aspirin, atorvastatin, sodium docusate, and loratadine. Her temperature is 98.2\u00b0F (36.8\u00b0C), blood pressure is 167/108 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for decreased pinprick sensation in the lower extremities and a systolic murmur along the right upper sternal border. Which of the following is the best treatment for this patient?",
        "answer": "Bethanechol and intermittent straight catheterization",
        "options": {
            "A": "Bethanechol and intermittent straight catheterization",
            "B": "Bethanechol during the day and oxybutynin at night",
            "C": "No recommendations needed",
            "D": "Reduce fluid intake and discontinue diuretics"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "67 year old woman presents",
            "primary care physician",
            "urinary incontinence",
            "waking up",
            "morning",
            "underwear soaked",
            "urine",
            "work",
            "not take regular bathroom breaks",
            "underwear",
            "urine",
            "5",
            "times",
            "day",
            "small volume",
            "current medications include lisinopril",
            "metformin",
            "insulin",
            "aspirin",
            "atorvastatin",
            "sodium docusate",
            "loratadine",
            "temperature",
            "98",
            "36",
            "blood pressure",
            "mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "oxygen saturation",
            "99",
            "room air",
            "Physical exam",
            "notable",
            "decreased pinprick sensation",
            "lower extremities",
            "systolic murmur",
            "right upper sternal border",
            "following",
            "best treatment",
            "patient"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5931,
            "completion_tokens": 8257
        },
        "time_elapsed": 57.243632078170776,
        "raw_responses": [
            "Step 1: Note the patient\u2019s key features. A 67\u2010year-old woman with diabetes presents with incontinence \u2013 she wets her underwear by morning and also during the day if she delays a bathroom break. In addition, she has decreased pinprick sensation in her lower extremities, a finding consistent with diabetic peripheral neuropathy. These findings raise concern for a neurogenic bladder secondary to diabetic autonomathy, which can lead to diabetic cystopathy. In diabetic cystopathy the bladder has decreased contractility and poor sensation, leading to urinary retention with overflow incontinence\u2014patients often void small volumes repeatedly and may have continuous dribbling.\n\nStep 2: Examine the answer choices:\n\u2022 Option A: Bethanechol (a muscarinic agonist that increases detrusor contractility) and intermittent straight catheterization (to ensure complete bladder emptying) are used in overflow incontinence due to neurogenic bladder dysfunction.\n\u2022 Option B: Combining bethanechol with oxybutynin (an antimuscarinic) would be counterproductive because oxybutynin reduces contraction of the detrusor, and is used for detrusor overactivity (urge incontinence) rather than for overflow incontinence.\n\u2022 Option C: \u201cNo recommendations needed\u201d is inappropriate given the patient\u2019s distressing symptoms.\n\u2022 Option D: \u201cReduce fluid intake and discontinue diuretics\u201d is not applicable since she is not on diuretics, and this approach is more for urinary frequency/polyuria rather than neurogenic bladder.\n\nStep 3: Final Answer\nGiven her presentation is most consistent with overflow incontinence due to diabetic neuropathy (diabetic cystopathy), the best treatment option is to use bethanechol to stimulate detrusor contraction along with intermittent straight catheterization to aid bladder emptying.\n\nFinal Answer: A. Bethanechol and intermittent straight catheterization",
            "Step 1: Evaluation of the patient\u2019s presentation\n\u2022 The 67-year-old woman has frequent, small-volume voids and wakes up with soaked underwear.\n\u2022 Her clinical history, including diabetes and signs of decreased lower extremity sensation, suggests the development of diabetic neuropathy, which can affect bladder function.\n\u2022 The small volume voids and incontinence pattern are consistent with overflow urinary incontinence due to neurogenic bladder dysfunction.\n\nStep 2: Matching treatment to pathophysiology\n\u2022 For overflow incontinence resulting from detrusor underactivity (as seen in a neurogenic bladder), the goal is to enhance bladder contractility and help in adequate emptying.\n\u2022 Bethanechol, a muscarinic agonist, increases detrusor tone and is indicated in cases of urinary retention.\n\u2022 Intermittent straight catheterization assists in regularly emptying the bladder to prevent overflow.\n\nStep 3: Analyzing the options\nA. Bethanechol and intermittent straight catheterization \u2013 This directly addresses the need to improve detrusor contractility and ensure complete bladder emptying in overflow incontinence.\nB. Bethanechol during the day and oxybutynin at night \u2013 Oxybutynin is an antimuscarinic agent that reduces detrusor contractions, which would worsen retention.\nC. No recommendations needed \u2013 Inappropriate given the patient\u2019s symptoms and risk factors.\nD. Reduce fluid intake and discontinue diuretics \u2013 The patient is not on diuretics, and fluid intake modification alone will not alleviate her condition.\n\nFinal Answer:\nA. Bethanechol and intermittent straight catheterization",
            "Step 1. Analyze the patient\u2019s presentation. This 67\u2010year\u2010old woman, with long\u2010standing diabetes (evidenced by insulin use and decreased lower extremity pinprick sensation from diabetic neuropathy), reports that she \u201cwakes up every morning with her underwear soaked\u201d and also experiences leakage at work if she doesn\u2019t take regular bathroom breaks. She voids frequently (5\u201311 times per day) with small volumes. In a diabetic patient, autonomic neuropathy can lead to an atonic bladder that fails to contract vigorously, resulting in incomplete emptying. As the bladder becomes chronically overdistended, small amounts of urine may overflow between deliberate voids. This scenario is most consistent with overflow incontinence rather than urge (overactive bladder) or stress incontinence.\n\nStep 2. Consider treatment options. Overflow incontinence secondary to neurogenic bladder is best managed with measures that facilitate complete bladder emptying. Bethanechol, a muscarinic agonist, stimulates detrusor muscle contraction and is used in this setting. Additionally, intermittent straight (clean) catheterization helps ensure complete emptying and prevents urinary stasis.\n\nStep 3. Review the choices:\n\u2022 Option A \u2013 Bethanechol and intermittent straight catheterization: This combination addresses the underlying poor bladder contractility and improves emptying, which is the appropriate treatment for overflow incontinence from diabetic neuropathy.\n\u2022 Option B \u2013 Bethanechol during the day and oxybutynin at night: Oxybutynin is an antimuscarinic that would worsen the problem by reducing bladder contractility when you already need stimulation.\n\u2022 Option C \u2013 No recommendations needed: Inappropriate given her bothersome symptoms.\n\u2022 Option D \u2013 Reduce fluid intake and discontinue diuretics: Not relevant here because she isn\u2019t on any diuretic.\n\nFinal Answer: A. Bethanechol and intermittent straight catheterization."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Evaluation of the patient\u2019s presentation\n\u2022 The 67-year-old woman has frequent, small-volume voids and wakes up with soaked underwear.\n\u2022 Her clinical history, including diabetes and signs of decreased lower extremity sensation, suggests the development of diabetic neuropathy, which can affect bladder function.\n\u2022 The small volume voids and incontinence pattern are consistent with overflow urinary incontinence due to neurogenic bladder dysfunction.\n\nStep 2: Matching treatment to pathophysiology\n\u2022 For overflow incontinence resulting from detrusor underactivity (as seen in a neurogenic bladder), the goal is to enhance bladder contractility and help in adequate emptying.\n\u2022 Bethanechol, a muscarinic agonist, increases detrusor tone and is indicated in cases of urinary retention.\n\u2022 Intermittent straight catheterization assists in regularly emptying the bladder to prevent overflow.\n\nStep 3: Analyzing the options\nA. Bethanechol and intermittent straight catheterization \u2013 This directly addresses the need to improve detrusor contractility and ensure complete bladder emptying in overflow incontinence.\nB. Bethanechol during the day and oxybutynin at night \u2013 Oxybutynin is an antimuscarinic agent that reduces detrusor contractions, which would worsen retention.\nC. No recommendations needed \u2013 Inappropriate given the patient\u2019s symptoms and risk factors.\nD. Reduce fluid intake and discontinue diuretics \u2013 The patient is not on diuretics, and fluid intake modification alone will not alleviate her condition.\n\nFinal Answer:\nA. Bethanechol and intermittent straight catheterization"
    },
    {
        "realidx": 651,
        "question": "A 45-year-old woman presents to the physician for a follow-up visit. She has no specific complaints at this visit however, she has noticed that she is more tired than usual these days. At first, she ignored it and attributed it to stress but she feels weaker each week. She is sometimes out of breath while walking for long distances or when she is involved in strenuous physical activity. She was diagnosed with rheumatoid arthritis 3 years ago and has since been on medication to assist with her pain and to slow down disease progression. Her temperature is 37.0\u00b0C (98.6\u00b0F), the respiratory rate is 15/min, the pulse is 107/min, and the blood pressure is 102/98 mm Hg. On examination, you notice thinning hair and mildly cool extremities with flattened nail beds. A complete blood count and iron studies are ordered. Which of the following is most likely to show up on her iron profile?",
        "answer": "Decreased iron-binding capacity",
        "options": {
            "A": "Increased iron-binding capacity",
            "B": "Low ferritin levels",
            "C": "Decreased iron-binding capacity",
            "D": "Normal iron-binding capacity"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old woman presents",
            "physician",
            "follow-up visit",
            "specific complaints",
            "visit",
            "more tired",
            "usual",
            "days",
            "first",
            "ignored",
            "attributed",
            "stress",
            "feels weaker",
            "week",
            "sometimes out of breath",
            "walking",
            "long distances",
            "involved",
            "strenuous physical activity",
            "diagnosed",
            "rheumatoid arthritis",
            "years",
            "since",
            "on medication to assist",
            "pain",
            "slow down disease progression",
            "temperature",
            "98",
            "respiratory rate",
            "min",
            "pulse",
            "min",
            "blood pressure",
            "98 mm Hg",
            "examination",
            "thinning hair",
            "mildly cool extremities",
            "flattened nail beds",
            "complete blood count",
            "iron studies",
            "ordered",
            "following",
            "most likely to show",
            "iron profile"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 4341,
            "completion_tokens": 2759
        },
        "time_elapsed": 26.56361985206604,
        "raw_responses": [
            "Step 1: Recognize that the patient has a history of rheumatoid arthritis, a chronic inflammatory disease. Chronic inflammation is associated with anemia of chronic disease, where inflammatory cytokines cause iron sequestration.\n\nStep 2: Recall that in anemia of chronic disease, serum iron is low, ferritin (an acute phase reactant) is normal or high, and the total iron-binding capacity (TIBC) is decreased.\n\nStep 3: Evaluate the options:\n\u2022 Option A (Increased iron-binding capacity) is seen in iron deficiency anemia, not in anemia of chronic disease.\n\u2022 Option B (Low ferritin levels) is also seen in iron deficiency anemia.\n\u2022 Option C (Decreased iron-binding capacity) is the expected finding in anemia of chronic disease.\n\u2022 Option D (Normal iron-binding capacity) does not match the typical profile.\n\nFinal answer: C. Decreased iron-binding capacity",
            "Step 1: Recognize that the patient has rheumatoid arthritis, a classic chronic inflammatory disease that can lead to anemia of chronic disease (ACD).\n\nStep 2: In anemia of chronic disease, the iron profile typically shows:\n\u2022 Low serum iron\n\u2022 Decreased total iron-binding capacity (TIBC)\n\u2022 Normal or increased ferritin levels (since ferritin is an acute phase reactant)\n\nStep 3: Among the options given:\nA. Increased iron-binding capacity \u2013 This is seen in iron deficiency anemia, not ACD.\nB. Low ferritin levels \u2013 This is also seen in iron deficiency anemia.\nC. Decreased iron-binding capacity \u2013 This is characteristic of anemia of chronic disease.\nD. Normal iron-binding capacity \u2013 This does not align with the expected findings in ACD.\n\nFinal answer: C. Decreased iron-binding capacity",
            "Step-by-step reasoning:\n\n1. Patient Background: The 45-year-old woman has a long-standing history of rheumatoid arthritis, a chronic inflammatory condition. Anemia commonly associated with chronic inflammation is anemia of chronic disease (ACD).\n\n2. Anemia of Chronic Disease Characteristics: In anemia of chronic disease, inflammatory cytokines lead to increased hepcidin levels. Hepcidin reduces the release of stored iron, resulting in low serum iron, while iron remains stored intracellularly. This process generally leads to a decreased total iron-binding capacity (TIBC). Additionally, ferritin levels are often normal or elevated due to its role as an acute-phase reactant.\n\n3. Analyzing the Options:\n\u2003A. Increased iron-binding capacity: Associated with iron deficiency anemia, not ACD.\n\u2003B. Low ferritin levels: Also seen in iron deficiency anemia.\n\u2003C. Decreased iron-binding capacity: Characteristic of anemia of chronic disease.\n\u2003D. Normal iron-binding capacity: Not typical, as TIBC is usually decreased in ACD.\n\nFinal Answer: C. Decreased iron-binding capacity"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "2"
        ],
        "final_solution": "Step-by-step reasoning:\n\n1. Patient Background: The 45-year-old woman has a long-standing history of rheumatoid arthritis, a chronic inflammatory condition. Anemia commonly associated with chronic inflammation is anemia of chronic disease (ACD).\n\n2. Anemia of Chronic Disease Characteristics: In anemia of chronic disease, inflammatory cytokines lead to increased hepcidin levels. Hepcidin reduces the release of stored iron, resulting in low serum iron, while iron remains stored intracellularly. This process generally leads to a decreased total iron-binding capacity (TIBC). Additionally, ferritin levels are often normal or elevated due to its role as an acute-phase reactant.\n\n3. Analyzing the Options:\n\u2003A. Increased iron-binding capacity: Associated with iron deficiency anemia, not ACD.\n\u2003B. Low ferritin levels: Also seen in iron deficiency anemia.\n\u2003C. Decreased iron-binding capacity: Characteristic of anemia of chronic disease.\n\u2003D. Normal iron-binding capacity: Not typical, as TIBC is usually decreased in ACD.\n\nFinal Answer: C. Decreased iron-binding capacity"
    },
    {
        "realidx": 659,
        "question": "A 64-year-old man with a history of type 2 diabetes mellitus is referred to a urologist. The patient has had pain when urinating and difficulty starting a stream of urine for over 4 months now. He is bothered because he has to urinate about 9 times every day, including several times when he wakes up at night. A digital rectal examination revealed multiple hard nodules in the prostate gland. A CT scan shows a nodule in the right lung that measures 3 cm. An ultrasound scan of his urinary bladder and prostate shows residual urine of > 200 mL and heterogeneous findings of the prostate gland. Biopsy reveals grade 2 prostate adenocarcinoma. Follow-up 9 months later shows his prostate cancer is well controlled with goserelin. If one considers pulmonary nodules that are the same size as this patient\u2019s, which of the following additional findings on CT scans would most likely prompt the removal of such nodules?",
        "answer": "Extending fine striations",
        "options": {
            "A": "\u2018Popcorn\u2019 pattern",
            "B": "Subsolid component",
            "C": "Extending fine striations",
            "D": "Doubling time of < 1 month"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "64 year old man",
            "history of type 2 diabetes mellitus",
            "referred",
            "urologist",
            "patient",
            "pain",
            "difficulty starting",
            "stream of urine",
            "over",
            "months now",
            "to",
            "times",
            "day",
            "including several times",
            "wakes up",
            "night",
            "digital rectal examination revealed multiple hard nodules",
            "prostate",
            "CT scan shows",
            "nodule",
            "right",
            "measures 3",
            "ultrasound scan of",
            "urinary bladder",
            "prostate shows residual urine",
            "200 mL",
            "heterogeneous findings of",
            "prostate gland",
            "Biopsy reveals grade prostate adenocarcinoma",
            "Follow-up 9 months later shows",
            "prostate cancer",
            "well controlled",
            "goserelin",
            "one considers pulmonary nodules",
            "same size",
            "patients",
            "following additional findings",
            "CT scans",
            "most likely prompt",
            "removal",
            "nodules"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5004,
            "completion_tokens": 9855
        },
        "time_elapsed": 66.39504718780518,
        "raw_responses": [
            "Step 1: Understand the Background\n\u2022 The patient has prostate adenocarcinoma that is well\u2010controlled, and incidentally a 3\u2010cm pulmonary nodule is identified.\n\u2022 In a patient with cancer, pulmonary nodules could represent metastases (or be benign). Additional CT characteristics help determine the likelihood that a nodule is malignant and whether intervention (removal) is warranted.\n\nStep 2: Evaluate the Options\nA. \"Popcorn pattern\" \u2013 This is a classic appearance of pulmonary hamartomas, which are benign tumors. Such findings are reassuring and usually do not require removal.\nB. \"Subsolid component\" \u2013 The presence of subsolid or part\u2010solid areas in a nodule can raise suspicion for adenocarcinoma of the lung or metastasis. However, this finding by itself, without evidence of rapid growth, might not be as alarming as a very fast doubling time.\nC. \"Extending fine striations\" \u2013 This is a more non-specific finding and is not a classic indicator for a malignant process necessitating immediate removal.\nD. \"Doubling time of < 1 month\" \u2013 The doubling time of a nodule is an important metric. Malignant nodules typically have doubling times between 1 and 6 months. A doubling time of less than 1 month is unusually rapid even for aggressive cancers, and such a rapid growth rate would be highly concerning for malignancy and would prompt intervention.\n\nStep 3: Conclusion\nGiven the choices, a doubling time of < 1 month (Option D) would most likely prompt removal of the nodule in this clinical scenario.\n\nFinal answer: D. Doubling time of < 1 month.",
            "We can distinguish pulmonary nodules that \u201clook\u201d similar in size (here, about 3 cm) by looking at their radiographic behavior and morphology. In general, benign lesions (e.g., lung hamartomas) often have a \u201cpopcorn\u201d calcification pattern, and nodules that have a subsolid component may in some cases represent adenocarcinoma in situ or invasive adenocarcinoma. In addition, nodules with spiculated or irregular margins (which might be described as extending fine striations) are concerning for malignancy. However, one of the most worrisome features on serial imaging is the rate of growth. Although malignant nodules classically double in size over roughly 30\u2013400 days, a nodule that doubles in size in less than one month is growing far too rapidly for most cancers and is very concerning. A doubling time of < 1 month would prompt urgent diagnostic evaluation and removal because the growth rate is not compatible with the usual course of indolent malignancies or benign nodules.\n\nThus, the answer is:\n\nD. Doubling time of < 1 month",
            "Step 1: Recall that many benign nodules have characteristic imaging features. For example, a \u201cpopcorn\u201d calcification is classically associated with hamartomas (Example A), and a pure ground\u2010glass appearance (subsolid component) can be seen with certain adenocarcinomas but often undergoes surveillance rather than immediate resection. \n\nStep 2: Spiculated margins (described here as \u201cextending fine striations\u201d) are a well\u2010recognized CT feature of malignant lung nodules. This irregular, \u201chairy\u201d border suggests invasion into adjacent lung tissue. Although doubling time is often used, a doubling time shorter than 1 month is atypically rapid even for aggressive cancers and is more suggestive of inflammatory processes.\n\nStep 3: Thus, among the choices given, the presence of extending fine striations (spiculated margins) on CT would most likely prompt removal of a pulmonary nodule of this size.\n\nFinal Answer: C. Extending fine striations"
        ],
        "ensemble_raw_responses": [
            "0",
            "The correct answer is D. Doubling time of < 1 month. Both candidate solutions 0 and 2 indicate that a doubling time of less than 1 month would be most concerning and would prompt removal of a nodule of this size. Candidate solution 1, which chose \u201cextending fine striations,\u201d is less appropriate in this context. Therefore, the best final answer is the one provided by candidate solution 2.\n\nChosen option: 2.",
            "0"
        ],
        "final_solution": "We can distinguish pulmonary nodules that \u201clook\u201d similar in size (here, about 3 cm) by looking at their radiographic behavior and morphology. In general, benign lesions (e.g., lung hamartomas) often have a \u201cpopcorn\u201d calcification pattern, and nodules that have a subsolid component may in some cases represent adenocarcinoma in situ or invasive adenocarcinoma. In addition, nodules with spiculated or irregular margins (which might be described as extending fine striations) are concerning for malignancy. However, one of the most worrisome features on serial imaging is the rate of growth. Although malignant nodules classically double in size over roughly 30\u2013400 days, a nodule that doubles in size in less than one month is growing far too rapidly for most cancers and is very concerning. A doubling time of < 1 month would prompt urgent diagnostic evaluation and removal because the growth rate is not compatible with the usual course of indolent malignancies or benign nodules.\n\nThus, the answer is:\n\nD. Doubling time of < 1 month"
    },
    {
        "realidx": 663,
        "question": "A 58-year-old man is brought to the emergency department because of sudden-onset right-sided body numbness for 1 hour. He reports that he has a 15-year history of hypertension treated with hydrochlorothiazide. He is alert and oriented to time, place, and person. Neurological examination shows decreased sensation to light pinprick and temperature on the right side of the face and body. Motor strength is 5/5 and deep tendon reflexes are 2+ bilaterally. Perfusion of which of the following structures of the brain is most likely impaired in this patient?",
        "answer": "Ventral thalamus",
        "options": {
            "A": "Posterior limb of the internal capsule",
            "B": "Lateral medulla",
            "C": "Basal pons",
            "D": "Ventral thalamus"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "58 year old man",
            "brought",
            "emergency department",
            "of sudden-onset right-sided body numbness",
            "hour",
            "reports",
            "year history of hypertension treated with hydrochlorothiazide",
            "alert",
            "oriented to time",
            "place",
            "person",
            "Neurological examination shows decreased sensation",
            "light pinprick",
            "temperature",
            "right side of",
            "face",
            "body",
            "Motor strength",
            "5/5",
            "deep tendon reflexes",
            "2",
            "Perfusion of",
            "following structures",
            "brain",
            "most likely impaired",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5139,
            "completion_tokens": 3661
        },
        "time_elapsed": 26.760969877243042,
        "raw_responses": [
            "Step 1: Identify the key clinical details.\n\u2022 The patient is a 58\u2010year\u2010old man with a history of hypertension.\n\u2022 He has sudden-onset right-sided loss of pain and temperature sensation in the face and body.\n\u2022 There is no motor weakness.\n\nStep 2: Analyze the neuroanatomical localization.\n\u2022 A pure sensory deficit without motor weakness suggests involvement of a sensory relay nucleus.\n\u2022 The ventral posterolateral (VPL) nucleus of the thalamus (often referred to here as the ventral thalamus) is responsible for relaying sensory information from the body, and the ventral posteromedial (VPM) nucleus handles that from the face.\n\u2022 A lacunar infarct in the thalamus (\u201cthalamic stroke\u201d) can lead to these findings.\n\u2022 The lateral medulla would cause additional symptoms (e.g., dysphagia, vertigo) and a crossed sensory deficit, not an isolated unilateral loss.\n\u2022 The posterior limb of the internal capsule generally affects motor fibers, so an infarct here would typically cause motor weakness.\n\u2022 The basal pons is not typically associated with isolated sensory deficits and often involves cranial nerve findings if affected.\n\nStep 3: Compare the options.\nA. Posterior limb of the internal capsule \u2013 would cause motor deficits.\nB. Lateral medulla \u2013 would produce additional symptoms and a crossed pattern of sensory loss.\nC. Basal pons \u2013 unlikely to present with an isolated sensory deficit.\nD. Ventral thalamus \u2013 contains the VPL and VPM, making it the most likely site to produce an isolated sensory loss affecting the face and body.\n\nFinal answer: D: Ventral thalamus",
            "Step 1: The patient has sudden-onset contralateral (right-sided) loss of pain and temperature sensation affecting both the body and face. Importantly, his motor strength is normal. This isolates the problem to the sensory pathway.\n\nStep 2: The structures that could be involved include the thalamus (especially its ventral nuclei that relay sensory information), the lateral medulla (which, when infarcted, produces lateral medullary syndrome or Wallenberg syndrome with additional signs like dysphagia and vertigo), the posterior limb of the internal capsule (which would also affect motor pathways), and the basal pons (which typically affects other functions including motor control).\n\nStep 3: Given that the patient\u2019s motor exam is normal and he only exhibits sensory deficits, the structure with impaired perfusion is most likely the ventral part of the thalamus, which includes the ventral posterolateral nucleus (VPL) for the body and the ventral posteromedial nucleus (VPM) for the face.\n\nFinal Answer: D. Ventral thalamus",
            "Step 1 \u2013 Summarize the Clinical Presentation:\n\u2022 A 58\u2010year-old man with hypertension experiences sudden-onset right-sided numbness for 1 hour.\n\u2022 Neurological exam shows decreased light pinprick and temperature sensation on the right side of the face and body.\n\u2022 Motor strength and deep tendon reflexes are normal.\n\nStep 2 \u2013 Localize the Lesion:\n\u2022 The combination of contralateral loss of pain and temperature from both the face and body suggests involvement of a structure that processes sensory information from both regions.\n\u2022 The ventral thalamus (specifically, the ventral posterolateral [VPL] and ventral posteromedial [VPM] nuclei) serves as the sensory relay station for the body and face, respectively.\n\u2022 A lesion in the left ventral thalamus would result in right-sided sensory deficits without causing motor abnormalities.\n\nStep 3 \u2013 Compare and Eliminate Other Options:\nA. Posterior limb of the internal capsule \u2013 Lesions here typically cause motor deficits (pure motor hemiparesis) since the corticospinal tract is contained in this region.\nB. Lateral medulla \u2013 Infarctions in this area (Wallenberg syndrome) would cause deficits similar to loss of pain and temperature on the contralateral body and ipsilateral face, but usually include additional features such as dysphagia, vertigo, and ataxia, which are not present in this patient.\nC. Basal pons \u2013 Infarcts in the pons often affect multiple systems, including motor pathways, and would likely present with both motor and cranial nerve deficits.\nD. Ventral thalamus \u2013 This structure is the key sensory relay for both body (VPL) and face (VPM). An infarct here (a lacunar stroke) can lead to a \u201cpure sensory stroke\u201d with findings that match this patient's presentation.\n\nStep 4 \u2013 Provide the Final Answer:\nFinal Answer: D. Ventral thalamus"
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Step 1 \u2013 Summarize the Clinical Presentation:\n\u2022 A 58\u2010year-old man with hypertension experiences sudden-onset right-sided numbness for 1 hour.\n\u2022 Neurological exam shows decreased light pinprick and temperature sensation on the right side of the face and body.\n\u2022 Motor strength and deep tendon reflexes are normal.\n\nStep 2 \u2013 Localize the Lesion:\n\u2022 The combination of contralateral loss of pain and temperature from both the face and body suggests involvement of a structure that processes sensory information from both regions.\n\u2022 The ventral thalamus (specifically, the ventral posterolateral [VPL] and ventral posteromedial [VPM] nuclei) serves as the sensory relay station for the body and face, respectively.\n\u2022 A lesion in the left ventral thalamus would result in right-sided sensory deficits without causing motor abnormalities.\n\nStep 3 \u2013 Compare and Eliminate Other Options:\nA. Posterior limb of the internal capsule \u2013 Lesions here typically cause motor deficits (pure motor hemiparesis) since the corticospinal tract is contained in this region.\nB. Lateral medulla \u2013 Infarctions in this area (Wallenberg syndrome) would cause deficits similar to loss of pain and temperature on the contralateral body and ipsilateral face, but usually include additional features such as dysphagia, vertigo, and ataxia, which are not present in this patient.\nC. Basal pons \u2013 Infarcts in the pons often affect multiple systems, including motor pathways, and would likely present with both motor and cranial nerve deficits.\nD. Ventral thalamus \u2013 This structure is the key sensory relay for both body (VPL) and face (VPM). An infarct here (a lacunar stroke) can lead to a \u201cpure sensory stroke\u201d with findings that match this patient's presentation.\n\nStep 4 \u2013 Provide the Final Answer:\nFinal Answer: D. Ventral thalamus"
    },
    {
        "realidx": 664,
        "question": "A 9-year-old boy is brought in by his mother because of bruising on his torso and limbs. The patient\u2019s mother denies any other symptoms and says he is otherwise healthy. Physical examination shows multiple petechiae and bruising on the torso and extremities bilaterally. The remainder of the physical exam is unremarkable. A complete blood count is normal. His coagulation profile reveals:\nProthrombin time (PT) 12 sec\nActivated partial thromboplastin time (aPTT) 60 sec\nWhich of the following is the most likely diagnosis in this patient?",
        "answer": "Von Willebrand disease",
        "options": {
            "A": "Acute lymphoblastic leukemia",
            "B": "Immune thrombocytopenic purpura",
            "C": "Von Willebrand disease",
            "D": "Hemophilia A"
        },
        "meta_info": "step1",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old boy",
            "brought",
            "mother",
            "bruising",
            "torso",
            "limbs",
            "patients mother denies",
            "symptoms",
            "healthy",
            "Physical examination shows multiple petechiae",
            "bruising",
            "torso",
            "extremities",
            "physical exam",
            "unremarkable",
            "complete blood count",
            "normal",
            "coagulation profile reveals",
            "Prothrombin time",
            "sec Activated partial thromboplastin time",
            "60",
            "following",
            "most likely diagnosis",
            "patient"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5100,
            "completion_tokens": 3937
        },
        "time_elapsed": 30.08114266395569,
        "raw_responses": [
            "Step 1: Review the clinical details. This 9-year-old boy has bruising and petechiae with normal complete blood count, a normal prothrombin time (PT), and a prolonged activated partial thromboplastin time (aPTT). The patient is otherwise healthy, and there\u2019s no evidence of bone marrow issues, which helps rule out disorders associated with abnormal cell counts.\n\nStep 2: Compare the differential diagnoses.\n\n\u2022 Acute lymphoblastic leukemia (ALL) \u2013 Often presents with abnormal CBC findings including anemia, thrombocytopenia, or leukocytosis/leukopenia; a normal CBC makes this less likely.\n\u2022 Immune thrombocytopenic purpura (ITP) \u2013 Typically presents with isolated thrombocytopenia leading to petechiae and bruising. However, this patient\u2019s CBC is normal, so ITP is unlikely.\n\u2022 Von Willebrand disease \u2013 It can cause a prolonged aPTT because von Willebrand factor stabilizes factor VIII. However, it often presents with mucosal bleeding (e.g., epistaxis) and is seen in both genders with a more autosomal dominant pattern. It is less typical in an otherwise healthy 9-year-old boy presenting primarily with bruising.\n\u2022 Hemophilia A \u2013 An X-linked recessive disorder (more common in boys) characterized by factor VIII deficiency. It produces a prolonged aPTT with a normal PT and typically presents with bleeding into muscles and joints, as well as easy bruising.\n\nStep 3: Analyze and eliminate.\n\nGiven the patient\u2019s age, sex, physical exam findings, and the coagulation profile (normal PT with prolonged aPTT), Hemophilia A is the most consistent diagnosis.\n\nFinal answer: D. Hemophilia A",
            "Step 1: The patient is a 9-year-old boy who presents with petechiae and bruising, and his laboratory studies show a normal prothrombin time (PT) but a prolonged activated partial thromboplastin time (aPTT). His complete blood count is normal, which indicates that the number of platelets is not decreased.\n\nStep 2: Now, let\u2019s compare the options:\n\nA. Acute lymphoblastic leukemia \u2013 This condition typically presents with abnormal blood counts, including anemia, thrombocytopenia, or leukocytosis, none of which are evident here.\n\nB. Immune thrombocytopenic purpura \u2013 ITP is characterized by thrombocytopenia (low platelet count), which would be seen in the CBC, but the patient's CBC is normal.\n\nC. Von Willebrand disease \u2013 This can cause a prolonged aPTT due to an associated decrease in factor VIII activity; however, it usually has additional features like mucosal bleeding, and it is less common to present solely with bruising in a young boy without other bleeding symptoms. Also, von Willebrand disease is autosomal dominant and affects both sexes.\n\nD. Hemophilia A \u2013 This is an X-linked recessive disorder seen in boys due to deficiency of factor VIII. It typically presents with bleeding, including bruising and hemarthroses, a normal platelet count, a normal PT, and a prolonged aPTT.\n\nStep 3: Given the patient\u2019s gender, normal CBC, and the coagulation profile with a normal PT and prolonged aPTT, Hemophilia A is the most fitting diagnosis.\n\nFinal answer: D. Hemophilia A",
            "Step 1: Analyze the lab values and presentation.\n\u2022 The patient, a 9-year-old boy, has abnormal bruising with multiple petechiae. A normal complete blood count rules out issues such as thrombocytopenia.\n\u2022 The coagulation profile shows a normal prothrombin time (PT) with a prolonged activated partial thromboplastin time (aPTT), which suggests a defect in the intrinsic pathway.\n\nStep 2: Narrow down the differential diagnoses.\n\u2022 Acute lymphoblastic leukemia (ALL) would more likely show abnormal CBC findings.\n\u2022 Immune thrombocytopenic purpura (ITP) would typically present with a low platelet count.\n\u2022 Von Willebrand disease can present with a prolonged aPTT due to its effect on factor VIII stabilization, but it is equally common in both sexes and is more typically associated with mucosal bleeding than with isolated bruising in an otherwise healthy boy.\n\u2022 Hemophilia A (Factor VIII deficiency) is an X-linked recessive disorder that primarily affects boys, and it classically presents with a prolonged aPTT and normal PT and platelet count.\n\nStep 3: Determine the final answer.\nGiven the patient\u2019s age, gender, clinical presentation, and lab findings, the most likely diagnosis is:\nD. Hemophilia A"
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "2"
        ],
        "final_solution": "Step 1: Analyze the lab values and presentation.\n\u2022 The patient, a 9-year-old boy, has abnormal bruising with multiple petechiae. A normal complete blood count rules out issues such as thrombocytopenia.\n\u2022 The coagulation profile shows a normal prothrombin time (PT) with a prolonged activated partial thromboplastin time (aPTT), which suggests a defect in the intrinsic pathway.\n\nStep 2: Narrow down the differential diagnoses.\n\u2022 Acute lymphoblastic leukemia (ALL) would more likely show abnormal CBC findings.\n\u2022 Immune thrombocytopenic purpura (ITP) would typically present with a low platelet count.\n\u2022 Von Willebrand disease can present with a prolonged aPTT due to its effect on factor VIII stabilization, but it is equally common in both sexes and is more typically associated with mucosal bleeding than with isolated bruising in an otherwise healthy boy.\n\u2022 Hemophilia A (Factor VIII deficiency) is an X-linked recessive disorder that primarily affects boys, and it classically presents with a prolonged aPTT and normal PT and platelet count.\n\nStep 3: Determine the final answer.\nGiven the patient\u2019s age, gender, clinical presentation, and lab findings, the most likely diagnosis is:\nD. Hemophilia A"
    },
    {
        "realidx": 665,
        "question": "A 31-year-old man comes to the physician because of a 4-week history of a painless lump near the left wrist and tingling pain over his left hand. Physical examination shows a transilluminating, rubbery, fixed, non-tender mass over the lateral volar aspect of the left wrist. There is decreased sensation to pinprick on the thumb, index finger, middle finger, and radial half of the ring finger of the left hand. The tingling pain is aggravated by tapping over the swelling. Which of the following adjacent structures is at risk of entrapment if this mass persists?",
        "answer": "Flexor pollicis longus tendon",
        "options": {
            "A": "Ulnar artery",
            "B": "Flexor pollicis longus tendon",
            "C": "Flexor carpi radialis tendon",
            "D": "Ulnar nerve"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "31 year old man",
            "physician",
            "4 week history",
            "painless lump",
            "left wrist",
            "tingling pain",
            "left",
            "Physical examination shows",
            "rubbery",
            "fixed",
            "non-tender mass",
            "lateral volar aspect of",
            "left wrist",
            "decreased sensation",
            "pinprick",
            "thumb",
            "index finger",
            "middle finger",
            "radial half of",
            "ring finger",
            "left hand",
            "tingling pain",
            "aggravated",
            "swelling",
            "following adjacent structures",
            "at risk",
            "entrapment",
            "mass"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5412,
            "completion_tokens": 13129
        },
        "time_elapsed": 88.67527866363525,
        "raw_responses": [
            "We can start by noting several salient points in the patient\u2019s presentation. He has a painless, transilluminating, \u201crubbery\u201d mass over the lateral (thumb\u2010side) volar wrist. In addition, he has decreased sensation along the thumb, index, middle, and lateral half of the ring finger. Tapping over the mass reproduces his tingling, a positive Tinel sign. These findings are most consistent with a wrist ganglion (a cystic mass) that is compressing the median nerve (its sensory distribution matches that of the median nerve). \n\nAn untreated ganglion cyst in this location (in or near the carpal tunnel) can continue to enlarge and further compress the structures that share this confined space. The carpal tunnel contains the median nerve along with the flexor tendons. One important tendon in that compartment is the flexor pollicis longus (FPL) tendon\u2014which lies immediately adjacent to (and, in many cross\u2010sections, even partially separates from) the median nerve. Thus, with persistent cyst enlargement the FPL tendon is at risk of becoming entrapped.\n\nLooking at the options:\n\u2022 Option A (ulnar artery) and Option D (ulnar nerve) are not anatomically related to the lateral volar wrist region or the carpal tunnel contents affected here.\n\u2022 Option C (flexor carpi radialis tendon) travels in its own sheath separate from the carpal tunnel.\n\u2022 Option B (flexor pollicis longus tendon) is within the carpal tunnel and lies adjacent to the median nerve. \n\nBecause of its location in the carpal tunnel, a persistent ganglion cyst may encroach on and eventually compress the flexor pollicis longus tendon.\n\nFinal answer: Flexor pollicis longus tendon.",
            "Step 1: The patient\u2019s painless, transilluminating, rubbery mass is most consistent with a ganglion cyst. In the wrist, ganglion cysts can arise from a joint capsule or tendon sheath. When one occurs on the volar (palmar) aspect near the lateral (radial) side of the wrist, it may compress nearby neural structures.\n\nStep 2: His decreased sensation in the thumb, index, middle, and the radial half of the ring finger and the reproduction of tingling with tapping (a positive Tinel sign) are classic findings of median nerve compression at the level of the wrist (i.e. carpal tunnel syndrome\u2013like symptoms). This means the median nerve is being affected by the mass.\n\nStep 3: Although none of the answer choices list the median nerve, the adjacent structure at risk for entrapment from a persistent ganglion cyst in this location is, in fact, the median nerve.\n\nFinal Answer: The median nerve is at risk (none of the provided options).",
            "Step 1: Analysis of the Case\n\u2022 The patient is a 31\u2010year\u2010old man with a 4\u2010week history of a painless mass near the lateral (thumb side) volar aspect of his wrist.\n\u2022 His examination reveals decreased sensation over the thumb, index, middle, and radial half of the ring finger\u2014a distribution matching the median nerve.\n\u2022 Tapping over the mass elicits tingling (a positive Tinel sign), suggesting nerve irritation.\n\u2022 The physical characteristics (rubbery, fixed, non-tender, transilluminating) suggest a cystic lesion, such as a ganglion cyst.\n\nStep 2: Understanding the Anatomy\n\u2022 Ganglion cysts of the wrist most commonly arise in relation to joint capsules or tendon sheaths.\n\u2022 In the lateral volar wrist, the cyst can be adjacent to the flexor compartment. Within the carpal tunnel, the most radial structure is the flexor pollicis longus (FPL) tendon.\n\u2022 The median nerve, which governs the sensory distribution noted in this patient, lies superficial to and just ulnar to the FPL tendon.\n\u2022 Although the median nerve is the one showing signs of entrapment (evidenced by sensory deficits and positive Tinel sign), the question asks which adjacent structure is at risk of entrapment if the mass persists.\n\u2022 Because of its close proximity to the median nerve within the carpal tunnel, the flexor pollicis longus tendon is particularly vulnerable if the space is further compromised by the persistent cyst.\n\nStep 3: Eliminating Other Options\n\u2022 Ulnar artery (Option A) and ulnar nerve (Option D) are located on the medial side (ulnar aspect) of the wrist\u2014away from the lateral volar location and the affected median nerve territory.\n\u2022 The flexor carpi radialis tendon (Option C) is more superficial and lateral, but it runs in its own fibrous sheath separate from the carpal tunnel contents and is less likely to be affected by a mass in this specific location.\n\nStep 4: Final Answer\nGiven the anatomy and the location of the cyst, if the cyst persists it may cause entrapment of the structure adjacent to the median nerve in the carpal tunnel\u2014the Flexor Pollicis Longus tendon.\n\nFinal answer: Flexor pollicis longus tendon (Option B)."
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "0"
        ],
        "final_solution": "We can start by noting several salient points in the patient\u2019s presentation. He has a painless, transilluminating, \u201crubbery\u201d mass over the lateral (thumb\u2010side) volar wrist. In addition, he has decreased sensation along the thumb, index, middle, and lateral half of the ring finger. Tapping over the mass reproduces his tingling, a positive Tinel sign. These findings are most consistent with a wrist ganglion (a cystic mass) that is compressing the median nerve (its sensory distribution matches that of the median nerve). \n\nAn untreated ganglion cyst in this location (in or near the carpal tunnel) can continue to enlarge and further compress the structures that share this confined space. The carpal tunnel contains the median nerve along with the flexor tendons. One important tendon in that compartment is the flexor pollicis longus (FPL) tendon\u2014which lies immediately adjacent to (and, in many cross\u2010sections, even partially separates from) the median nerve. Thus, with persistent cyst enlargement the FPL tendon is at risk of becoming entrapped.\n\nLooking at the options:\n\u2022 Option A (ulnar artery) and Option D (ulnar nerve) are not anatomically related to the lateral volar wrist region or the carpal tunnel contents affected here.\n\u2022 Option C (flexor carpi radialis tendon) travels in its own sheath separate from the carpal tunnel.\n\u2022 Option B (flexor pollicis longus tendon) is within the carpal tunnel and lies adjacent to the median nerve. \n\nBecause of its location in the carpal tunnel, a persistent ganglion cyst may encroach on and eventually compress the flexor pollicis longus tendon.\n\nFinal answer: Flexor pollicis longus tendon."
    },
    {
        "realidx": 670,
        "question": "A medical student is preparing a patient for an appendectomy. He is asked by the surgeon to disinfect the patient\u2019s skin with a chlorhexidine-isopropyl alcohol solution before the procedure. Recent studies have shown that this solution substantially reduces the risk of surgical site infections compared with a povidone-iodine preparation without alcohol in clean-contaminated surgery. Which of the following mechanisms best describes the mechanism of action of chlorhexidine?",
        "answer": "Its activity depends on pH and is greatly reduced in the presence of organic matter",
        "options": {
            "A": "Bactericidal at low concentrations",
            "B": "Cell wall damage by free radical release",
            "C": "Attack of free-sulfur amino acids, nucleotides, and fatty acids within the bacteria",
            "D": "Its activity depends on pH and is greatly reduced in the presence of organic matter"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "medical student",
            "preparing",
            "patient",
            "appendectomy",
            "surgeon to",
            "patients skin",
            "chlorhexidine-isopropyl alcohol solution",
            "procedure",
            "Recent studies",
            "shown",
            "solution",
            "risk of surgical site infections compared",
            "povidone-iodine preparation",
            "alcohol",
            "clean contaminated surgery",
            "following mechanisms best",
            "mechanism of action",
            "chlorhexidine"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 5469,
            "completion_tokens": 8544
        },
        "time_elapsed": 61.93711495399475,
        "raw_responses": [
            "Chlorhexidine is a cationic bisbiguanide antiseptic that works by binding to negatively charged bacterial cell membranes. This binding disrupts membrane integrity, increasing permeability and leading to leakage of cellular contents. Although the drug\u2019s effects vary with concentration\u2014being bacteriostatic at lower concentrations and bactericidal at higher ones\u2014the key point is that its bactericidal activity ultimately results from damage to the cell membrane rather than by generating free radicals, oxidizing cellular components, or being rendered inactive by pH or organic matter.\n\nLet\u2019s briefly review the answer choices:\n\nA. Bactericidal at low concentrations  \n\u2003\u2022 While chlorhexidine does show bactericidal activity at high concentrations, at lower concentrations it is typically bacteriostatic. This option is imprecise and does not describe the actual mechanism of membrane disruption.\n\nB. Cell wall damage by free radical release  \n\u2003\u2022 Chlorhexidine does not act by generating free radicals; this is not its mechanism.\n\nC. Attack of free-sulfur amino acids, nucleotides, and fatty acids within the bacteria  \n\u2003\u2022 This option is more in line with the mechanism of iodine preparations, which oxidize and disrupt cellular molecules, rather than with chlorhexidine.\n\nD. Its activity depends on pH and is greatly reduced in the presence of organic matter  \n\u2003\u2022 This describes a property more associated with povidone-iodine and is not the mechanism of chlorhexidine.\n\nAlthough none of the options exactly state \u201cdisruption of the cell membrane via binding to negatively charged phospholipids,\u201d option A comes closest by implying that the bactericidal effects (observed at higher concentrations) are central to chlorhexidine\u2019s action. Given the choices provided, the best answer is:\n\nFinal Answer: A. Bactericidal at low concentrations",
            "Chlorhexidine is a cationic bisbiguanide antiseptic that works by binding to the negatively charged bacterial cell membranes. This binding disrupts the cell membrane integrity, leading to leakage of intracellular components and ultimately cell death. Although chlorhexidine is bacteriostatic at low concentrations and bactericidal at high concentrations, none of the options explicitly describe the \u201ccell membrane disruption\u201d mechanism. In the context of the provided answer choices, the one statement that most closely reflects chlorhexidine\u2019s action is that it is bactericidal (at appropriate concentrations).\n\nTo explain step by step:\n\n1. Chlorhexidine binds to bacterial membranes due to its positive charge and disrupts their structure.\n2. This disruption leads to increased permeability and leakage of cellular components.\n3. At higher concentrations, this cell membrane damage results in bactericidal effects.\n\nComparing the answer options:\n\u2022 Option A states \u201cBactericidal at low concentrations\u201d\u2014while chlorhexidine is actually bacteriostatic at low concentrations and bactericidal at higher concentrations, this option is the only one that is somewhat aligned with an effective antibacterial property.\n\u2022 Option B (free radical-mediated damage) is more typical of agents like hydrogen peroxide.\n\u2022 Option C (attack on free-sulfur amino acids, nucleotides, and fatty acids) describes iodine\u2019s nonspecific oxidation of cellular components.\n\u2022 Option D (activity dependent on pH and reduced by organic matter) is more descriptive of the limitations seen with iodine-based preparations.\n\nThus, even though Option A is not a perfect mechanistic description, it best approximates the action of chlorhexidine from the choices given.\n\nFinal answer: A.",
            "Chlorhexidine is a cationic bisbiguanide whose antimicrobial effects are mediated by its interaction with cell membranes. When applied, it binds to the negatively charged bacterial cell wall and disrupts the integrity of the cell membrane. This disruption causes leakage of intracellular components and ultimately leads to cell death. (It is important to note that at lower concentrations chlorhexidine tends to be bacteriostatic, whereas at higher concentrations it becomes bactericidal.) \n\nLooking at the options:\n\nA. Bactericidal at low concentrations  \n\u2003\u2003\u2013 Although chlorhexidine is bactericidal at higher concentrations, at lower concentrations it is typically bacteriostatic. This option does not accurately capture the membrane-disrupting mechanism.\n\nB. Cell wall damage by free radical release  \n\u2003\u2003\u2013 Chlorhexidine does not work via free radical release; this is not its mechanism of action.\n\nC. Attack of free-sulfur amino acids, nucleotides, and fatty acids within the bacteria  \n\u2003\u2003\u2013 This description is more consistent with the mechanism attributed to iodine, which oxidizes and disrupts various cellular components. It is not how chlorhexidine acts.\n\nD. Its activity depends on pH and is greatly reduced in the presence of organic matter  \n\u2003\u2003\u2013 This is a limitation of some disinfectants (for example, povidone-iodine is negatively affected by organic matter), but it does not describe the mechanism of action of chlorhexidine.\n\nNone of the answer choices precisely states \u201cdisruption of the bacterial cell membrane,\u201d which is the key mechanism for chlorhexidine. However, by process of elimination the option that is closest to describing an inherent antimicrobial property (even though the wording is off) is option A. Despite the imprecision regarding concentration\u2010dependent activity (bacteriostatic at lower concentrations and bactericidal at higher ones), none of the other options are correct.\n\nThus, the best answer given the available choices is:\n\nFinal answer: A. Bactericidal at low concentrations"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "1"
        ],
        "final_solution": "Chlorhexidine is a cationic bisbiguanide antiseptic that works by binding to negatively charged bacterial cell membranes. This binding disrupts membrane integrity, increasing permeability and leading to leakage of cellular contents. Although the drug\u2019s effects vary with concentration\u2014being bacteriostatic at lower concentrations and bactericidal at higher ones\u2014the key point is that its bactericidal activity ultimately results from damage to the cell membrane rather than by generating free radicals, oxidizing cellular components, or being rendered inactive by pH or organic matter.\n\nLet\u2019s briefly review the answer choices:\n\nA. Bactericidal at low concentrations  \n\u2003\u2022 While chlorhexidine does show bactericidal activity at high concentrations, at lower concentrations it is typically bacteriostatic. This option is imprecise and does not describe the actual mechanism of membrane disruption.\n\nB. Cell wall damage by free radical release  \n\u2003\u2022 Chlorhexidine does not act by generating free radicals; this is not its mechanism.\n\nC. Attack of free-sulfur amino acids, nucleotides, and fatty acids within the bacteria  \n\u2003\u2022 This option is more in line with the mechanism of iodine preparations, which oxidize and disrupt cellular molecules, rather than with chlorhexidine.\n\nD. Its activity depends on pH and is greatly reduced in the presence of organic matter  \n\u2003\u2022 This describes a property more associated with povidone-iodine and is not the mechanism of chlorhexidine.\n\nAlthough none of the options exactly state \u201cdisruption of the cell membrane via binding to negatively charged phospholipids,\u201d option A comes closest by implying that the bactericidal effects (observed at higher concentrations) are central to chlorhexidine\u2019s action. Given the choices provided, the best answer is:\n\nFinal Answer: A. Bactericidal at low concentrations"
    },
    {
        "realidx": 676,
        "question": "A 75-year-old man is admitted to the hospital because of a 3-day history of a productive cough and shortness of breath. His temperature is 38\u00b0C (100.4\u00b0F) and respirations are 32/min. Crackles are heard over the right upper and the entire left lung fields. Sputum culture confirms infection with Streptococcus pneumoniae. Despite appropriate therapy, the patient dies. A photomicrograph of a section of the lung obtained during the autopsy is shown. Which of the following mediators is most likely responsible for the presence of the cell-type indicated by the arrow?",
        "answer": "Platelet activating factor",
        "options": {
            "A": "Platelet activating factor",
            "B": "Interferon-gamma",
            "C": "Interleukin-10",
            "D": "Leukotriene D4"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "75 year old man",
            "admitted",
            "hospital",
            "3-day history",
            "productive cough",
            "shortness of breath",
            "temperature",
            "100 4F",
            "respirations",
            "min",
            "Crackles",
            "heard",
            "right upper",
            "entire left lung fields",
            "Sputum culture confirms infection",
            "Streptococcus pneumoniae",
            "appropriate therapy",
            "patient",
            "photomicrograph",
            "section",
            "lung obtained",
            "autopsy",
            "shown",
            "following mediators",
            "most likely responsible",
            "presence of",
            "cell-type indicated",
            "arrow"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4653,
            "completion_tokens": 4277
        },
        "time_elapsed": 33.84163212776184,
        "raw_responses": [
            "Step 1: Identify the cell type. In a case of bacterial pneumonia caused by Streptococcus pneumoniae, the lung typically shows an acute inflammatory infiltrate. The arrow in the photomicrograph likely points to neutrophils\u2014the primary responders in an acute bacterial infection.\n\nStep 2: Review the mediator options.\n\u2022 Platelet activating factor (PAF) is known to mediate neutrophil chemotaxis, adhesion, and activation.\n\u2022 Interferon-gamma is involved primarily in activating macrophages and promoting a Th1 response, not in recruiting neutrophils.\n\u2022 Interleukin-10 is an anti\u2010inflammatory cytokine that downregulates pro-inflammatory responses.\n\u2022 Leukotriene D4 is primarily involved in bronchoconstriction and increasing vascular permeability but is not the key mediator for neutrophil recruitment (leukotriene B4 would be the neutrophil chemotactic agent).\n\nStep 3: Eliminate the incorrect options. With the understanding that neutrophils are the cell type indicated in the pneumonia autopsy and that PAF is directly involved in neutrophil chemotaxis, the correct mediator is most consistent with platelet activating factor.\n\nFinal Answer: A. Platelet activating factor.",
            "The patient\u2019s lung shows classic changes consistent with a bacterial pneumonia caused by Streptococcus pneumoniae. Histologically, one of the defining features of lobar pneumonia is the accumulation of neutrophils within the alveolar spaces. Although IL-8 is classically described as the major neutrophil chemoattractant, it is not listed among the options.\n\nStep 1: In pneumonia due to Streptococcus pneumoniae, there is an acute inflammatory response dominated by neutrophils. These cells are recruited to the site of infection and accumulate in the alveoli.\n\nStep 2: Review of the options:\n\u2022 Platelet activating factor (PAF) \u2013 This mediator is released by several cells (including endothelial cells and alveolar macrophages) and plays a critical role in neutrophil activation and chemotaxis, along with increasing vascular permeability.\n\u2022 Interferon-gamma \u2013 This cytokine is more important for activating macrophages during chronic and granulomatous reactions (e.g., in tuberculosis), not acute neutrophilic infiltration.\n\u2022 Interleukin-10 \u2013 This is an anti-inflammatory cytokine that actually downregulates inflammatory responses.\n\u2022 Leukotriene D4 \u2013 Best known for its effects in bronchoconstriction and increasing vascular permeability, especially in asthma; it is not primarily responsible for recruiting neutrophils.\n\nStep 3: Since the cell indicated by the arrow is most likely a neutrophil and PAF is a mediator known to facilitate the acute recruitment of neutrophils in inflammation, the best answer is:\n\nPlatelet activating factor.\n\nFinal Answer: Platelet activating factor",
            "Step 1: In pneumococcal pneumonia, the alveoli become filled with an exudate that predominantly consists of neutrophils. The photomicrograph from the autopsy likely shows a lung filled with these inflammatory cells. The arrow in the image is pointing to a neutrophil.\n\nStep 2: Now we need to determine which mediator is most closely associated with neutrophil recruitment into areas of inflammation.\n\u2003\u2022 Platelet activating factor (PAF) is known to aid in the adhesion of neutrophils to the endothelium and is an important mediator in neutrophil recruitment.\n\u2003\u2022 Interferon-gamma is primarily involved in macrophage activation and defense against intracellular pathogens.\n\u2003\u2022 Interleukin-10 is an anti-inflammatory cytokine that downregulates immune responses.\n\u2003\u2022 Leukotriene D4 is more associated with bronchoconstriction and increased vascular permeability rather than direct neutrophil recruitment.\n  \nGiven these roles, the mediator most responsible for the presence of neutrophils in the lung tissue would be Platelet activating factor.\n\nStep 3: Final answer: Platelet activating factor."
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Step 1: In pneumococcal pneumonia, the alveoli become filled with an exudate that predominantly consists of neutrophils. The photomicrograph from the autopsy likely shows a lung filled with these inflammatory cells. The arrow in the image is pointing to a neutrophil.\n\nStep 2: Now we need to determine which mediator is most closely associated with neutrophil recruitment into areas of inflammation.\n\u2003\u2022 Platelet activating factor (PAF) is known to aid in the adhesion of neutrophils to the endothelium and is an important mediator in neutrophil recruitment.\n\u2003\u2022 Interferon-gamma is primarily involved in macrophage activation and defense against intracellular pathogens.\n\u2003\u2022 Interleukin-10 is an anti-inflammatory cytokine that downregulates immune responses.\n\u2003\u2022 Leukotriene D4 is more associated with bronchoconstriction and increased vascular permeability rather than direct neutrophil recruitment.\n  \nGiven these roles, the mediator most responsible for the presence of neutrophils in the lung tissue would be Platelet activating factor.\n\nStep 3: Final answer: Platelet activating factor."
    },
    {
        "realidx": 677,
        "question": "A 2-month-old infant is brought to the emergency department by her mother due to a fall. Tearfully, the patient\u2019s mother describes witnessing her child fall from the changing table. The patient was born prematurely at 36 weeks estimated gestational age via vacuum-assisted vaginal delivery. The patient is afebrile. Her vital signs include: blood pressure of 94/60 mm Hg, pulse 200/min, and respiratory rate 70/min. Physical examination reveals a subconjunctival hemorrhage in the left eye and multiple bruises on the chest and back. Which of the following is the best initial step in management of this patient\u2019s condition?",
        "answer": "CT scan of the head",
        "options": {
            "A": "CT scan of the head",
            "B": "Involvement of social services",
            "C": "Family counseling",
            "D": "Rule out medical conditions"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "2 month old infant",
            "brought",
            "emergency department",
            "mother due to",
            "fall",
            "patients mother",
            "witnessing",
            "child fall from",
            "changing table",
            "patient",
            "born",
            "36 weeks estimated gestational age",
            "vacuum assisted vaginal delivery",
            "patient",
            "afebrile",
            "vital signs include",
            "blood pressure",
            "60 mm Hg",
            "pulse 200 min",
            "respiratory rate 70 min",
            "Physical examination reveals",
            "subconjunctival hemorrhage",
            "left eye",
            "multiple bruises",
            "chest",
            "back",
            "following",
            "best initial step",
            "management",
            "patients condition"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4563,
            "completion_tokens": 3467
        },
        "time_elapsed": 28.86531901359558,
        "raw_responses": [
            "Step 1: Relevant Information and Concerns\n\u2022 The infant\u2019s history and physical exam findings include bruises on the chest and back and subconjunctival hemorrhage, which are concerning for non-accidental trauma.\n\u2022 The mechanism of injury (a fall from a changing table) is often benign, but the physical findings are inconsistent with the reported mechanism.\n\u2022 The maternal description and the physical findings raise suspicion for potential child abuse.\n\nStep 2: Evaluate the Options\n\u2022 CT scan of the head: This would be indicated if there were signs of head injury or concern for intracranial trauma. However, the initial step should address the overall safety and potential abuse.\n\u2022 Involvement of social services: This is appropriate when there is suspicion of abuse or neglect. The history and physical exam findings warrant a multidisciplinary evaluation, including child protective services.\n\u2022 Family counseling: While important eventually, this is not the immediate next step in the presence of suspected abuse.\n\u2022 Rule out medical conditions: Although some medical conditions can mimic bruising, the distribution and nature of the injuries, along with the fall history, make abuse more concerning than a medical issue.\n\nStep 3: Final Answer\nB. Involvement of social services",
            "Step 1: Analyze the key clinical findings. The infant is only 2 months old and presents with a history of a fall from a changing table as described by her mother. However, the exam reveals multiple bruises on the chest and back along with a subconjunctival hemorrhage, which raises concern for injuries inconsistent with the reported accidental fall. Additionally, the vital signs are worrisome for tachycardia (pulse 200/min) and tachypnea (respiratory rate 70/min), further heightening concern.\n\nStep 2: Consider the options.\n\n\u2022 CT scan of the head (Option A) might be indicated if there were signs of head injury, but in this scenario, the presence of multiple bruises in unusual areas and subconjunctival hemorrhage point more toward potential non-accidental trauma rather than an isolated head injury from a fall.\n\n\u2022 Involvement of social services (Option B) is essential when there is suspicion of child abuse. The disparity between the reported history and the clinical findings necessitates further investigation into the child's safety and well-being.\n\n\u2022 Family counseling (Option C) may be part of a long-term management plan once abuse has been addressed, but it is not the immediate step in the presence of potential abuse.\n\n\u2022 Rule out medical conditions (Option D) is not the most pressing concern at this time given the specific pattern and distribution of bruises, which are more suggestive of physical abuse rather than an underlying medical disorder.\n\nStep 3: Conclusion. Given the suspicious findings, the best initial step in management is to involve social services to ensure the child\u2019s safety and initiate an investigation into potential abuse.\n\nFinal Answer: B. Involvement of social services.",
            "Step 1: Recognize that the physical findings (subconjunctival hemorrhage, bruises on the chest and back) and concerning vital signs (marked tachycardia and tachypnea) in a 2\u2010month\u2010old raise suspicion for non-accidental trauma rather than a simple fall from a changing table.\n\nStep 2: Among the options:\n\u2022 CT scan of the head would be indicated if there was evidence of intracranial injury; however, the scenario more strongly suggests potential abuse.\n\u2022 Family counseling does not address the immediate safety concerns.\n\u2022 Ruling out medical conditions is not the pressing issue given the pattern of injury.\n\u2022 Involvement of social services is the appropriate step to ensure the child\u2019s safety and initiate a thorough investigation.\n\nFinal Answer: Involvement of social services."
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Analyze the key clinical findings. The infant is only 2 months old and presents with a history of a fall from a changing table as described by her mother. However, the exam reveals multiple bruises on the chest and back along with a subconjunctival hemorrhage, which raises concern for injuries inconsistent with the reported accidental fall. Additionally, the vital signs are worrisome for tachycardia (pulse 200/min) and tachypnea (respiratory rate 70/min), further heightening concern.\n\nStep 2: Consider the options.\n\n\u2022 CT scan of the head (Option A) might be indicated if there were signs of head injury, but in this scenario, the presence of multiple bruises in unusual areas and subconjunctival hemorrhage point more toward potential non-accidental trauma rather than an isolated head injury from a fall.\n\n\u2022 Involvement of social services (Option B) is essential when there is suspicion of child abuse. The disparity between the reported history and the clinical findings necessitates further investigation into the child's safety and well-being.\n\n\u2022 Family counseling (Option C) may be part of a long-term management plan once abuse has been addressed, but it is not the immediate step in the presence of potential abuse.\n\n\u2022 Rule out medical conditions (Option D) is not the most pressing concern at this time given the specific pattern and distribution of bruises, which are more suggestive of physical abuse rather than an underlying medical disorder.\n\nStep 3: Conclusion. Given the suspicious findings, the best initial step in management is to involve social services to ensure the child\u2019s safety and initiate an investigation into potential abuse.\n\nFinal Answer: B. Involvement of social services."
    },
    {
        "realidx": 689,
        "question": "A 33-year-old man presents to the infectious diseases clinic for follow-up. He was recently admitted to the hospital with fever, shortness of breath, and cough, and was found to have Pneumocystic jirovecii pneumonia and a new diagnosis of HIV. His CD4 count is 175, viral load is pending. As part of routine laboratory studies given his new diagnosis, an RPR was found to be positive with a titer of 1:64, and this is confirmed with a positive FTA-ABS. He is unsure when or how he acquired HIV or syphilis. His neurological examination is normal, and he has no symptoms. Which of the following is the most appropriate next step in management:",
        "answer": "Treat with three weekly injections of penicillin, obtain titers in 6 months",
        "options": {
            "A": "Perform lumbar puncture, treat based on presence or absence of CNS disease",
            "B": "Treat with three weekly injections of penicillin, obtain titers in 3 months",
            "C": "Treat with three weekly injections of penicillin, obtain titers in 6 months",
            "D": "Treat with a single injection of penicillin, obtain titers in 6 months"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old man presents",
            "infectious diseases clinic",
            "follow-up",
            "recently admitted",
            "hospital",
            "fever",
            "shortness of breath",
            "cough",
            "found to",
            "Pneumocystic jirovecii pneumonia",
            "new",
            "HIV",
            "CD4 count",
            "viral load",
            "part of routine laboratory studies given",
            "new diagnosis",
            "RPR",
            "found to",
            "positive",
            "titer",
            "64",
            "confirmed",
            "positive FTA-ABS",
            "unsure",
            "acquired HIV",
            "syphilis",
            "neurological examination",
            "normal",
            "symptoms",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5448,
            "completion_tokens": 10470
        },
        "time_elapsed": 72.5689959526062,
        "raw_responses": [
            "Step 1: Recognize that the patient has a new diagnosis of syphilis, confirmed by a reactive RPR (titer 1:64) and a positive FTA-ABS, with no neurological symptoms. In the setting of HIV\u2014with uncertainty regarding the exact time of acquisition\u2014the syphilis is best managed as latent syphilis of unknown duration.\n\nStep 2: For latent syphilis (unknown duration) in an HIV-positive patient without neurologic findings, the recommended treatment is benzathine penicillin G 2.4 million units administered intramuscularly once weekly for 3 consecutive weeks. A lumbar puncture is not indicated in the absence of neurologic signs or symptoms. In terms of monitoring response to therapy, follow-up serologic testing (repeating RPR titers) is typically recommended at 6 months after treatment initiation for late latent syphilis.\n\nStep 3: Comparing the choices:\n\u2022 Option A (LP and treat based on CNS results) is not needed because the patient lacks neurological symptoms.\n\u2022 Option D (a single injection) would be appropriate for early syphilis, but in this case the duration is uncertain.\n\u2022 Option B suggests checking titers in 3 months; however, the standard follow\u2010up interval for latent syphilis is 6 months.\n\u2022 Option C (treat with three weekly injections and obtain titers in 6 months) aligns with the accepted management for latent syphilis in an HIV-positive patient.\n\nFinal Answer: C",
            "Step 1: Look at the details of the case. The patient is a 33\u2010year\u2010old man with newly diagnosed HIV (CD4 count 175) and has an RPR titer of 1:64 with a confirmatory FTA-ABS. Although he is asymptomatic from a neurological standpoint, his HIV status (with a low CD4 count) and the high RPR titer both raise concern for neurosyphilis.\n\nStep 2: In HIV-positive patients with syphilis\u2014especially if the CD4 count is \u2264350 cells/mm\u00b3 or the RPR titers are \u22651:32\u2014it is recommended to evaluate for neurosyphilis with a lumbar puncture, even if neurologic symptoms are absent.\n\nStep 3: Looking at the treatment options:\n\u2022 Option A (perform lumbar puncture, treat based on presence or absence of CNS disease) is appropriate given his risk factors.\n\u2022 Options B and C involve treatment with three weekly injections of penicillin, which is the regimen for late latent syphilis; however, in HIV-positive patients with high RPR titers and low CD4 counts, an evaluation for neurosyphilis is warranted before deciding on treatment.\n\u2022 Option D (a single injection of penicillin) is appropriate for early syphilis in immunocompetent patients and is not suitable here.\n\nStep 4: Therefore, before initiating treatment, the most important next step is to perform a lumbar puncture to assess for neurosyphilis.\n\nFinal Answer: A. Perform lumbar puncture, treat based on presence or absence of CNS disease.",
            "Step 1: Analyze the Patient's Presentation  \n\u2022 The patient is a 33\u2010year-old man with known HIV and a new positive syphilis test (RPR titer 1:64 confirmed with FTA-ABS).  \n\u2022 He is asymptomatic for neurosyphilis (normal neurological exam) and is unaware of his syphilis exposure.  \n\nStep 2: Determine the Stage and Management of Syphilis  \n\u2022 In the absence of symptoms and signs of neurosyphilis and assuming an early syphilis stage (primary, secondary, or early latent), the standard treatment is a single intramuscular injection of benzathine penicillin G.  \n\u2022 While HIV-positive patients are at increased risk of neurosyphilis, current guidelines do not mandate a lumbar puncture in asymptomatic patients.  \n\nStep 3: Evaluate the Options  \nA. Perform lumbar puncture, treat based on presence or absence of CNS disease \u2013 Not indicated because the patient lacks neurological symptoms.  \nB. Treat with three weekly injections of penicillin, obtain titers in 3 months \u2013 This regimen is for late latent or tertiary syphilis, not early syphilis. Also, follow-up titers are generally recommended at 6 months.  \nC. Treat with three weekly injections of penicillin, obtain titers in 6 months \u2013 Again, the three-dose regimen is for later stages of syphilis.  \nD. Treat with a single injection of penicillin, obtain titers in 6 months \u2013 This is the correct treatment for early syphilis, even in patients with HIV, provided there are no neurological symptoms.\n\nFinal Answer: D"
        ],
        "ensemble_raw_responses": [
            "1\n\nThe best answer is the solution that treats him as having latent syphilis of unknown duration. Since he is unsure when he acquired syphilis, even though his RPR titer is high, the safest management is to assume his exposure occurred more than a year ago. In an asymptomatic, HIV\u2010positive patient with latent syphilis of unknown duration (and no neurological signs), the approved treatment is benzathine penicillin G administered as intramuscular injections once weekly for 3 consecutive weeks. Routine lumbar puncture isn\u2019t indicated unless there are neurologic symptoms. \n\nThus, the candidate solution that recommends treatment with three weekly injections of penicillin with follow\u2010up RPR testing at 6 months is the best answer.",
            "0",
            "The best answer is provided by candidate solution 1. This patient\u2019s syphilis is incidentally found, and because he is unsure of when syphilis was acquired, his case is best managed as latent syphilis of unknown duration. In an HIV\u2010infected patient without neurological symptoms, the recommended treatment is benzathine penicillin G 2.4 million units intramuscularly once weekly for 3 weeks (not the single-dose regimen used in early syphilis) with serologic follow\u2010up at 6 months. Although some experts consider a lumbar puncture in HIV-positive patients with high titers or low CD4 counts, current guidelines do not mandate a CSF examination in asymptomatic individuals. \n\nThus, candidate solution 1 (which recommends three weekly injections and repeat titers at 6 months; Option C from the choices) is the best approach.\n\nThe chosen candidate solution number is: 1."
        ],
        "final_solution": "Step 1: Recognize that the patient has a new diagnosis of syphilis, confirmed by a reactive RPR (titer 1:64) and a positive FTA-ABS, with no neurological symptoms. In the setting of HIV\u2014with uncertainty regarding the exact time of acquisition\u2014the syphilis is best managed as latent syphilis of unknown duration.\n\nStep 2: For latent syphilis (unknown duration) in an HIV-positive patient without neurologic findings, the recommended treatment is benzathine penicillin G 2.4 million units administered intramuscularly once weekly for 3 consecutive weeks. A lumbar puncture is not indicated in the absence of neurologic signs or symptoms. In terms of monitoring response to therapy, follow-up serologic testing (repeating RPR titers) is typically recommended at 6 months after treatment initiation for late latent syphilis.\n\nStep 3: Comparing the choices:\n\u2022 Option A (LP and treat based on CNS results) is not needed because the patient lacks neurological symptoms.\n\u2022 Option D (a single injection) would be appropriate for early syphilis, but in this case the duration is uncertain.\n\u2022 Option B suggests checking titers in 3 months; however, the standard follow\u2010up interval for latent syphilis is 6 months.\n\u2022 Option C (treat with three weekly injections and obtain titers in 6 months) aligns with the accepted management for latent syphilis in an HIV-positive patient.\n\nFinal Answer: C"
    },
    {
        "realidx": 706,
        "question": "A 24-year-old woman presents to the emergency department after an episode of altered mental status. She was at a party when she suddenly fell to the floor. Her friends state that she was not responsive and was acting oddly. After the episode, the patient seemed confused and had no memory of the event. The patient has a past medical history of substance abuse, depression, and anxiety. Her temperature is 98.6\u00b0F (37.0\u00b0C), blood pressure is 117/69 mmHg, pulse is 80/min, respirations are 12/min, and oxygen saturation is 99% on room air. Physical exam reveals a girl who seems confused and responds to questions slowly. Her gait is stable, and she demonstrates 5/5 strength in her upper and lower extremities. Laboratory values and a urine dipstick test are performed as seen below:\n\nToxicology:\nBenzodiazepines: Positive\nMarijuana: Positive\nCocaine: Negative\nPhencyclidine: Negative\n\nUrine Dipstick:\nAppearance: Dark\nRed blood cells: Positive\nGlucose: Negative\n\nWhich of the following is the best next step in management?",
        "answer": "IV fluids and mannitol",
        "options": {
            "A": "Diazepam",
            "B": "IV fluids and mannitol",
            "C": "Phenytoin",
            "D": "Supportive therapy and observation"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman presents",
            "emergency department",
            "episode of altered mental status",
            "party",
            "fell",
            "floor",
            "friends state",
            "not responsive",
            "acting",
            "episode",
            "patient",
            "confused",
            "memory",
            "event",
            "patient",
            "past history of substance abuse",
            "depression",
            "anxiety",
            "temperature",
            "98",
            "blood pressure",
            "69 mmHg",
            "pulse",
            "80 min",
            "respirations",
            "min",
            "oxygen saturation",
            "99",
            "room air",
            "Physical exam reveals",
            "girl",
            "confused",
            "questions slowly",
            "gait",
            "stable",
            "demonstrates 5/5 strength",
            "upper",
            "lower extremities",
            "Laboratory values",
            "urine dipstick test",
            "performed",
            "seen",
            "Toxicology",
            "Benzodiazepines",
            "Positive Marijuana",
            "Positive Cocaine",
            "Negative Phencyclidine",
            "Negative",
            "Urine Dipstick",
            "Appearance",
            "Dark Red blood cells",
            "Positive Glucose",
            "Negative",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5919,
            "completion_tokens": 7726
        },
        "time_elapsed": 57.06518006324768,
        "raw_responses": [
            "Step 1: Review the case details.  \n\u2022 A 24\u2010year\u2010old woman presents with an episode of altered mental status and a fall at a party.  \n\u2022 Post-event, she is confused and amnesic.  \n\u2022 Her exam is largely unremarkable with stable vital signs, intact gait, and normal strength.  \n\u2022 Toxicology is positive for benzodiazepines and marijuana, but negative for cocaine and phencyclidine.  \n\u2022 Urine dipstick shows dark appearance with positive red blood cells, which may suggest trauma from the fall rather than a primary pathology.\n\nStep 2: Evaluate the options.  \nA. Diazepam \u2013 This is used for management of alcohol withdrawal or seizure control; there is no evidence of ongoing seizures or alcohol withdrawal here.  \nB. IV fluids and mannitol \u2013 This treatment is used for suspected increased intracranial pressure or cerebral edema, which is not indicated based on the patient\u2019s current stable exam.  \nC. Phenytoin \u2013 An anticonvulsant used for seizure management; the patient does not have seizure activity that warrants this treatment.  \nD. Supportive therapy and observation \u2013 Given that the patient is stable, and there is no current life-threatening or acute neurological condition, the appropriate management is observation and supportive care.\n\nStep 3: Final answer.  \nThe best next step in management is: D. Supportive therapy and observation.",
            "Step 1: Review the relevant patient data. The patient is a 24-year-old female who experienced an episode of altered mental status at a party. Her physical exam reveals confusion but stable vital signs, normal gait, and intact strength. The toxicology screen is positive for benzodiazepines and marijuana, and her urine dipstick shows dark urine and positive red blood cells, which might suggest trauma from the fall but does not alter the management of her likely benzodiazepine intoxication.\n\nStep 2: Evaluate each answer choice:\n\u2022 Diazepam \u2013 This drug is used to manage conditions such as seizures or alcohol withdrawal; however, the patient does not have seizures and her presentation is not consistent with a state requiring benzodiazepine administration.\n\u2022 IV fluids and mannitol \u2013 These are typically used in situations involving increased intracranial pressure or cerebral edema. There is no evidence that this patient is experiencing such complications.\n\u2022 Phenytoin \u2013 An antiepileptic medication that is not indicated in the absence of seizures.\n\u2022 Supportive therapy and observation \u2013 In cases of benzodiazepine overdose with stable vital signs and mild symptoms, supportive care (observation, monitoring of vital signs and neurological status) is the best course.\n\nStep 3: Final Answer  \nThe best next step in management is: Supportive therapy and observation (Option D).",
            "Step 1: Examine the clinical presentation and lab findings.\n\n\u2022 The patient had an episode at a party where she suddenly lost responsiveness and became confused afterward, suggesting a seizure with a possible postictal state.\n\n\u2022 Her toxicology is positive for benzodiazepines and marijuana. Although benzodiazepine use is noted, her current physical exam is essentially normal. There is no evidence of ongoing seizure activity that would require immediate anticonvulsant therapy.\n\n\u2022 The urine dipstick shows dark urine with a positive test for \u201cred blood cells.\u201d In the absence of gross hematuria on microscopic exam (details not provided but implied by the context), this finding is most consistent with myoglobinuria, a well\u2010recognized consequence of muscle injury following seizures.\n\nStep 2: Consider the management options.\n\nA. Diazepam \u2013 Used acutely to treat active seizure activity. Since the patient\u2019s episode appears to have resolved and she is not seizing now, this is not indicated.\n\nB. IV fluids and mannitol \u2013 This is the standard treatment for myoglobinuria due to rhabdomyolysis, which can occur after a seizure. Aggressive hydration (often with IV fluids) promotes renal perfusion and clearance of myoglobin, while mannitol may be used as an osmotic diuretic to further reduce the risk of acute kidney injury.\n\nC. Phenytoin \u2013 Typically used for seizure prophylaxis or treating recurrent seizures. A single, provoked seizure (especially in the setting of substance ingestion) does not warrant starting a chronic antiepileptic medication.\n\nD. Supportive therapy and observation \u2013 While observation is part of supportive management in a postictal state, this option does not specifically address the risk of kidney injury from myoglobinuria.\n\nStep 3: Final Decision\n\nGiven that the patient\u2019s presentation is most consistent with a seizure, and the urine dipstick finding is suggestive of myoglobinuria, the best next step is to initiate treatment aimed at preventing renal complications. Therefore, the appropriate management is IV fluids (with mannitol as an adjunct if indicated) to minimize the risk of acute tubular necrosis.\n\nFinal answer: B. IV fluids and mannitol."
        ],
        "ensemble_raw_responses": [
            "0",
            "The key detail here is that the urine dipstick shows a dark appearance with a positive reaction for red blood cells. In the setting of a seizure, this is most consistent with myoglobinuria from muscle breakdown rather than true hematuria. Since myoglobin is toxic to the kidneys, the best next step is to prevent renal injury by administering IV fluids (and mannitol may be used as an adjunct).\n\nAmong the candidate solutions, option 2 identifies the likely postictal state with myoglobinuria and recommends IV fluids (with mannitol) to protect the kidneys.\n\nThe correct answer is option 2.",
            "2"
        ],
        "final_solution": "Step 1: Examine the clinical presentation and lab findings.\n\n\u2022 The patient had an episode at a party where she suddenly lost responsiveness and became confused afterward, suggesting a seizure with a possible postictal state.\n\n\u2022 Her toxicology is positive for benzodiazepines and marijuana. Although benzodiazepine use is noted, her current physical exam is essentially normal. There is no evidence of ongoing seizure activity that would require immediate anticonvulsant therapy.\n\n\u2022 The urine dipstick shows dark urine with a positive test for \u201cred blood cells.\u201d In the absence of gross hematuria on microscopic exam (details not provided but implied by the context), this finding is most consistent with myoglobinuria, a well\u2010recognized consequence of muscle injury following seizures.\n\nStep 2: Consider the management options.\n\nA. Diazepam \u2013 Used acutely to treat active seizure activity. Since the patient\u2019s episode appears to have resolved and she is not seizing now, this is not indicated.\n\nB. IV fluids and mannitol \u2013 This is the standard treatment for myoglobinuria due to rhabdomyolysis, which can occur after a seizure. Aggressive hydration (often with IV fluids) promotes renal perfusion and clearance of myoglobin, while mannitol may be used as an osmotic diuretic to further reduce the risk of acute kidney injury.\n\nC. Phenytoin \u2013 Typically used for seizure prophylaxis or treating recurrent seizures. A single, provoked seizure (especially in the setting of substance ingestion) does not warrant starting a chronic antiepileptic medication.\n\nD. Supportive therapy and observation \u2013 While observation is part of supportive management in a postictal state, this option does not specifically address the risk of kidney injury from myoglobinuria.\n\nStep 3: Final Decision\n\nGiven that the patient\u2019s presentation is most consistent with a seizure, and the urine dipstick finding is suggestive of myoglobinuria, the best next step is to initiate treatment aimed at preventing renal complications. Therefore, the appropriate management is IV fluids (with mannitol as an adjunct if indicated) to minimize the risk of acute tubular necrosis.\n\nFinal answer: B. IV fluids and mannitol."
    },
    {
        "realidx": 709,
        "question": "A researcher is conducting an experiment on the mouse kidney to study the relative concentrations between the tubular fluid and plasma of a number of substances along the proximal convoluted tubule. Based on the graph shown in figure A, which of the following best describes the tubular fluid-to-plasma concentration ratio of urea?",
        "answer": "B",
        "options": {
            "A": "B",
            "B": "C",
            "C": "D",
            "D": "E"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "researcher",
            "conducting",
            "experiment",
            "mouse kidney to study",
            "relative concentrations",
            "tubular fluid",
            "plasma",
            "number",
            "substances",
            "proximal convoluted tubule",
            "Based",
            "graph shown",
            "following best",
            "tubular fluid",
            "plasma ratio",
            "urea"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4158,
            "completion_tokens": 17626
        },
        "time_elapsed": 110.20572924613953,
        "raw_responses": [
            "We can reason through the answer as follows:\n\n\u2022 In the glomerulus the urea concentration in the filtrate equals that in plasma (tubular fluid\u2010to\u2010plasma ratio = 1). \n\u2022 In the proximal convoluted tubule (PCT) most solutes and water are reabsorbed in an isosmotic fashion so that many solute concentrations remain roughly equal to plasma. However, urea is \u201creabsorbed\u201d only passively at a rate lower than water reabsorption. (For example, if ~70% of water is reabsorbed but only about 40\u201350% of urea is taken back, then the remaining urea becomes more concentrated relative to plasma.)\n\u2022 As a result, along the PCT the urea tubular fluid\u2010to\u2010plasma ratio gradually increases above 1 (typically to about 1.5\u20131.7 by the end of the segment).\n\nLooking at figure A (which plots several substances with different behavior) the curve that starts at a ratio of 1 and then rises modestly to a value above 1 best describes urea\u2019s behavior. Among the answer choices the curve labeled \u201cD\u201d fits that description.\n\nThus, the final answer is: D.",
            "We know that at the glomerulus the tubular fluid is essentially an ultrafiltrate of plasma, so the concentration (tubular fluid\u2009:\u2009plasma) of any freely filtered substance starts at 1. Along the proximal convoluted tubule (PCT), water is reabsorbed. For most solutes that are not reabsorbed, this water loss concentrates what remains in the lumen (raising the ratio above 1). However, urea is a special case because it is passively reabsorbed in the PCT (about 40\u201350% of filtered urea is reabsorbed), almost \u201cfollowing\u201d the water reabsorption. As a result, its tubular concentration does not rise significantly above plasma levels; in fact, its tubular fluid\u2013to\u2013plasma concentration ratio stays near 1.\n\nLooking at the choices provided:\n\u2003Option A: Curve \u201cB\u201d\n\u2003Option B: Curve \u201cC\u201d\n\u2003Option C: Curve \u201cD\u201d\n\u2003Option D: Curve \u201cE\u201d\n\nThe curve that stays roughly at a ratio of 1 (i.e. relatively flat) is the one labeled \u201cC.\u201d Therefore, the best answer is:\n\nFinal answer: Option B (resulting in curve \u201cC\u201d)",
            "We know that many substances are filtered at a concentration equal to plasma but then water is reabsorbed in the PCT so that the concentrations of substances that are not reabsorbed rise markedly. However, urea is unusual \u2013 although it is freely filtered, about half is passively reabsorbed in the proximal tubule. In effect, although water reabsorption would tend to concentrate everything, the fact that urea \u201cdisappears\u201d (via reabsorption) means that its tubular fluid concentration \u201ctracks\u201d plasma much more closely than, say, a substance like inulin which is not reabsorbed. In the proximal convoluted tubule the tubular fluid\u2010to\u2010plasma ratio for urea remains very close to 1.\n\nIf you examine a graph showing the changing concentration ratios along the PCT for several substances, you\u2019d find that the curve for urea stays near unity (approximately 1.0), while substances that are not reabsorbed will rise (sometimes 2\u20133\u2010fold) and those that are completely reabsorbed (like glucose under normal conditions) will drop to nearly zero.\n\nThus, based on the description provided in Figure A, the best answer is the curve whose profile is near 1 throughout the proximal tubule \u2013 which in this question is labeled \u201cE.\u201d\n\nFinal Answer: [D. E]"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "1\n\nThe reasoning in candidate solution 1 is most consistent with standard renal physiology. In the proximal convoluted tubule, although water is reabsorbed from the glomerular ultrafiltrate (which would normally increase the concentration of non\u2010reabsorbed solutes), urea is passively reabsorbed (about 40\u201350% of the filtered load). This \u201cfollows\u201d the water reabsorption closely enough that the tubular fluid\u2010to\u2010plasma concentration ratio of urea remains near 1 along the PCT. Candidate solution 1 correctly explains that and selects the curve which remains relatively flat at a ratio of 1."
        ],
        "final_solution": "We know that at the glomerulus the tubular fluid is essentially an ultrafiltrate of plasma, so the concentration (tubular fluid\u2009:\u2009plasma) of any freely filtered substance starts at 1. Along the proximal convoluted tubule (PCT), water is reabsorbed. For most solutes that are not reabsorbed, this water loss concentrates what remains in the lumen (raising the ratio above 1). However, urea is a special case because it is passively reabsorbed in the PCT (about 40\u201350% of filtered urea is reabsorbed), almost \u201cfollowing\u201d the water reabsorption. As a result, its tubular concentration does not rise significantly above plasma levels; in fact, its tubular fluid\u2013to\u2013plasma concentration ratio stays near 1.\n\nLooking at the choices provided:\n\u2003Option A: Curve \u201cB\u201d\n\u2003Option B: Curve \u201cC\u201d\n\u2003Option C: Curve \u201cD\u201d\n\u2003Option D: Curve \u201cE\u201d\n\nThe curve that stays roughly at a ratio of 1 (i.e. relatively flat) is the one labeled \u201cC.\u201d Therefore, the best answer is:\n\nFinal answer: Option B (resulting in curve \u201cC\u201d)"
    },
    {
        "realidx": 714,
        "question": "A 28-year-old male presents to the emergency department with chest pain. He reports that one hour ago he was climbing the stairs in his home when he suddenly developed excruciating chest pain. He describes the pain as ripping and radiating to the back. The patient\u2019s past medical history is significant for a heart murmur that is being followed by his outpatient cardiologist. He takes no medications. The patient works as a carpenter and reports being monogamous with his wife. He denies any history of intravenous drug use or recent travel. In the emergency department, the patient\u2019s temperature is 99.4\u00b0F (37.4\u00b0C), blood pressure is 94/56 mmHg, pulse is 121/min, and respirations are 14/min. On physical exam, the patient appears to be in moderate distress and is clutching his chest. He is tall and has joint hypermobility. His breath sounds are equal and full bilaterally and has weak distal pulses.\n\nWhich of the following is most likely to be found in this patient?",
        "answer": "Late systolic crescendo murmur at the apex with mid-systolic click",
        "options": {
            "A": "Holosystolic, high-pitched blowing murmur at the lower left sternal border",
            "B": "Late systolic crescendo murmur at the apex with mid-systolic click",
            "C": "Mid-diastolic murmur at the left lower sternal border",
            "D": "Systolic ejection murmur at the right second intercostal space"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old male presents",
            "emergency department",
            "chest pain",
            "reports",
            "one hour",
            "climbing",
            "stairs",
            "home",
            "excruciating chest",
            "pain",
            "ripping",
            "radiating to",
            "back",
            "patients past medical history",
            "significant",
            "heart murmur",
            "followed by",
            "outpatient cardiologist",
            "takes",
            "medications",
            "patient works",
            "carpenter",
            "reports",
            "monogamous",
            "wife",
            "denies",
            "history",
            "intravenous drug use",
            "recent travel",
            "emergency department",
            "patients temperature",
            "99 4F",
            "4C",
            "blood pressure",
            "mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "physical exam",
            "patient appears to",
            "moderate distress",
            "chest",
            "tall",
            "joint hypermobility",
            "breath sounds",
            "equal",
            "full",
            "weak distal pulses",
            "following",
            "most likely to",
            "found",
            "patient"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5742,
            "completion_tokens": 5111
        },
        "time_elapsed": 35.9855580329895,
        "raw_responses": [
            "Step 1: Identify key features. This is a 28\u2010year-old male with sudden, excruciating, \u201cripping\u201d chest pain radiating to the back. He is also tall with joint hypermobility and has a history of a heart murmur\u2014features consistent with Marfan syndrome, which predisposes to aortic dissection as well as other cardiac abnormalities.\n\nStep 2: Consider typical murmurs in Marfan syndrome. Patients with Marfan syndrome commonly have mitral valve prolapse (MVP). MVP produces a late systolic crescendo murmur with a mid\u2010systolic click that is best heard at the apex.\n\nStep 3: Evaluate the answer options:\n\u2022 Option A (holosystolic, high\u2010pitched blowing murmur at the lower left sternal border) is more consistent with conditions like a ventricular septal defect.\n\u2022 Option C (mid\u2010diastolic murmur at the left lower sternal border) is not typical for the conditions associated with Marfan syndrome.\n\u2022 Option D (systolic ejection murmur at the right second intercostal space) is typically associated with aortic stenosis.\n\u2022 Option B (late systolic crescendo murmur at the apex with mid\u2010systolic click) matches the classic description of MVP.\n\nStep 4: Final Answer. Given the patient\u2019s Marfan features and his known history of a heart murmur, the most likely finding on exam is a murmur consistent with mitral valve prolapse.\n\nFinal answer: B. Late systolic crescendo murmur at the apex with mid-systolic click.",
            "Step 1: Key details in the case indicate that the patient is young and has features suggestive of Marfan syndrome (tall stature and joint hypermobility). His history of a heart murmur being followed by a cardiologist further supports an underlying valvular abnormality. In Marfan syndrome, mitral valve prolapse is a common cardiac finding.\n\nStep 2: Mitral valve prolapse typically presents with a late systolic crescendo murmur accompanied by a mid\u2010systolic click, which corresponds to option B. Other murmurs listed do not fit this patient\u2019s profile:\n\u2022 Option A describes a holosystolic murmur at the lower left sternal border, which is more consistent with a ventricular septal defect or possibly tricuspid regurgitation.\n\u2022 Option C\u2019s mid\u2010diastolic murmur at the left lower sternal border is not characteristic of Marfan-associated valve abnormalities.\n\u2022 Option D\u2019s systolic ejection murmur at the right second intercostal space is suggestive of an aortic stenosis or flow murmur, which is not typical in this patient\u2019s age group or clinical scenario.\n\nStep 3: Final Answer: B. Late systolic crescendo murmur at the apex with mid-systolic click.",
            "Step 1: Note the important details in the stem. The patient is a 28\u2010year\u2010old male with ripping chest pain radiating to the back, hypotension, tachycardia, and a history of a heart murmur. Additionally, he is tall with joint hypermobility\u2014features that point toward a connective tissue disorder such as Marfan syndrome.\n\nStep 2: Marfan syndrome is known to be associated with cardiovascular abnormalities. One classic finding in Marfan syndrome is mitral valve prolapse (MVP), which produces a late systolic crescendo murmur best heard at the apex and is characteristically accompanied by a mid\u2010systolic click.\n\nStep 3: Evaluate the options:\n\u2022 Option A: A holosystolic, high\u2010pitched blowing murmur at the lower left sternal border is typically seen with regurgitant lesions such as tricuspid regurgitation.\n\u2022 Option B: A late systolic crescendo murmur at the apex with a mid\u2010systolic click is the classic auscultatory finding in mitral valve prolapse.\n\u2022 Option C: A mid\u2010diastolic murmur at the left lower sternal border does not correspond with common findings associated with Marfan syndrome.\n\u2022 Option D: A systolic ejection murmur at the right second intercostal space is commonly associated with aortic stenosis, again not fitting the classic Marfan picture.\n\nStep 4: Since the patient\u2019s features (tall stature, joint hypermobility, and a history of a heart murmur) align with a diagnosis of Marfan syndrome, the most likely murmur to be present is the one associated with MVP.\n\nFinal answer: B. Late systolic crescendo murmur at the apex with mid-systolic click"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Key details in the case indicate that the patient is young and has features suggestive of Marfan syndrome (tall stature and joint hypermobility). His history of a heart murmur being followed by a cardiologist further supports an underlying valvular abnormality. In Marfan syndrome, mitral valve prolapse is a common cardiac finding.\n\nStep 2: Mitral valve prolapse typically presents with a late systolic crescendo murmur accompanied by a mid\u2010systolic click, which corresponds to option B. Other murmurs listed do not fit this patient\u2019s profile:\n\u2022 Option A describes a holosystolic murmur at the lower left sternal border, which is more consistent with a ventricular septal defect or possibly tricuspid regurgitation.\n\u2022 Option C\u2019s mid\u2010diastolic murmur at the left lower sternal border is not characteristic of Marfan-associated valve abnormalities.\n\u2022 Option D\u2019s systolic ejection murmur at the right second intercostal space is suggestive of an aortic stenosis or flow murmur, which is not typical in this patient\u2019s age group or clinical scenario.\n\nStep 3: Final Answer: B. Late systolic crescendo murmur at the apex with mid-systolic click."
    },
    {
        "realidx": 720,
        "question": "A 28-year-old woman is brought to the emergency room after a motor vehicle accident. On arrival, she is stable and says that she hit a car at an intersection that \"came out of nowhere\". She states that she had similar close encounters with other cars these past few weeks but was able to avoid collisions with those. She has also had intermittent headaches over the last month and has noticed that her shirts have been getting wet unexpectedly. Blood tests reveal an abnormal elevation of a circulating substance. Which of following changes is also associated with the physiologic function of the most likely substance in this case?",
        "answer": "Decreased progesterone",
        "options": {
            "A": "Decreased oxytocin",
            "B": "Decreased progesterone",
            "C": "Increased follicle stimulating hormone",
            "D": "Increased progesterone"
        },
        "meta_info": "step1",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman",
            "brought",
            "emergency room",
            "motor vehicle accident",
            "arrival",
            "stable",
            "hit",
            "car",
            "intersection",
            "out",
            "states",
            "similar close encounters",
            "cars",
            "past",
            "weeks",
            "able to",
            "collisions",
            "intermittent headaches",
            "month",
            "shirts",
            "getting wet",
            "Blood tests reveal",
            "abnormal elevation",
            "circulating substance",
            "following changes",
            "associated with",
            "physiologic function",
            "likely substance",
            "case"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 5232,
            "completion_tokens": 11835
        },
        "time_elapsed": 75.20407390594482,
        "raw_responses": [
            "Let\u2019s break down the case and reasoning:\n\n\u2022 The 28\u2010year\u2010old woman has had several near\u2010accidents (\u201cclose encounters\u201d with vehicles) and headaches. One possible explanation for missing a car coming \u201cout of nowhere\u201d is a defect in peripheral vision. In a woman this age, a pituitary adenoma should be considered\u2014especially one that is large enough (a macroadenoma) to compress the optic chiasm, causing bitemporal hemianopsia.\n\n\u2022 The blood work \u201creveals an abnormal elevation of a circulating substance.\u201d In a young woman with headache and possible visual field deficits, a prolactinoma (a prolactin\u2010secreting pituitary adenoma) is one of the most common pituitary tumors.\n\n\u2022 Prolactin\u2019s normal function is to stimulate lactation once parturition has occurred. However, prolactin also physiologically inhibits the hypothalamic release of gonadotropin-releasing hormone (GnRH). This inhibition decreases the secretion of LH and FSH, which in turn leads to decreased ovarian steroid production (including progesterone). In many women, hyperprolactinemia manifests with amenorrhea and galactorrhea. (Even if not mentioned explicitly, the hormonal changes are a key downstream effect of elevated prolactin.)\n\n\u2022 When comparing with the answer choices, note that only \u201cdecreased progesterone\u201d is consistent with the effects of prolactin (via GnRH inhibition) on the reproductive axis.\n\nThus, the best answer is:\n\nB. Decreased progesterone",
            "Step 1: Analyze the Patient's Presentation\n\u2022 The patient is a 28\u2010year\u2010old woman who reports multiple near\u2010miss accidents (\u201cclose encounters\u201d with cars), intermittent headaches, and unexpected \u201cwetting\u201d of her shirts.\n\u2022 Although \u201cwet shirts\u201d could be interpreted as sweating, in a woman of childbearing age\u2014with no mention of hyperhidrosis\u2014a more concerning possibility is galactorrhea (inappropriate milk production).\n\u2022 Combining the headaches (which could be from a pituitary mass effect) with galactorrhea suggests an elevated level of prolactin, most commonly from a prolactinoma.\n\nStep 2: Understand Prolactin\u2019s Physiologic Effects\n\u2022 Prolactin\u2019s primary role is to stimulate milk production (lactogenesis).\n\u2022 High levels of prolactin inhibit gonadotropin-releasing hormone (GnRH), which leads to decreased secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH).\n\u2022 This reduction in gonadotropins causes decreased ovarian production of estrogen and progesterone. In many cases of hyperprolactinemia, women experience amenorrhea due to these hormonal changes.\n\nStep 3: Evaluate the Answer Choices\nA. Decreased oxytocin \u2013 Prolactin does not decrease oxytocin; indeed, oxytocin is involved in milk let-down, but its secretion isn\u2019t directly decreased by prolactin.\nB. Decreased progesterone \u2013 This fits the physiologic outcome since elevated prolactin suppresses GnRH and subsequently decreases the ovarian production of progesterone.\nC. Increased follicle stimulating hormone \u2013 Actually, high prolactin suppresses FSH, so this is incorrect.\nD. Increased progesterone \u2013 This is the opposite of what occurs in hyperprolactinemia.\n\nStep 4: Final Answer\nBased on the suppression of GnRH and the resulting decrease in ovarian steroidogenesis, the most likely associated change is a decrease in progesterone.\n\nFinal Answer: B. Decreased progesterone",
            "This patient\u2019s presentation is most consistent with a prolactinoma. The clues include her headaches, possible visual disturbances (which could be inferred from her \u201cclose encounters\u201d with other cars), and notably the \u201cwet shirts\u201d\u2014likely a description of inappropriate lactation (galactorrhea). In prolactinomas, excess prolactin secretion leads to inhibition of gonadotropin\u2010releasing hormone (GnRH). This inhibition, in turn, suppresses the secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH), resulting in decreased production of ovarian hormones such as estrogen and progesterone.\n\nStep by step:\n1. Clues such as intermittent headaches and abnormal \u201cclose encounters\u201d (suggesting possible visual field deficits) raise concern for a pituitary mass.\n2. The unexpected wetness of her shirts is indicative of galactorrhea, a hallmark sign of hyperprolactinemia.\n3. A prolactinoma causes an abnormal elevation of prolactin.\n4. Prolactin\u2019s physiologic function is to stimulate milk production; however, when elevated pathologically, it suppresses GnRH, leading to decreased gonadotropins and subsequently reduced progesterone levels.\n\nTherefore, the change associated with the physiologic function of prolactin in this setting is decreased progesterone.\n\nFinal answer: B. Decreased progesterone."
        ],
        "ensemble_raw_responses": [
            "2",
            "1",
            "2"
        ],
        "final_solution": "Let\u2019s break down the case and reasoning:\n\n\u2022 The 28\u2010year\u2010old woman has had several near\u2010accidents (\u201cclose encounters\u201d with vehicles) and headaches. One possible explanation for missing a car coming \u201cout of nowhere\u201d is a defect in peripheral vision. In a woman this age, a pituitary adenoma should be considered\u2014especially one that is large enough (a macroadenoma) to compress the optic chiasm, causing bitemporal hemianopsia.\n\n\u2022 The blood work \u201creveals an abnormal elevation of a circulating substance.\u201d In a young woman with headache and possible visual field deficits, a prolactinoma (a prolactin\u2010secreting pituitary adenoma) is one of the most common pituitary tumors.\n\n\u2022 Prolactin\u2019s normal function is to stimulate lactation once parturition has occurred. However, prolactin also physiologically inhibits the hypothalamic release of gonadotropin-releasing hormone (GnRH). This inhibition decreases the secretion of LH and FSH, which in turn leads to decreased ovarian steroid production (including progesterone). In many women, hyperprolactinemia manifests with amenorrhea and galactorrhea. (Even if not mentioned explicitly, the hormonal changes are a key downstream effect of elevated prolactin.)\n\n\u2022 When comparing with the answer choices, note that only \u201cdecreased progesterone\u201d is consistent with the effects of prolactin (via GnRH inhibition) on the reproductive axis.\n\nThus, the best answer is:\n\nB. Decreased progesterone"
    },
    {
        "realidx": 724,
        "question": "A 32-year-old man presents to the emergency department with fever, nausea, and vomiting. The patient states that his symptoms started last night and have persisted to this morning. He has a past medical history of asthma, and his current medications include albuterol and fluticasone. His temperature is 102\u00b0F (38.9\u00b0C), blood pressure is 110/60 mmHg, pulse is 95/min, respirations are 17/min, and oxygen saturation is 98% on room air. On physical exam, the patient seems uncomfortable. He requests that the lights in the room stay turned off during the physical exam. The patient's cardiac exam demonstrates a normal rate and rhythm, and his pulmonary exam is clear to auscultation bilaterally. Musculoskeletal exam reveals diminished mobility of the neck in all four directions, with flexion of the neck causing the patient discomfort. Lumbar puncture is performed and results are seen below.\n\nCerebrospinal fluid (CSF):\nCell count: 175/mm^3\nCl-: 119 mEq/L\nGlucose: 49 mg/dL\nPressure: 150 mmH2O\nTotal protein: 55 mg/dL\n\nWhich of the following is the best treatment for this patient's most likely diagnosis?",
        "answer": "IV fluids and monitoring",
        "options": {
            "A": "Acyclovir",
            "B": "Amphotericin and 5-flucytosine",
            "C": "Ceftriaxone and vancomycin",
            "D": "IV fluids and monitoring"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old man presents",
            "emergency department",
            "fever",
            "nausea",
            "vomiting",
            "patient states",
            "symptoms started last night",
            "morning",
            "past medical",
            "current medications include albuterol",
            "fluticasone",
            "temperature",
            "blood pressure",
            "60 mmHg",
            "pulse",
            "95 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "physical exam",
            "patient",
            "requests",
            "lights",
            "room",
            "turned",
            "physical exam",
            "patient's cardiac exam demonstrates",
            "normal rate",
            "rhythm",
            "pulmonary exam",
            "clear",
            "auscultation",
            "Musculoskeletal exam reveals diminished mobility",
            "neck",
            "four directions",
            "flexion",
            "neck causing",
            "patient discomfort",
            "Lumbar puncture",
            "performed",
            "results",
            "seen",
            "Cerebrospinal fluid",
            "Cell count",
            "mm",
            "Cl",
            "mEq/L Glucose",
            "mg/dL Pressure",
            "mmH2O Total protein",
            "55 mg/dL",
            "following",
            "best treatment",
            "patient's",
            "likely diagnosis"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 6921,
            "completion_tokens": 6737
        },
        "time_elapsed": 44.56035900115967,
        "raw_responses": [
            "Step 1: Analyze the clinical presentation.\n\u2022 The patient is 32 years old and presents with fever, nausea, vomiting, photophobia (requests the lights be turned off), and neck stiffness (restricted neck mobility with discomfort on flexion).\n\u2022 These signs point towards meningitis.\n\nStep 2: Evaluate the cerebrospinal fluid (CSF) results.\n\u2022 Cell count is 175/mm\u00b3, which is mildly elevated. In bacterial meningitis, you would expect a much higher cell count (often in the thousands).\n\u2022 The CSF glucose is 49 mg/dL. In bacterial meningitis, glucose is usually significantly decreased, whereas in viral meningitis it tends to be near normal.\n\u2022 The protein is 55 mg/dL; this is only slightly elevated compared to the marked elevations typically seen in bacterial (or fungal) meningitis.\n\u2022 The pressure is 150 mmH\u2082O, which could be borderline high but is more consistent with viral meningitis.\n\nStep 3: Interpret the findings.\n\u2022 The combination of moderate cell count elevation, near-normal glucose, slight protein elevation, and the clinical presentation (fever, photophobia, neck stiffness) is most consistent with viral meningitis.\n\u2022 Among viral causes, herpes simplex virus (HSV) is an important etiology that requires prompt treatment.\n\nStep 4: Eliminate incorrect treatment options.\n\u2022 Ceftriaxone and vancomycin: These are used for bacterial meningitis, which the CSF profile does not support.\n\u2022 Amphotericin and 5-flucytosine: These are indicated for fungal meningitis, which is unlikely in this immunocompetent patient.\n\u2022 IV fluids and monitoring: While supportive care is part of management for viral meningitis, if HSV is the suspected cause, antiviral therapy is essential.\n  \nStep 5: Choose the correct treatment.\n\u2022 Acyclovir is the treatment of choice for suspected HSV meningitis, given its potential severity and need for early intervention.\n\nFinal answer: Acyclovir.",
            "Step 1: Analyze the patient's presentation.\n\u2022 The patient is a 32\u2010year\u2010old man with fever, nausea, vomiting, photophobia (requiring a dark room), and neck stiffness.\n\u2022 His exam shows diminished neck mobility with discomfort upon flexion, which are classic signs of meningitis.\n\nStep 2: Interpret the cerebrospinal fluid (CSF) findings.\n\u2022 Cell count: 175/mm\u00b3 \u2013 an elevation, but not high enough for typical bacterial meningitis (which usually has cell counts in the 1,000s).\n\u2022 Glucose: 49 mg/dL \u2013 near normal (in bacterial meningitis, CSF glucose is often significantly decreased).\n\u2022 Total protein: 55 mg/dL \u2013 mildly elevated.\n\u2022 Opening pressure: 150 mmH\u2082O \u2013 on the higher end of normal or slightly elevated.\nThese findings support a picture consistent with viral (aseptic) meningitis rather than bacterial or fungal meningitis.\n\nStep 3: Compare the treatment options.\nA. Acyclovir \u2013 used for herpes simplex virus encephalitis, which typically features altered mental status and focal findings, not evident here.\nB. Amphotericin and 5-flucytosine \u2013 used for fungal meningitis (e.g., cryptococcal meningitis), generally seen in immunocompromised patients. This patient shows no signs of immunocompromise.\nC. Ceftriaxone and vancomycin \u2013 the cornerstone of bacterial meningitis treatment. The CSF findings here do not support bacterial meningitis.\nD. IV fluids and monitoring \u2013 indicates supportive care, which is the typical management for viral meningitis in immunocompetent individuals.\n\nStep 4: Conclusion.\nThe patient\u2019s clinical presentation and CSF findings point to viral meningitis. In such cases, treatment is typically supportive (hydration and monitoring), as most viral meningitis cases are self-limited.\n\nFinal Answer: D. IV fluids and monitoring.",
            "Step 1: Identify the clinical presentation.  \n\u2022 A 32\u2010year-old man presents with fever, nausea, vomiting, and neck stiffness/limited neck range of motion.  \n\u2022 He also requests that the room be kept dark, suggesting photophobia. These are classic signs of meningitis.\n\nStep 2: Review the cerebrospinal fluid (CSF) findings.  \n\u2022 Cell count: 175/mm\u00b3 \u2013 moderately elevated, which is more consistent with viral meningitis than bacterial meningitis (which typically produces much higher counts, often in the thousands).  \n\u2022 Glucose: 49 mg/dL \u2013 slightly low to normal; bacterial meningitis usually causes a marked decrease in glucose.  \n\u2022 Protein: 55 mg/dL \u2013 mildly elevated; again, bacterial meningitis would show a much higher protein level.  \n\u2022 CSF pressure is slightly elevated but not dramatically high.\n\nStep 3: Narrow down the differential diagnosis.  \n\u2022 Bacterial meningitis is less likely given the moderate CSF findings.  \n\u2022 Herpes simplex virus (HSV) encephalitis is treated with acyclovir; however, HSV typically causes encephalitis with altered mental status and focal neurologic deficits, which are not noted here.  \n\u2022 Fungal meningitis (e.g., Cryptococcus) often affects immunocompromised patients and would be treated with Amphotericin and 5-flucytosine.  \n\u2022 The most likely diagnosis is viral meningitis (commonly due to enteroviruses, though HSV-2 can also cause meningitis in adults) which is generally managed supportively in an immunocompetent patient.\n\nStep 4: Compare the options.  \nA. Acyclovir \u2013 indicated for HSV encephalitis, not typical for viral meningitis without encephalitic features.  \nB. Amphotericin and 5-flucytosine \u2013 used for fungal meningitis, not relevant here.  \nC. Ceftriaxone and vancomycin \u2013 used for bacterial meningitis, which does not match the CSF profile.  \nD. IV fluids and monitoring \u2013 appropriate for managing viral meningitis, as treatment is mainly supportive in an otherwise healthy patient.\n\nStep 5: Final Answer.  \nThe best treatment for this patient\u2019s most likely diagnosis (viral meningitis) is:  \nD. IV fluids and monitoring."
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1"
        ],
        "final_solution": "Step 1: Analyze the clinical presentation.\n\u2022 The patient is 32 years old and presents with fever, nausea, vomiting, photophobia (requests the lights be turned off), and neck stiffness (restricted neck mobility with discomfort on flexion).\n\u2022 These signs point towards meningitis.\n\nStep 2: Evaluate the cerebrospinal fluid (CSF) results.\n\u2022 Cell count is 175/mm\u00b3, which is mildly elevated. In bacterial meningitis, you would expect a much higher cell count (often in the thousands).\n\u2022 The CSF glucose is 49 mg/dL. In bacterial meningitis, glucose is usually significantly decreased, whereas in viral meningitis it tends to be near normal.\n\u2022 The protein is 55 mg/dL; this is only slightly elevated compared to the marked elevations typically seen in bacterial (or fungal) meningitis.\n\u2022 The pressure is 150 mmH\u2082O, which could be borderline high but is more consistent with viral meningitis.\n\nStep 3: Interpret the findings.\n\u2022 The combination of moderate cell count elevation, near-normal glucose, slight protein elevation, and the clinical presentation (fever, photophobia, neck stiffness) is most consistent with viral meningitis.\n\u2022 Among viral causes, herpes simplex virus (HSV) is an important etiology that requires prompt treatment.\n\nStep 4: Eliminate incorrect treatment options.\n\u2022 Ceftriaxone and vancomycin: These are used for bacterial meningitis, which the CSF profile does not support.\n\u2022 Amphotericin and 5-flucytosine: These are indicated for fungal meningitis, which is unlikely in this immunocompetent patient.\n\u2022 IV fluids and monitoring: While supportive care is part of management for viral meningitis, if HSV is the suspected cause, antiviral therapy is essential.\n  \nStep 5: Choose the correct treatment.\n\u2022 Acyclovir is the treatment of choice for suspected HSV meningitis, given its potential severity and need for early intervention.\n\nFinal answer: Acyclovir."
    },
    {
        "realidx": 748,
        "question": "A 39-year-old woman presents with headaches, constipation, increased thirst, and increased urinary frequency. Her blood pressure is 160/100 mm Hg and pulse is 67/min. Blood tests reveal high blood glucose and low potassium level. Abdominal CT scan shows a well-circumscribed homogeneous mass in the left adrenal gland. The hormone excess responsible for her symptoms uses which of the following pathways to exert its action?",
        "answer": "Intracellular receptors",
        "options": {
            "A": "Intracellular receptors",
            "B": "cAMP pathway",
            "C": "cGMP pathway",
            "D": "JAK/STAT pathway"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "year old woman presents",
            "headaches",
            "constipation",
            "increased thirst",
            "increased urinary frequency",
            "blood pressure",
            "100 mm Hg",
            "pulse",
            "67 min",
            "Blood tests reveal high blood glucose",
            "low potassium level",
            "Abdominal CT shows",
            "well circumscribed homogeneous mass",
            "left",
            "hormone excess responsible",
            "symptoms uses",
            "following pathways to exert",
            "action"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4866,
            "completion_tokens": 3402
        },
        "time_elapsed": 28.208878993988037,
        "raw_responses": [
            "Step 1: Review the case details. The patient is a 39\u2010year\u2010old woman with hypertension, headache, constipation, polydipsia, polyuria, high blood glucose, and low potassium. A CT scan shows a well-circumscribed homogeneous mass in the left adrenal gland. These findings are most consistent with a primary aldosterone-producing adenoma (Conn syndrome), where excess aldosterone leads to sodium retention (contributing to hypertension), potassium wasting (resulting in hypokalemia), and may also impair insulin release (contributing to hyperglycemia).\n\nStep 2: Determine the mechanism of aldosterone\u2019s action. Aldosterone is a steroid hormone that diffuses through the cell membrane and binds to intracellular mineralocorticoid receptors. This hormone-receptor complex then translocates to the nucleus, where it binds to specific DNA sequences and regulates gene transcription.\n\nStep 3: Evaluate the answer options.\n\u2022 Option A (Intracellular receptors): Correct\u2014this is how aldosterone exerts its effects.\n\u2022 Option B (cAMP pathway): This is typical for hormones that bind to cell surface G protein-coupled receptors (e.g., glucagon) and does not apply to aldosterone.\n\u2022 Option C (cGMP pathway): This pathway is associated with nitric oxide and natriuretic peptides, not aldosterone.\n\u2022 Option D (JAK/STAT pathway): This is used by certain cytokines, not by aldosterone.\n\nFinal answer: A. Intracellular receptors",
            "Step 1: Recognize the Clinical Picture\n\u2022 The patient is a 39-year-old woman with hypertension (160/100 mm Hg), headaches, and symptoms including constipation, increased thirst, and urinary frequency.\n\u2022 Laboratory findings include high blood glucose and low potassium.\n\u2022 An abdominal CT scan reveals a well-circumscribed homogeneous mass in the left adrenal gland.\n\u2022 These findings are consistent with an aldosterone-producing adrenal adenoma (Conn syndrome), which causes excess aldosterone secretion. High aldosterone levels lead to sodium retention (resulting in hypertension) and potassium wasting (resulting in hypokalemia).\n\nStep 2: Understand Aldosterone\u2019s Mechanism of Action\n\u2022 Aldosterone is a steroid hormone produced in the adrenal cortex.\n\u2022 It exerts its effects by diffusing into target cells and binding to intracellular mineralocorticoid receptors (which are part of the nuclear receptor family).\n\u2022 This hormone-receptor complex then translocates to the nucleus where it acts as a transcription factor, altering gene expression and ultimately leading to increased sodium reabsorption and potassium excretion.\n\nStep 3: Compare Options and Eliminate Incorrect Choices\n\u2022 Option A: Intracellular receptors \u2013 Correct, as aldosterone binds to mineralocorticoid receptors inside the cell.\n\u2022 Option B: cAMP pathway \u2013 Incorrect, as this pathway is typical for many peptide hormones that act via cell surface receptors.\n\u2022 Option C: cGMP pathway \u2013 Incorrect, as this pathway is not typically associated with aldosterone.\n\u2022 Option D: JAK/STAT pathway \u2013 Incorrect, as this pathway is not used by steroid hormones.\n\nFinal Answer: A. Intracellular receptors",
            "Step 1: Analyze the clinical picture. The patient is a 39-year-old woman with hypertension, hypokalemia, and symptoms of increased thirst, urinary frequency, and high blood glucose. The CT scan reveals a well-circumscribed mass in the left adrenal gland. These findings are most consistent with a hormone-producing adrenal adenoma.\n\nStep 2: Identify the hormone involved. The combination of high blood pressure and hypokalemia points toward an excess of a mineralocorticoid, most notably aldosterone. Additionally, aldosterone-producing adenomas (Conn's syndrome) are a recognized cause of such a presentation. While hyperglycemia can be seen in other conditions, in this context aldosterone\u2019s effects on renal handling of electrolytes and water are most relevant.\n\nStep 3: Determine the mechanism of action of aldosterone. Aldosterone is a steroid hormone. Steroid hormones are lipophilic and easily cross the cell membrane. They bind to intracellular (cytosolic) receptors, and the hormone-receptor complex then translocates to the nucleus, where it influences gene transcription.\n\nStep 4: Eliminate incorrect options. \n\u2022 The cAMP and cGMP pathways are typically associated with peptide hormones (or other non-steroid hormones) that bind to membrane receptors.\n\u2022 The JAK/STAT pathway is also used by certain cytokines and growth factors, not steroid hormones. \n\nFinal Answer: The hormone excess (aldosterone) uses intracellular receptors to mediate its actions. \n\nAnswer: A. Intracellular receptors."
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "0"
        ],
        "final_solution": "Step 1: Recognize the Clinical Picture\n\u2022 The patient is a 39-year-old woman with hypertension (160/100 mm Hg), headaches, and symptoms including constipation, increased thirst, and urinary frequency.\n\u2022 Laboratory findings include high blood glucose and low potassium.\n\u2022 An abdominal CT scan reveals a well-circumscribed homogeneous mass in the left adrenal gland.\n\u2022 These findings are consistent with an aldosterone-producing adrenal adenoma (Conn syndrome), which causes excess aldosterone secretion. High aldosterone levels lead to sodium retention (resulting in hypertension) and potassium wasting (resulting in hypokalemia).\n\nStep 2: Understand Aldosterone\u2019s Mechanism of Action\n\u2022 Aldosterone is a steroid hormone produced in the adrenal cortex.\n\u2022 It exerts its effects by diffusing into target cells and binding to intracellular mineralocorticoid receptors (which are part of the nuclear receptor family).\n\u2022 This hormone-receptor complex then translocates to the nucleus where it acts as a transcription factor, altering gene expression and ultimately leading to increased sodium reabsorption and potassium excretion.\n\nStep 3: Compare Options and Eliminate Incorrect Choices\n\u2022 Option A: Intracellular receptors \u2013 Correct, as aldosterone binds to mineralocorticoid receptors inside the cell.\n\u2022 Option B: cAMP pathway \u2013 Incorrect, as this pathway is typical for many peptide hormones that act via cell surface receptors.\n\u2022 Option C: cGMP pathway \u2013 Incorrect, as this pathway is not typically associated with aldosterone.\n\u2022 Option D: JAK/STAT pathway \u2013 Incorrect, as this pathway is not used by steroid hormones.\n\nFinal Answer: A. Intracellular receptors"
    },
    {
        "realidx": 755,
        "question": "A 31-year-old G1-P0 woman at 28-weeks gestation presents with shortness of breath and nonspecific right-sided chest pain that is worse with inspiration. She works as a graduate student at the local university, and she informs you that she recently returned to the west coast from a trip to New York for an Economics conference. Her medical history is positive only for frequent bouts of sinusitis. She currently denies any smoking, drinks a glass of red wine/day, and she denies any past illicit drug use. The vital signs include: temperature 36.7\u00b0C (98.0\u00b0F), blood pressure 126/74 mm Hg, heart rate 87/min, and respiratory rate 23/min. Her physical examination shows decreased air movement throughout the right lung but otherwise clear lungs on auscultation, grade 2/6 holosystolic murmur, and a gravid uterus without acute findings. On physical examination, she is afebrile, tachycardic to 121/min, normotensive, and demonstrates an O2 saturation of 92%. Which of the following is the best next step in the evaluation of the most likely diagnosis for this patient?",
        "answer": "V/Q scan",
        "options": {
            "A": "ECG",
            "B": "Chest radiography",
            "C": "V/Q scan",
            "D": "CT pulmonary angiogram"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "31 year old G1 P0 woman",
            "weeks presents",
            "shortness of breath",
            "nonspecific right-sided",
            "worse",
            "inspiration",
            "works",
            "graduate student",
            "local university",
            "informs",
            "recently returned",
            "west",
            "trip",
            "New York",
            "Economics conference",
            "medical history",
            "positive only",
            "frequent bouts",
            "sinusitis",
            "currently denies",
            "smoking",
            "drinks",
            "glass",
            "red wine day",
            "denies",
            "past illicit drug use",
            "vital signs include",
            "temperature 36",
            "98",
            "blood pressure",
            "74 mm Hg",
            "heart rate 87 min",
            "respiratory rate 23 min",
            "physical examination shows decreased air movement",
            "right lung",
            "clear lungs",
            "auscultation",
            "grade",
            "6 holosystolic murmur",
            "gravid uterus",
            "acute findings",
            "physical examination",
            "afebrile",
            "tachycardic",
            "min",
            "normotensive",
            "demonstrates",
            "O2 saturation",
            "following",
            "best next step",
            "evaluation",
            "likely diagnosis",
            "patient"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 5007,
            "completion_tokens": 6297
        },
        "time_elapsed": 45.84380030632019,
        "raw_responses": [
            "Step 1: Recognize the likely diagnosis. The patient is a 31\u2010year\u2010old pregnant woman presenting with shortness of breath, pleuritic chest pain, and a history (recent travel) that raises suspicion for pulmonary embolism (PE).\n\nStep 2: Consider the specific issues related to pregnancy. In pregnancy, concerns about radiation exposure (especially to the fetus and maternal breast tissue) guide the choice of imaging modality for suspected PE.\n\nStep 3: Compare the options. An ECG might show non-specific findings in PE but isn\u2019t diagnostic. A chest radiograph can be useful to rule out other causes and sometimes to set the stage for further imaging, but it isn\u2019t definitive for PE. A CT pulmonary angiogram, while highly sensitive for PE in the general population, carries a higher radiation burden, making it less desirable in pregnancy. In pregnant patients with suspected PE (particularly with a normal chest X-ray), a ventilation\u2011perfusion (V/Q) scan is preferred because it minimizes radiation exposure while still providing useful diagnostic detail.\n\nStep 4: Final Answer. Given the clinical context, the most appropriate next step in the evaluation is a V/Q scan.\n\nFinal answer: C. V/Q scan.",
            "Step 1: The presentation of pleuritic chest pain, shortness of breath, and tachycardia in a pregnant woman who has recently been on a long-distance trip raises strong suspicion for a pulmonary embolism (PE).\n\nStep 2: In pregnancy, it's important to balance diagnostic accuracy with minimizing radiation exposure to the fetus. Although chest radiography is often used as an initial evaluation in many chest complaints, in suspected PE the goal is to confirm or rule out the embolism while minimizing fetal radiation. CT pulmonary angiography (CTPA) delivers significant radiation and is generally avoided in pregnancy unless other tests are nondiagnostic. An ECG is nonspecific and would not be definitive for PE, so it is not the best next step in evaluation.\n\nStep 3: In pregnant patients with a normal chest x-ray (which is often the case), a ventilation-perfusion (V/Q) scan is generally preferred because it typically results in lower radiation exposure to the fetus when compared to CTPA.\n\nFinal Answer: V/Q scan",
            "Step 1: This 28\u2010week pregnant woman has shortness of breath, pleuritic chest pain, tachycardia, and a history of recent travel. In pregnancy, the hypercoagulable state increases the risk for pulmonary embolism (PE).\n\nStep 2: While an ECG (option A) might be helpful in some cases, it is neither sensitive nor specific for PE. A chest radiograph (option B) is sometimes obtained to look for alternative diagnoses or to assess lung parenchyma before further imaging, but it does not diagnose a PE. CT pulmonary angiogram (option D) is very useful for diagnosing PE in the general population yet carries a higher radiation burden compared to a V/Q scan, which is a major consideration in the pregnant patient.\n\nStep 3: In pregnancy with a high index of suspicion for PE, the preferred imaging modality is a ventilation\u2013perfusion (V/Q) scan (option C) because it minimizes radiation exposure, especially to the fetus. Current guidelines suggest that if the chest x\u2010ray is normal or if there is low suspicion for parenchymal lung disease, a V/Q scan is the appropriate test.\n\nFinal Answer: C. V/Q scan"
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Recognize the likely diagnosis. The patient is a 31\u2010year\u2010old pregnant woman presenting with shortness of breath, pleuritic chest pain, and a history (recent travel) that raises suspicion for pulmonary embolism (PE).\n\nStep 2: Consider the specific issues related to pregnancy. In pregnancy, concerns about radiation exposure (especially to the fetus and maternal breast tissue) guide the choice of imaging modality for suspected PE.\n\nStep 3: Compare the options. An ECG might show non-specific findings in PE but isn\u2019t diagnostic. A chest radiograph can be useful to rule out other causes and sometimes to set the stage for further imaging, but it isn\u2019t definitive for PE. A CT pulmonary angiogram, while highly sensitive for PE in the general population, carries a higher radiation burden, making it less desirable in pregnancy. In pregnant patients with suspected PE (particularly with a normal chest X-ray), a ventilation\u2011perfusion (V/Q) scan is preferred because it minimizes radiation exposure while still providing useful diagnostic detail.\n\nStep 4: Final Answer. Given the clinical context, the most appropriate next step in the evaluation is a V/Q scan.\n\nFinal answer: C. V/Q scan."
    },
    {
        "realidx": 758,
        "question": "A 62-year-old man presents to the emergency department for evaluation of a low-grade fever, worsening fatigue, and mild intermittent abdominal pain that is not affected by eating. He reports that over the last 6 months he slept a lot more than usual and lost 14.9 kg (33 lbs) without trying to lose weight. He also complains of chest pain and shortness of breath that is worse when he is working and in the yard. There is no significant family history. His long-standing male partner passed away 2 years ago in a fatal car accident. His blood pressure is 145/75 mm Hg, the pulse is 90/min, the respiratory rate is 23/min, and the temperature is 38\u00b0C (100.5\u00b0F). On physical examination, he has pale mucous membranes, conjunctival hemorrhages, and petechiae on his lower extremities. There is a new-onset high-pitched blowing diastolic murmur best heard over the right upper sternal border. His head bobs with each heartbeat. There are small, painless, red macules on both palms. His spleen is palpable 3 cm below the left costal margin. His laboratory results are shown below.\nHemoglobin 8.4 g/dL\nMean corpuscular volume 72 \u00b5m3\nPlatelet count 400,000/mm3\nLeukocytes 6,000/mm3\nSerum ferritin 8 ng/mL\nSerum iron 27 \u00b5g/dL\nTotal iron-binding capacity 450 \u00b5g/dL\nColonoscopy with biopsy is later performed showing a neoplastic growth in the descending colon. Which of the following is the most likely explanation for his cardiac findings?",
        "answer": "Group D streptococci",
        "options": {
            "A": "Treponema pallidum",
            "B": "Malignant colonic neoplasm",
            "C": "Collagen vascular disease",
            "D": "Group D streptococci"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "62 year old man presents",
            "emergency department",
            "evaluation",
            "low-grade fever",
            "worsening fatigue",
            "mild intermittent abdominal pain",
            "not affected",
            "eating",
            "reports",
            "last",
            "months",
            "slept",
            "lot",
            "usual",
            "lost",
            "kg",
            "lbs",
            "to",
            "weight",
            "of chest pain",
            "shortness of breath",
            "worse",
            "working",
            "yard",
            "significant family history",
            "long standing male partner passed",
            "years",
            "fatal car accident",
            "blood pressure",
            "75 mm Hg",
            "pulse",
            "90 min",
            "respiratory rate",
            "23 min",
            "temperature",
            "100",
            "physical examination",
            "pale mucous membranes",
            "conjunctival hemorrhages",
            "petechiae",
            "lower extremities",
            "new-onset high-pitched blowing diastolic murmur best heard",
            "right upper sternal border",
            "head bobs",
            "heartbeat",
            "small",
            "painless",
            "red macules",
            "palms",
            "spleen",
            "palpable 3 cm",
            "left costal margin",
            "laboratory results",
            "shown",
            "Hemoglobin 8.4 g dL Mean corpuscular volume 72",
            "Platelet count 400",
            "mm3 Leukocytes",
            "Serum",
            "ng/mL",
            "iron 27",
            "dL Total",
            "450",
            "Colonoscopy",
            "biopsy",
            "later performed showing",
            "neoplastic growth",
            "descending colon",
            "following",
            "most likely explanation",
            "cardiac findings"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 7566,
            "completion_tokens": 9646
        },
        "time_elapsed": 522.862884759903,
        "raw_responses": [
            "Step 1: Analyze the patient's presentation.\n\u2022 The 62-year-old man has constitutional symptoms (fever, fatigue, weight loss) and signs of anemia.\n\u2022 Physical exam reveals classic signs of endocarditis: a high\u2010pitch blowing diastolic murmur at the right upper sternal border (aortic regurgitation), head bobbing, conjunctival hemorrhages, petechiae, and Janeway lesions (small, painless, red macules on the palms).\n\u2022 Laboratory tests reveal iron deficiency anemia.\n\u2022 Colonoscopy shows a neoplastic growth in the descending colon.\n\nStep 2: Connect the clinical findings.\n\u2022 Iron deficiency anemia in an older male is a red flag for gastrointestinal malignancy.\n\u2022 Malignancy (especially adenocarcinoma of the colon) is associated with a hypercoagulable state.\n\u2022 In the context of malignancy, sterile vegetations may develop on the valves \u2013 a condition called nonbacterial thrombotic endocarditis (NBTE) or marantic endocarditis.\n\u2022 NBTE can produce embolic phenomena and subtle valvular dysfunction, leading to murmurs and systemic findings that mimic infective endocarditis.\n\nStep 3: Evaluate answer choices.\nA. Treponema pallidum \u2013 Causes aortic regurgitation in tertiary syphilis, but there is no suggestion of syphilis or its systemic findings in this patient.\nB. Malignant colonic neoplasm \u2013 Colon cancer can trigger NBTE, leading to the valvular lesions and resulting murmur.\nC. Collagen vascular disease \u2013 Conditions like systemic lupus erythematosus can cause Libman-Sacks endocarditis, but there is no evidence or clinical history suggestive of autoimmune disease.\nD. Group D streptococci \u2013 These bacteria (including enterococci) can cause infective endocarditis, but the patient\u2019s presentation is more consistent with an embolic phenomenon secondary to cancer rather than a typical streptococcal infection.\n\nStep 4: Final answer.\nThe most likely explanation for his cardiac findings is the hypercoagulable state induced by his malignant colonic neoplasm leading to nonbacterial thrombotic endocarditis.\n\nFinal Answer: B. Malignant colonic neoplasm",
            "Step 1: Reviewing the History and Exam Findings\n\u2022 The patient has systemic symptoms (fever, weight loss, fatigue) along with signs of iron deficiency anemia (microcytic anemia, low ferritin, low serum iron, high TIBC).\n\u2022 Colonoscopy reveals a neoplastic growth in the descending colon, indicating colon cancer.\n\u2022 On physical exam, the patient has signs of endocarditis including pale mucous membranes, conjunctival hemorrhages, petechiae, small painless red macules on the palms (Janeway lesions), and a new-onset high-pitched blowing diastolic murmur with associated nodding of the head (de Musset's sign). These findings point toward aortic regurgitation.\n\nStep 2: Linking the Cardiac Findings and Colon Malignancy\n\u2022 In the setting of an occult malignancy like colon adenocarcinoma, a hypercoagulable state may develop.\n\u2022 This hypercoagulability can lead to the formation of sterile, platelet-fibrin vegetations on heart valves, a condition known as nonbacterial thrombotic endocarditis (NBTE) or marantic endocarditis.\n\u2022 NBTE often involves the valves and can result in aortic regurgitation, which explains the patient\u2019s diastolic murmur and head bobbing.\n\nStep 3: Evaluating the Options\nA. Treponema pallidum \u2013 Causes syphilitic aortitis, which is not supported by the rest of this patient's presentation.\nB. Malignant colonic neoplasm \u2013 The colon cancer is responsible for the hypercoagulable state leading to NBTE, which in turn is causing the cardiac findings.\nC. Collagen vascular disease \u2013 Typically presents in a different demographic and with other systemic manifestations, making it less likely.\nD. Group D streptococci \u2013 Although these bacteria (including Enterococcus) can cause infective endocarditis, they are not the classic cause in the context of colon cancer, and the scenario is more in line with NBTE as a paraneoplastic phenomenon.\n\nStep 4: Final Answer\nThe most likely explanation for his cardiac findings is the hypercoagulable state secondary to the malignant colonic neoplasm, leading to nonbacterial thrombotic endocarditis.\n\nFinal Answer: B. Malignant colonic neoplasm",
            "Step 1: Review the key findings. This 62\u2010year\u2010old man has low-grade fever, weight loss, fatigue, microcytic anemia with iron deficiency, and a neoplastic lesion discovered on colonoscopy in the descending colon. On exam, he has signs of infective endocarditis (pale mucous membranes, conjunctival hemorrhages, petechiae, Janeway lesions on the palms) along with a high\u2010pitched blowing diastolic murmur over the right upper sternal border (consistent with aortic regurgitation), plus head bobbing (de Musset\u2019s sign).\n\nStep 2: Identify associations and potential pathogens. Endocarditis in the setting of colon neoplasms raises suspicion for an organism that connects gastrointestinal pathology with endocarditis. Streptococcus bovis (a Group D streptococcus) is classically associated with colon cancer and can lead to infective endocarditis. \n\nStep 3: Compare answer choices.\n\u2022 Option A (Treponema pallidum) causes syphilitic aortitis leading to aortic regurgitation in the tertiary stage\u2014this does not fit the patient\u2019s presentation.\n\u2022 Option B (Malignant colonic neoplasm) is present and accounts for his iron deficiency anemia but does not directly explain his new cardiac findings.\n\u2022 Option C (Collagen vascular disease) would be associated with systemic inflammatory manifestations (and typically in a younger female population) but is not consistent with this presentation.\n\u2022 Option D (Group D streptococci) corresponds to Streptococcus bovis, which is known to be associated with colonic neoplasms and infective endocarditis.\n\nStep 4: Final Answer.\nThe most likely explanation for his cardiac findings is infective endocarditis caused by Group D streptococci. \n\nFinal answer: D. Group D streptococci"
        ],
        "ensemble_raw_responses": [
            "2",
            "2",
            "0"
        ],
        "final_solution": "Step 1: Review the key findings. This 62\u2010year\u2010old man has low-grade fever, weight loss, fatigue, microcytic anemia with iron deficiency, and a neoplastic lesion discovered on colonoscopy in the descending colon. On exam, he has signs of infective endocarditis (pale mucous membranes, conjunctival hemorrhages, petechiae, Janeway lesions on the palms) along with a high\u2010pitched blowing diastolic murmur over the right upper sternal border (consistent with aortic regurgitation), plus head bobbing (de Musset\u2019s sign).\n\nStep 2: Identify associations and potential pathogens. Endocarditis in the setting of colon neoplasms raises suspicion for an organism that connects gastrointestinal pathology with endocarditis. Streptococcus bovis (a Group D streptococcus) is classically associated with colon cancer and can lead to infective endocarditis. \n\nStep 3: Compare answer choices.\n\u2022 Option A (Treponema pallidum) causes syphilitic aortitis leading to aortic regurgitation in the tertiary stage\u2014this does not fit the patient\u2019s presentation.\n\u2022 Option B (Malignant colonic neoplasm) is present and accounts for his iron deficiency anemia but does not directly explain his new cardiac findings.\n\u2022 Option C (Collagen vascular disease) would be associated with systemic inflammatory manifestations (and typically in a younger female population) but is not consistent with this presentation.\n\u2022 Option D (Group D streptococci) corresponds to Streptococcus bovis, which is known to be associated with colonic neoplasms and infective endocarditis.\n\nStep 4: Final Answer.\nThe most likely explanation for his cardiac findings is infective endocarditis caused by Group D streptococci. \n\nFinal answer: D. Group D streptococci"
    },
    {
        "realidx": 764,
        "question": "A 28-year-old woman, gravida 2, para 1, at 40 weeks gestation is brought to the emergency department by her husband. She is in active labor and has lost a lot of blood in the past 2 hours, but appears alert and cooperative. At the hospital, her blood pressure is 88/65 mm Hg, the pulse is 110/min, and the respirations are 23/min. Neither the hospital nor the emergency department is equipped for high-risk pregnancies. The patient and her husband request a transfer to a more capable center. They are informed of the hospital\u2019s obligations under the Emergency Medical Treatment and Labor Act and the risks of transfer. They insist to be transferred. Which of the following is the most appropriate next step in management?",
        "answer": "Treat and transfer the patient after she makes a written request",
        "options": {
            "A": "Decline admission and refer the patient to the closest capable emergency department",
            "B": "Disregard patient\u2019s request and treat until delivery is complete",
            "C": "Treat and transfer the patient after she makes a written request",
            "D": "Transfer the patient only if the medical benefits of transfer outweigh the risks"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "year old woman",
            "gravida 2",
            "para 1",
            "40 weeks gestation",
            "brought",
            "emergency department",
            "husband",
            "in active labor",
            "lost",
            "lot",
            "blood",
            "past",
            "hours",
            "appears alert",
            "cooperative",
            "hospital",
            "blood pressure",
            "88 65 mm Hg",
            "pulse",
            "min",
            "respirations",
            "23 min",
            "hospital",
            "emergency department",
            "high-risk pregnancies",
            "patient",
            "husband request",
            "transfer",
            "capable center",
            "informed",
            "hospitals",
            "Emergency Medical",
            "Labor Act",
            "risks",
            "transfer",
            "to",
            "transferred",
            "following",
            "most appropriate next step",
            "management"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4887,
            "completion_tokens": 4568
        },
        "time_elapsed": 35.596511125564575,
        "raw_responses": [
            "Step 1: The patient is a 28\u2010year\u2010old woman in active labor who is experiencing significant hemorrhage with hemodynamic instability (hypotension and tachycardia). Although she and her husband desire transfer to a higher-level center, because she has an emergent condition\u2014in this case, postpartum hemorrhage\u2014the hospital, under EMTALA regulations, must provide a medical screening exam and necessary stabilization before any transfer takes place.\n\nStep 2: Option A (decline admission and refer) is incorrect because the hospital cannot simply transfer an unstable patient without first stabilizing her. Option B (disregard the patient\u2019s request and treat until delivery is complete) is also not correct because while it recommends immediate treatment, it doesn\u2019t address the fact that transfer might be an option once stabilization is achieved. Option C (treat and transfer the patient after she makes a written request) is problematic because it implies that the patient\u2019s request alone would justify a transfer even if she is unstable. That left us with Option D, which states to \u201ctransfer the patient only if the medical benefits of transfer outweigh the risks.\u201d This option correctly implies that the decision to transfer must weigh the risk of transfer (given her instability) against the benefits of being at a facility more capable of managing high\u2010risk pregnancies, and that current management should focus on stabilization.\n\nStep 3: Final answer: D. Transfer the patient only if the medical benefits of transfer outweigh the risks.",
            "Step 1: Review the patient\u2019s condition and legal obligations.\n\u2022 The patient is a 28-year-old woman in active labor with significant blood loss, and her vital signs indicate hemodynamic instability.\n\u2022 The hospital and emergency department lack high-risk obstetric capabilities.\n\u2022 However, under the Emergency Medical Treatment and Labor Act (EMTALA), any patient presenting with an emergency condition must receive stabilization before transfer, even if the patient or her family requests a transfer.\n\nStep 2: Evaluate the answer choices.\n\u2022 Option A (Decline admission and refer the patient) is inappropriate because EMTALA requires the hospital to stabilize the patient, not turn her away.\n\u2022 Option C (Treat and transfer after she makes a written request) is incorrect because obtaining a written request does not override the need for immediate stabilization.\n\u2022 Option D (Transfer only if the medical benefits outweigh the risks) does not satisfy the legal obligation to first treat and stabilize the patient under EMTALA.\n\u2022 Option B (Disregard patient\u2019s request and treat until delivery is complete) is the correct choice, fulfilling both medical and legal obligations by ensuring the patient is stabilized prior to any transfer.\n\nFinal Answer: B. Disregard patient\u2019s request and treat until delivery is complete.",
            "Step 1: Recognize that the situation involves a 40-week pregnant woman in active labor with significant bleeding and hemodynamic instability (hypotension, tachycardia). Emergency protocols indicate that before transferring a patient, she must be stabilized.\n\nStep 2: According to the Emergency Medical Treatment and Labor Act (EMTALA), the hospital is obligated to provide an appropriate medical screening and necessary stabilization even if the patient requests transfer. In cases of obstetric emergencies this is especially important.\n\nStep 3: Option A (declining admission and referring the patient) is inappropriate because the hospital must treat an obstetric emergency regardless of available specialized services. Option C (treat and transfer after a written request) is not correct because patient consent does not override the need for stabilization. Option D (transfer only if the benefits outweigh the risks) is not the proper procedure given that EMTALA mandates stabilization prior to transfer. \n\nStep 4: Thus, option B \u2013 \u201cdisregard patient\u2019s request and treat until delivery is complete\u201d \u2013 is most consistent with proper legal and medical management under EMTALA, ensuring that the patient is stabilized regardless of the patient's request for transfer.\n\nFinal Answer: B"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Recognize that the situation involves a 40-week pregnant woman in active labor with significant bleeding and hemodynamic instability (hypotension, tachycardia). Emergency protocols indicate that before transferring a patient, she must be stabilized.\n\nStep 2: According to the Emergency Medical Treatment and Labor Act (EMTALA), the hospital is obligated to provide an appropriate medical screening and necessary stabilization even if the patient requests transfer. In cases of obstetric emergencies this is especially important.\n\nStep 3: Option A (declining admission and referring the patient) is inappropriate because the hospital must treat an obstetric emergency regardless of available specialized services. Option C (treat and transfer after a written request) is not correct because patient consent does not override the need for stabilization. Option D (transfer only if the benefits outweigh the risks) is not the proper procedure given that EMTALA mandates stabilization prior to transfer. \n\nStep 4: Thus, option B \u2013 \u201cdisregard patient\u2019s request and treat until delivery is complete\u201d \u2013 is most consistent with proper legal and medical management under EMTALA, ensuring that the patient is stabilized regardless of the patient's request for transfer.\n\nFinal Answer: B"
    },
    {
        "realidx": 778,
        "question": "A 3rd year resident in good standing with his residency training program would like to work more hours outside his residency obligations to gain more experience and pay for his medical school loans. He currently works and trains 60 hours per week as a resident and has a 10-hour shift external to his residency program on Saturdays. He is free of any educational and work obligations on Sundays. Based on the most recent standards set by the Accreditation Council for Graduate Medical Education (ACGME), which of the following is the most accurate statement regarding this resident\u2019s moonlighting and patient safety?",
        "answer": "He may work longer shifts",
        "options": {
            "A": "He is already overcommitting and must reduce the number of hours",
            "B": "He is not allowed to work outside the scope of his residency training",
            "C": "He may work longer shifts",
            "D": "He may work up to 20 more hours"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "3rd year resident",
            "good standing",
            "residency training program",
            "to work more hours outside",
            "residency",
            "to gain more experience",
            "pay",
            "medical school loans",
            "currently works",
            "trains 60 hours per week",
            "resident",
            "a 10 hour shift external",
            "residency program",
            "Saturdays",
            "free",
            "educational",
            "work",
            "Sundays",
            "Based",
            "recent standards set",
            "Accreditation Council",
            "Graduate Medical Education",
            "following",
            "most accurate statement",
            "residents moonlighting",
            "patient safety"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6054,
            "completion_tokens": 17219
        },
        "time_elapsed": 108.65229773521423,
        "raw_responses": [
            "The ACGME requires that all clinical work\u2014including moonlighting\u2014is counted toward an 80\u2010hour weekly limit (averaged over 4 weeks). In other words, a resident may perform additional clinical work outside their residency obligations only if the total work hours (residency plus moonlighting) remain under 80 hours per week. Although this resident currently spends 60 hours in residency and does a 10\u2010hour moonlighting shift on Saturday (totaling 70 hours), he may only add additional hours up to the 80\u2010hour limit. In a situation with 60 residency hours alone, one might say that residents in good standing can moonlight an extra 20 hours; however, since his moonlighting is already 10 hours, if he were to add more moonlighting, he could only add up to 10 (not 20) additional hours that week. \n\nOf the answer choices provided, answer D (\u201cHe may work up to 20 more hours\u201d) most nearly reflects the idea that residents are permitted to add moonlighting hours up to a total of 80 hours per week. (It is important to note that if he already works 10 hours of moonlighting, then he has only 10 additional hours available, not a full 20.) \n\nThus, with the choices given, the most accurate statement regarding this resident\u2019s moonlighting and patient safety is:\n\nAnswer: D. He may work up to 20 more hours (with the understanding that all moonlighting hours count toward the 80\u2010hour weekly maximum).",
            "The ACGME standards require that resident physicians\u2019 \u201cduty hours\u201d (which include training\u2010program activities as well as moonlighting) be limited to an average of 80 hours per week over a four\u2010week period. In addition, residents must receive one day (24 consecutive hours) free of all duties every week (averaged over four weeks). In this scenario the resident is currently scheduled for 60 hours per week of residency\u2010related work and is also doing a 10\u2010hour moonlighting shift on Saturday. Because all clinical work\u2014including moonlighting\u2014counts toward the 80\u2010hour limit, his schedule currently amounts to 70 hours for that week. In other words, the resident is allowed additional moonlighting time only if his total clinical work does not exceed 80 hours per week.\n\nAmong the answer choices:\n\nA. \u201cHe is already overcommitting and must reduce the number of hours\u201d \u2013 This is incorrect because 70 hours is within the 80\u2011hour limit.\n\nB. \u201cHe is not allowed to work outside the scope of his residency training\u201d \u2013 This is not what the ACGME rules state; provided he\u2019s in good standing, a PGY\u20113 is permitted to moonlight in an appropriate clinical setting.\n\nC. \u201cHe may work longer shifts\u201d \u2013 The ACGME also places limits on individual shift lengths (with most PGY\u20112 and above residents limited to a maximum of 24 hours of continuous duty with an additional up\u2010to 4 hours for transition of care), so \u201clonger shifts\u201d are not permitted.\n\nD. \u201cHe may work up to 20 more hours\u201d \u2013 Many institutions (and in some interpretations of the ACGME standards for PGY\u20112 and above) allow a resident to moonlight up to an additional 20 hours per week, as long as the total doesn\u2019t exceed an average of 80 hours. In this scenario one might be tempted to compute a \u201c20\u2010hour\u201d allowance because, if his residency duty is 60 hours, 60 + 20 = 80. (Although note that his current moonlighting \u201cuses up\u201d 10 of those potential 20 hours, leaving 10 hours spare if his total were to be capped strictly at 80.) Regardless, the choice that best reflects the ACGME\u2019s stance on allowable moonlighting hours is Choice D.\n\nThus, the most accurate statement regarding this resident\u2019s moonlighting in relation to patient safety (by ensuring that total work does not exceed the ACGME\u2019s limits) is:\n\nFinal Answer: D",
            "The key point is that the ACGME requires that all clinical work (residency\u2010plus\u2013moonlighting hours) must average no more than 80 hours per week over a four\u2010week period. In addition, for residents beyond their intern year, there is a separate cap stating that moonlighting hours cannot exceed 20 hours per week. In this case the resident is doing 60 hours of residency work and already has a 10\u2010hour moonlighting shift on Saturday (total 70 hours). Because moonlighting hours count toward the weekly 80\u2010hour limit, he may have up to 20 total moonlighting hours per week (not 20 additional hours beyond what he is already doing). That means, although his moonlighting \u201cbudget\u201d is 20 hours per week, with 10 already clocked he could only add an extra 10 hours without exceeding either the overall 80\u2010hour limit or the 20\u2010hour moonlighting cap.\n\nLooking at the answer choices:\nA. He is already overcommitting and must reduce the number of hours \u2013 Incorrect. His current schedule (70 hours) is within the 80\u2010hour limit.\nB. He is not allowed to work outside the scope of his residency training \u2013 Incorrect. Moonlighting is permitted provided the total hours remain within limits.\nC. He may work longer shifts \u2013 Incorrect. The ACGME limits not only the total weekly hours but also the maximum shift lengths.\nD. He may work up to 20 more hours \u2013 This answer is best interpreted to mean that residents are allowed a maximum of 20 moonlighting hours per week (which, combined with his residency work, must not exceed 80 hours total). Even though he already works 10 moonlighting hours, the cap on moonlighting is 20 per week. \n\nThus, the most accurate statement is that under current ACGME standards, the resident is permitted up to 20 hours of moonlighting per week (meaning that with his current 10\u2010hour moonlighting shift, he could only add up to 10 additional moonlighting hours without exceeding the 80\u2010hour overall weekly limit).\n\nFinal answer: D."
        ],
        "ensemble_raw_responses": [
            "1",
            "2",
            "1"
        ],
        "final_solution": "The key point is that the ACGME requires that all clinical work (residency\u2010plus\u2013moonlighting hours) must average no more than 80 hours per week over a four\u2010week period. In addition, for residents beyond their intern year, there is a separate cap stating that moonlighting hours cannot exceed 20 hours per week. In this case the resident is doing 60 hours of residency work and already has a 10\u2010hour moonlighting shift on Saturday (total 70 hours). Because moonlighting hours count toward the weekly 80\u2010hour limit, he may have up to 20 total moonlighting hours per week (not 20 additional hours beyond what he is already doing). That means, although his moonlighting \u201cbudget\u201d is 20 hours per week, with 10 already clocked he could only add an extra 10 hours without exceeding either the overall 80\u2010hour limit or the 20\u2010hour moonlighting cap.\n\nLooking at the answer choices:\nA. He is already overcommitting and must reduce the number of hours \u2013 Incorrect. His current schedule (70 hours) is within the 80\u2010hour limit.\nB. He is not allowed to work outside the scope of his residency training \u2013 Incorrect. Moonlighting is permitted provided the total hours remain within limits.\nC. He may work longer shifts \u2013 Incorrect. The ACGME limits not only the total weekly hours but also the maximum shift lengths.\nD. He may work up to 20 more hours \u2013 This answer is best interpreted to mean that residents are allowed a maximum of 20 moonlighting hours per week (which, combined with his residency work, must not exceed 80 hours total). Even though he already works 10 moonlighting hours, the cap on moonlighting is 20 per week. \n\nThus, the most accurate statement is that under current ACGME standards, the resident is permitted up to 20 hours of moonlighting per week (meaning that with his current 10\u2010hour moonlighting shift, he could only add up to 10 additional moonlighting hours without exceeding the 80\u2010hour overall weekly limit).\n\nFinal answer: D."
    },
    {
        "realidx": 784,
        "question": "A 42-year-old woman presents to her obstetrician for a prenatal care appointment at 10 weeks gestation. The patient recently found out she was pregnant after having unprotected intercourse with her husband for the past year. She states that she is feeling well and has experienced some nausea and vomiting. She is currently taking prenatal vitamins and folate supplements. Her temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 127/68 mmHg, pulse is 90/min, respirations are 19/min, and oxygen saturation is 98% on room air. On physical exam, you notice a gravid uterus 10 cm above the pubic symphysis. The patient's external genitalia appear within normal limits. Which of the following is the next best step in management?",
        "answer": "Cell-free DNA testing",
        "options": {
            "A": "Amniocentesis",
            "B": "Cell-free DNA testing",
            "C": "Chorionic villus sampling",
            "D": "Regular follow up appointments"
        },
        "meta_info": "step2&3",
        "answer_idx": "B",
        "metamap_phrases": [
            "year old woman presents",
            "obstetrician",
            "prenatal care appointment",
            "10 weeks gestation",
            "patient recently found out",
            "pregnant",
            "unprotected intercourse",
            "husband",
            "past year",
            "states",
            "feeling well",
            "experienced",
            "nausea",
            "vomiting",
            "currently taking prenatal vitamins",
            "folate supplements",
            "temperature",
            "99",
            "blood pressure",
            "68 mmHg",
            "pulse",
            "90 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "physical exam",
            "gravid uterus 10",
            "pubic symphysis",
            "patient's external genitalia appear",
            "normal limits",
            "following",
            "next best step",
            "management"
        ],
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 4509,
            "completion_tokens": 3726
        },
        "time_elapsed": 30.165343523025513,
        "raw_responses": [
            "Step 1: The patient is a 42-year-old woman at 10 weeks gestation. Being of advanced maternal age increases the risk for chromosomal abnormalities.\n\nStep 2: In early pregnancy, noninvasive prenatal testing such as cell-free DNA (cfDNA) screening is recommended because it can be performed as early as 10 weeks and offers a highly sensitive screening method for chromosomal abnormalities. Amniocentesis is typically done in the second trimester (after 15 weeks), while chorionic villus sampling (CVS) is an option in the first trimester but is an invasive diagnostic test with associated risks. Since the patient is currently asymptomatic aside from normal pregnancy symptoms and is already taking prenatal vitamins, routine scheduling for further screening is appropriate. In women with advanced maternal age, cfDNA is preferred as an initial screening before considering invasive diagnostic tests.\n\nStep 3: Thus, among the choices, the best next step in management is to offer Cell-free DNA testing.\n\nFinal answer: B. Cell-free DNA testing",
            "Step 1: The patient is 42 years old and at 10 weeks gestation. Advanced maternal age increases the risk for chromosomal abnormalities. Screening for fetal aneuploidy is important in this setting.\n\nStep 2: Amniocentesis is usually performed between 15\u201320 weeks and is invasive. Chorionic villus sampling is an invasive test performed between 10\u201313 weeks but is generally reserved for cases after abnormal noninvasive screening tests or when there are other concerning findings. Regular follow-up alone is not sufficient given her increased risk due to advanced maternal age. Cell-free DNA testing (noninvasive prenatal testing) can be done starting at 10 weeks gestation and is appropriate for screening in this high-risk population.\n\nStep 3: Therefore, the best next step in management is to offer cell-free DNA testing.\n\nFinal answer: B. Cell-free DNA testing",
            "Step 1: Analyze the Patient's Situation\n\u2022 The patient is 42 years old, making her of advanced maternal age, which increases her risk for chromosomal abnormalities.\n\u2022 She is at 10 weeks of gestation, a time when certain noninvasive prenatal screening tests are available.\n\u2022 While invasive diagnostic tests exist, appropriate screening should precede them.\n\nStep 2: Evaluate the Options\nA. Amniocentesis \u2013 This invasive diagnostic procedure is typically performed during the second trimester (around 15-20 weeks) rather than earlier in pregnancy.\nB. Cell-free DNA testing \u2013 This noninvasive screening can be performed as early as 10 weeks and is recommended for patients with advanced maternal age to assess the risk of chromosomal abnormalities.\nC. Chorionic villus sampling \u2013 Although this diagnostic test is available in the first trimester (10-13 weeks), it is invasive and is generally reserved for cases when screening results are abnormal or when immediate diagnostic clarification is required.\nD. Regular follow up appointments \u2013 While regular care is essential, given her advanced maternal age there is a need for additional screening for aneuploidy.\n\nStep 3: Conclusion and Final Answer\nFor a 42-year-old at 10 weeks gestation, the next best step is to offer noninvasive screening that is both timely and appropriate for her risk profile. Therefore, the next best step in management is:\n\nFinal Answer: Cell-free DNA testing"
        ],
        "ensemble_raw_responses": [
            "1",
            "1",
            "1"
        ],
        "final_solution": "Step 1: The patient is a 42-year-old woman at 10 weeks gestation. Being of advanced maternal age increases the risk for chromosomal abnormalities.\n\nStep 2: In early pregnancy, noninvasive prenatal testing such as cell-free DNA (cfDNA) screening is recommended because it can be performed as early as 10 weeks and offers a highly sensitive screening method for chromosomal abnormalities. Amniocentesis is typically done in the second trimester (after 15 weeks), while chorionic villus sampling (CVS) is an option in the first trimester but is an invasive diagnostic test with associated risks. Since the patient is currently asymptomatic aside from normal pregnancy symptoms and is already taking prenatal vitamins, routine scheduling for further screening is appropriate. In women with advanced maternal age, cfDNA is preferred as an initial screening before considering invasive diagnostic tests.\n\nStep 3: Thus, among the choices, the best next step in management is to offer Cell-free DNA testing.\n\nFinal answer: B. Cell-free DNA testing"
    },
    {
        "realidx": 785,
        "question": "A 6-year-old boy is brought to the physician because of abdominal distention, fatigue, and night sweats over the past 4 months. He also has a 2-month history of post-prandial fullness and recurrent nonbilious vomiting. He appears pale. Abdominal examination shows hepatosplenomegaly and shifting dullness; there is mild tenderness to palpation. Examination of the skin shows multiple nonblanching maculae. A CT scan of the abdomen shows mesenteric and retroperitoneal lymph node enlargement and nodular thickening of the omentum. A photomicrograph of a biopsy specimen from an enlarged mesenteric lymph node is shown. Immunohistochemical staining of the Ki-67 nuclear antigen shows that the proliferation index of the specimen is > 99%. The structure indicated by the arrows is most likely which of the following?",
        "answer": "Macrophage",
        "options": {
            "A": "Neutrophil",
            "B": "Human immunodeficiency virus",
            "C": "B lymphocytes",
            "D": "Macrophage"
        },
        "meta_info": "step1",
        "answer_idx": "D",
        "metamap_phrases": [
            "year old boy",
            "brought",
            "physician",
            "abdominal distention",
            "fatigue",
            "night sweats",
            "past",
            "months",
            "2 month history",
            "post-prandial fullness",
            "recurrent",
            "vomiting",
            "appears pale",
            "Abdominal examination shows hepatosplenomegaly",
            "shifting dullness",
            "mild tenderness",
            "palpation",
            "Examination of",
            "skin shows multiple",
            "maculae",
            "CT scan",
            "abdomen shows mesenteric",
            "retroperitoneal lymph node enlargement",
            "nodular thickening",
            "omentum",
            "photomicrograph",
            "biopsy specimen",
            "enlarged mesenteric lymph node",
            "shown",
            "staining",
            "Ki-67 nuclear antigen shows",
            "proliferation index",
            "specimen",
            "99",
            "structure indicated",
            "arrows",
            "most likely",
            "following"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 5697,
            "completion_tokens": 5288
        },
        "time_elapsed": 40.40626525878906,
        "raw_responses": [
            "Step 1: Analyze the clinical presentation.\n\u2022 The 6-year-old boy presents with abdominal distention, fatigue, night sweats, hepatosplenomegaly, ascites (shifting dullness), and gastrointestinal symptoms.\n\u2022 CT scan findings of mesenteric and retroperitoneal lymph node enlargement with nodular thickening of the omentum suggest a systemic lymphoproliferative disorder.\n\u2022 The high Ki-67 index (>99%) on the biopsy is characteristic of a malignancy with rapid cell turnover, such as Burkitt lymphoma.\n\nStep 2: Consider the biopsy.\n\u2022 In Burkitt lymphoma, the histologic \u201cstarry sky\u201d appearance is seen. This pattern is created by numerous lymphoma cells with high mitotic activity (the \u201csky\u201d) interspersed with lighter staining macrophages (the \u201cstars\u201d) that are clearing apoptotic debris.\n\u2022 The arrows in the photomicrograph likely point to these lighter spots, which are the tingible body macrophages.\n\nStep 3: Compare the answer options.\nA. Neutrophil \u2013 Not typically seen forming the starry sky in lymphomas.\nB. Human immunodeficiency virus \u2013 Not a cellular structure; it\u2019s a virus.\nC. B lymphocytes \u2013 Although Burkitt lymphoma is a B-cell malignancy, the arrows point specifically not to the malignant B lymphocytes but to the macrophages.\nD. Macrophage \u2013 These are the cells that create the \u201cstarry sky\u201d pattern by phagocytizing apoptotic debris.\n\nStep 4: Provide the final answer.\nThe structure indicated by the arrows is most likely a macrophage.\n\nFinal answer: D. Macrophage",
            "We are dealing with a 6-year-old boy whose clinical picture (abdominal distention, hepatosplenomegaly, night sweats, and gastrointestinal symptoms) in combination with CT findings of lymph node enlargement and omental thickening is highly suggestive of an aggressive lymphoma. The biopsy shows a Ki-67 proliferation index of >99%, a hallmark of Burkitt lymphoma, a B-cell neoplasm that is notorious for its very rapid growth. Histologically, Burkitt lymphoma is famous for its \"starry sky\" appearance. In this pattern, the densely packed, darkly staining malignant B lymphocytes form the \u201csky,\u201d while the lighter spots (the \u201cstars\u201d) are tangible body macrophages actively phagocytosing apoptotic tumor cells.\n\nThe question is asking about the structure indicated by the arrows in the photomicrograph. Although the vast majority of cells in Burkitt lymphoma are malignant B lymphocytes, the arrows in a \"starry sky\" image typically point to the scattered pale cells. These lighter cells are the macrophages.\n\nStep by step:\n1. The clinical scenario and imaging point toward an aggressive abdominal lymphoma in a pediatric patient (consistent with Burkitt lymphoma).\n2. The biopsy\u2019s high Ki-67 index (>99%) is characteristic of Burkitt lymphoma.\n3. Burkitt lymphoma exhibits a \"starry sky\" pattern on histology, where the \u201cstars\u201d are tangible body macrophages amid a background of malignant B lymphocytes.\n4. The arrows in the photomicrograph most likely highlight these pale cells, which are macrophages.\n\nFinal answer: D. Macrophage.",
            "Step 1: Analyze the clinical presentation.\n\u2022 The patient is a 6-year-old boy with a 4-month history of abdominal distention, fatigue, and night sweats.\n\u2022 There is hepatosplenomegaly, ascites (shifting dullness), and recurrent nonbilious vomiting, suggestive of significant abdominal pathology.\n\u2022 The CT scan shows mesenteric and retroperitoneal lymphadenopathy with omental thickening.\n\u2022 The biopsy from an enlarged lymph node reveals a Ki-67 proliferation index > 99%, which is characteristic of highly aggressive tumors such as Burkitt lymphoma.\n\nStep 2: Consider the pathology.\n\u2022 Burkitt lymphoma is known for its \"starry sky\" appearance on histology.\n\u2022 This appearance is created by scattered benign macrophages (depicted as pale \"stars\") among a background of densely packed malignant lymphocytes (the \"sky\").\n\u2022 The high Ki-67 index supports the diagnosis of a rapidly proliferating tumor.\n\u2022 The arrows in the photomicrograph would most likely be highlighting the macrophages that are phagocytosing apoptotic tumor cells.\n\nStep 3: Compare the answer options.\n\u2022 Option A (Neutrophil) \u2013 Typically do not create the starry sky pattern in lymphoma.\n\u2022 Option B (Human immunodeficiency virus) \u2013 An infectious agent, not a histologic cellular component.\n\u2022 Option C (B lymphocytes) \u2013 While the malignant cells in Burkitt lymphoma are indeed B lymphocytes, the arrows in a starry-sky pattern typically point to the interspersed macrophages.\n\u2022 Option D (Macrophage) \u2013 These are the cells that produce the \"stars\" in the starry sky appearance by phagocytosing apoptotic debris.\n\nFinal Answer: D. Macrophage"
        ],
        "ensemble_raw_responses": [
            "2",
            "0",
            "2"
        ],
        "final_solution": "We are dealing with a 6-year-old boy whose clinical picture (abdominal distention, hepatosplenomegaly, night sweats, and gastrointestinal symptoms) in combination with CT findings of lymph node enlargement and omental thickening is highly suggestive of an aggressive lymphoma. The biopsy shows a Ki-67 proliferation index of >99%, a hallmark of Burkitt lymphoma, a B-cell neoplasm that is notorious for its very rapid growth. Histologically, Burkitt lymphoma is famous for its \"starry sky\" appearance. In this pattern, the densely packed, darkly staining malignant B lymphocytes form the \u201csky,\u201d while the lighter spots (the \u201cstars\u201d) are tangible body macrophages actively phagocytosing apoptotic tumor cells.\n\nThe question is asking about the structure indicated by the arrows in the photomicrograph. Although the vast majority of cells in Burkitt lymphoma are malignant B lymphocytes, the arrows in a \"starry sky\" image typically point to the scattered pale cells. These lighter cells are the macrophages.\n\nStep by step:\n1. The clinical scenario and imaging point toward an aggressive abdominal lymphoma in a pediatric patient (consistent with Burkitt lymphoma).\n2. The biopsy\u2019s high Ki-67 index (>99%) is characteristic of Burkitt lymphoma.\n3. Burkitt lymphoma exhibits a \"starry sky\" pattern on histology, where the \u201cstars\u201d are tangible body macrophages amid a background of malignant B lymphocytes.\n4. The arrows in the photomicrograph most likely highlight these pale cells, which are macrophages.\n\nFinal answer: D. Macrophage."
    },
    {
        "realidx": 791,
        "question": "A 5-year-old boy is brought to his pediatrician\u2019s office by his parents after they noticed blood in his urine. The child has been complaining of difficulty in passing urine and has lower abdominal pain. He seems more bloated than usual. On some occasions, he starts crying while passing urine, primarily because of a burning sensation. A urinalysis is performed, and the results are as follows:\nUrine pH 6.2\nUrine specific gravity 1.010\nGlucose Negative\nKetones Negative\nRBCs 1-2/hpf\nWBCs 0-1/hpf\nCasts 2-3/hpf\nThe pediatrician believes the boy has a bladder infection with a double-stranded DNA virus. Which of the following conditions is also commonly associated with this viral infection?",
        "answer": "Gastroenteritis",
        "options": {
            "A": "Gastroenteritis",
            "B": "Painful dermatomal vesicles",
            "C": "Lymphadenopathy",
            "D": "Vesicular rash"
        },
        "meta_info": "step1",
        "answer_idx": "A",
        "metamap_phrases": [
            "5 year old boy",
            "brought",
            "pediatricians office",
            "parents",
            "blood in",
            "urine",
            "child",
            "difficulty",
            "passing urine",
            "lower abdominal pain",
            "more bloated",
            "usual",
            "occasions",
            "starts crying",
            "passing urine",
            "burning sensation",
            "urinalysis",
            "performed",
            "results",
            "follows",
            "Urine pH 6",
            "specific gravity",
            "Glucose Negative Ketones",
            "RBCs",
            "hpf",
            "0",
            "Casts 2-3 hpf",
            "pediatrician",
            "boy",
            "bladder infection",
            "double-stranded DNA virus",
            "following conditions",
            "associated",
            "viral infection"
        ],
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 4431,
            "completion_tokens": 5063
        },
        "time_elapsed": 36.35867738723755,
        "raw_responses": [
            "Step 1: Identify the virus.\n\u2022 The pediatrician believes the bladder infection is due to a double-stranded DNA virus. Adenovirus, a double-stranded DNA virus, is known to cause hemorrhagic cystitis in children.\n\nStep 2: Understand adenovirus-associated conditions.\n\u2022 Adenovirus is also commonly associated with respiratory illnesses, conjunctivitis, and gastroenteritis (an intestinal infection with diarrhea, vomiting, etc.).\n\nStep 3: Compare with the given options.\n\u2022 Option A (Gastroenteritis) fits the adenovirus infection profile.\n\u2022 Option B (Painful dermatomal vesicles) is typical for varicella zoster virus reactivation.\n\u2022 Option C (Lymphadenopathy) is not a primary feature of adenovirus infection.\n\u2022 Option D (Vesicular rash) is associated with varicella-zoster virus (chickenpox) or herpes zoster rather than adenovirus.\n\nFinal Answer: A. Gastroenteritis",
            "Step 1: Identify the virus \u2013 The pediatrician suspects a bladder infection caused by a double\u2010stranded DNA virus. In children, adenovirus is a common double\u2010stranded DNA virus associated with hemorrhagic cystitis (bladder infection).\n\nStep 2: Recall associations with adenovirus \u2013 Adenovirus is well known to cause not only respiratory illnesses and conjunctivitis but also gastroenteritis in children, which is characterized by diarrhea. \n\nStep 3: Evaluate other options \u2013\n\u2022 Painful dermatomal vesicles (Option B) are associated with herpes zoster reactivation, not adenovirus.\n\u2022 Lymphadenopathy (Option C) is commonly linked to EBV (infectious mononucleosis), another double\u2010stranded DNA virus, but not with hemorrhagic cystitis.\n\u2022 Vesicular rash (Option D) also points toward herpes viruses but is not typically seen with adenovirus infections.\n\nFinal Answer: A. Gastroenteritis",
            "Step 1: Identify the pathogen.  \nThe pediatrician suspects a viral cause of hemorrhagic cystitis. In children, adenovirus\u2014a nonenveloped, double-stranded DNA virus\u2014is known to cause hemorrhagic cystitis.\n\nStep 2: Recall adenovirus-associated symptoms.  \nIn addition to urinary tract involvement, adenovirus is also classically associated with respiratory illnesses (pharyngoconjunctival fever) and gastroenteritis in children.\n\nStep 3: Evaluate the answer choices.  \nA. Gastroenteritis \u2013 This is a common manifestation of adenovirus infection in children.  \nB. Painful dermatomal vesicles \u2013 These are typical of herpes zoster (a dsDNA virus), not adenovirus.  \nC. Lymphadenopathy \u2013 While it can be present in many infections, it is not a hallmark of adenoviral infections.  \nD. Vesicular rash \u2013 This is more consistent with varicella (chickenpox) or herpes zoster, rather than adenovirus.\n\nStep 4: Choose the best answer.  \nSince adenovirus is the implicated virus and it is also known to cause gastroenteritis, the best answer is: Gastroenteritis.\n\nFinal answer: A. Gastroenteritis"
        ],
        "ensemble_raw_responses": [
            "0",
            "0",
            "1"
        ],
        "final_solution": "Step 1: Identify the pathogen.  \nThe pediatrician suspects a viral cause of hemorrhagic cystitis. In children, adenovirus\u2014a nonenveloped, double-stranded DNA virus\u2014is known to cause hemorrhagic cystitis.\n\nStep 2: Recall adenovirus-associated symptoms.  \nIn addition to urinary tract involvement, adenovirus is also classically associated with respiratory illnesses (pharyngoconjunctival fever) and gastroenteritis in children.\n\nStep 3: Evaluate the answer choices.  \nA. Gastroenteritis \u2013 This is a common manifestation of adenovirus infection in children.  \nB. Painful dermatomal vesicles \u2013 These are typical of herpes zoster (a dsDNA virus), not adenovirus.  \nC. Lymphadenopathy \u2013 While it can be present in many infections, it is not a hallmark of adenoviral infections.  \nD. Vesicular rash \u2013 This is more consistent with varicella (chickenpox) or herpes zoster, rather than adenovirus.\n\nStep 4: Choose the best answer.  \nSince adenovirus is the implicated virus and it is also known to cause gastroenteritis, the best answer is: Gastroenteritis.\n\nFinal answer: A. Gastroenteritis"
    },
    {
        "realidx": 803,
        "question": "A 75-year-old woman presents to the emergency department with 30 minutes of slurred speech and arm weakness. On the drive over to the hospital, her symptoms have resolved completely. The patient has a past medical history of hypertension, atrial fibrillation, diabetes, morbid obesity, gout, and vascular claudication. Her temperature is 99.0\u00b0F (37.2\u00b0C), blood pressure is 184/111 mmHg, pulse is 88/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals cranial nerves II-XII as grossly intact with normal strength and sensation in the patient's upper and lower extremities. The patient's memory is intact and her speech seems normal and fluent. Her gait is stable with no ataxia. An initial head CT demonstrates diffuse atrophy which is consistent with previous head CT scans. Which of the following is the best next step in management?",
        "answer": "CT angiogram",
        "options": {
            "A": "CT angiogram",
            "B": "Echocardiogram",
            "C": "Heparin",
            "D": "MRI"
        },
        "meta_info": "step2&3",
        "answer_idx": "A",
        "metamap_phrases": [
            "75 year old woman presents",
            "emergency department",
            "30 minutes",
            "slurred speech",
            "arm weakness",
            "drive",
            "hospital",
            "symptoms",
            "resolved completely",
            "patient",
            "past medical",
            "atrial fibrillation",
            "diabetes",
            "morbid obesity",
            "gout",
            "vascular claudication",
            "temperature",
            "99",
            "blood pressure",
            "mmHg",
            "pulse",
            "88 min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "Physical exam reveals cranial nerves II XII",
            "intact",
            "normal strength",
            "sensation",
            "patient's upper",
            "lower extremities",
            "patient's memory",
            "intact",
            "speech",
            "normal",
            "fluent",
            "gait",
            "stable",
            "ataxia",
            "initial head CT demonstrates diffuse atrophy",
            "consistent with previous head CT scans",
            "following",
            "best next step",
            "management"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 4929,
            "completion_tokens": 3289
        },
        "time_elapsed": 26.12355351448059,
        "raw_responses": [
            "Step 1: Identify the likely diagnosis. This 75\u2010year\u2010old woman experienced transient neurological deficits (slurred speech and weakness lasting 30 minutes) with complete resolution on arrival. This presentation is most consistent with a transient ischemic attack (TIA).\n\nStep 2: Realize that the initial evaluation of TIA includes a noncontrast CT scan to rule out acute hemorrhage, which in her case showed only nonspecific findings (diffuse atrophy). However, CT is not very sensitive to small areas of ischemia.\n\nStep 3: Understand that further evaluation is required to look for subtle ischemic changes that may not be evident on CT. Diffusion-weighted MRI is especially sensitive for acute ischemic changes and is the preferred next step in the workup of TIA to detect small infarcts.\n\nStep 4: Compare the Options:\n\u2022 CT angiogram \u2013 Useful for assessing vascular anatomy and detecting large vessel occlusions or stenoses, but not the best for identifying subtle parenchymal ischemic changes after a TIA.\n\u2022 Echocardiogram \u2013 Valuable for evaluating cardioembolic sources (especially given her history of atrial fibrillation); however, this is generally performed after confirming any infarct or as part of a broader workup after stabilizing the patient.\n\u2022 Heparin \u2013 Anticoagulation is usually not initiated immediately in TIA without clear evidence of a thrombus or ongoing infarct.\n\u2022 MRI \u2013 Diffusion-weighted MRI is the most sensitive imaging study for detecting small ischemic lesions which might be missed on CT scan.\n\nStep 5: Final Answer:\nThe best next step in management is to obtain an MRI.\n\nFinal Answer: D. MRI",
            "Step 1: Review the case details.\n\u2022 The patient experienced a transient episode (slurred speech and arm weakness lasting 30 minutes) that resolved completely by the time she presented. This is highly suggestive of a transient ischemic attack (TIA).\n\u2022 Her risk factors (hypertension, atrial fibrillation, diabetes, etc.) further support the possibility of a vascular event.\n\u2022 The head CT shows only diffuse atrophy with no acute findings.\n\nStep 2: Evaluate the answer choices:\nA. CT angiogram \u2013 While this test can evaluate the cerebral vasculature, it is not the first step after a TIA when the CT is unremarkable.\nB. Echocardiogram \u2013 Although the patient has atrial fibrillation and may require further cardiac evaluation, the immediate next step is to assess the brain for subtle ischemic changes.\nC. Heparin \u2013 This is not indicated at this stage for a patient with TIA, especially in the context of atrial fibrillation where long-term anticoagulation decisions are made separately.\nD. MRI \u2013 An MRI, particularly with diffusion-weighted imaging, is more sensitive for detecting small or acute ischemic changes that might be missed on CT. It is the best next step in the evaluation of a TIA.\n\nStep 3: Provide the Final Answer.\nThe best next step in management is to obtain an MRI.\n\nFinal answer: D. MRI",
            "Step 1: The patient's transient neurologic deficit with complete resolution is most consistent with a transient ischemic attack (TIA).\n\nStep 2: Since a CT scan can miss small areas of infarct in the acute setting, further evaluation with a more sensitive imaging modality is warranted. Although options such as CT angiogram and echocardiogram play important roles in evaluating other aspects (vascular anatomy and cardiac sources of emboli), in the context of a suspected TIA with a non-diagnostic CT, the next step in management is to obtain an MRI, which is more sensitive, especially using diffusion-weighted imaging (DWI).\n\nStep 3: The best answer is D. MRI."
        ],
        "ensemble_raw_responses": [
            "0",
            "2",
            "1"
        ],
        "final_solution": "Step 1: Identify the likely diagnosis. This 75\u2010year\u2010old woman experienced transient neurological deficits (slurred speech and weakness lasting 30 minutes) with complete resolution on arrival. This presentation is most consistent with a transient ischemic attack (TIA).\n\nStep 2: Realize that the initial evaluation of TIA includes a noncontrast CT scan to rule out acute hemorrhage, which in her case showed only nonspecific findings (diffuse atrophy). However, CT is not very sensitive to small areas of ischemia.\n\nStep 3: Understand that further evaluation is required to look for subtle ischemic changes that may not be evident on CT. Diffusion-weighted MRI is especially sensitive for acute ischemic changes and is the preferred next step in the workup of TIA to detect small infarcts.\n\nStep 4: Compare the Options:\n\u2022 CT angiogram \u2013 Useful for assessing vascular anatomy and detecting large vessel occlusions or stenoses, but not the best for identifying subtle parenchymal ischemic changes after a TIA.\n\u2022 Echocardiogram \u2013 Valuable for evaluating cardioembolic sources (especially given her history of atrial fibrillation); however, this is generally performed after confirming any infarct or as part of a broader workup after stabilizing the patient.\n\u2022 Heparin \u2013 Anticoagulation is usually not initiated immediately in TIA without clear evidence of a thrombus or ongoing infarct.\n\u2022 MRI \u2013 Diffusion-weighted MRI is the most sensitive imaging study for detecting small ischemic lesions which might be missed on CT scan.\n\nStep 5: Final Answer:\nThe best next step in management is to obtain an MRI.\n\nFinal Answer: D. MRI"
    },
    {
        "realidx": 822,
        "question": "A 27-year-old man presents to the emergency department due to a change in his skin color. The patient went on a long hike this morning, and his girlfriend noticed that his skin had changed color when they were driving home. The patient has a past medical history of marijuana use, IV drug use, alcohol use, and asthma. His current medications include albuterol, fluticasone, and ibuprofen. His temperature is 97.5\u00b0F (36.4\u00b0C), blood pressure is 120/75 mmHg, pulse is 60/min, respirations are 10/min, and oxygen saturation is 98% on room air. Laboratory studies are ordered and are seen below.\n\nHemoglobin: 10 g/dL\nHematocrit: 32%\nLeukocyte count: 5,500 cells/mm^3 with normal differential\nPlatelet count: 207,000/mm^3\n\nSerum:\nNa+: 139 mEq/L\nCl-: 99 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 24 mEq/L\nBUN: 17 mg/dL\nGlucose: 89 mg/dL\nCreatinine: 1.0 mg/dL\nCa2+: 10.1 mg/dL\nBilirubin, total: 11.3 mg/dL\nBilirubin, direct: 7.8 mg/dL\n\nPhysical exam is notable for a patient with skin that appears yellow/orange. Cardiac, pulmonary, abdominal, and neurological exams are within normal limits. Which of the following is associated with this patient's underlying pathology?",
        "answer": "Hyperpigmentation of the liver",
        "options": {
            "A": "A pathology responsive to sofosbuvir",
            "B": "Decreased UDP-glucuronyl transferase activity",
            "C": "Hyperpigmentation of the liver",
            "D": "Increased consumption of beta-carotene"
        },
        "meta_info": "step2&3",
        "answer_idx": "C",
        "metamap_phrases": [
            "27 year old man presents",
            "emergency department due",
            "change in",
            "skin color",
            "patient",
            "long",
            "morning",
            "girlfriend",
            "skin",
            "changed color",
            "driving home",
            "patient",
            "past medical history of marijuana use",
            "IV drug use",
            "alcohol use",
            "asthma",
            "current medications include albuterol",
            "fluticasone",
            "ibuprofen",
            "temperature",
            "97",
            "36 4C",
            "blood pressure",
            "75 mmHg",
            "pulse",
            "60 min",
            "respirations",
            "10/min",
            "oxygen saturation",
            "98",
            "room air",
            "Laboratory studies",
            "ordered",
            "seen",
            "Hemoglobin",
            "10 g/dL Hematocrit",
            "Leukocyte count",
            "5 500 cells mm",
            "normal differential Platelet count",
            "mm",
            "Serum",
            "Na",
            "mEq/L Cl",
            "99 mEq/L K",
            "4",
            "mEq/L HCO3",
            "mEq/L",
            "mg/dL Glucose",
            "mg/dL Creatinine",
            "1 0 mg/dL Ca2",
            "10",
            "mg/dL Bilirubin",
            "total",
            "mg/dL Bilirubin",
            "direct",
            "mg/dL",
            "Physical exam",
            "notable",
            "patient",
            "skin",
            "appears yellow orange",
            "Cardiac",
            "pulmonary",
            "abdominal",
            "neurological exams",
            "normal limits",
            "following",
            "associated with",
            "patient's",
            "pathology"
        ],
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 7485,
            "completion_tokens": 8935
        },
        "time_elapsed": 62.16362476348877,
        "raw_responses": [
            "Step 1: Summarize the clinical picture.\n\u2022 A 27\u2010year\u2010old man presents with a change in skin color (\u201cyellow/orange\u201d skin) after a long hike.\n\u2022 His history includes IV drug use, which raises concern for hepatitis C.\n\u2022 Vital signs are stable.\n\u2022 Laboratory values reveal anemia (hemoglobin 10 g/dL) and significant hyperbilirubinemia with a total bilirubin of 11.3 mg/dL and a direct (conjugated) bilirubin of 7.8 mg/dL, suggesting cholestasis or hepatocellular dysfunction.\n\nStep 2: Analyze the options.\nA. A pathology responsive to sofosbuvir.\n\u2003\u2013 Sofosbuvir is an antiviral used in the treatment of hepatitis C.\n\u2003\u2013 The patient\u2019s IV drug use history makes hepatitis C a likely possibility, and advanced liver disease (cirrhosis) can cause elevated conjugated bilirubin.\nB. Decreased UDP-glucuronyl transferase activity.\n\u2003\u2013 This is seen in conditions like Gilbert syndrome, which causes unconjugated hyperbilirubinemia (mild jaundice) rather than the conjugated hyperbilirubinemia seen here.\nC. Hyperpigmentation of the liver.\n\u2003\u2013 This finding is associated with Dubin\u2013Johnson syndrome. Although Dubin-Johnson can cause conjugated hyperbilirubinemia, the typical gross pathology is a dark (black) liver rather than an association with \u201corange\u201d skin.\nD. Increased consumption of beta\u2010carotene.\n\u2003\u2013 Excess beta-carotene intake leads to carotenemia (yellow/orange discoloration of the skin) but does not affect bilirubin levels. In carotenemia, bilirubin lab values would be normal.\n\nStep 3: Compare and eliminate incorrect choices.\n\u2022 Option B is incorrect because Gilbert syndrome involves unconjugated bilirubin and typically presents with mild jaundice.\n\u2022 Option C is not supported because while Dubin\u2013Johnson syndrome involves conjugated hyperbilirubinemia, its liver pathology (black liver) and clinical context do not fit well with this patient\u2019s presentation.\n\u2022 Option D is unlikely because carotenemia would cause orange skin without the abnormal bilirubin levels seen here.\n\nStep 4: Final Answer.\nGiven the patient\u2019s elevated conjugated bilirubin and his risk factors (including IV drug use), hepatitis C is a likely underlying pathology. Hepatitis C is treated with antivirals such as sofosbuvir.\n\nFinal answer: A. A pathology responsive to sofosbuvir.",
            "Step 1: Analyze the patient\u2019s presentation and lab values.\n\u2022 The patient is a 27\u2010year\u2010old man with a change in skin color described as yellow/orange.\n\u2022 Lab values show a total bilirubin of 11.3 mg/dL and a direct (conjugated) bilirubin of 7.8 mg/dL, indicating predominantly conjugated hyperbilirubinemia.\n\u2022 His other vitals and examinations are normal.\n\nStep 2: Correlate lab findings with possible liver pathologies.\n\u2022 Decreased UDP-glucuronyl transferase (Option B) is seen in Gilbert syndrome, which results in unconjugated hyperbilirubinemia (and usually has only mild bilirubin elevations), not the conjugated hyperbilirubinemia seen here.\n\u2022 Increased beta-carotene consumption (Option D) causes carotenemia, which gives a yellow/orange discoloration of the skin but does not affect bilirubin levels.\n\u2022 Hepatitis C (Option A) is treated with sofosbuvir; however, while the patient has risk factors, the laboratory findings described are not typical of acute viral hepatitis, and there is no mention of other liver function abnormalities or symptoms of hepatitis.\n\u2022 Dubin-Johnson syndrome (reflected in Option C) is a benign disorder characterized by conjugated hyperbilirubinemia and is associated with the deposition of dark pigment in the liver (i.e., hyperpigmentation of the liver). This syndrome explains the lab findings (elevated direct bilirubin) and the skin discoloration seen in this patient.\n\nStep 3: Final Answer\nBased on the reasoning, the most appropriate association with the patient\u2019s underlying pathology is:\nC. Hyperpigmentation of the liver",
            "Step 1: Evaluate the patient\u2019s presentation and labs.\n\u2022 The patient is a 27\u2010year\u2010old man who was noted to have a change in skin color (\u201cyellow/orange\u201d) after a hike.\n\u2022 His labs show an elevated total bilirubin (11.3 mg/dL) with a predominance of direct (conjugated) bilirubin (7.8 mg/dL).\n\u2022 Other laboratory values are largely normal, and exam is unremarkable aside from the skin discoloration.\n\nStep 2: Consider potential diagnoses.\n\u2022 Hepatitis C is a consideration in someone with IV drug use and is treated with sofosbuvir. However, hepatitis C typically results in elevations of liver enzymes (ALT, AST) and a mixed picture that isn\u2019t classically limited to a conjugated hyperbilirubinemia.\n\u2022 Decreased UDP\u2010glucuronyl transferase activity (as seen in Gilbert\u2019s syndrome or Crigler-Najjar syndrome) causes unconjugated hyperbilirubinemia\u2014not what is seen here.\n\u2022 Increased ingestion of beta\u2010carotene leads to carotenemia, which causes yellow/orange skin discoloration. However, carotenemia does not alter bilirubin levels.\n\u2022 Dubin\u2013Johnson syndrome is an autosomal recessive disorder characterized by impaired hepatocanalicular excretion of conjugated bilirubin. Patients present with a conjugated hyperbilirubinemia and typically have a grossly pigmented (black) liver on pathology.\n\nStep 3: Apply the information.\n\u2022 The lab results (especially elevated conjugated bilirubin) are most consistent with cholestatic or transport-related issues.\n\u2022 Dubin\u2013Johnson syndrome would explain the conjugated hyperbilirubinemia and is classically associated with a hyperpigmented liver.\n\u2022 Although the patient\u2019s history of IV drug use might raise suspicion for hepatitis C, the laboratory pattern here (without mention of transaminase abnormalities) fits better with Dubin\u2013Johnson syndrome.\n\u2022 Also, the choice \u201cHyperpigmentation of the liver\u201d is a specific association with Dubin\u2013Johnson syndrome.\n\nFinal answer: C. Hyperpigmentation of the liver"
        ],
        "ensemble_raw_responses": [
            "0",
            "1",
            "2"
        ],
        "final_solution": "Step 1: Evaluate the patient\u2019s presentation and labs.\n\u2022 The patient is a 27\u2010year\u2010old man who was noted to have a change in skin color (\u201cyellow/orange\u201d) after a hike.\n\u2022 His labs show an elevated total bilirubin (11.3 mg/dL) with a predominance of direct (conjugated) bilirubin (7.8 mg/dL).\n\u2022 Other laboratory values are largely normal, and exam is unremarkable aside from the skin discoloration.\n\nStep 2: Consider potential diagnoses.\n\u2022 Hepatitis C is a consideration in someone with IV drug use and is treated with sofosbuvir. However, hepatitis C typically results in elevations of liver enzymes (ALT, AST) and a mixed picture that isn\u2019t classically limited to a conjugated hyperbilirubinemia.\n\u2022 Decreased UDP\u2010glucuronyl transferase activity (as seen in Gilbert\u2019s syndrome or Crigler-Najjar syndrome) causes unconjugated hyperbilirubinemia\u2014not what is seen here.\n\u2022 Increased ingestion of beta\u2010carotene leads to carotenemia, which causes yellow/orange skin discoloration. However, carotenemia does not alter bilirubin levels.\n\u2022 Dubin\u2013Johnson syndrome is an autosomal recessive disorder characterized by impaired hepatocanalicular excretion of conjugated bilirubin. Patients present with a conjugated hyperbilirubinemia and typically have a grossly pigmented (black) liver on pathology.\n\nStep 3: Apply the information.\n\u2022 The lab results (especially elevated conjugated bilirubin) are most consistent with cholestatic or transport-related issues.\n\u2022 Dubin\u2013Johnson syndrome would explain the conjugated hyperbilirubinemia and is classically associated with a hyperpigmented liver.\n\u2022 Although the patient\u2019s history of IV drug use might raise suspicion for hepatitis C, the laboratory pattern here (without mention of transaminase abnormalities) fits better with Dubin\u2013Johnson syndrome.\n\u2022 Also, the choice \u201cHyperpigmentation of the liver\u201d is a specific association with Dubin\u2013Johnson syndrome.\n\nFinal answer: C. Hyperpigmentation of the liver"
    },
    {
        "realidx": 829,
        "question": "A 66-year-old man presents to the emergency department for a cough and fatigue. The patient was brought in from a nursing home with documentation stating that he has seemed confused for the past day according to the staff. The patient has a past medical history of diabetes and hypertension. He is currently taking insulin, metformin, lisinopril, and atorvastatin. His temperature is 102\u00b0F (38.9\u00b0C), blood pressure is 107/58 mmHg, pulse is 120/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam reveals crackles on pulmonary exam and S4 on cardiac auscultation. Which of the following is the next best step in management?",
        "answer": "Moxifloxacin and admission to the medical floor",
        "options": {
            "A": "Azithromycin and admission to the medical floor",
            "B": "Azithromycin and discharge",
            "C": "Azithromycin, moxifloxacin, and admission to the intensive care unit",
            "D": "Moxifloxacin and admission to the medical floor"
        },
        "meta_info": "step2&3",
        "answer_idx": "D",
        "metamap_phrases": [
            "66 year old man presents",
            "emergency department",
            "cough",
            "fatigue",
            "patient",
            "brought",
            "nursing",
            "documentation stating",
            "confused",
            "past day",
            "staff",
            "patient",
            "past medical diabetes",
            "hypertension",
            "currently taking insulin",
            "metformin",
            "lisinopril",
            "atorvastatin",
            "temperature",
            "blood pressure",
            "58 mmHg",
            "pulse",
            "min",
            "respirations",
            "min",
            "oxygen saturation",
            "98",
            "room air",
            "Physical exam reveals crackles",
            "pulmonary exam",
            "S4",
            "cardiac auscultation",
            "following",
            "next best step",
            "management"
        ],
        "predicted_answer": "D",
        "token_usage": {
            "prompt_tokens": 6255,
            "completion_tokens": 11255
        },
        "time_elapsed": 71.51957726478577,
        "raw_responses": [
            "Step 1: Analyze the Patient\u2019s Presentation\n\u2022 Age and Setting: A 66\u2010year\u2010old man from a nursing home is at increased risk for pneumonia due to close living quarters and underlying comorbidities.\n\u2022 Symptoms: Cough, fatigue, and confusion suggest an infectious process. In elderly patients, confusion is often a presenting sign of pneumonia.\n\u2022 Vital Signs: Fever (102\u00b0F), tachycardia (pulse 120/min), and borderline low blood pressure (107/58 mmHg) indicate a systemic infection.\n\u2022 Physical Exam: Pulmonary crackles support a diagnosis of pneumonia. The presence of an S4 on cardiac exam suggests underlying cardiac issues but does not change the immediate need for pneumonia management.\n\nStep 2: Determine the Appropriate Level of Care\n\u2022 The patient\u2019s overall presentation (confusion, vital sign abnormalities) suggests that he should be admitted for treatment rather than managed as an outpatient.\n\u2022 His oxygen saturation is normal, and his respiratory rate is not severely increased (15/min), so ICU-level care is not immediately indicated. Admission to the medical floor is appropriate.\n\nStep 3: Choose the Appropriate Antibiotic Regimen\n\u2022 In hospitalized patients with community-acquired pneumonia who do not require intensive care unit (ICU) care, current guidelines recommend either:\n\u2003\u2003\u2013 Combination therapy with a beta-lactam (such as ceftriaxone) plus a macrolide (such as azithromycin)\n\u2003\u2003\u2013 Monotherapy with a respiratory fluoroquinolone (such as moxifloxacin)\n\u2022 Among the answer choices, Option A (Azithromycin and admission to the medical floor) suggests initiating treatment with azithromycin and managing him on the floor. While a beta-lactam isn\u2019t mentioned, azithromycin is often used as part of combination therapy for typical and atypical pathogens in CAP.\n\u2022 Option D (Moxifloxacin and admission to the medical floor) represents monotherapy with a respiratory fluoroquinolone, which is also acceptable in CAP. However, given this patient\u2019s overall presentation and risk factors (elderly, nursing home resident, confusion), azithromycin-based therapy is a safe and standard choice.\n\u2022 Options B and C can be ruled out because outpatient management (B) isn\u2019t appropriate for someone with altered mental status, and ICU admission with overly aggressive combination therapy (C) is not warranted given his stable oxygenation and respiratory rate.\n\nStep 4: Final Decision\nConsidering the patient\u2019s presentation, risk factors, and standard treatment guidelines for CAP in hospitalized patients (non-ICU), the next best step is to admit the patient to the medical floor and initiate azithromycin therapy.\n\nFinal Answer: A. Azithromycin and admission to the medical floor",
            "Step 1: Identify the clinical diagnosis.\n\u2022 The 66\u2010year-old man from the nursing home presents with cough, fever, tachycardia, and confusion. His exam reveals pulmonary crackles, suggesting pneumonia. In an older patient from a nursing facility with confusion, a diagnosis of pneumonia (likely healthcare\u2010associated pneumonia) is highly suspected.\n\nStep 2: Decide on treatment setting.\n\u2022 Since the patient is older, confused, and exhibits systemic signs (fever, tachycardia), he meets criteria (e.g., CURB-65) that suggest the need for hospitalization rather than outpatient management.\n\nStep 3: Evaluate antibiotic options.\n\u2022 For inpatient management of community-acquired pneumonia, typical regimens include a combination of a beta-lactam (e.g., ceftriaxone) plus a macrolide (e.g., azithromycin) or monotherapy with a respiratory fluoroquinolone (e.g., moxifloxacin).\n\u2022 The options given are:\n\u2003A. Azithromycin and admission to the medical floor \u2013 this implies starting empiric therapy appropriate for a non-ICU hospitalized patient.\n\u2003B. Azithromycin and discharge \u2013 discharging is inappropriate given the patient's age, confusion, and severity.\n\u2003C. Azithromycin, moxifloxacin, and ICU admission \u2013 ICU-level care and dual therapy with two antibiotics is reserved for patients with severe illness, which this patient does not clearly demonstrate.\n\u2003D. Moxifloxacin and admission to the medical floor \u2013 while a respiratory fluoroquinolone is acceptable, the provided option A is more aligned with the treatment strategy indicated by our examples.\n\nStep 4: Final answer determination.\n\u2022 Option A (Azithromycin and admission to the medical floor) is the most appropriate next step, given that it ensures proper inpatient management of pneumonia with appropriate antibiotic coverage for the likely pathogens.\n\nFinal Answer: A. Azithromycin and admission to the medical floor.",
            "Step 1 \u2013 Identify the patient\u2019s pneumonia severity and risk factors:\n\u2022 The patient is an elderly (66-year-old) nursing home resident with comorbidities (diabetes and hypertension) and shows signs of confusion.\n\u2022 His vital signs include a high fever (102\u00b0F) and tachycardia (120/min), and his exam shows crackles on pulmonary exam.\n\u2022 Using a scoring system like CURB-65, he scores points for age (\u226565) and confusion. This supports the need for hospitalization.\n\nStep 2 \u2013 Determine inpatient management and appropriate antibiotic regimen:\n\u2022 In hospitalized patients with community-acquired pneumonia (CAP) and comorbidities, guidelines recommend either combination therapy (a beta\u2010lactam plus a macrolide) or monotherapy with a respiratory fluoroquinolone.\n\u2022 While an outpatient without comorbidities might be treated with a macrolide like azithromycin alone, this patient\u2019s risk factors and presentation warrant inpatient therapy.\n\u2022 Among the options, \u201cAzithromycin and discharge\u201d is inappropriate because he requires admission.\n\u2022 \u201cAzithromycin plus ICU admission\u201d is overly aggressive since his oxygenation and hemodynamic parameters do not indicate ICU-level care.\n\u2022 \u201cAzithromycin alone\u201d would be appropriate only for low-risk outpatient management.\n\u2022 \u201cMoxifloxacin and admission to the medical floor\u201d represents an appropriate inpatient monotherapy option for CAP in a patient with comorbidities.\n\nStep 3 \u2013 Final answer:\nD. Moxifloxacin and admission to the medical floor"
        ],
        "ensemble_raw_responses": [
            "1",
            "0",
            "0"
        ],
        "final_solution": "Step 1 \u2013 Identify the patient\u2019s pneumonia severity and risk factors:\n\u2022 The patient is an elderly (66-year-old) nursing home resident with comorbidities (diabetes and hypertension) and shows signs of confusion.\n\u2022 His vital signs include a high fever (102\u00b0F) and tachycardia (120/min), and his exam shows crackles on pulmonary exam.\n\u2022 Using a scoring system like CURB-65, he scores points for age (\u226565) and confusion. This supports the need for hospitalization.\n\nStep 2 \u2013 Determine inpatient management and appropriate antibiotic regimen:\n\u2022 In hospitalized patients with community-acquired pneumonia (CAP) and comorbidities, guidelines recommend either combination therapy (a beta\u2010lactam plus a macrolide) or monotherapy with a respiratory fluoroquinolone.\n\u2022 While an outpatient without comorbidities might be treated with a macrolide like azithromycin alone, this patient\u2019s risk factors and presentation warrant inpatient therapy.\n\u2022 Among the options, \u201cAzithromycin and discharge\u201d is inappropriate because he requires admission.\n\u2022 \u201cAzithromycin plus ICU admission\u201d is overly aggressive since his oxygenation and hemodynamic parameters do not indicate ICU-level care.\n\u2022 \u201cAzithromycin alone\u201d would be appropriate only for low-risk outpatient management.\n\u2022 \u201cMoxifloxacin and admission to the medical floor\u201d represents an appropriate inpatient monotherapy option for CAP in a patient with comorbidities.\n\nStep 3 \u2013 Final answer:\nD. Moxifloxacin and admission to the medical floor"
    }
]